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Abstract
Abstract
Tuberculosis kills an estimated 2 million people each year. The causative organism, 
Mycobacterium tuberculosis, has evolved the ability to survive within human 
macrophages and avoid the destructive action of the host immune response. 
Understanding the molecular mechanisms of intracellular survival will uncover new 
targets for effective drug and vaccine design. High-throughput screening of 
M. tuberculosis transposon mutants selected during macrophage infection was used to 
identify mutants which were unable to inhibit phagosome-lysosome fusion. One of the 
mutants carried an insertion in a gene, Rv2745c, encoding a putative transcriptional 
regulator. Targeted gene knock-out of Rv2745c and two other putative regulators 
(Rv3058c and Rv2548) was successfully achieved in an M  tuberculosis H37Rv 
background. These mutant strains were complemented by réintroduction of the wild-type 
gene and each strain was characterised for in vitro growth and growth in J774 
macrophages. All the mutants had reduced survival following heat shock. Only 
ARv2745c showed any evidence of attenuation for intracellular growth.
Microarray analysis was performed to generate transcriptional profiles of each mutant 
strain grown in culture compared with the wild-type H37Rv strain. Gene expression 
differences in the ARv3058c strain appeared to be associated with differences in growth 
phase of the mutant and wild-type strain. No direct regulon for Rv3058c could be 
identified from the transcriptional profile o f the mutant. Thirty eight gene transcripts 
were significantly more abundant and none less abundant in the ARv2548 strain. This is 
consistent with Rv2548 functioning as the Ribonuclease component of a toxin-antitoxin 
system.
Transcriptional profiling of the ARv2745c mutant demonstrated that 31 genes were up- 
regulated compared to the wild-fype and 9 genes were down-regulated. Bioinformatic 
analysis revealed Rv2745c to be similar to the transcriptional activator ClgR from the 
related bacterial species Streptomyces and Corynebacterium. The putative binding site of 
ClgR is CGC-N5-GCG shown to be involved in cell cycle and growth regulation in 
Streptomyces. A bioinformatic analysis o f those genes down-regulated in the ARv2745c 
mutant revealed the following genes to have ClgR-like binding motifs: acr2, Rv1043c,
XVI
Abstract
ptrB, clpP and clpC. Expression changes of these genes in the mutant were confirmed 
using quantitative real-time PCR (QRTPCR).
Recombinant GST-Rv2745c (ClgR) was expressed and purified in Escherichia coli. 
Electrophoretic mobility shift assays demonstrated recombinant GST-Rv2745c to bind 
ClgR-like promoter regions o fptrB and acr2 genes. Together, this project demonstrates 
that M. tuberculosis controls expression of stress induced chaperones Acr2, ClpC and 
proteases ClpP, Rvl043c and PtrB using a transcriptional activator, Rv2745c (ClgR). 
These chaperones and proteases are likely to be important in regulation of the protein 
content of the cell and this study provides preliminary evidence that correct coordination 
of this fimction is required for the survival within the macrophage.
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Chapter 1. Introduction
Studies on Mycobacterium tuberculosis transcriptional 
regulators involved in intraceiluiar infection 
1 Introduction
In 1882, Robert Koch published conclusive findings that Mycobacterium tuberculosis was 
the causative organism of human tuberculosis (TB), a highly infectious disease (Koch 1882) 
and still a major health concern today killing more people than any other single infectious 
disease (Harries & Dye 2006). This pathogenic organism is a member of the 
M. tuberculosis-comyliQx which comprises Mycobacterium tuberculosis, Mycobacterium 
africanum, Mycobacterium canettii, Mycobacterium microti and Mycobacterium bovis. All 
of which belong to the group of Gram-positive bacteria called the Actinomycetes, which also 
includes Nocardia, Actinomyces and Streptomyces (Madigan & Martinko 2005).
The characteristic feature of the mycobacteria is a hydrophobic cell envelope or wall which 
is impermeable to the Gram-stain although they are still technically classified as Gram- 
positive bacteria. Structurally, the cell wall is comprised of a thick outer layer, composed of 
lipids and mycohc acids covalently bound to arabinogalactan-peptidoglycan co-polymer, and 
a thinner inner membrane (Brennan & Nikaido 1995). The peptidoglycan-containing wall of 
M. tuberculosis is particularly rigid due to the arrangement of complex lipidoglycans 
enabling the bacillus to resist desiccation in harsh environments and providing a pre­
adaptation to the stresses of a pathogenic existence (Russell 2001).
M. tuberculosis is an intracellular pathogen and the key to its success is an ability to live 
within the host immune cell, the macrophage. Understanding how the bacterium achieves 
this has been an aim of microbiologists for decades but sequencing of the mycobacterial 
genome in 1998 (Cole et al. 1998) revolutionised the approach to this research. The 
resulting identification of virulence genes and their products and elucidation of their function 
is leading to a steady increase in knowledge of the pathogenesis of M. tuberculosis. The 
work in this thesis forms a small part of this effort to translate genetic sequence into an 
understanding of the biology of this pathogen. Ultimately, it is hoped that these advances 
will lead to the development of new control strategies for tuberculosis.
1
Chapter 1. Introduction
1.1 The worldwide problem of tuberculosis
Evidence of TB infection m human populations dates back to 4000 B.C (Bloom & Murray 
1992). According to the World Health Organisation (WHO) there are approximately 8 
million new cases of TB each year, 2 million deaths attributable to TB and one third of the 
worlds population is infected with the causative organism (Centers for Disease Control and 
Prevention 2006). In recent decades TB has been a growing concern amongst health 
officials owing to a combination of factors contributing to an increase in incidence rates 
(World Health Organisation 2005). Co-infection with HIV is one such factor that increases 
the probability of developing active TB fi*om 10% over a lifetime to 10% in a year. The 
significance of this is best illustrated in Africa where the highest incidence of HIV infection 
occurs in Kenya and Zimbabwe which also rank among the top TB-endemic countries 
(World Health Organisation 2008a). The world-wide spread of multi-drug resistant (MDR) 
and more recently extensively drug resistant (XDR) strains of M. tuberculosis has also 
impacted on the incidence of TB (Fattorini, Migliori, & Cassone 2007). Based on data 
collected between 2002 and 2006, the WHO reported the highest rates of MDR TB 
accounting for approximately 5% of new cases (World Health Organisation 2008b). A 
major hindrance to TB control is the requirement for lengthy courses of chemotherapy, 
which patients often fail to complete. With the control of TB requiring greater attention TB 
treatment programs are counteractively declining and therefore fiirther exacerbating the 
problem. Some research suggests that the initial benefits of the BCG vaccine have waned 
since its introduction (Behr & Small 1997). Continuous culturing of organisms can result in 
the loss of virulence and this process may occur during the continual reproduction of the 
vaccine thereby reducing the efficacy of the vaccine. Studies have shown that it fails to 
provide universal protection across age groups (Fine 2001) and ethnic populations (Black et 
al. 2002). Without the introduction of a more efficacious vaccine disease prevention is 
limited.
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1.2 Transmission, infection & disease
TB can manifest in a variety of forms as the bacilli can cause disease in all tissue and cell 
types of the human host (Kusner 2004). Commonly, TB is of the pulmonary form and 
follows a primary infection route by inhalation of tubercle through airborne droplet nuclei, 
released by coughing and sneezing, (Balasubramanian et al. 1994). The tough resistant cell 
wall of M. tuberculosis aids the organisms’ survival outside the host during unfavourable 
environmental conditions (Zahrt 2003). Although less effective, transmission of 
sedimentary organisms associated with dust particles in the environment can also occur 
(Bloom & Murray 1992).
Once bacilli enter the airway, they implant on the lung surface where they are ingested by 
alveolar macrophages which migrate into the lung parenchyma. Here they attract 
neutrophils, further macrophages and eventually T cells which aggregate to form the primary 
lesion. The bacilli also infect dendritic cells, which traffic bacteria to lymph nodes 
disseminating bacteria around the body (Lipscomb & Masten 2002). The primary lesion can 
develop within any area of the lung, differing from single cavitary lesions, proposed to be 
confined to the apical region of the lung (Balasubramanian et al. 1994). The combination of 
a primary lesion and the subsequent spread to hilar lymph nodes with granuloma formation 
is known as a Ghon complex (focus) (Gomez & McKinney 2004). Development of 
pathology of the primary lesion can be broken down over four stages. Stage one is 
characterised by the infiltration of neutrophils to the site of infected macrophages. Stage two 
involves bacillary multiphcation within the macrophage followed by host cell death and the 
subsequent recruitment of monocytes to the site of infection. Stage three is characterised by 
the formation of the granuloma in the lung parenchyma. This is a cell-mediated immune 
(CMI) response (see section 1.5) which functions to limit the progress of infection by 
containing bacilli within the granuloma formed of infected macrophages and foamy giant 
cells walled by lymphocytes (Figure 1.1). It is when this containment breaks down that a 
diseased state ensues. The fourth and final stage of TB pathology is marked by caseous 
necrosis. Caseation releases infectious bacteria into the airway, where there is extracellular 
multiplication of bacilli and the host is able to transmit infection via a productive cough.
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Figure 1.1: Pathology of cavitation
Primary infection of macrophages and foamy giant cells with TB bacilli elicits a T cell-mediated immune 
response. A non caseating lesion can develop into a caseating lesion with a necrotic core. The break-down of 
containment results in cavitation of the lesion of foci present in the bronchia leading to the release o f infectious 
bacilli into the airway.
M tuberculosis is able to spread to a variety of tissues and organs of the body including 
lymph nodes, kidneys, bones, joints, skin, the abdomen and the central nervous system. 
There area variety of pathophysiological lesions that form and these can fall into various 
descriptive groups. Primary pulmonary TB includes the localised Ghon complex and the 
severe disseminated form of the disease is known as miliary tuberculosis (Grange 1996). 
Miliary disease is so called due to the pattern of multiple lesions being of similar size to 
millet seeds (1-3 mm) and occurs in immunocompromised individuals when multiple bacilli 
gain entry to the pulmonary or systemic veins (Vijayan 2007). Typically miliary TB is 
associated with an adult form of disease and looks different to childhood forms. The classic 
Ghon Complex is associated with childhood forms of disease and is persistent and
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asymptomatic. Post-primary pulmonary TB either occurs via direct progression of the 
primary lesion, reactivation of a dormant lesion, haematogenous spread to lungs or 
exogenous superinfection. Where secondary TB is due to reactivation of disease it is often 
because the host has become immunosuppressed and therefore impairing host resistance. 
The symptoms of active TB disease in the human host include fatigue, weight loss, fever and 
a productive cough (Zahrt 2003).
1.3 Active disease versus latent infection
The pathology of tuberculosis infection can follow one of two paths; initial exposure to the 
organism can cause illness within 1 to 2 years, (defined as primary TB) (Stewart, Robertson, 
& Young 2003) or bacilli can remain dormant in the very immune cells whose purpose is to 
kill such infectious organisms only to cause active disease at a later date. The occurrence of 
active disease from a source of dormant bacilli describes latent disease and is also referred to 
as endogenous reactivation (Balasubramanian et al. 1994;de Boer et al. 2003;Lambert et al. 
2003). The period prior to reactivation of infection is termed persistent infection and is an 
asymptomatic disease state. Host defences to TB infection result in active disease in less 
than 10% of infected individuals. Ordinarily, only those individuals with a lowered immune 
response will subsequently develop disease from primary infection (Sonnenberg et al. 2001). 
Evidence of latent chronic infection has been provided by molecular sub-typing using RFLP 
analysis to characterise strains of M. tuberculosis. In one study (Lillebaek et al. 2002), 
M. tuberculosis isolates taken from a father in 1961 and his son suffering from active TB in 
1994 exhibited identical RFLP patterns. Such molecular evidence supports the theory that 
M. tuberculosis can remain dormant at length and reactivation can occur even after 33 years 
of latent infection. It has been hypothesised that within the granuloma the reduced 
availability of oxygen triggers dormancy in contained bacilli resulting in latent infection 
(Wayne & Lin 1982).
HIV afflicted patients have an increased risk of active TB when previously exposed to 
M  tuberculosis (Selwyn et al. 1989). Active TB in HIV-infected individuals is more often 
due to the reactivation of dormant tubercle bacilli. It is, however, not understood whether
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bacilli lie in a state of dormancy or if they are actively rephcating at a reduced metabolic rate 
(Bentrup & Russell 2001;Butler 2000). An infected individual may still be infected by a 
second exposure to the organism whereby an active disease state is referred to as exogenous 
re-infection (Balasubramanian et al. 1994). Similarly to HIV infected individuals previously 
exposed to M. tuberculosis being at greater risk for developing active disease, re-infection is 
also significantly more likely to develop into active disease in HIV infected individuals 
(Sonnenberg et al. 2001).
1.4 TB control, prevention and treatment
1.4.1 Drug treatment
A combination of antibiotics is used to treat TB over a 6-8 month regimen. The common 
cocktail includes ethambutol, pyrazinamide, isoniazid and rifampicin for the first two 
months. This is followed by therapy with only isoniazid and rifampicin continued for the 
duration of the treatment course (Zahrt 2003). These antibiotics do not target persistent 
bacteria but are directed at cell growth and division, thus explaining further why infection 
persists under current treatment methods (McKinney 2000;Zhang 2004). The WHO 
implemented the directly observed treatment, short course (DOTS) program to turn around 
the increasing trend of TB incidence (World Health Organisation 1994;World Health 
Organisation 2002). The WHO strategy is to treat all high risk patients with positive skin 
test (see Section 1.4.3) with chemotherapy (World Health Organisation 2006). The aim of 
the DOTS programme is to enforce supervision of all TB patients receiving chemotherapy to 
ensure completion of prophylactic courses. One problem with the WHO strategy is that it 
relies on detecting and treating a sufficient number of TB cases which is not possible in all 
countries. In addition, this strategy does not target the reservoir of latent infection. Control 
programmes and novel drugs that target both active and latent/persistent infections will be 
needed to more effectively reduce the incidence of TB. The Stop TB strategy was launched 
by the WHO in 2006 and targets the reversal of TB incidence by 2015 by using multiple 
control measures such as expanding the DOTS programme, targeting HIV co-infection and 
MDR TB, strengthening health systems by engaging all care workers, empowering
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individuals and communities through education and promoting research (World Health 
Organisation 2008a).
1.4.2 Vaccination
In the late nineteenth century French scientists Calmette and Guerin created an attenuated 
isolate of M bovis (the causative bacillus of TB in cattle) by repeatedly passaging this strain 
on potato slices. This isolate proved successful as a vaccine for human TB and is the Bacille 
Calmette-Guérin (BCG) vaccine still in use today (Kaufinann 2001). Incidence rates of TB 
declined substantially in the UK by the late 1980s and this is partly attributable to the 
introduction of school-based vaccination programs in the 1950s (Davies 2000;Hart 1967) 
followed by the establishment of programs in the 1960s for the selective immunisation of 
babies bom to immigrants in the UK (BMJ Pubhshing Group Limited 2002). Since the early 
1990s many countries are now reporting an increasing trend of new TB cases (Smith 2003). 
BCG vaccine efficacy in newborns has been shown to not always extend to preventing 
pulmonary TB in adults (Kaufinann 2001). Moreover in many high prevalence countries 
such as sub-Saharan Africa this vaccine provides httle or no protection against tuberculosis. 
The insufficient immune response produced in adults to the BCG vaccine together with 
evidence that BCG protection is waning over time (Behr & Small 1997;Dietrich, Vivet, & 
Hess 2003) highlights the need for the development of a more efficacious vaccine. 
Attenuated strains of M. tuberculosis have been used successfully to prime the immune 
system without causing disease (Kana & Mizrahi 2004) and further development and clinical 
evaluation of such attenuated mutants may look to replace the current BCG vaccine. Other 
novel vaccines including protein subunit vaccines and live viral vectors expressing 
M tuberculosis antigens are also undergoing clinical trials (Kaufinann 2007).
1.4.3 Detection of tuberculosis exposure
The purified protein derivative (PPD) or tuberculin skin test (TST) (Ewer et al. 2003) 
provides antigenic stimulation and a positive reaction translates to either active disease or 
previous exposure to M tuberculosis (Bloom & Murray 1992). However, the value of the
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TST is falling over time since BCG vaccination can give false positive results causing 
complexity in the diagnosis of infection (Huebner, Schein, & Bass 1993). An additional 
drawback of the TST is the requirement of a subsequent visit to estabhsh the test result 
which is often open to interpretation (Taylor & O'Brien 2001).
A more sensitive test based on the detection of antigen specific T cells has been recently 
developed. The enzyme-linked immunospot (ELlSpot) based assay, sold commercially as T- 
SpoT® tb , detects the presence of early secretory antigen target- 6  (ESAT-6 ) specific T 
cells and culture filtrate protein 10 (CFPIO) which are strongly indicative forM tuberculosis 
antigens (Lalvani et al. 2001). A comparative study of the newly developed ELlSpot-based 
assay and the TST was performed in a school subject to a tuberculosis outbreak (Ewer et al. 
2003). Positive TST results were more likely in BCG-vaccinated individuals than in non­
vaccinated subjects whereas the results from ELlSpot testing showed no significant 
correlation with BCG vaccination (Ewer et al. 2003). ELlSpot results related more closely 
with M tuberculosis exposure than TST thereby proving to have better specificity than the 
current diagnostic method for detection of latent infection. Obviously, specificity of new TB 
detection strategies will be a key feature for controlling disease so that the occurrence of 
false positive results due to environmental exposures and/or BCG vaccination are reduced.
An in vitro test with enhanced specificity to T-SPOT®.TB, marketed as QuantiFERON®-TB 
Gold, measures the ex vivo secretion of interferon-y (INF-y) from lymphocytes exposed to 
M. tuberculosis (Rothel & Andersen 2005) and is also described as an INF-y release assay 
(IGRA) (Eisenhut et al. 2009). Unlike the TST, QuantiFERON®-TB Gold is not affected by 
previous exposure to BCG and has not been linked to reversion (a change from a positive to 
a negative result indicating eradication of the bacteria or bacterial dormancy) as seen with T- 
SpoT® tb  (Hill et al. 2007). Although in vitro testing can be costly and difficult to 
implement, the improved detection of latent infection (see Section 1.3) will, if followed by 
treatment, ultimately lead to a decline in active TB cases thereby offsetting initial costs in 
implementing new IFN-y-based tests.
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1.5 Cell-mediated Immune response
Infection with M tuberculosis results in activation of a cell-mediated inunune response 
(CMI) which attempts to contain infection but ultimately causes the destruction of host 
tissues (Balasubramanian, Wiegeshaus, Taylor, & Smith 1994). The bacterium resides 
largely in macrophages. In addition, infected dendritic cells migrate to draining lymph 
nodes and present antigen to T cells which prohferate to generate memory and effector T 
cells.
During an effective host immune response T cells travel to the site of infection and produce 
cytokines which in turn activate macrophages to kill invading bacilli. The cellular immune 
response regulates infection by alerting T cells of the presence of mycobacteria by a process 
of antigen presentation. Infected macrophages or antigen-presenting cells (APC) 
communicate the presence of mycobacteria via molecules on their surface; major 
histocompatibility complex (MHC) in the mouse or human leukocyte antigens (HLA) 
(Russell 2001). MHC molecules of the Class 1 variety present antigenic peptides from the 
cytosol of the host cell whereas Class n  molecules present peptides from the endosomal 
system of the host cell. The mycobacterial containing phagosome lies within the endosomal 
system and therefore it is these Class n  molecules which are so important for signalling the 
presence of these vacuolar residing pathogens (Russell 2001). Evidence for phagosomal 
communication with the cell plasma membrane is indicated by the presence of MHC Class 11 
molecules (Clemens 1996;Clemens & Horwitz 1995). Processing of the MHC Class 11 
molecules occurs from the trans-Golgi network (TGN) where it is then dehvered to the 
acidic, hydrolytic, MHC compartment containing digested antigens (Russell 2001). 
Following priming of the Class n  molecule for antigen sampling by H2-M (mouse) or HLA- 
DM (human) chaperones the MHC Class 11 molecule is loaded with antigen and transported 
to the cell surface where it can interact with T cell receptors (TCR) (Russell 2001). Antigen 
presentation to T cells, expressing the surface molecule CD4, via MHC Class 11 results in the 
generation of memory and effector T cells of the adaptive T helper cell 1 (TrI) mediated 
type. Th cells activate and direct other immune cells via production of specific cytokines. 
TrI cells increase macrophage killing activity via the production of USTF-y and tumour
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necrosis factor-p (TNF-P). Th2 cells differ as they produce IL-4 and IL-10 and function to 
stimulate B cell proliferation and increase antibody production (Raja 2004).
Through the interaction with Toll-like receptors (TLR) mycobacteria trigger macrophage 
production of Tnl-type cytokines; interleukin 12 (lL-12), lL-18 and IFN-y (Underhill et al. 
1999;Schluger 2001). The adaptive Tyl-mediated host immunity inhibits the multiplication 
of bacilli in the lung via movement of effector T cells; CD4+, CD8 +, yS T cells and double 
negative or CD4/CD8 single positive T cells and their production of IFN-y (Shi et al. 
2003;Raupach & Kaufmann 2001). In combination with macrophage production of tumour 
necrosis factor-a (TNF-a), there is the lysis of infected target cells, tissue damage and 
necrosis. The aggregate of immune cells that forms is the granuloma and functions to wall 
off the pathogen preventing further spread (Zahrt 2003).
Within infected macrophages the phagocytosed bacilli inhabit a membrane bound vesicle, 
the phagosome, which ties within the endosomal system (Kaufinann 2001). Phagocytosis of 
mycobacteria necessitates macrophages to be equipped with surface receptors that assist 
antigen recognition, mediate binding and initiate phagocytosis (Ehlers & Daffé 1998;Emst 
1998; Velasco-Velazquez et al. 2003). Complement receptor 3 (CR3) is an important surface 
receptor involved in the phagocytosis of M. tuberculosis (Velasco-Velazquez et al. 2003) 
and is expressed on neutrophils, monocytes, macrophages and Natural Killer (NK) cells 
(Amaout 1990). Although other receptors (surfactant, mannose, scavenger and 
GPl-anchored receptors) are recognised to be involved, much of the interaction between the 
phagocytic cell and M. tuberculosis is initiated by CR3 (Schlesinger et al. 1990;Thorson et 
al. 2 0 0 1 ) in both type 1 (nonopsonic) and type 11 (complement-opsonised) phagocytosis 
(Le Cabec et al. 2002;Velasco-Velâzquez et al. 2003). Binding of CR3 occurs at a lectin­
like site and at the iC3b-binding site in nonopsonic and opsonic phagocytosis respectively 
(Velasco-Velazquez et al. 2003). Deficiency in CR3 binding appears not to effect the 
survival or growth of mycobacteria within the macrophage as M. tuberculosis has evolved 
the recognition of multiple receptors to facilitate entry into macrophages (Zimmerh, 
Edwards, & Ernst 1996). The mannose receptor, a transmembrane protein involved in 
nonopsonic-mediated phagocytosis is down regulated by IFN-y suggesting their role to be 
important during early infection (Ernst 1998). Since IFN-y activates macrophages for
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bacterial killing down-regulation of the mannose receptor suggests that it may not be 
involved in the uptake of persistent bacteria.
In addition to IFN-y, TNF-a is also a potent macrophage activator acting to promote 
maturation and acidification of the phagosome (Balcewicz-Sablinska et al. 1998;Schaible et 
al. 1998;Via et al. 1998). Upon macrophage activation M  tuberculosis can no longer inhibit 
maturation of the phagosome. IFN-y also stimulates production of antimicrobial molecules 
such as reactive oxygen intermediates (ROl) and reactive nitrogen intermediates (RNl) 
(Bentrup & Russell 2001;Bloom & Murray 1992). M. tuberculosis is relatively resistant to 
the ROl produced by immune cells due to their enzymatic degradation by KatG (catalase- 
peroxidase) and SodA (superoxide dismutase) (Smith 2003) but is susceptible to RNl such as 
nitric oxide. With the onset of adaptive host immunity sodA is down-regulated (Shi et al. 
2003) and would contribute to the mycobacterial killing as toxic levels of ROl would 
accumulate as part of an effective host immune response. Clearly, M. tuberculosis can avoid 
the host mediated killing described here and persist within an individual for a hfetime (see 
Section 1.6). The mechanisms with which it achieves this longevity within the host are 
described in subsequent sections.
1.6 Maturation of the mycobacterial phagosome
Macrophages are the primary cells involved in killing bacteria that invade the host. The 
processes involved are: (i) the processing of antigens to generate T cell responses (as 
described in section 1.5), (ii) the introduction of proteolytic enzymes to the phagosome via 
phagosome-lysosome fusion, (iii) gradual acidification of the phagosome due to 
accumulation of an ATPase proton pump within the phagosomal membrane and (iv) the 
introduction of reactive oxygen and nitrogen species to the phagosome. All these processes 
are part of normal phagosome maturation and are influenced by T cell-dependent activation 
of the macrophage.
There are opposing views on the progression of phagosome maturation (Desjardins 1995). 
The ‘pre-existing compartment model’ proposes that endocytosed matter is passed via a 
series of distinct pre-existing organelles (Feng, Press, & Wandinger-Ness 1995;Ludwig,
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Griffiths, & Hoflack 1991). Another model describes interactions of phagosomes with 
endocytic organelles by multiple fusion and fission events between the phagosome, early and 
late endosomes and finally the lysosome and is referred to as the ‘Kiss and Run’ hypothesis 
(Desjardins 1995;Duclos, Corsini, & Desjardins 2003). The ‘maturation model’ suggests 
that endocytosed matter is not moved from vesicle to vesicle but rather the organelle in 
question is gradually modified to its’ final state, the lysosome (Murphy 1991). The most 
accepted model is the ‘Kiss and Run’ hypothesis as there is comprehensive support for the 
transient interaction between the phagosomal and endosomal network (Sturgill-Koszycki, 
Schaible, & Russell 1996;Duclos, Corsini, & Desjardins 2003;Hao & Maxfield 
2000;Drecktrah et al. 2007). This model is highly convincing as it provides a logical and 
energy efficient explanation for a system that necessitates a dynamic environment.
1.6.1 Host cell actin and tubulin assembly enables phagocytosis of 
bacteria and vesicle formation
The internalisation of mycobacteria by phagocytosis occurs by mobilisation of the actin 
cytoskeleton (Russell 2003) and progression of the mycobacterial containing phagosome to 
the phagolysosome must occur by the nucléation of actin as the phagosome matures (Henry 
et al. 2004). Both actin and tubulin are thought to be associated with the mycobacterial 
phagosome. Tubulin has been reported to be exclusively associated with phagosomes 
containing dead bacilli (Ferrari 1999) thereby implicating a role for tubulin in phagosome- 
lysosome fusion within the activated macrophage. Conflicting evidence showed the prompt 
occurrence of actin assembly to be induced in phagosomes containing either killed bacilli or 
non-pathogenic bacilli but a reduction in actin nucléation in phagosomes infected with the 
virulent M avium strain (Anes et al. 2003). Lipid components of the phagosome membrane 
have been indicated to play a regulatory role in directing actin nucléation and therefore it has 
been proposed that diet may influence the course of infection whereby inclusion of certain 
lipids may effectively arrest maturation of the phagosome (Anes et al. 2003). Others suggest 
that lipids may promote mycobacterial growth as fatty acids are used as a carbon source 
(Russell 2003).
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1.6.2 Lysosome fusion introduces proteolytic enzymes
In the activated macrophage, the common view is that the inhabited phagosome merges with 
the endosomal pathway, acidifies and fuses with the lysosome to form the phagolysosome 
(Desjardins et al. 1994). Figure 1.2 shows a simplified representation of the proposed 
organelle interaction during phagosome maturation. Progression to the phagolysosome 
occurs via multiple fission-fusion events involving dynamic signalhng and trafficking of 
molecules to facihtate maturation of the phagosome (Desjardins et al. 1997;Desjardins et al. 
1994;Lee et al. 2005;Yates, Hermetter, & Russell 2005). Lysosomes function in the 
endocytic pathway to break down phagocytosed matter via the enzymatic activity of acid 
hydrolases (Mellman, Fuchs, & Helenius 1986) and are distinguished from endosomes by 
the presence of lysosome-associated membrane protein 1 (LAMPl) (Henry et al. 2004;Via et 
al. 1997).
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Figure 1.2: Phagosome maturation adapted from (Russel! 2001).
The phagosome matures to an acidic phagolysosome in activated macrophages to kill invading bacilli. One 
theory suggests separate organelles of the phagocytic and endocytic pathways undergo multiple fusion and 
fission events. Early endosomal antigen 1 (EEAl) appears on early phagosome and endosome compartments 
along with Rab5. Later markers, lysosome-associated membrane glycoprotein 1 (LAMPl), Rab7 and the 
matured form of procathepsin D (Cathepsin D) are linked to late phagosomal organelles. The trans-Golgi 
network (TGN) transports proton-ATPases and procathepsin D to phagosomal/endosomal compartments. 
Another model suggests the gradual modification of a single organelle to form the matured acidic 
phagolysosome.
The fusion of phagosomes with lysosomes introduces proton pumping activity to the 
phagosome (Oh & Straubinger 1996). Phagosomes of activated macrophages have a lower 
pH than resting macrophages and this lower pH demonstrates a positive correlation with the 
accumulation of vesicular proton-adenosine triphosphatase (V-ATPase) (Schaible et al. 
1998) sourced from the TGN (Fratti et al. 2003). The maturation of phagosomes can be 
readily determined by the measurement of pH (Schlesinger 1994). The importance of the 
acidic phagolysosome in mycobacterial eradication is underlined by the finding that fusion 
with lysosomes occurs at a significantly higher rate when using heat killed bacilli contrasting 
with reduced phagosome-lysosome interaction in the presence of live bacilli (Oh & 
Straubinger 1996;Yates, Hermetter, & Russell 2005). Blocking acidification with a proton- 
ATPase inhibitor, concanamycin A, prevents phagosome maturation and significantly
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reduces the rate of lysosomal fusion (Rohde et al. 2007) indicating acidification to be a 
driving factor in the fiision process.
1.6.3 Signalling events during phagosome maturation
Several biochemical pathways have been indicated in promoting bacterial cell death within 
the phagosome however much is still to be determined (Fairbaim et al. 2001;Huynh & 
Grinstein 2007;Malik, Iyer, & Kusner 2001). The Ca^  ^ signalling pathway has been well 
established as an integral molecular regulator of phagosome maturation (Kusner 2004). The 
increase in cytosolic Ca^  ^during phagocytosis of killed M  tuberculosis activates the effector 
protein calmodulin (CaM) (Malik, Iyer, & Kusner 2001). Ca^ -^CaM complexes migrate to 
the phagosomal membrane and are involved in initiating phagosomal maturation in 
macrophages containing dead bacteria. Inhibition of the Ca^ -^CaM complex blocks its’ 
translocation from the cytosol to the phagosome membrane and inhibits phagosomal 
acidification consequently promoting survival of M. tuberculosis (Malik, Iyer, & Kusner 
2001).
Furthermore, the increase in cytosolic Ca^  ^ concentration ([Ca^^jj is a requirement for 
extracellular ATP induced killing of intracellular bacilli (Kusner & Barton 2001). Coupled 
to the extracellular ATP stimulated killing of bacilli is the ATP induced restriction of M  
tuberculosis viability within the phagosome mediated by the P2X7 cell surface receptor for 
ATP which controls host phospholipase D (PLD) activity (Kusner & Adams 2000). 
Strengthening the case for the role of increased Ca^  ^signalling in promoting bacterial killing 
is the finding that inhibition of Ca^  ^ is positively correlated with the inhibition of 
phagosome-lysosome fusion (Malik, Denning, & Kusner 2000).
Several signalling mechanisms are [Ca^^c-dependent highlighting the importance of [Ca^^c 
as a regulator of antimicrobial responses (Connolly & Kusner 2007;Malik, Denning, & 
Kusner 2000). Viable, pathogenic M tuberculosis strains prevent macrophage activation by 
inhibiting host cell Ca^  ^signalling. Disruption of [Ca^ ]^c-dependent signalling mechanisms 
occurs via the microbial inhibition of sphingosine kinase and prevents maturation of the 
phagosome to an acidic organelle (Malik et al. 2003). Interestingly, the type of phagocytosis
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(type I or II) influences the viability of intracellular M tuberculosis. Type II opsonic- 
mediated tubercle entry to the macrophage (see section 1.5) is documented to inhibit 
phagosome-lysosome fusion and specifies no increase in [Ca^ '^ Jc, whereas Ab-mediated 
phagocytosis of bacilli is associated 'with reduced bacterial survival and elevated [Ca^^c 
(Malik, Denning, & Kusner 2000). Complement receptor mediated phagocytosis results in 
the inhibition of [Ca^ ’^ c increase and arrests phagosomal development. It is hypothesised 
that M. tuberculosis alters macrophage activity by interfering with Ca^  ^ signalling, which 
favours mycobacterial intracellular survival (Malik, Denning, & Kusner 2000).
1.6.4 Markers associated with phagosome maturation
Henry et al (Henry et al. 2004) used ratiometric fluorescence microscopy and chimeric 
molecules to observe association and dissociation of various markers connected with 
phagosome maturation in murine macrophages. The sequential appearance of these markers 
on phagosomal membranes begins with actin during phagosome formation, followed by 
Rab5a, Rab7 and finally LAMP-1. The uniformity of these markers is not replicated for 
phosphatidylinositol 3-phosphate (P1(3)P) (Henry et al. 2004), which transiently accumulates 
on the phagosomal membrane and is also required for phagosomal formation (Vieira et al. 
2001). Roles for those markers associated with progression of phagosome maturation have 
been elucidated to and are discussed below.
1.6.4.1 Rab-famiiy of GTPases coordinate membrane trafficking 
events in the endocytic pathway
The Rab-family of GTPases are small molecular weight proteins that cycle between the 
active GTP-bound and inactive GDP-bound forms (Clemens, Lee, & Horwitz 2000a). Of 
the 50 or more Rab-GTPases that have been identified (Stenmark & Olkkonen 2001), Rab5 
and Rab7 are well recognised for their involvement in the coordination of membrane 
trafficking events (Feng, Press, & Wandinger-Ness 1995;Stenmark & Olkkonen 2001).
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Following phagocytosis, the early phagosome acquires markers of early endosomes such as 
mannose receptor and Rab5 (Figure 1.2). RabSa plays a role in directing contact between 
phagosomes and early endosomes (Desjardins 1995;Feng, Press, & Wandinger-Ness 1995) 
by controlling vesicle formation at the plasma membrane and movement of structures in the 
endocytic pathway (Stenmark & Olkkonen 2001). The phagosomal preservation of 
mycobacteria is dependent upon fusion with early endosomes and therefore inhibition of 
normal phagosomal maturation is reliant upon Rab5 activity (Kelley & Schorey 2003).
With maturation, M. tuberculosis phagosomes lose the early endocytic markers and recruit 
markers characteristic of late endosomes including mannose-6-phosphate receptors and Rab7 
(Feng, Press, & Wandinger-Ness 1995;Vieira, Botelho, & Grinstein 2002). Rab7 is involved 
in regulation of the endocytic pathway associated with late endosome fiision (Clemens, Lee, 
& Horwitz 2000b;Feng, Press, & Wandinger-Ness 1995) and important in the biogenesis and 
maintenance of lysosomal compartments which are found predominantly aggregating in the 
perinuclear region (Bucci et al. 2000). Human phagosomes containing live, virulent 
mycobacteria were found to be associated with the presence of Rab7 suggesting that the 
arrest of phagosome maturation occurs following the acquisition of Rab7 (Clemens, Lee, & 
Horwitz 2000b). The importance of Rab7 in the inhibition of phagosome maturation was 
also observed in mycobacterial phagosomes in macrophages where transient recruitment of 
Rab7 and its subsequent release from the phagosome Hmited recruitment of Cathepsin D, a 
lysosomal marker (Seto et al. 2009). Contrary to these findings are those of Via et al (Via et 
al. 1997) who reported that M. bovis BCG phagosomes in murine macrophages did not 
acquire Rab7 maturation of the phagosome was therefore determined to be interrupted at a 
point between the acquisition of Rab5 and Rab7. The inconsistencies seen here may reflect 
the differences of murine macrophages from their human counterparts. Murine macrophages 
have been documented to be reasonably resistant to intracellular pathogens and do not 
develop the granuloma that is seen in human infection (Kaufmann 2001;Kusner 2004). It is 
likely that variation in phagosome maturation gives rise to differences in the 
pathophysiology seen in different model systems.
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1.6.4.2 Lipid kinases regulate membrane traffic in the endocytic 
pathway
The phosphotidylinositol-3-OH kinase (PI(3)K) product; phosphotidylinositol 3-phosphate 
(PI(3)P), is a membrane trafficking regulatory lipid required for development of lysosomal 
characteristics of the phagosome. P1(3)P has been reported to appear on the phagosomal 
membrane in cyclical waves (Chua & Deretic 2004) but also shows multiple patterns of 
phagosomal attachment differing in rates of association and dissociation (Henry et al. 2004). 
Early endosomal antigen 1 (EEAl), a Rab5 effector, is also required for maturation of 
phagosomes into late endosomes (Fratti et al. 2001;Simonsen et al. 1998) and is associated 
with vesicle tethering and docking during membrane fusion (Simonsen et al. 1998). A 
FYVE domain of EEAl is necessary to bind PI(3)P. Similarly, Rab5 is dependent on an 
upstream region of FYVE for EEAl binding. In the inhibition of PI(3)K activity, excess 
Rab5-GTP will increase and stabilise EEAl endosomal membrane association, decreasing 
P1(3)P affectivity (Lawe et al. 2000;Simonsen et al. 1998). The class I P1(3)K is involved in 
the phagocytic process whereas class 111 PI(3)K directs fusion of phagosomes with late 
endosomes/lysosomes (Vieira et al. 2001).
1.6.4.3 LAMP-1 associates late in the endocytic pathway
LAMP-1 is associated with maturation of the phagosome to the phagolysosome and appears 
readily when phagosomes are infected with heat killed M tuberculosis (Clemens, Lee, & 
Horwitz 2000a). Although its exact function is unknown, LAMP-1 has been indicated to 
associate later than Rab7 during the maturation pathway of phagosomes (Henry et al. 2004) 
and therefore appears late in the endocytic pathway. Analysis of immunogold labelled cells 
expressing Enhanced Green Fluorescent Protein (EGFP)-tagged LAMP-1 illustrated 
expression on the internal surface of the lysosomal membrane (Bucci et al. 2000).
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1.7 Inhibition of phagosome maturation
In the previous section the ‘normal’ progression of phagosome maturation is described 
whereby the phagosome acidifies and any residing bacilli are killed (Schaible et al. 
1998;Schluger 2001;Via et al. 1998). However, mycobacterial survival within macrophages 
has been illustrated in studies of M avium (Crowle et al. 1991;Frehel et al. 1986;Oh & 
Straubinger 1996;Sturgill-Koszycki et al. 1994), M. tuberculosis (Crowle et al. 
1991 ;Mwandumba et al. 2004) and M. bovis (BCG) (Via et al. 1997). Perhaps the most 
important reason for this intracellular survival is that mycobacterium can inhibit phagosome 
maturation in nmve macrophages. Activation of the macrophage by IFNy, however, can 
overcome this bacterial block and will result in killing of mycobacteria. To counter this, the 
mycobacterium has strategies to prevent the generation of a T cell response and cytokine 
production. It does this by disrupting antigen presentation by macrophages by hampering 
MHC class n expression (Chang, Linderman, & Kirschner 2005;Noss, Harding, & Boom
2000), maturation (Hmama et al. 1998), trafficking, peptide binding and antigen processing 
(Hmama et al. 1998;Noss, Harding, & Boom 2000) and by down-regulating the macrophage 
production of proinflammatory cytokines and responsiveness to IFN-y. Knowledge of the 
molecular mechanisms involved in mycobacterial inhibition of phagosome maturation is 
limited and the topic of intense research. The following sections summarise the present state 
of our understanding.
1.7.1 Phagosomal arrest occurs at a point before phagosome- 
lysosome interaction
Mycobacteria arrest maturation of the phagosome at a stage of interaction of the phagosome 
with early and late endosomes and not lysosomes, enabling the organism to survive within 
the un-activated macrophage (Clemens & Horwitz 1996;Clemens, Lee, & Horwitz 
2000a;Frehel, Chastellier, Lang, & Rastogi 1986;Kelley & Schorey 2003;Via et al. 1997a). 
Phagosomal arrest is characterised by the retention of early endosomal markers; Rab5 and 
EEAl and failed recruitment of late endosomal markers; Rab7, Cathepsin D and LAMP-1 
(Deretic et al. 2006). Inhibitory cytokines, transforming growth factor-gl and EL-10, are
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released causing a reduction of both macrophage activation and bacterial suppression 
(Bogdan et al. 1992). A significant reduction in phagosome-lysosome interaction was 
illustrated in vitro using macrophages infected with live bacilli (Yates, Hermetter, & Russell 
2005). Persistence of Rab5 on the M. tuberculosis phagosome contrasts with phagosomes 
infected with the successful intracellular pathogen, Legionella pneumophila, which fails 
does not display Rab5. M. tuberculosis arrests maturation at an early stage along the 
endosomal pathway and retains Rab5 whereas the absence of Rab5 on the L. pneumophila 
phagosome may be the inhibitory factor responsible for the prevention these phagosomes 
maturing along the endocytic pathway (Clemens, Lee, & Horwitz 2000a). This highlights 
the importance of Rab5 in maintaining the phagosome and conserving its early endosome 
characteristics.
Live, virulent mycobacteria are necessary for phagosomal arrest (Malik, Denning, & Kusner 
2000;Sturgill-Koszycki et al. 1994;Sturgill-Koszycki, Schaible, & Russell 1996) as 
phagosomes infected with dead mycobacteria exhibit late endosomal markers; proton 
ATPase (Sturgill-Koszycki et al. 1994), mannose-6-phosphate receptor (M6PR) (Vieira, 
Botelho, & Grinstein 2002) and lysosomal protease Cathepsin D (Clemens & Horwitz 1995) 
and fiise with lysosomes (Armstrong & Hart 1971). This further underlines the phagosomal 
association with early endosomes and their associated markers rather than their later 
counterparts (Hestvik, Hmama, & Av-Gay 2005). The exclusion of M6PR and Cathepsin D 
molecules on phagosomes is owed to the disruption of trafficking between the TGN and the 
mycobacterial phagosome (Fratti et al. 2003). It is proposed that the presence of 
mycobacteria may either interfere with the recruitment of Rab7 or its selective removal so 
the bacteria may escape the Rab7 regulated pathway (Via et al. 1997).
Membrane trafficking systems such as vesicle tethering and fusion maintain organelle 
integrity and enable organelle biogenesis (Fratti et al. 2003). The machinery necessary for 
Golgi-derived vesicle to plasma membrane fusion and endosomal fusion involves soluble V- 
ethylmaleimide-sensitive factor attachment protein receptor (SNARE) molecules (Fratti et al. 
2003) composed of a complex arrangement of four helical bundles (Sutton et al. 1998). 
SNARES direct the fusion events and phagosomal interactions with other organelles during 
phagosome biogenesis and maturation (Parlati et al. 2002). Arrest of phagosomal maturation
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is associated with the alteration of SNAREs preventing the mycobacterial phagosomes from 
interacting with the sorting organelles responsible for development of the phagolysosome 
(Fratti et al. 2003).
Another marker of the mycobacterial phagosome is the actin-binding protein tryptophane 
aspartate-containing coat protein (TACO), more recently termed coronin, which normally 
appears transiently on the phagosomal membrane before being released prior to development 
of the phagolysosome (Ferrari 1999;Schuller et al. 2001;Yan et al. 2005;Zheng & Jones 
2003). However, during arrest of phagosome maturation mycobacteria have evolved the 
capacity to retain coronin (via the mycobacterial hpoamide dehydrogenase C (LpdC) binding 
protein) (Deghmane et al. 2007) and prevent lysosomal delivery of bacteria (Ferrari 1999). 
In contrast to the retention of coronin in resting mouse macrophages (Ferrari 1999), its 
association with human macrophages ceases after mycobacterial phagocytosis and is not 
associated with late arrested phagosomal compartments (Schuller et al. 2001). It was 
therefore suggested that coronin may have no role in maintenance of the phagosome 
(Schuller et al. 2001) but its function necessary for phagocytosis in macrophages (Yan et al. 
2005).
The arrested mycobacterial phagosome does not accumulate the proton ATPase and does not 
acidify. This has been demonstrated in murine macrophages (Crowle et al. 1991;Sturgill- 
Koszycki et al. 1994) and recently in macrophages from human infections (Mwandumba et 
al. 2004).
1.8 Virulence determinants
Identifying which mycobacterial components are responsible for/or important for the above 
observed in vivo phenotypes, is a major goal of TB research. The following sections 
describe the techniques used for identifying virulence genes and summarise the most 
important findings on M tuberculosis virulence genes/determinants.
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1.8.1 Techniques for discovery of virulence genes
The sequenced genome ofM  tuberculosis (Cole et al. 1998) has provided much information 
regarding the organisms biology and has revealed the sequence of all potential gene targets 
for drug and vaccine development. Approximately 3924 open reading frames (ORFs) exist 
in the genome, however, only a third of these ORFs encode proteins whose predicted 
function can be made with a degree of certainty. Determination of protein function is 
primary to understanding the biology of the organism and how it infects and causes disease. 
Therefore whilst drawing from all possible information in the sequenced genome the current 
challenge is identification of genes involved in infection and elucidating their function. 
Although many aspects of biology can be used to connect genotype to phenotype the 
generation of a KO strain by either Tn mutagenesis or allehc exchange is essential in 
fulfilling Koch’s molecular postulates. The assertions that form Koch’s molecular postulates 
are: the phenotype of interest is associated with only pathogenic strains of a species, 
inactivation of the associated gene in a virulent strain will measure a loss in pathogenicity 
compared to the parental strain, reversion of the mutated gene will restore pathogenicity, the 
virulence gene must be expressed during infection, introduction of biomedical intervention 
such as a vaccine must be protective (Falkow 1988).
1.8.1.1 Transposon mutagenesis
Transposon (Tn) mutagenesis is a molecular genetic tool that has been applied to the study 
of many bacterial organisms (Hamer et al. 2001;McAdam et al. 2002) including 
M. tuberculosis (McAdam et al. 2002) and uses the inherent attribute of Tns as mobile 
genetic elements which randomly insert into the bacterial genome, sometimes mutating 
virulence genes. These defective isolates can then be used to study the effects on 
pathogenicity.
The first Tn to be effectively used to intentionally generate mutants in mycobacteria was the 
1^1096 element (Cirillo et al. 1991) isolated from M. smegmatis and from which numerous 
derivatives have followed (McAdam et al. 1995). Libraries of Tn mutants have been 
generated by delivery of ISJOPti-based Tns on either temperature sensitive plasmids (Pelicic
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et al. 1997) or bacteriophages (Bardarov et al. 1997). IS1096 was subsequently 
implemented in a transposon-based mutagenesis technique called signature-tagged 
mutagenesis (STM) (Hensel et al. 1995) which is used to identify virulence genes in a 
simultaneous screen (Camacho et al. 1999;Cox et al. 1999;Hamer et al. 2001). STM relies 
on uniquely tagged transposons integrating into the M. tuberculosis genome. Resulting 
mutants are screened for survival during infection studies (Camacho et al. 1999;McAdam, et 
al. 1995;Smith 2003). Insertional mutants of significance can be identified from the unique 
tag and in so doing the Tn interrupted gene is also located enabling mutants with insertions 
in genes essential for survival to be retraced as well as identification of mutants with 
decreased virulence.
Other Tns used in mycobacteria include the Mariner based Himar Tn (Sassetti, Boyd, & 
Rubin 2001) from Drosophila and the Tn5-based Ez:Tn transposon (Stewart et al. 2005). A 
limitation of some of these studies, based on the Tn dependent technique they employ, is that 
individual Tns demonstrate sequence preferences for insertion site within the mycobacterial 
chromosome (McAdam et al. 2002). Tn libraries have been generated using an effective 
technique for the delivery of Tns to M  tuberculosis via bacteriophages (Bardarov et al. 
1997). Shuttle phasmids were constructed from the mycobacteriophages D29 and TM4 
using an Escherichia coli cosmid vector containing a Tn5367 Q.S1096 derivative) (McAdam 
et al. 1995) within the phage genome.
1.8.1.2 Transposon Screening by Microarray
Using microarrays to monitor Tn mutant identity and relative abundance in pools of mutants 
was the logical extension of the STM concept. Pioneering techniques developed by Hensel 
et al (Hensel et al. 1995) were apphed in the production of transposon libraries of 
Salmonella typhimurium. This technique was further developed by Badarinarayana et al 
(2001) using E. coli and then by Sassetti et al using M. tuberculosis (Sassetti, Boyd, & 
Rubin 2001). Sassetti termed the technique Tn site hybridisation (TraSH) (see Chapter 2 
Section 2.7 for descriptive illustration) and used a Himar 1 -\> 2l s q 6  mariner derived Tn within 
a phagemid to generate mutations in thousands of genes. The insertion sites of the Tn
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mutants are simultaneously amplified and fluorescently labelled before hybridisation to an 
M  tuberculosis microarray containing a probe/spot of each predicted gene in the 
M. tuberculosis genome. By comparing saturated mutant hbraries grown under different 
conditions all the genes required for growth in a specified environment are indicated by the 
pattern of hybridisation to the microarray. The TraSH technique is suited for the study of 
sets of genes across the genome whereas STM investigates individual genes fi’om small 
pools of mutants. For the large scale investigation of gene fimction via Tn mutagenesis, 
TraSH is better suited for looking at the effects of a specified environment on the growth of 
large pools of mutants. This technique, or related techniques, have been used to examine the 
M  tuberculosis genes required for optimum growth in macrophages, mice, minimal media 
and also used to identify the genes important for inhibiting phagosome acidification 
(Camacho et al. 1999;McAdam et al. 2002;Pethe et al. 2004;Sassetti & Rubin 2003;Sassetti, 
Boyd, & Rubin 2001 ;Schnappinger et al. 2003;Stewart et al. 2005).
1.8.1.3 Allelic exchange mutagenesis
Allelic exchange mutagenesis uses homologous recombination to specifically knockout a 
target gene. Allelic exchange was first reported in 1990 (Husson, James, & Young 1990) 
with the efficient delivery of a suicide vector into M. smegmatis resulting in homologous 
recombination and insertion of a stress protein antigen from M  leprae. In the past 
difficulties arose in applying this technique to the slow growing mycobacteria due to the low 
transformation efficiencies (Kana & Mizrahi 2004), the low frequency of allehc exchange 
demonstrated by these species (McFadden 1996) and high degrees of illegitimate 
recombination, which occurs by the non-homologous joining of linear DNA fragments that 
were previously nonadjacent (Kalpana, Bloom, & Jacobs 1991). It was for a time speculated 
that perhaps M. tuberculosis was deficient in one of the key enzymes involved in 
recombination and repair, RecA (McFadden 1996). The recA gene of M. tuberculosis, 
M. leprae andM bovis BCG is interrupted by an intein ‘protein intron’ (Davis et al. 1992) 
that is spliced out (Davis et al. 1994). Other non-pathogenic species of mycobacteria, like 
M. smegmatis, do not contain an intein within the recA gene (Davis et al. 1994) but exhibit a 
high degree of homologous recombination (Husson, James, & Young 1990) and, therefore, it
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was hypothesised that the intein may account for the difficulties of achieving homologous 
recombination in pathogenic mycobacteria (Davis et al. 1992;McFadden 1996) including M. 
bovis BCG (Reyrat, Berthet, & Gicquel 1995). Evidence opposing this hypothesis was 
provided by complementation experiments in which a RecA' knockout mutant of M  
smegmatis was fully restored to RecA^ phenotype by complementation with M  tuberculosis 
recA (Frischkom et al. 1998).
Difficulties were overcome with successful efforts of homologous recombination performed 
in M  bovis BCG strain (Norman et al. 1995;Reyrat, Berthet, & Gicquel 1995). Initially, 
successful homologous recombination in M tuberculosis resulted only when using large 
stretches of homologous DNA flanking either side of the mutagenised gene 
(Balasubramanian et al. 1996). Further advances were made in methodology when 
observations confirmed an increase in transformation efficiency of slow growing 
mycobacteria when electroporation is performed at higher temperatures (Wards 1996). 
Selectable markers like the pyrF system enabled selection of transformants on medium 
containing 5-fluoroorotic acid (FOA) which is lethal to pyrF^ phenotypes but not in pyrF  
phenotypes where the gene is disrupted by aph (kanamycin resistance gene) (Husson, James, 
& Young 1990). Counterselective selection properties of the sacB gene, previously 
demonstrated as a counterselective marker in mycobacteria (Pelicic, Reyrat, & Gicquel 
1996), enabled selection against single crossover integration of delivery vectors and 
detection of gene replacement by double crossover (Pehcic et al. 1997). Homologous 
recombination efficiency was further improved with low dose UV-irradiation of the suicide 
plasmid prior to electroporation (Hinds et al. 1999).
1.8.2 Mycobacterial molecules involved in inhibition of phagosome 
maturation
The aforementioned techniques have provided a foundation for defining the genetic basis of 
virulence in revealing those genes associated with survival and disease. In the following 
section the virulence determinants of M tuberculosis are outlined with particular reference
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to those contributing to growth in the macrophage. A summary of the most studied 
virulence determinants, updated from Smith (Smith 2003), is presented in Table 1.1.
The M  tuberculosis glycolipid, phosphatidylinositol mannose-capped hpoarabino-mannan 
(ManLAM) disrupts the trafficking pathway from the TGN to the phagosome by preventing 
the translocation of lysosomal constituents and effectively arresting phagosomal maturation 
(Fratti et al. 2003). ManLAM inhibits the acquisition of both syntaxin 6 (a SNARE protein) 
and EEAl disrupting the dehvery of M6PR-bound lysosomal hydrolases intended for the 
lysosome (Fratti et al. 2003;Fratti et al. 2001). In the absence of EEAl there is no binding of 
P1(3)P (ordinarily found on the early endosomal membrane) (Gillooly et al. 2000) and no 
EEAl interaction vrith syntaxin 6 (Simonsen et al. 1999) causing a block in delivery of 
lysosomal enzymes and V-ATPase (Sturgill-Koszycki et al. 1994) from the TGN to the 
mycobacterial phagosome (Fratti et al. 2003), Lipoarabinamannan (LAM) also blocks the 
increase in [Ca^ "^ ]c, preventing the cascade of events rehant on Ca^ /^calmodulin effector, 
Ca^Vcahnodulin kinase n  (CaMKH), involved in production of PI(3)P (Vergne, Chua, & 
Deretic 2003).
It is clear however, that LAM is not the only mycobacterial molecule involved in altering 
phagosome maturation. Tn mutants of M  tuberculosis defective in phagosomal arrest have 
been isolated and characterised by Pethe et al (Pethe et al. 2004). The Tn libraiy used boasts 
approximately 8,000 mutants confirmed by random analysis of 100 isolates and was 
screened in pools of 1,000. Macrophages were fed iron-dextran to label lysosomes and then 
infected with an M. tuberculosis Tn mutant hbrary. The cells were then lysed and the iron- 
dextran containing lysosomes recovered by several rounds of magnetic selection to enrich 
for mutants unable to avoid fusion with the lysosomal compartment and therefore defective 
in phagosomal arrest. Many mutants identified were also shown to be attenuated for 
intracellular survival. Affected genes were varied in function; the role of Rv3527 unknown, 
Rvl522c a mmpL12, Rv2941 (fadD28), Rvl819c and Rv0986 both ABC transporters (Pethe 
et al. 2004). This study indicates multiple effectors involved in phagosomal maturation and 
the intra-macrophage survival analysis of these mutants demonstrates that the inability to 
regulate phagosome maturation correlates with decreased bacterial survival in macrophages.
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A similar high-throughput study of Tn mutants by Stewart et al (2005) identified over 40 
genes that were important for M.bovis BCG to inhibit acidification of the phagosome. 
Included in these genes was kefB (Rv3236c) encoding a potassium transporter, a ppe gene 
(Rv0442c) and genes from the mce operon {Rv0170-Rv0178) (Rengarajan, Bloom, & Rubin 
2005;Sassetti & Rubin 2003;Stewart et al. 2005) previously shown to be involved in 
mycobacterial host cell entry (Chitale et al. 2001). 80% of the identified genes were either 
secreted or associated with the cell wall of the bacterium and a high proportion were located 
within a single genomic region which was consequently termed the virulence-associated 
membrane protein region (VAMP).
Another mycobacterial molecule associated with inhibition of phagosome maturation is 
protein kinase G (encoded by pknG) an enzyme involved in signal transduction following its 
secretion into the cytosol of infected macrophages (Koul et al. 2001). The mycobacterial 
PknG promotes bacterial survival within the macrophage and is likely involved in 
modulating the host cell signalling pathways (Walburger et al. 2004).
1.8.3 The role of Iron in mycobacterial growth and virulence
Mycobacteria are particularly responsive to iron levels (Lounis et al. 2001). For 
M. tuberculosis, an excess of iron has deleterious effects on the host whilst facilitating the 
organisms’ viability (Cronje et al. 2005;Traoré & Meyer 2007), invasion, replication and 
promotes tissue damage by free radicals (Ratledge 2004). Additionally, many virulence 
proteins in M tuberculosis are controlled by an iron-dependent regulator, IdeR (Manabe et 
al. 1999a). Genome analysis indicates iron as an essential cofactor of about 40 different 
enzymes (Cole et al. 1998;De Voss et al. 1999). In the instance of iron deprivation the CMI 
response is effected by way of decreased lymphocyte response. Natural Killer cell activity 
(Weiss 2002), impairment of macrophage function (Moyo et al. 1997;Weiss 2002) and 
inability of mycobacteria to prevent normal phagosomal maturation in Rab5 defective 
macrophages (Kelley & Schorey 2003) as retention of Rab5 is necessary for maintenance of 
the early endosome. Removal of iron by chelating agents such as desferrioxamine and the 
plant flavonoid, silybin, have been shown to reduce extracellular M tuberculosis growth and
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suppress production of oxygen radicals by macrophages (Cronje et a l 2005). These effects 
lend support to the role of iron in mycobacterial growth and virulence and such agents have 
potential for therapeutic use to facilitate the host immune response and suppress 
mycobacterial replication. Mycobactins of M. tuberculosis are responsible for extracting 
iron from the macrophage (Luo, Fadeev, & Groves 2005). Although much support lends 
itself to the correlation of iron and the promotion of bacterial virulence, there is yet to be 
evidence for iron preventing phagosome maturation per se.
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Table 1.1: Identified molecules associated with virulence determinants o f Mycobacterium tuberculosis.
Virulence factor Identified protein(s) Reference
Arrest of phagosome ManLAM, LAM, Coronin (Ferrari 1999d r^atti, Chua,
maturation Vergne, & Deretic 
2003;Schuller et al. 
2001;Vergne, Chua, & Deretic 
2003)
Iron dependent inhibition IdeR, KatG, SodA, CAT, (Edwards et al. 2001 d^ errari
of host responses, iron mycobactin 1999;Luo, Fadeev, & Groves
acquisition 2005;Manabeetal. 1999a)
Cell wall VAMP, PDIMs, LAM, mmpL12, (Brennan & Nikaido
Trehalose-6,6 ’ -dimycolate 1995;Glickman, Cox, & 
Jacobs 2000;Hunter & 
Brennan 1990;Pethe et al. 
2004;Sassetti & Rubin 
2003;Stewart et al. 
2005;Thorson et al. 2001)
RDI locus Esat6, CFP-10 (Smith 2003;Stanley et al.
2003)
Metabolism ICL (McKinney John D et al. 2000)
DNA repair Uracil glycosylase, exonuclease (Mizrahi & Andersen
in, endonuclease IV, UvrABC 
excinuclease, RecBCD
1998;Sassetti & Rubin 2003)
Transcriptional regulation SigA, SigB, SigE, SigF, SigH, (Anes et al. 2003;Fratti et al.
MprA, DosR 2003;Mellman, Fuchs, & 
Helenius 1986;Murphy 
1991 ;0h & Straubinger 
1996;Viaetal. 1997)
29
Chapter 1. Introduction
1.8.4 Secreted Proteins
The secretion of effector proteins that interact with the host cell is an important virulence 
factor of many pathogens and in M  tuberculosis there is evidence of a speciahsed secretion 
system, independent of the Sec pathway that is used by many other organisms. The 
pathway, designated the snm pathway, is located in the RDI deletion region; a region found 
to be absent from M  bovis BCG but present in all virulent strains of 
M  tuberculosis and M  bovis (Smith 2003). The Rv3875 and Rv3874 genes of the snm 
pathway encode the secreted proteins ESAT-6 and CF-10 (Smith 2003) which lack the 
typical signal sequences associated with the Sec system (Stanley et al. 2003). Their function 
is unknown but analysis of flanking genes of the esat-6-cJp-lO operon is suggestive of their 
involvement in the secretion of ESAT-and CFP-10 (Stanley et al. 2003). ESAT-and CFP-10 
substrates are dependent upon the components snml, 2 and 4 for secretion. Without 
functional snml, 2 and 4 substrates, snm mutants exhibit reduced virulence in murine 
macrophages. Further gene targets of the RDI locus (Rv3872 and Rv3873) were also found 
to be attenuating and indicated to be important for bacterial survival in the spleen (Sassetti & 
Rubin 2003).
The SecA protein is essential for the secretion of virulence factors and the accessory protein 
SecA2 is necessary for SodA secretion. Mutants of secA2 have reduced survival due to their 
increased susceptibility to oxidative stress (Braunstein et al. 2003). Both SecA and SecA2 
have also been shown to be important for bacterial survival in the spleen in addition to the 
secreted protein, pirG, of unknown function (Sassetti & Rubin 2003). In addition to SodA, 
KatG and catalase (CAT) are further enzymes known to be secreted into the phagosome, 
functioning to protect bacteria from ROI (Edwards et al. 2001).
1.8.5 Metabolism
Within the granuloma, mycobacteria are subject to reduced O2 availability (Bentrup & 
Russell 2001) which may induce a reduction in bacterial metabolism during persistence 
(McKirmey et al. 2000). Bacterial survival within a microaerophilic environment is
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proposed to be possible due to the shift in carbon source fi'om glucose to fatty acids which 
correlates with the induction of a fatty acid diet in mycobacteria that inhabit the lipid rich 
environment of a granuloma. Adaptation to such conditions induces activation of enzymes 
involved in the glyoxylate shunt (McKinney et al. 2000); a secondary metabolic pathway 
induced when the primary carbon source is hmiting (Muhoz-Elias et al. 2006). Isocitrate 
lyase (ICL) is the first enzyme in the glyoxylate cycle and functions to control the 
conversion of isocitrate into succinate and glyoxylate in the glyoxylate pathway (Russell
2001). ICL enzymes are encoded by two genes; icll and icl2 (McKinney et al. 2000) and 
their expression is shown to be directly linked to activated macrophages (Bentrup & Russell 
2001;McKinney et al. 2000). M. tuberculosis mutants lacking icll and icl2 exhibit 
attenuated virulence and are unable to sustain infection in mice, suggesting ICL to be 
important in the persistent stages of infection (McKinney et al. 2000;Muhoz-Elias & 
McKinney 2005).
The beta-oxidation cycle (p-ox) degrades fatty acids to acetyl-CoA and propionyl-CoA. 
Acetyl-CoA production is used in the glyoxylate cycle and metabolism of propionyl-CoA is 
achieved by the methylcitrate cycle (Muhoz-Elias & McKinney 2005), which provides an 
alternative pathway for fatty acid metabohsm (Gould et al. 2006). Homologous enzymes of 
the methylcitrate cycle occur in M. ^Mèercw/o5Z5-methylcitrate synthase (prpC) and 
methylcitrate dehydratase (prpD). Methylisocitrate lyase (prpB) is absent in the M. 
tuberculosis genome, however, the ICL genes exhibit hmited homology and activity to 
methylisocitrate lyase. Together with the observation that both ICLl and ICL2 are mutually 
required for M tuberculosis survival in macrophages, there is good indication for ICL as a 
substitute for methylisocitrate lyase (Gould et al. 2006;Munoz-Elias & McKinney 2005).
1.8.6 DNA repair
Many bacterial species use homologues of the E. coli LexA repressor and depend on a 
functional RecA protein for the regulation of DNA damage response genes (Erill, Campoy, 
& Barbé 2007). Although the DNA repair mechanisms in mycobacteria are less well defined 
they appear to be independent of RecA (Rand et al. 2003) and involve genes of the DNA
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repair system, i.e. base excision repair (BER). BER genes in mycobacteria are essential for 
growth in mice and attenuating mutations in BER genes (e.g. uracil glycosylase (wng), 
exonuclease HI {xthA) and endonuclease IV {end)) imply the BER repair system to be the 
primary mechanism used for bacterial protection from ROI and RNI damage (Sassetti & 
Rubin 2003). Furthermore, genes involved in nucleotide excision repair (NER), UvrABC, 
were also identified in M. tuberculosis as was the RecBCD pathway involved in 
recombinational repair (Mizrahi & Andersen 1998). Mutants of the NER system in 
M. smegmatis exhibited higher sensitivity to common DNA-damaging agents than mutants 
in ung and formamidopyrimidine DNA glycosylase (§?g) of the BER pathways indicating 
the NER system as an important repair mechanism of mycobacteria (Kurthkoti et al. 2008).
1.8.7 Cell wall structure
The cell wall of M tuberculosis widely accepted to be involved in virulence and differs 
from other gram-positive bacteria in its complex composition of unique glycolipids, mycohc 
acids, and long-chain fatty acids (Zahrt 2003). Trehalose 6,6' dimycolate (cord factor) is a 
major component of the cell wall of mycobacteria and is responsible for producing the 
morphological growth pattern of rope-like braiding of bacilli known as serpentine cording 
(Hunter, Venkataprasad, & Olsen 2006). The pcoA gene product is responsible for 
enzymatically incorporating a cyclopropane ring on a-mycolic acids in the cell wall and is 
necessary to produce this braiding of microscopic bundles. bqpcoA mutants show reduced 
virulence in vivo and pcoA is predicted to be involved in the persistent stages of infection 
(GHckman, Cox, & Jacobs 2000).
Mycobacterial lipoglycan molecules, LAM and hpomannan (LM), are multi-glycosylated 
versions of phosphatidylinositol mannosides (PIMs) (Brennan & Nikaido 1995) found in the 
bacterial cell envelope and have been indicated in the mediation of phagocytosis (Hoppe et 
al. 1997;Schlesinger, Hull, & Kaufman 1994). These molecules have been shown to inhibit 
bacterial binding to macrophages (Stokes & Speert 1995) and it has been suggested that the 
phosphatidylinositol (PI) anchor of LAM and LM enables the molecules to be exposed to the 
extracellular environment and are also indicated to be the inhibitory component (Hunter &
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Brennan 1990;Thorson et al. 2001). Another phosphohpid, cardiolipin (CL), stimulates 
mycobacterial and macrophage interaction and phagocytosis (Thorson et al. 2001). A cluster 
of genes were found to be involved in the synthesis and export of the cell wall associated 
lipid viz. phthiocerol dimycocerosate (PDIM) (Sassetti & Rubin 2003). PDIM was found to 
be required for bacterial replication in the lung and insertional mutants (see section 1.8.1.1) 
offadD26 and fadD28 exhibited a disruption in phthiocerol biosynthesis (Cox et al. 1999). 
Closely located genes to fadD26 and fadD28 are mas (an enzyme involved in the synthesis 
of mycoceroic acids encoded by Rv2940c) and mmpL7 (a putative transmembrane protein 
encoded by Rv2942), which, respectively have also been implicated in the synthesis and 
transportation of PDIM, (Cox et al. 1999;Smith 2003).
1.8.8 Gene regulation
The ability of M tuberculosis to survive and adapt to different environmental conditions is 
achieved by controlling the production of proteins through regulating the transcription of 
genes across its genome or by controlling the translation and degradation of mRNA 
transcripts. Of the 189 identified regulatory proteins across the M tuberculosis genome 
(Camus et al. 2002) a number of control mechanisms for the transcription of mycobacterial 
genes have been implicated in the adaptation to intracellular survival of mycobacteria. 
Several alternative sigma factors have been identified and their role in mediating conditional 
expression of genes during M. tuberculosis growth in vivo has been elucidated. Among the 
many imcharacterised transcription factors 11 two component regulatory systems have been 
identified (Cole et al. 1998). Many of these regulatory factors are activated in response to 
environmental cues such as temperature, oxygen, pH, reactive compounds and nutrient 
availability, and others are activated in vivo by unknown signals.
1.8.8.1 Alternative sigma factors
Alternative sigma factors provide a means of regulating gene expression during changing 
environmental conditions. They do this by promoting gene transcription via interacting with 
RNA polymerase and directing it to promoters that are not recognised by the polymerase
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when controlled by the housekeeping sigma factor (Gomez & McKinney 2004). Currently, a 
total of 13 RNA polymerase sigma factors have been identified in M tuberculosis (Cole et 
al. 1998). Evidence points to SigA as the primary sigma factor in mycobacteria with its 
homologue in M smegmatis shown to be essential (Gomez et al. 1998) and a sigA mutant in 
M. bovis exhibiting attenuated virulence (Collins et al. 1995).
The M  tuberculosis sigma factor, SigF, is homologous to SigB of Bacillus subtilis (De Maio 
et al. 1997) and in S. coelicolor SigF is involved in sporulation (Potuckova et al. 1995). 
SigF appears to be important during stationary phase growth (De Maio et al. 1996) and is 
induced during anaerobic metabolism and antibiotic exposure (Michele, Ko, & Bishai 1999), 
however alternate theories exist for a role for SigF in mediating immunopathogenesis by 
differential regulation of cell wall-associated proteins (Wilhams et al. 2007a). A number of 
genes are implicated to be under SigF control including Rvl823, Rv2884, usjx and phoYl 
(Rv3301c), a probable transcriptional regulatory protein (Williams et al. 2007a). The 
expression of sigÇ is dependent on SigF (Geiman et al. 2004;Lee, Karakousis, & Bishai 
2008). Regulation of the 16-kDa alpha-crystallin-like protein, Acrl (HspX) encoded by 
Rv2031c, is also controlled by SigF (Geiman et al. 2004;Manabe et al. 1999b) and may be 
important in persistence of infection indicated by infection studies in BALB/c mice (Chen et 
al. 2000). The expression of Acrl is up-regulated during RNI stress in reduced oxygen 
conditions (Bentrup & Russell 2001;Timm et al. 2002) during the transition fi'om 
exponential to stationary phase (Timm et al. 2002) and is thought to aid survival within the 
granuloma by stabihsing the cell structure during persistent infection (Wilkinson et al. 1998). 
Induction of SigF and Acrl expression was also observed in recovering cultures re-entering 
aerobic conditions after a period of stationary phase growth in M  tuberculosis (De Maio et 
al. 1996;Manabe et al. 1999b).
Sigma factors SigH, SigB and SigE have all shown increased expression in response to heat 
shock and SigB and SigE show increased transcription upon exposure to detergent in growth 
medium (Manganelli et al. 1999). Responsiveness to stress may be indicative of importance 
during infection. Indeed SigE and SigH mutants were attenuated for growth in ex vivo 
macrophages and in mice (Kaushal et al. 2002;Manganelli et al. 2004a). Interestingly, there 
is cross regulation between these regulators as SigH regulates SigE and both sigma factors
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are required for sigB expression (Raman et al. 2001). Perhaps of particular interest during 
infection is that SigE is responsive to oxidative stress such as may be encountered in the 
macrophage (Raman et al. 2001). In addition, SigI is responsive to mild cold shock and has 
therefore been indicated to be important during conditions below 37°C such as during 
transmission of mycobacteria outside of the human host (Manganelli et al. 1999).
1.8.8.2 Two component regulatory systems
Two component regulatory systems are composed of a histidine sensor kinase and a response 
regulator (West & Stock 2001). Phosphotransfer from the histidine residue of the sensor 
kinase to the aspartate residue of the response regulator mediates binding to promoters 
inducing or repressing gene transcription. M  tuberculosis has 11 complete two component 
regulatory gene pairs (Cole et al. 1998). The regulator, MprA (Rv0981), is of the two 
component regulatory class and disruption of this gene resulted in impaired persistence of 
the mutant strain in the lungs of chronically infected mice (Zahrt & Deretic 2001). In the 
spleen however, the mutant had reduced survival during acute infection. The dormancy 
survival (two-component) regulator, DosR {Rv313Sc), is induced during anaerobic 
conditions where it binds to a consensus motif present in most genes induced by levels of 
reduced oxygen including the hypoxic response gene acr (Park et al. 2003;Zhang et al. 
2008). DosR regulates almost 50 genes during growth in vitro (Park et al. 2003) and a DosR 
mutant exhibited increased virulence in a murine model (Parish et al. 2003). Evidence 
suggests that DosR is important during chronic infection (Sherman et al. 2001) and its 
induction during hypoxia corresponds to the oxygen deprived conditions of the granuloma 
during persistent infection. DosR is hypothesised to be a primary mediator of the hypoxic 
response (Boon & Dick 2002;Park et al. 2003) however a recent study suggests it is involved 
during the initial stage of hypoxia and is followed by an enduring hypoxic response (EHR) 
independent of DosR (Rustad et al. 2008).
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1.8.8.3 WhiB regulators
The family of 7 whiB-\\kQ genes apparent in M. tuberculosis encode small DNA binding 
proteins thought to be involved in transcriptional regulation (Cole et al. 1998;Davis & Chater 
1992;Sohveri et al. 2000). WhiB was originally found in S. coelicolor to be necessary for 
the differentiation of aerial hyphae (Davis & Chater 1992). Many of the whiB genes are 
highly responsive to stress conditions in particular whiB6 and the induction of whiBS during 
late stationary phase (Geiman et al. 2006) gives foundation to their biological role in chronic 
infection. whiBl gene transcription has been shown to be dependent on cAMP levels via 
modulation of its cAMP receptor protein (CRP)-dependent promoter (Agarwal, Raghunand, 
& Bishai 2006).
1.8.8.4 Transcriptional regulation of heat shock proteins
During infection the induction of heat shock proteins in microbial pathogens is 
up-regulated in response to stress stimuli. A complete profile of heat shock inducible genes 
was produced using a whole genome microarray (Stewart et al. 2002b). In addition to the 
positive regulation of heat shock genes by SigE and SigH there is transcription of heat-shock 
proteins of the hsp60 (groE) operon, negatively regulated by HrcA (Stewart et al. 2002a) and 
the hsp70 (dnaK) operon regulated by the HspR repressor. Deletion mutants of HspR 
exhibit survival rates in vivo equivalent to that of wild-type strains during acute stages of 
infection (Stewart et al. 2001). However, survival of the AhspR mutant is significantly 
reduced during the chronic stage of infection suggesting that the acquired immunological 
response is required to clear the AhspR mutant (Stewart et al. 2001).
1.8.8.5 Hyperphosphorylated guanine regulation of gene 
expression
Periods of reduced nutrient availability induce a mycobacterial response to starvation called 
the stringent response. The Rel protein (Rv2583c) mediates production of 
hyperphosphorylated guanine, (p)ppGpp, to modulate gene expression. The Rel protein is
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dual in function with identified amino acid fragments for the synthesis and hydrolysis of 
(p)ppGpp and recognised residues within the C-terminus of the protein shown to interact 
with the Rel activating complex (RAC) responsible for its regulation (Avarbock et al. 2005). 
The distribution of Rel expression within a bacterial population has been described to be 
heterogenous with sub-populations expressing high or low levels of Rel (Sureka et al. 2008). 
Sub-populations expressing differing levels of Rel are selected based on the concentration of 
polyphosphate kinase 1 (PPKl). PPKl synthesises polyphosphate required for the activation 
of the two-component regulatory system MprAB and also SigE in response to stress. 
Induction of SigE then activates transcription of Rel completing the positive feedback loop 
mechanism. In starved conditions Rel-deficient mutants exhibit significantly reduced 
growth and compromised long term survival compared with wild-type strains (Dahl et al. 
2003;Primm et al. 2000) and is therefore indicated in persistence.
1.9 Project aims
The overall aim of this project was to identify M. tuberculosis transcriptional regulators 
involved in intra-macrophage survival and investigate the genes that they control. 
Specifically, we aimed to
1. Re-screen the selected Tn library by Pethe and colleagues (Pethe et al. 2004) to 
identify genes involved in macrophage survival.
2. Analyse the transposon library screen and screens obtained by other researchers in 
order to select transcriptional regulators for targeted development of knockout mutants using 
the allehc exchange method of mutagenesis.
3. Perform transcriptional profiling of knockout strains versus wild-type to elucidate the 
putative transcriptional régulons.
4. Confirm direct regulation of a subset of regulated genes by gel shift EMSA analysis.
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2 Materials and methods
2.1 Bacterial strains and culture conditions
M. tuberculosis H37Rv strain (obtained from Imperial College London) was cultured in 
Middlebrook 7H9 broth or on Middlebrook 7H11 agar (as detailed in Appendix 5) at 37°C 
within a Containment Laboratory of biosafety level 3 conditions. Media was supplemented 
with 15 pg/ml kanamycin, 50 pg/ml hygromycin and 2% (v/v) sucrose as necessary. 
Escherichia coli DH5a cells were cultured using Luria-Bertani (LB) broth or agar as detailed 
in Appendix 5 and supplemented with 50 pg/ml kanamycin or 150 pg/ml hygromycin as 
required. OneShot® TOPIO E. coli cells (Livitrogen, Paisley, Renfrewshire, UK, product 
#C4040-03) were also cultured in LB, supplemented with 100 pg/ml ampicillin. Stored 
protein-fusion constructs were maintained in DH5a cells and transformed into One Shot® 
BL21(DE3)pLysS Competent E. coli cells (Invitrogen, product #C6060-03) for expression 
analysis in 2 x YTA medium.
2.2 PCR amplification
PCR amplification was performed on the Applied Biosystems GeneAmp® PCR System 9700 
Thermocycler (ABI, Foster City, United States) with an initial dénaturation step at 95°C for
3 min. Standard cycling continued between 94°C (30 s), 56°C (30 s) and 72°C (60 s) for 30 
cycles with a final extension step of 1 0  min to ensure frill length product before cooling the 
reaction to 4°C. When using primer pairs with a high GC content it was typical to raise the 
annealing temperature and empirically optimise the specificity of the amplification reaction. 
Fresh PCR products were used directly in TOPO® cloning reactions.
2.3 Ligation
Ligation reactions were prepared using endonuclease digested vector and insert DNA 
fragments. Fragments for ligation were purified using the Qiagen Gel Extraction Kit 
(Qiagen, Crawley, England, product #28604) or QIAquick PCR Purification Kit (Qiagen,
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product #28104) according to the manufacturers’ instructions. Vectors for ligation were 
treated with 0.01 U/pmol of ends of calf intestinal alkaline phosphatase (CIAP) (Promega, 
Southampton, England, product #M1821) at 37°C for 40 min to prevent re-ligation of the 
vector. Ligation reactions used 150 ng of DNA with an insert to vector molar ratio of 3:1. 
Reactions were mixed and placed at 14°C overnight and 1 pi of the reaction used in 
transforming chemically competent cells.
2.4 Agarose gel electrophoresis
Agarose gel electrophoresis was performed in an electrophoresis tank using 1 x TAB buffer 
(Appendix 5). Depending on the size of the product to be visualised 0.8, 1, 1.5, 1.8 and 
2.0% agarose gel was prepared for suitable resolution of the product sizes. Agarose gels 
were electrophoresed at lOOv until products were separated (0.5 -  1.5 h). Gels were 
removed from the tanks and placed in 1 x XAE buffer with 0.5 pg/ml of ethidium bromide 
solution (Mercury Brand Reagents, Northampton, England, product #5450) for 10 min. 
Ethidium bromide stained gels were viewed by UV light in a GEL Documentation system.
2.5 Transformation of E. co/i
A tube of chemically competent DH5a E. coli cells was transformed with 1 ng of plasmid 
vector or 1 pi of ligation reaction. The cells were gently stirred and incubated on ice for 30 
min. Cells were heat shocked for 30 s at 42°C before immediately transferring the tube to 
ice. S.O.C. medium, pre-warmed to 37°C, was added in 250 pi aliquots to the tube of E. coli 
cells. The tube was capped tightly, placed on its’ side at 37°C and shaken for 1 h. 
Pre-warmed LB plates supplemented with appropriate antibiotics were spread with dilutions 
of the transformation culture and incubated overnight at 37°C. Transformants were analysed 
by inoculating a 5 ml LB broth with a colony from the selective LB plates and incubated 
overnight at 37°C with shaking. Plasmid DNA was prepared using QIAgen Spin Miniprep 
kit (Qiagen, product #27106) and analysed by restriction digest.
39
Chapter 2. Materials and methods
2.6 Development of allelic exchange constructs
The deletion of targeted genes {Rv3058c, Rv2548 and Rv2745c) to generate mutant strains 
was accomplished using a suicide delivery vector to replace the target gene with the 
hygromycin-resistance gene. Approximately 1.5 kb fragments upstream and downstream of 
the gene targeted for deletion were amplified with the Pwo and Taq high fidelity DNA 
polymerase mix (Roche Molecular Biochemicals, Lewes, England, product #03553400001) 
using the primer pairs indicated in Table 2.1 The upstream and downstream fragments were 
cloned around the hygromycin gene in the mycobacterial suicide plasmid pSMTlOO 
(Figure 2.1) to create the allelic exchange construct (Figure 2.2). Upon transformation of 
M. tuberculosis H37Rv by electroporation of the construct, homologous recombination 
(Figure 2.3) occurs between upstream and downstream regions of the gene on the 
chromosome and those regions inserted into the suicide vector, resulting in exchange of the 
target gene with the hygromycin resistance cassette of the vector. The plasmid is unable to 
replicate in mycobacteria. The presence of sacB enables counterselection against single 
crossover events as this gene is lethal in the presence of sucrose. Double crossover mutants 
are selected in a single step by plating on media containing 2 % sucrose and hygromycin.
Table 2.1: Primer sequences and restriction endonuclease (REN) sites used in the cloning and 
development of allelic exchange constructs.
Construct Primer Sequence 5’-3’ 5 -REN site
Rv3058cA/Rv3058cB 
(R v ^ “c (upstream fragment)
CGGGATCCAACCGGATCGACTCGTTCAT BamHI 
CGGGATCCCTGCTTCTCGTCTGCGGCAT BamHI
I JVV.3UD0 C
KO vector) Rv3058cC/Rv3058cD
(downstream fragment)
GCTCTAGACTGCTGCTGGCCAAAGGCGG Xbal 
GCTCTAGAGCGGCAAGGCCCCATAGCTA Xbal
Rv2548A/Rv2548B 
(upstream fragment)
GGACTAGTGGCCAAACCTGGAAATTCAA Spel 
GGACTAGTTGGTGGTGTCGATCAGCTTC Spel
(i\V 2D 4o
KG vector) Rv2548C/Rv2548D 
(downstream fragment)
GCTCTAGACGATGTTCCCGGATCTGCAG Xbal 
GCTCTAGAACACTTCATCCAGGTCACCA Xbal
Rv2745cA/Rv2745cB 
c (upstream fragment)
GGACTAGTACTGGTGGTGTCCAGCCAGT Spel 
GGACTAGTACGACCTCACGCACCAAAGC Spel
(J\.V Z /4dC — ...........—  ■■ ’
KO vector) Rv2745cC/Rv2745cD 
(downstream fragment)
GCTCTAGACGGTGGTGTCGCTGGCGGTG Xbal 
GCTCTAGAATCGCCGCCGAAGTCTGGTTG Xbal
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Pvul (4 5 3 9 )
Xmal (17) 
'sm al (19) 
BamHI (2 2 )
C0LE1 ORI
-4paLI (3 8 5 2 ) 
5ssSI (3 7 1 1 )
Mscl (2 4 5 5 )
Spel (2 8 )
A pal (3 8 )
.Vrul (1 0 5 ) 
5c/I (3 5 2 )
Drain (6 2 6 )
pSMTlOO
4 6 5 5  bp
.ApaBI (6 2 7 )
BsfEII (8 6 9 )
aril (8 9 8 )
sal (1 0 6 2 )
Bglll (1158)
Yoal (1164)
Pstl (11 7 4 )
Yael (12 2 3 )
£coR\ (1 2 7 5 )
4c/I(i393)
sacB
Figure 2.1: Suicide vector pSMTlOO is a pUC19-based vector carrying a hygromycin resistance cassette 
(HYG), the counterselectable marker sacB and the E. coli origin of replication (COIEI ori).
The pSMTlOO plasmid contains an origin of replication (COIEI ori) that will replicate in E. coli but not 
mycobacteria and therefore will be lost upon transformation into M. tuberculosis. It carries sacB for 
counterselection against single crossover events and illegitimate integration of the plasmid.
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upstream
Kan
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ynpstream
Kan
TOPO
Rv3058c upstream
-j- TOPO
Q  Rv30S8c upstream
Hyg
pSMTlOO
sacB
D Hyg
upstrearn
pM1
sacB
+
upstream
pM1
sacB
Hyg
pM2
sacB
Figure 2.2: Schematic diagram of the cloning process used to create an allelic exchange construct.
Shown in this example is the cloning process performed for the construction of the allelic exchange construct 
pM2 used to create the ARv3058c KO mutant. (A) The upstream sequence of the target gene (Rv3058c 
upstream) is amplified by PCR and ligated into the pCR®-Blunt II-TOPO® vector. TOPO® cloning o f the 
downstream sequence of the target gene (Rv3058c downstream) is performed in parallel. All transformants are 
selected by plating on kanamycin containing media. (B) TOPO® cloned PCR fragments are individually 
excised from the vector to release the insert leaving a linearised TOPO® vector. (C) The released insert 
(Rv3058c upstream) is cloned into the pSMTlOO suicide vector and transformants with the correct orientation 
of the insert positioned upstream of the hygromycin resistance cassette are chosen to create the pMl 
intermediate construct. (D) The TOPO® excised Rv3058c downstream fragment is subsequently cloned, also in 
an orientated manner, to lie downstream of the hygromycin resistance cassette creating the allelic exchange 
construct (pM2). Note: the pSMTlOO vector was used in the production of the pM2 allelic exchange construct 
whereas the pSMTlOO-derived vector, pG5, was used to create the pM4 and pM6 constructs.
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Rv3058c upstream Rv3058c Rv3058c downstream
H37Rv chromosome
Hyg
Rv305ajc
d^ownttream
pM2
sacB
Rv30S8c upstream
I
Hyg Rv30S8c downstream
Rv3058c mutant
Figure 2.3: Schematic diagram of homologous recombination events occurring between the allelic 
exchange construct (pM2) and the H37Rv chromosome.
Electroporation of the allelic exchange construct (pM2) enables homologous recombination to occur between 
the wild-type H37Rv chromosome and the construct. Loss of the suicide plasmid and selection o f recombinant 
clones with a positive selective marker (Hyg) and a counterselective marker (sacB) results in the isolation of  
knockout mutants.
To ensure whole PCR products were cloned into the pSMTlOO suicide vector, upstream and 
downstream regions of the target gene were initially cloned into the TOPO® vector. Primer 
sequences (Table 2.1) containing a 5’ restriction endonuclease (REN) site were used in PCR 
amplification of M tuberculosis genomic DNA (gDNA). Amplified fragments with REN 
sites were cloned into TOPO® using the Zero Blunt TOPO® PCR cloning kit (Invitrogen, 
Paisley, England, product #K2800-20) and the recombinant plasmid digested with the 
appropriate restriction enzyme to release each cloned fragment. Products were separated by
43
Chapter 2. Materials and methods
agarose gel electrophoresis and the cloned fragment was gel extracted. Upstream and 
downstream fragments were then individually cloned into pSMTlOO treated with 0.01 
U/pmol of ends of CIAP to prevent re-circularisation and re-ligation. Plasmids from the 
resulting transformants were REN digested to confirm the correct orientation of each 
fragment inserted into the allelic exchange construct for each mutant. The pSMTlOO vector 
was used in the development of the pM2 allelic exchange construct, however for 
development of pM4 and pM6  the pSMT 100-derived suicide vector, pG5 (Figure 2.4), was 
used as an alternative. The advantage of pG5 is that it carries a kanamycin resistance 
cassette enabling an additional route for positive selection of the transformants.
.Yftol (5~36) 
55^ 1(5413).
KAN
/yiMKso-S) 
.Ybfll (4646) 
jsgin (4 6 4 0 )
Xarl (4632)
-4aîn (4380)
Sail (4364) 
(4349)
^ 0 1 (4 1 5 5 ) 
.4paBI (4109) 
HYG
Vdel(50)
£coR\ (102)
%I(-29)
Ssa.AJ (-9 6 )
Psil (905)
.t/scl (1 2 8 2 )
5895 b?
.4pal(3520)
I (3 5 1 0 ) 
Bam HI (3304)
Sapl(2249)
Ppil (3 0 S0 )
.4pcLI(26-'9) 
COLEI ORI
Figure 2.4: pG5 is a pSMTlOO-based plasmid carrying a kanamycin resistance cassette (KAN), the 
hygromycin resistance cassette (HYG) and sacB.
The pG5 suicide plasmid has all the features of pSMTlOO with the addition of a kanamycin resistance cassette 
that enables its selection on either kanamycin or hygromycin containing media.
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2.6.1 Genomic DNA preparation
Cultures of M  tuberculosis were grown to late log phase. In Universal tubes, 20 ml aliquots 
of the culture were pelleted by centrifugation (3 500 rpm, 15 min). The supernatant was 
carefully removed and the pellet resuspended in 1 ml of GTE solution (50 mM glucose, 25 
mM Tris-HCl, 10 mM EDTA) before transferring the culture to a 2 ml microcentrifiige tube 
and centrifuging (13 500 rpm, 5 min). The supernatant was aspirated and the cell pellet 
resuspended in 450 pi of GTE solution. Lysozyme (0.5 mg) was added to the suspensions 
followed by gentle mixing and incubation overnight at 37°C without shaking. Following 
incubation the suspension was heated to 80 °C for 2 h before further processing in the 
Category n  laboratory. lOOpl of 10% SDS (sodium dodecyl sulphate) was added and the 
suspension was gently mixed before adding 0.5 mg of proteinase K (Sigma, Gillingham, 
England, product #P4914). The mixed suspension was incubated at 55°C for 30 min. 
Following incubation, 200 pi of 5 M NaCl was added and the suspension mixed before 
addition of 160 pi of preheated (65°C) cetyltrimethylammonium bromide (CTAB) solution 
(6.3 mM sodium chloride, 2.47 mM cetrimide (Sigma, product #H5882)). The gDNA 
preparations were gently mixed prior to incubation at 65°C for 10 min. An equal volume of 
chloroform-isoamyl alcohol (24:1) was added and gently shaken to mix followed by 
centrifugation (13 500 rpm, 5 min). The aqueous upper layer was aspirated and transferred 
to a fresh microcentrifuge tube and the chloroform-isoamyl alcohol (24:1) extraction was 
repeated. An 800 pi aliquot of the aqueous layer was transferred to a new microcentrifuge 
tube, 560 pi of isopropanol added and the tube inverted to mix imtil the DNA was seen to 
precipitate out of solution. The gDNA prep was incubated at room temperature for 5 min 
and centrifiiged (13 500 rpm, 10 min). The supernatant was aspirated and 1 ml of 70% 
ethanol was used to wash the DNA pellet by inverting the tube followed by centrifiigation 
(13 500 rpm, 5 min). The supernatant was again removed and the pellet air dried with care 
to avoid over drying. The dried DNA pellet was resuspended with 50 pi of Tris-EDTA 
buffer and stored at 4°C to aUow the pellet to resuspend overnight.
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2.6.2 Transformation of Mycobacterium tuberculosis by 
electroporation
Competent cells were prepared by inoculating 80 ml of Middlebrook 7H9 broth, containing 
10% OADC, with 5 ml of late exponential phase culture of M tuberculosis H37Rv in a 
sterile conical flask. The culture was grown for a further 7 days with shaking (225 rpm) 
until turbid and transferred to 2 x 50 ml falcon tubes for centrifugation (3 500 rpm, 15 min). 
The supernatant was removed, the pellet resuspended and the cells washed twice in 40 ml of 
10% sterile glycerol. Following the second wash the pellet was resuspended in up to 1 ml of 
1 0 % glycerol (depending on the size of the pellet and the required volume of cells, i.e. 
200 pi of cells is required per electroporated sample). For allehc exchange the plasmid 
construct for electroporation was prepared to 200 ng/pl in water and 5 pi of the construct 
ahquoted onto a Petri dish then UV irradiated with one cycle of auto-cross-linking using a 
UV Stratalinker 1800 (Stratagene, La JoUa, California, United States). For replicating and 
AttB-integrative constructs, approximately 400 ng of the construct was used without UV 
treatment. The constructs ware then transferred to a 0.2 cm cuvette (EquiBio 
Electroporation cuvettes, Geneflow Ltd, Staffordshire, England, product #ECU-102) and a 
negative control transformation prepared using 5 pi of nuclease free water instead of 
plasmid. A 200 pi ahquot of competent M tuberculosis cells was added to each cuvette, 
pipetted to mix and the cuvettes incubated at 37°C for 10 min. The electroporator (BioRad 
Gene Puiser II (165-2105) connected to Pulse Controller II) was set to lOOOQ resistance, a 
capacitance of 25 pFd and a voltage of 2.5 kV. Each cuvette was electroporated individually 
and 1 ml of Middlebrook 7H9 broth + 10% OADC was added to the electroporated cells. 
The transformation cultures were mixed by pipetting and transferred from the cuvettes to 
sterile bijous, enclosed with parafilm and incubated overnight at 37°C with shaking. 
Following incubation the transformation reactions were plated-out onto Middlebrook 7H11 
media with 10% OADC (media supplemented with 2% sucrose, 50 pg/ml hygromycin or 
25 pg/ml of kanamycin dependent on selection criteria of construct).
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2.6.3 Southern Blot confirmation of knockout mutants
Replacement of the wild-type gene with the deleted gene was confirmed by Southern Blot 
analysis. A probe for the detection of the knockout mutant is designed to detect a specific 
sequence present in both the wild-type and the mutant. However, due to the presence of a 
unique restriction site present only in the mutant, the probed fragment is of % kb in the wild- 
type H37Rv chromosome and of y kb in the knockout. This distinguishes those isolates 
where a double crossover between the chromosome and the allelic exchange construct 
should result in the replacement of the chromosomal gene with the hygromycin resistance 
gene cassette.
The Rv3058c probe was developed using the Rv3058A and Rv3058B primer pairs (detailed 
in Table 2.1) which detects the upstream sequence of the Rv3058c gene. Similarly, the 
Rv2548 probe was developed using the Rv2548A and Rv2548B primers for detection of the 
upstream sequence of Rv2548 and the Rv2745c probe, developed from the PCR product of 
Rv2745A and Rv2745B primers, was used for detection of the upstream sequence of the 
target gene, Rv2745c.
Each probe was prepared using the DIG High Prime DNA labelling and Detection Starter kit 
II (Roche Molecular Biochemicals, product #11585614910) as per manufacturer’s 
instructions. Following incubation overnight at 37°C the labelling reaction was stopped and 
1 pi of the reaction used to determine the labelling efficiency with DIG Quantification 
Teststrips (Roche Molecular Biochemicals, product #1669958) and DIG Control Teststrips 
(Roche Molecular Biochemicals, product #1669966). Quantified probes were diluted to 
10 ng/ml in DIG Easy Hyb buffer.
Following restriction digestion of gDNA samples, from wild-type and mutant strains, the 
DNA was separated on a 0.8% agarose gel (see Section 2.4). The gel was processed 
according to the DIG Application Manual for Filter Hybridisation (Roche Diagnostics 2003). 
The gel was briefly stained in ethidium bromide and, following imaging, washed in 250 mM 
HCl for 10 min followed by gentle agitation in 200 ml Dénaturation Solution (2.5 M NaCl, 
0.5 M NaOH) for 2  x 1 5  min. The wash was repeated in Neutrahsing Solution (0.5 M
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Tris-HCl pH7.5,2.5 M NaCl) and the blot set up in  2 0  x SSC (Fluka, product #93017) buffer 
and DNA transferred overnight onto a nitrocellulose membrane.
Subsequent to DNA transfer onto the membrane, the blot was orientated DNA side up and 
processed by washing in  6  x SSC for 2 min. Excess buffer was drained from the membrane 
and the blot left to air dry followed by UV-crosslinking (1200 mJ) of the DNA to the 
membrane. The blot was then prehybridised with DIG Easy Hyb (10 ml/100 cm  ^filter) for 
30 min. The probe was denatured by boiling for 10 min and hybridisation of the probe to the 
membrane occurred overnight at 42°C with agitation. The blot was washed in succession 
begirming with 200 ml of Washing Buffer (0.1 M maleic acid, 0.15 M NaCl pH 7.5, 0.3% 
Tween 20) for 1 min followed by 100 ml of 1 x Blocking Solution (prepared at a 1:10 ratio 
of 1 part Blocking Solution to 10 parts Maleic Acid Buffer (0.1 M maleic acid, 0.15 M NaCl 
pH 7.5)) for 30 min. Binding with 20 ml of Antibody Solution (2 pi of Anti-Digoxigenin- 
AP, 20 ml of Blocking Solution) for 1 h was followed by two sequential wash steps using 
200 ml of Washing Buffer for 2 min followed by agitation of the blot in 20 ml Detection 
Buffer (0.1 M Tris-HCl, 0.1 M NaCl pH 9.5). The blot was carefully placed on saran wrap 
and 1 ml of CSPD ready-to-use solution pipetted over the blot which was then enclosed in 
the wrap (being careful to avoid production of air bubbles) and the blot incubated at room 
temperature for 5 min. Excess liquid was drained from the blot and it was transferred into a 
fresh wrap, incubated at 37°C for 10 min before detection of chemiluminescent hybridisation 
patterns with photographic film.
2.6.4 Complementation of M. tuberculosis knockout mutants
Complementation of knockout mutants was achieved by cloning each gene and its promoter 
into the integrating vector pKinta (a kind gift from Douglas Young’s lab). This vector 
(Figure 2.5) carries the kanamycin resistance gene, Kan, the int gene and the attP site 
allowing site specific integration of the plasmid at the attB site in the mycobacterial 
chromosome (Stover et al. 1992).
The ARv3058c mutant strain was complemented with the gene Rv3058c gene and another 
271 bp upstream of the start codon as the promoter site was unknown. Similarly the
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promoter region of Rv2745c was unknown and therefore the ARv2745c strain was 
complemented with 381 bp upstream of the start codon in addition to the Rv2745c gene. 
There is no intergenic region immediately upstream of Rv2548 as Rv2547 reads into the start 
codon of Rv2548. A  region of 378 bp upstream of Rv2548 was used for complementation of 
the ARv2548 strain which included the Rv2547 gene in addition to Rv2548. Complementing 
constructs were developed by amplifying these fragments (primers detailed in Table 2.2), 
cloning them into the Notl site of pKinta and transforming mutants with the complementing 
vectors by electroporation and selection on Middlebrook 7H11 with kanamycin.
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Figure 2.5: pKINTA suicide vector uses the int gene (INT) for site specific integration of the plasmid into 
the mycobacterial chromosome.
pKINTA is a ColEl-E.coli based plasmid which carries the aph gene confirming kanamycin resistance (KAN). 
It is unable to replicate in mycobacteria as an extra chromosomal plasmid but carries the int region and attP site 
from the L5 mycobacteriophage allowing it to integrate into the attB site on the chromosome of mycobacteria.
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Table 2.2: The primer sequences and restriction endonuclease (REN) sites used in the cloning of each 
complementation construct
Constni Primer Sequence 5’-3’ 5’-REN site
pKl
pK2
pK3
Rv3058c Compl_C 
Rv3058c ComplD 
Rv2745c Compl_A 
Rv2745c (TomplJB 
Rv2548 CompI A 
Rv2548 CompI_B
TGCGGCCGCGCTGCCTGGCGGCGGTTCGG
TGCGGCCGCCTATGKKRjCCTTGCCGCCACCCC
TCjCGGCCCjCTCGGATTGTCGATGC
TGCGGCCGCTTAGGCCACCGCCAG
TGCGGCCGCGTGTGGCATTACGACGAGAACTA
TGCGGCCGCAACGTTTTAGTCGAGTCGACG
Notl
Notl
Notl
Notl
Notl
Notl
2.6.5 Sequencing of complement constructs
Table 2.3 hsts the sequencing primers used for sequencing the complement constructs pKl, 
pK2 and pK3. All sequencing was performed by Lark Sequencing Technologies using the 
dye-termination method for sequencing on the ABI 3130x1 DNA Analyser instrument.
Table 23: Sequencing primers used for sequencing of complement constructs.
Constmct Primer Sequence 5’-3’
pKl pKl seq F3 Rv3058c CompIC
GTTTCTACTTCTACTTCGATTC
T(3C<3GCCGCœTœCT(jGC(j<3C(3GTTCGG
pK2 pK2 seq FI Rv2745c ComplA
TGACGATTGCGAGGTG
TGCGGCCGCTCGGATTGTCGATGC
pK3 pK3 seq FI Rv2548 ComplA
ACCTCAACGAACGACTTG
TGCGGCCGCGTGTGGCATTACGACGAGAACTA
2.7 Transposon Screen by Microarray
In addressing our aim to identify transcriptional regulators contributing to defective 
phagosomal maturation, the M. tuberculosis transposon hbrary (see Introduction section 
1.8.2), provided by David Russell, was re-analysed using a microarray readout of mutant 
identity. The identity of disrupted genes was revealed by labelling the transposon insertion 
sites and hybridising to a whole-genome microarray. The analysis of the transposon hbrary 
by microarray, termed Transposon Screen by Microarray (TSM), followed methods 
previously described (Badarinarayana et al. 2001;Stewart et al. 2005). Such screens are also 
known as transposon site hybridisation (TraSH).
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2.7.1 Preparation and labelling of TraSH screen 1
The transposon screen compared the M. tuberculosis transposon library of mutants before 
macrophage infection (input pool) against the mutants remaining after macrophage infection 
and iron-dextran selection (output pool) -see Chapter 1: Introduction, Section 3.6 for 
description of transposon hbrary selection. Genomic DNA was prepared from the pools of 
transposon mutants. DNA (1 pg) from each the input and output pool was digested with 
Haell generating an average fragment size of approximately 500 bp (see Figure 2.6 for 
schematic diagram of experimental design). The restriction digest was then purified using 
the QIAquick PCR Purification Kit. Oligonucleotides TAl and TA2 (Table 2.4) were 
annealed at 99°C and slowly cooled to room temperature to make a Y-shaped linker with a 
F?rie//-compatible 3' overhang. Approximately 100 ng of the Haell digested genomic DNA 
was ligated to 100 pmol of Y-linker with 500U of ligase in an overnight reaction at 14°C. 
The ligation was cleaned using MinElute PCR Purification Kit (Qiagen, product #28004) 
and 50 ng of ligated DNA was used as a template for the first Transposon Screen by 
Microarray PCR amphfication (TSMl) of transposon-fianking regions using 10 pmol of the 
Y-hnker specific primer TA4 (Table 2.4) and 10 pmol of the 1^1096 transposon specific 
primer ISl (Table 2.4). The hot start PCR reaction used 10% dimethyl sulfoxide (DMSO), 
500 pmol of a deoxyribonucleotide triphosphate (dNTP) mix and foUowing an initial 
dénaturation step of 2 min at 95°C, 0.85U of High Fidelity expand polymerase (Roche 
Molecular Biochemicals, product #11732650001) was added during a 30 s pause at 84°C. 
Cycling was then continued between 94.5°C (30 s) and 72°C (90 s) for 24 cycles. Amphfied 
products <350 bp were purified from a 1.3% agarose gel using the Qiagen Gel Extraction Kit 
and eluted into 30 jxl of EB buffer. The TSMl product was then used in a second round of 
PCR amplification (TSM2).
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Table 2.4; Primer and Y-linker sequences for each Transposon Screen by Microarray PCR (TSM) 
amplification round and their target sequence.
TSM amplification 
round
Primer/
Y-linker Sequence 5’-3’ Target
TAl ACTACGCACGCGACGAGACGTAGCGTCGCœ TA2/T1
TSMl TA2 GACGCTACGTCTCGTGTTGTCGGTCCTG TAl
T1 CGGACGCTACGTCCGTGTTGTCGGTCCTG TAl
TSMl/2/3/4 TA4 ACGACGCGACGAGACGTAGC Y-linker
TSMl ISI GCACGTCGAGGTCTTTCAGATGGATGGCG m 0 9 6
TSM2 IS2Nest TGGATGGCGTAGGAACCTCCATCATCGGA IS1096
TSM3 IS3 CCAGCGTCGGCCATTAGCTTCTGCAGC m 0 9 6
TSM4 IS4Nest GCTTCTGCAGCAACGCCAGGTCCACACTG IS>1096
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Figure 2.6: Schematic diagram of the experimental design for amplifîcation and labelling of the 
M. tuberculosis transposon library
Genomic DNA from input and output pools of the M. tuberculosis transposon library is digested with HaeW to 
produce fragments with HaeW overhang to which the Y-linker binds. First round amplification (TSM1/TSM3) 
of each flanking region of the transposon produces PCR products that are then targeted in a second round of 
amplification (TSM2/TSM4) to enrich for the transposon interrupted gene. Input and output pools are 
differentially labelled and hybridised to a whole genome microarray. Based on the figure by Badarinarayana 
(Badarinarayana et al. 2001).
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TSM2 included 10 pmol of the Y-linker-specific primer, TA4, and 10 pmol of a nested 
1^1096 transposon-specific primer, IS2Nest (Table 2.4) to increase the specificity and yield 
of transposon-flanking products whilst incorporating Cy3 or Cy5 labelled-dCTP (GE 
Healthcare Life Sciences, Chalfont, England, product #PA53031 and #PA55031 
respectively) into the nested PGR product. The PGR reaction included 1 pM Gy-dGTP, 180 
pM dGTP, and 200 pM of dATP, dGTP, dTTP in the same cycling conditions used in TSMl 
but for a total of 12 cycles. DNA from input and output pools are differentially labelled with 
Gy3 or Gy5 PGR products then cleaned using the MinElute PGR Purification Kit and 
products eluted in 10.5 pi of nuclease free water (Ambion, Warrington, England, product 
#9937).
TSMl and TSM2 reactions amplify one end flanking the transposon. Amplification of the 
other flanking sequence was performed in a separate PGR reaction, TSM3, using the 
Y-linker specific primer TA4 and the IS1096 transposon specific primer IS3 (Table 2.4). 
After gel extraction of TSM3 products <350 bp the product was used as a template in the 
nested PGR amplification TSM4. TSM4 was performed in a multiplex reaction with TSM2 
and included the nested 1^1096 specific primer with IS4Nest (Table 2.4).
Following amplification and labelling of both regions flanking the transposon, the 
differentially labelled DNA from the input pool was combined with the output pool and the 
paired reaction purified using Qiagen MinElute kit (Qiagen, product #28004) eluting into 
10.5 pi of nuclease free water.
2.7.2 Preparation and labelling of TraSH screen 2
In an alternative screen attempting to recover a greater proportion of mutants from the 
transposon library, the library was partially digested with MspI and HinPlI. These 
restriction enzymes cut more frequently (approximately every 74 bp and 8 6  bp, respectively) 
across the M. tuberculosis genome producing a greater coverage for the transposon screen. 
The digested products were combined and fragments were size selected by gel extracting 
products between 250-1500 bp in size. The Y-shaped hnker, TAl and T1 (Table 2.4) with 
an Msp//H/«P/-compatible 3’ overhang, was ligated to the fragments, followed by TSMl
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and TSM3 amplification as previously described. TSMl and TSM3 products were 
processed for further size selection by gel extraction of products <450 bp in size. The 
multiplex reaction of TSM2 and TSM4 performed in screen 1 was considered to be 
potentially inhibitory to the amplification of each target and therefore in screen 2  these 
nested amplifications were performed in separate reactions. Products of TSM2 and TSM4 
were then combined and purified as per screen 1 .
2.8 Expression profiling
2.8.1 RNA isolation from Mycobacterium tuberculosis
Cultures of M. tuberculosis were grown to late exponential phase in universal tubes and 
2 X volumes (20 ml) of RNAprotect Cell Reagent (Qiagen, product #76526) were added and 
immediately vortexed to quench the culture. Following incubation at room temperature for 
10 min the suspension was pelleted by centrifugation (3 500 rpm, 15 min). The supernatant 
was carefully removed and the pellet resuspended in 1.2 ml of Trizol Reagent (Invitrogen 
Life Technologies product #15596026) before transferring the suspension to a 
microcentrifuge tube containing 0.5 ml of 0.1 mm silica/ceramic beads and processed at 
6.5W for 45 s in a Ribolyser (Hybaid). Further processing of the samples was performed in 
the Category II laboratory. Chloroform (240 pi) was added to each tube and vortexed for 
15 s. The samples were then allowed to stand at room temperature for 2 min before 
centrifiiging (12 000 x g°C, 10 min). The aqueous phase was removed and re-extracted 
with chloroform (equal volume). Isopropanol (600 pi) was used to precipitate the RNA at 
room temperature for 15 min. The RNA was then pelleted by centrifiigation (12 000 x g, 
8 °C, 10 min). The supernatant was removed and the precipitated RNA was washed with 
75% ethanol before centrifugation (7 500 x g^  g°C, 5 min). The pellet was air dried and 
resuspended in 40 pi of nuclease fi*ee water.
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2.8.2 RNA purification, quantification and integrity analysis
Following extraction, the RNA was cleaned up using the RNeasy Mini kit (Qiagen, product 
#7410) according to the manufacturer’s instructions for RNA stabilisation and isolation for 
bacteria without lysozyme treatment. Briefly, the RNA samples were adjusted to 100 pi 
with nuclease fi*ee water and 350 pi of RLT buffer added. Following mixing, 250 pi of 
1 0 0 % ethanol was added and the samples mixed again by pipetting before transferring the 
samples to an RNeasy mini column in a 2 ml collection tube and centrifuging (10 000 rpm, 
15 s). The flow through was discarded and the column replaced in a clean microcentrifuge 
tube and 350 pi of Buffer RWl was added to the column followed by centrifugation 
(10 000 rpm, 15 s). The eluate was discarded and on-column DNA digestion was carried out 
by adding 80 pi of RNase-free DNase I solution (Qiagen, product #79254) to the column and 
incubating the samples at room temperature for 15 min. To the column, 350 pi of Buffer 
RWl was added and the samples were centrifuged (10 000 rpm, 15 s), the flow through 
discarded, and 500 pi of wash buffer RPE added before centrifuging (10 000 rpm, 15 s) 
again. The flow through was discarded and the wash repeated followed by centrifuging the 
samples (10 000 ipm, 2 min). Each column was then placed in new microcentrifuge tubes 
and centrifuged (10 000 rpm, 1 min) to remove residual alcohol. The RNA was eluted in 
50 pi of RNase-fi’ee water into a clean 1.5 ml microcentrifuge tube and samples stored at 
-80°C until use. The quantity of RNA was determined using the NanoDrop^^ ND-1000 
UV-Vis Spectrophotometer (Thermo Scientific, Waltham, U.S.) and the quahty of RNA 
determined using the Agilent 2100 Bioanalyser using the Agilent RNA 6000 Nano Kit 
(Agilent, product #5067-1511). A rRNA ratio [23S / 16S] >1 indicated good quality RNA 
and together with an RNA integrity number (RIN) >9 the sample was confirmed to be of 
sufficient quality for cDNA synthesis.
2.8.3 cDNA preparation and labelling
Following quantification of RNA samples 8.5 pg of each sample was transferred into 
nuclease free tubes. Random primers (Invitrogen #48190-011) (3 pg/pl) were added and the 
reaction volume brought to 11 pi with nuclease free water. The reaction was heated to 95°C
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for 5 min, snap cooled on ice, and centrifuged briefly to collect the reaction volume at the 
bottom of the tube. To the reaction a 5  x solution of First Strand Buffer (250 mM Tris-HCl, 
pH 8.3, 375 mM KCl, 15 mM MgCl:) was added in addition to 0.2 pM of dithiothreitol 
(DTT), dNTPs (5 mM dA/G/TTP and 2 mM dCTP), Cy3/Cy5-labelled dCTP and 500U of 
Superscript II (Invitrogen, product #18064-014). The reaction was placed at 25°C in the 
dark for 10 min followed by incubation at 42°C for 2 h to transcribe the template RNA to 
cDNA incorporating the Cy-labelled dCTPs. The labelling reactions were then combined 
and purified using the Qiagen MinElute PGR Purification Kit according to the 
manufacturer’s instructions. The labelling efficiency was determined using the NanoDrop^ 
ND-100 UV-vis Spectrophotometer. If Cy dye incorporation was >5 pmol/pl then the 
samples could be used for microarray hybridisation.
2.9 Macrophage infection
The murine macrophage cell line, J774, was cultured fi*om hquid nitrogen fi’ozen stocks in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen, product #11885-092) with 
glutamine supplemented with 10% v/v foetal bovine serum (Invitrogen, product #10109- 
155) lOOU/ml penicillin and 100 pg/ml streptomycin (Invitrogen, product #10378-016) at 
37°C with 5% CO2 . J774 cells were counted using a Neubaeur hemocytometer (Weber 
Scientific, Int., Middlesex, England), seeded in 24-well plates at a density of 4 x 10^  
cells/ml/well and incubated overnight to allow adhesion of the cells to the base of each well. 
Bacterial strains were grown to late log phase without antibiotics and pelleted (3 500 rpm, 8  
min) before removing the media and resuspending the pellet in the same culture volume of 
phosphate buffered saline (PBS). The bacterial count was determined by UV absorbance at 
ODeoo nm given that an optical density (OD) of 1.0 is equivalent to 1 x 1 0 * cells/ml. 
Macrophages were infected with M tuberculosis strains at a 1:1 ratio by pipetting the 
appropriate volume of bacterial cells into antibiotic fi'ee DMEM and transferring 1 ml of the 
homogenous suspension to each well. Four biological replicates were performed for each 
strain at each time point. Following 2 h of infection at 37°C the cultures were washed 
extensively in PBS to remove extracellular bacteria before adding 1 ml of fi’esh antibiotic 
fi*ee media to each well. The time of incubation varied fi’om 0 h to 5 days and is stipulated
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for each experiment described in the results. Macrophages were lysed with 1 ml of 0.1% v/v 
Triton-X-100 and serial dilutions of the cultures were plated onto Middlebrook 7H11 agar 
without antibiotic using the Miles-Misra technique (Miles & Misra 1938). Colony forming 
units/ml (CFU/ml) in a bacterial suspension were counted by preparing serial dilutions of the 
culture and dispensing 0.02 ml drops of suspension onto agar plates. For each biological 
replicate, four technical replicate samples were plated to determine the survival count for 
each strain. Following 2-3 weeks incubation colonies were counted and the macrophage 
survival counts (CFU/ml) of each strain were compared against that of the wild-type 
M. tuberculosis H37Rv strain. Survival counts were plotted and the standard error of the 
mean (om) is used to indicate the standard deviation of the sampling distribution of the mean 
using the formula: om = o/Vn where a is the standard deviation and N the sample size. This 
provides a simple measurement of the uncertainty associated with the spread of values 
obtained through biological and technical replication. The om has been applied here to data 
sets over other calculations of confidence as it provides an unbiased estimate that is based on 
sample size. That is, with increasing sample size the standard error of the mean is smaller 
and the estimation of error more accurate.
2.10 Mouse infection
In vivo work was performed by the Group at Imperial College London. Groups of 24 
C57BL/6 mice were infected with 3  x 1 0  ^ CFU/ml of wild-type, ARv2548 or ARv2548 
complemented strains prepared in 40 pi of PBS/Tween 80. Infection was via the intranasal 
route and the mice were killed at 14,36 and 56 days following infection. Dissected lung and 
spleen were transported to the University of Surrey Category HI facility where each organ 
was resuspended in 2  ml of distilled H2O and placed in a stomacher bag for manual 
homogenisation. Dilutions of the homogenised organs were prepared and the Miles and 
Misra technique for quantifying CFU/ml was employed. Further in vivo work on ARv2745c 
and the ARv2745c complemented strain was performed at The Institute of Pasteur. C57BL/6 
mice were infected with 1 x 10^  CFU/ml via the intranasal route.
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2.11 Growth curves
Growth curves for mutant and wild-type M. tuberculosis strains were performed in 100 ml 
volumes of antibiotic free Middlebrook 7H9 broth in sterile conical flasks. Bacterial 
cultures were grown to late exponential phase in 5 ml volumes and a 1% v/v inoculum of 
culture was added to the 100 ml broth cultures. ODeoo measurements were taken every 24 h 
for a maximum duration of 14 days. Miles and Misra dilutions were plated onto 
Middlebrook 7H11 agar at 24 h time points. Samples of bacterial cultures were plated onto 
Brain Heart Infusion agar (Oxoid, Basingstoke, U.K., product #CM0225) to test for the 
presence of contaminants over the course of the growth curve. Phenotypic differences for 
each strain were compared to that of the wild-type strain by plotting colony counts and 
absorbance readings for the duration of the growth curve. The mean generation time for 
each strain was calculated empirically from the exponential phase of growth as determined 
from the growth curve. Generation time (g) was determined using the equation: g = 
(logioNt-logioNo)/ logio  ^where to = ODeoo at the time point at the base of the exponential part 
of the growth curve and t = ODeoo at the peak of the exponential curve and N = logic viable 
cells/ml.
2.12 Estimation of viabiiity under stress conditions
M. tuberculosis strains were grown in Middlebrook 7H9 broth containing 0.05% Tween 80 
supplemented with 10% OADC until all strains had reached mid-log phase and a similar 
ODeoo. A series of 5 ml standing cultures (with 2 or 3 biological replicates) were used for 
determination of the number of CFU/ml after exposure to stress. For heat shock the cultures 
were shifted from 37°C to 53°C, and the numbers of CFU/ml were determined at 0, 30, 60, 
90, and 120 min. Results are expressed as the percentage of survivors with respect to to. For 
oxidative stress, 0 pM, 2 pM and 8  pM concentration of hydrogen peroxide was added to the 
culture medium and the cultures were incubated at 37°C. The numbers of CFU/ml were 
determined following 90 min incubation.
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2.13 Microarrays and hybridisations
The M. tuberculosis microarrays were provided by the Bacterial Microarray Group at 
St. George’s (Bpg@s) (http://www.bugs.sgul.ac.uk) and consist of 4295 70mer 
ohgonucleotides representing the 3924 open reading frames (ORFs) for M. tuberculosis 
taken from the Qiagen Tuberculosis Genome Oligo set. Microarray hybridisation followed 
the Bpg@s’ protocol for RNA/cDNA hybridisation. Briefly, pre-hybridisation solution 
(3.5 X SSC, 0.1% SDS and 10 mg/ml BSA) was preheated to 65°C and the microarrays were 
incubated in the solution for 20 min. The slides were rinsed in distilled water for 1 min then 
propan-2-ol for 1 min followed by centrifugation (1 500 rpm, 5 min) to dry the slides.
The Qiagen MinElute purified Cy3/Cy5-labelled DNA sample for hybridisation to the 
microarray was adjusted to 16 pi using hybridisation solution (4 x SSC, 0.3% SDS) followed 
by heating to 95°C for 2 min. The hybridization solution was allowed to cool to room 
temperature, briefly centrifuged and pipetted onto the microarray. Using fine forceps, care 
was taken to place a LifterSlip (Erie Scientific, Portsmouth, U.S.A., product #221x25-2- 
4733) across the array avoiding the introduction of bubbles beneath the cover slip. A 
Coming® Hybridisation Chamber (Coming, product #2551) was prepared with a 15 pi 
ahquot of water m the well at each end of the cassette and the slide was sealed within. 
Incubation of the cassette protected from light at 65 °C provided the required humidity for 
hybridisation of the microarray for a period of 16-20 h. Following hybridisation the slide 
was washed for 2 min at 65°C in pre-heated Wash A ( 1  x SSC, 0.05% SDS), 2 min at room 
temperature in Wash B (0.06 x SSC) and then dried by centrifugation (1 500 rpm, 5 min).
2.13.1 Scanning TraSH microarrays using GenePix
Hybridised TraSH microarrays were scanned with an Axon GenePix® 4000B Microarray 
dual-laser Scanner (Axon Instruments, Wokingham, U.K.). The scanned JPEG images 
produced were analysed with GenePix® Pro version 6.0 and the median fluorescent intensity 
(MFI) of each spot calculated.
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2.13.1.1 Data analysis of TraSH microarrays using GenePix
A specified GAL (GenePix Array List) file was uploaded into GenePix® Pro version 6.0 
software which identifies each gene and describes the position of each gene in relation to the 
size of the array. The GAL file was used to fit a grid over the array and the fluorescent 
signal in each channel was quantified. Absent or bad spots were flagged by manual 
selection using GenePix® Pro software and data was filtered by removing any spots <50 
MFI; these spots were excluded from further analysis. Remaining spots were included and 
the MFI calculated by the software. Ratio (Cy3/Cy5) values were determined for each gene 
using the MFI of the output pool divided by the MFI of the input pool (see Section 2.7.1). 
T-tests were performed for each gene across independent duplicate microarray TraSH 
experiments with dye flips to allocate a significance level to each gene. The cut-off value 
applied for determining non significance was greater than or equal to 0.05. Raw data was 
also analysed using Significance Analysis of Microarrays (SAM) software developed by 
Stanford University, California (http://www-stat.stanford.edu/~tibs/SAM/). T-tests were 
performed using the SAM software which corrects for multiple testing.
2.13.2 Scanning expression profiling arrays using Affymetrix
array scanner
The Affymetrix 428™ Array Scanner was used to scan expression profiling microarrays. 
Following excitation at two different wavelengths (532 and 635 nm) the scanner produces a 
separate TIFF image file and an Excel spreadsheet file of fluorescence values for each 
wavelength.
2.13.2.1 Data analysis using BlueFuse/GeneSpring
The image files produced from the Affymetrix Array Scanner were imported into BlueFuse 
software (Blue Gnome) for two-channel microarray image analysis. The signal channel 
(knockout mutant sample or complemented sample) was labelled as channel 1 and the 
control channel (wild-type sample) labelled channel 2. BlueFuse performs automated grid
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placement using the specified GAL file containing gene identification and positioning 
information for the array. The IDs of control features present in the array were manually 
entered and the fluorescent signal of each spot on the microarray quantified by the BlueFuse 
software. The batch of results for replicate arrays including dye swaps is saved and the 
software produces an Excel spreadsheet file of non-normalised data for each chaimel. The 
Excel files were then uploaded into GeneSpring GX Software version 7.3 (Agilent 
Technologies). Signal channels are set as AMPCHl and the control channel set to AMPCH2 
taking into account dye swaps of the experiment. Normalisation of the data was performed 
using the Lowess (locally weighted linear regression) normalisation procedure which 
subtracts a Lowess regression curve from the data in order to linearise it. The regression 
curve calculates the dependence of the ratio on the intensity across the data set by weighting 
each point for the distance they are from the regression point. The local regression was 
based on 20% of the spots that are closest in terms of intensity value to the spot for which 
the local regression is being predicted.
2.13.2.2 Data analysis using Limma
The Limma (linear models for microarray analysis) (Smyth 2005) package was applied by 
Dr Andrzej Kierzek for analysis of all expression profiling data generated. Limma creates 
an MA plot which shows the intensity-dependent ratio of raw microarray data. 
M is defined as the intensity ratio (logiR - logiG) for each gene and plotted on the y-axis and 
A defined as the average intensity for a data point (% x (logiR + log2G) and plotted on the x- 
axis. The MA plot clearly visuahses any significant curvature of the un-normalised data. 
Often at low signal intensities there is a systematic bias skewing the data. Any bias observed 
in the data was removed by applying Lowess normalisation. By applying Lowess 
normalisation each spot is normahsed to the local average in a block within an array (see 
Figure 2.7 for an example). This accounts for any hybridisation variability across an array. 
Importantly, control spots were excluded from the normalisation process as these spots 
would affect the regression analysis for each of the genes. Following normalisation, 
duplicate spots were averaged across each array and then across duplicate arrays taking into 
account dye swaps. Overall, within each experiment (e.g. mutant versus wild-type) an
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average value is achieved for each gene across three to four replicate arrays as predicted by a 
linear model.
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Figure 2.7: MA plots illustrating data before Lowess regression analysis and the resulting smoothing of 
data following normalisation.
The Limma (Linear Models for Microarray Analysis) package enables Lowess normalisation to be performed 
on microarray data that exhibits systematic bias. (A) Un-normalised MA plot. Each spot is normalised, using 
Lowess, to the local average (red line) in a block within the array removing systematic bias that commonly 
occurs at low intensity signal. (B) The spread of data following Lowess regression analysis results in a 
smoothing of the data.
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Following normalisation the fold change was determined for each gene across rephcate 
arrays. A t-Test was then performed to determine statistically significant differences 
between gene expression across replicate arrays. The t-Test implemented in LIMMA is a 
moderated t-Test which differs from the Student’s t-Test in how the variance is calculated. 
The Student’s t-Test calculates variance from the data available for each gene whereas a 
moderated t-Test estimates the variance for each gene using information from all genes 
(Smyth 2004). It uses an empirical Bayes method which functions to reduce the estimated 
sample variance to a pooled estimate. An adjusted P-value was used to determine a 
significance level for each gene, where the cut-off for non-significance is P>0.05. The 
Benjamini and Hochberg (Hochberg & Benjamini 1990) method for adjustment of multiple 
testing was applied which calculates a False Discovery Rate (FDR) representing the 
expected proportion of false positives. The FDR is also important when determining 
whether a gene is significantly up or down regulated and the cut-off is user defined at 0.1.
2.14 Validating microarray data
Microarray data provides a broad overview of gene expression occurring in a sample and is a 
valuable analytical tool for highlighting significantly up/down regulated genes in a 
complicated milieu. However, other independent gene expression profiling methods are 
necessary to confirm the validity of the microarray results that are of particular interest. 
Quantitative real time PCR (qRT-PCR) analysis was applied to cDNA samples to 
independently confirm the expression of a small subset of genes highlighted by the 
microarray results.
2.14.1 RNA preparation
RNA was extracted as before (see Section 2.8.1) and purified (Section 2.8.2) until the point 
of DNase treatment whereby the removal of contaminating genomic DNA from samples was 
performed by DNase treatment. The DNase treatment reaction, using the Promega RQl 
RNase-Free DNase set (Promega, product #M6101), contained 5 pg of RNA, 2 pi of DNase 
buffer, 2 pi of RNase-free DNasel and the addition of nuclease free water brought the
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reaction to a final volume of 20 pi. Following incubation of the reaction at 37°C for 30 min 
2 pi of DNase Stop solution was added (Promega, product #M199A), samples were then 
incubated at 65°C for 10 min and stored at -80°C. RNA samples were quantified on the 
Nanodrop™ Spectrophotometer and the integrity assessed using the Agilent Bioanalyser as 
described in Section 2.8.2.
2.14.2 Reverse Transcription PCR
Complementary DNA (cDNA) sequences were prepared from aU bacterial strains by reverse 
transcription (RT) of extracted RNA samples using Superscript II (Invitrogen, product 
#18064-022). RT reactions were prepared using 1 pg of RNA sample (DNase treated) in a 
4 pi volume, 1.5 pi of 10 mM dNTPs, 4.5 pg of random hexamers (Invitrogen, product 
#48190-011) and the reaction brought to a total volume of 12 pi with RNase-free water. 
Reactions were incubated at 65°C for 5 min then placed on ice. RT mastermix was prepared 
on ice in 8 pi volumes containing 1 x RT buffer, 2 pi 0.1 M DTT, 1 pi RNaseOUT™ 
Recombinant Ribonuclease Inhibitor (Invitrogen, product #10777-019), 50U Superscript II 
and 0.75 pi of nuclease free water. The RT mastermix was scaled up accordingly and 8 pi 
added to the RNA/primer mix. RT reactions without Superscript II or Ribonuclease 
Inhibitor (RT-) were prepared in parallel and all reactions placed at 25°C for 10 min, then 
50 min at 42°C, followed by 15 min at 70°C. Water was added to bring the input RNA 
concentration to 10 ng/pl and the cDNA samples stored at -20°C.
2.14.3 Quantitative real time PCR
Quantitative real time PCR (qRT-PCR) was performed using the Applied Biosystems (ABI) 
Prism® 7000 Sequence Detection System for quantitative gene expression analysis. Primer 
Express® software (ABI) version 2.0 was used to design the TaqMan® probe and primer sets 
(Table 2.5) according to the parameters described by ABI. Primers are unmodified and each 
probe is dual labelled with 5’ FAM and 3’ TAMRA. Genomic DNA (gDNA) standards
were used for the construction of a standard curve enabling the relative expression of each
target gene to be determined. A six-point standard curve was prepared by diluting a stock of
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gDNA prepared to 1 x 10^  genomes/pl. A single copy of an M tuberculosis genome is 
4.791 X 10'^  pg in weight. Therefore, 1 x 10^  genomes/pl = 4.791 x 10'^  x lo^ or 47.91 ng. 
PCR reactions were prepared for each gene target, in 25 pi volumes, using 10 pmol of each 
forward and reverse primer, 2.5 pmol TaqMan probe, 2 x QPCR ROX (500 nM) Mix 
(ABgene, product #AB-1138/a) and 5 pi of water. The PCR mastermix was scaled up for 
four biological replicates of cDNA, each with a technical replicate and RT- (without 
Superscript II) reactions. gDNA standards and cDNA samples were pipetted in duplicate 5 
pi volumes into a 96-well plate (ABgene, product #AB-1100/w). To each sample 25 pi of 
mastermix was added, the plate sealed with a QPCR adhesive seal (ABgene, product #AB- 
1170) and the plate centrifuged (1 000 rpm, 1 min) to ensure collection and mixing of the 
reaction contents. The plate was loaded onto the ABI Prism® 7000 Sequence Detection 
System instrument and set to heat to 95°C for 15 min to activate the polymerase, and then 
cycled from 56°C for 30 s to 72°C for 30 s for a total of 30 cycles.
Table 2.5: Oligonucleotide sequences and probe modifications nsed for quantitative real time PCR of 
gene targets.
Oligonucleotide Sequence (S’- 3’) Modifications
Rv0251cFwd GAACAATCTCGCATTGTGGT
Rv0251cRev CGCCATCCTTGACGATCT
Rv0251c Probe TGACTTCTTCGGCCCTGCCG 5’ Fluorescein, 3’ Tamra
Rvl043cFwd TTGACTCGGATATCGGTCTG
Rvl043c Rev GATGTACTTCTGCCCCATGA
Rvl043c Probe GGACTTCTGCTGCCGCTCGG 5’ Fluorescein, 3’ Tanua
Rv2461cFwd AAAGAAATGTTCCGGCTCAA
Rv2461cRev ACTGTGCTTCTCCATTGACG
Rv2461c Probe ATCGCGACCGCTGGTTCA 5’ Fluorœcein, 3’ Tamra
Rv3596cFwd TCCTGTTTATCGACGAGCTG
Rv3596c Rev CGATGTACTTGCGGTATTCG
Rv3596c Probe CGCTCGCGGTGAACTGCAAA 5’ Fluorœcein, 3’ Tamra
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2.14.4 Data analysis
Following amplification, the standard curve was used to set the baseline and was determined 
empirically fi'om cycle 2 and finishing at the cycle number where the plot initially takes off 
minus 3 cycles. The threshold was also determined empirically and defined by the user to be 
centred at the exponential phase of the plot and the run analysed automatically by the ABI 
Prism® 7000 software. The extracted raw data gave quantitative figures of mRNA transcript 
copy numbers present in each sample. Values for RT- (reverse transcription reactions 
without Superscript II) reactions were subtracted from RT+ (reverse transcription reactions 
with Superscript II) reactions as a control for gDNA contamination that may have been 
present. Technical and biological replicates were averaged across 3-4 replicate experiments 
and the induction ratio of each gene determined against the wild-type control RNA sample. 
Microarray induction ratios of each gene target were compared with qRT-PCR ratios using 
Merlin statistics software version 2.5. The Pearson Correlation was used as a parametric test 
for correlation between the microarray and qRT-PCR data. The non-parametric Spearman 
Correlation coefficient (p) was also used to test the relationship between data sets. The 
equation for p = 1- (6%di^ /n(n -^l)) where the Spearman Correlation ranks the data to 
compute 2]di^  before determining the correlation coefficient and is therefore not affected by 
outliers like the Pearson Correlation (Corder & Foreman 2009).
2.15 Bioinformatic analysis
The following bioinformatics search tools were used for sequence analysis of genes, plasmid 
constructs, and protein sequence ahgnment and in searching transcriptional binding motifs.
2.15.1 Vector NTI
The AlignX function in Vector NTI software version 10.3.0 was used for the alignment of 
sequencing data against M  tuberculosis H37Rv exported sequences from TubercuList.
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2.15.2 BLAST
The Basic Local Ahgnment Search Tool (BLAST) available at http://ncbi.nlm.gov/ 
pubmed/ was used to BLAST two sequences to provide comparisons of identity and 
similarity between amino acid or nucleotide ahgnment.
2.15.3 CLUSTALW
Protein sequence alignment was performed using ClustalW2 (http://ebi.ac.uk/tools/ 
clustalw2/index.html) web based program. Sequences were provided in PASTA format for 
pile up and phylogénie tree production.
2.16 Over expression of recombinant Rv2745c (CigR)
2.16.1 Development of expression construct with native
N-terminus in E. coli
To overproduce the Rv2745c transcriptional regulator the inducible expression vector, 
pETlOl/D-TOPO®, (Figure 2.8) (Invitrogen, product #K101-01) was selected for the 
development of a fusion protein with a native N-terminus. The pETlOl/D-TOPO® vector 
enables directional cloning of the target gene and carries the Tl/lac promoter for high level 
expression of the recombinant protein tagged to 6xHis residues at the C-terminal for 
detection and purification. The pET101/D-TOPO/Rv2745c recombinant expression 
construct was created by amplifying Rv2745c from the M. tuberculosis H37Rv chromosome 
with 0.1 pM pET101-Rv2745c Forward and pET101-Rv2745c Reverse primers (Table 2.6) 
using the Pwo Superyield proof reading polymerase (Roche Molecular Biochemicals, 
product #04 340 868 001), 1.5 mM dNTPs and 10% DMSO. PCR cycling continued 
between 94.5°C (30 s), 63°C (30 s) and 72°C (60 s) for 30 cycles with a final extension step 
of 10 min to ensure full length product. The PCR product was electrophoresed (see Section 
2.4) in a 2% agarose gel and gel extracted. Rv2745c was cloned downstream of the 
pET101/D-TOPO®-encoded ribosomal binding sites and the recombinant vector was then
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transformed into One Shot TOPIO E. coli. Cloning reactions used 1 pi of fresh PCR 
product, 1 pi salt solution, 1 pi TOPO® cloning vector prepared to a final volume of 6 pi 
with sterile water. The reaction was gently mixed and incubated at room temperature for 
30 min. Chemical transformation reactions used 3 pi of the described cloning reaction 
gently stirred into a vial of OneShot® TOPIO competent cells, incubated at room temperature 
for 15 min, heat-shocked for 30 s at 42°C then placed on ice. The cells were resuspended in 
250 pi of room temperature SOC medium, incubated at 37®C for 1 h then plated onto LB 
agar containing 50 pg/ml of ampicillin. Positive transformants were identified by PCR 
screening of colonies using pET101-Rv2745c Forward and pET101-Rv2745c Reverse 
primers. Those clones identified to contain the gene were then further characterised by Bgll 
digests to ensure correct length and orientation of insert before proceeding to expression 
studies using BL21 Star™ (DE3) cells. Propagation and maintenance of the recombinant 
vector was restricted to TOPIO cells. The recombinant vector was sequenced by Cogenics 
Ltd and this confirmed the gene was in frame with the C-terminal fusion tag.
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Figure 2.8: The pETlOl/D-TOPO expression vector carries P-lactamase, the ampicillin resistance gene 
(AMP), the high-level IPTG-inducible promoter, the C-terminal V5 epitope tag and the C-terminal 
6 xHis tag.
pETlOl/D-TOPO® vector contains the selective ampicillin resistance marker, Amp, the high-level 
IPTG-inducible promoter, TlUac, the C-terminal V5 epitope tag and the C-terminal 6xHis tag. It is a low-copy 
number plasmid containing the la d  ORF encoding the lac repressor which binds to the Tllac promoter to block 
basal transcription of the cloned gene. The lac repressor also binds to the lacUVS promoter in the host E. coli 
chromosome to repress transcription of T7 RNA polymerase.
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Table 2.6: Primer sequences used in the cloning of Rv2745c into the pETlOl/D-TOPO expression vector 
and the primers used for sequencing o f positive clones.
Primer Sequence (5’-3’)
pETlOl -Rv2745c Forward CACCATGGCGGCTTTGGTG
PET101-Rv2745c Reverse GGCCACCGCCAGCGA
T7 TAATACGACTCACTATAGGG
T7 Reverse TAGTTATTGCTCACGGTGG
2.16.2 Pilot expression of His-tagged protein
BL21 Star™ (DE3) E. coli strain was used for the expression of genes regulated by the T7 
promoter. The pET101/D-TOPO/Rv2745c expression construct was transformed into BL21 
cells and cultured with 100 pg/ml ampicillin and 1% glucose to prevent leakiness of 
expression. The culture was grown overnight at 37°C with shaking and used to inoculate 
(1:100 dilution) a fresh 10 ml broth the following day. The culture was grown to an ODeoo 
of 0.5-1.0 (approximately 2 h), split across two universal tubes and one culture induced with 
0.5-1 mM isopropyl p-D-l-thiogalactopyranoside (fPTG). Samples (0.5 ml) were taken each 
hour for six hours, pelleted down by centrifugation (13 000 rpm, 1 min) and pellets frozen at 
-20°C. An overnight sample was also harvested. Samples were analysed by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Blue.
2.16.3 Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis
SDS-PAGE was performed using BioRad Mini-Gel apparatus with a 4% stacking gel and a 
12% separating g e l in  1 x SDS-PAGE Running Buffer (10 x Running Buffer: 0.25 M Tris, 
0.55 M glycine, 1% SDS). SDS-PAGE gels were run at 150-200v for approximately 1 h. 
Protein sizes were compared to the BenchMark™ Pre-stained Protein Ladder (Invitrogen, 
product #10748-010). Gels were stained with Coomassie Blue Staining Solution (50% (v/v) 
methanol, 10% (v/v) acetic acid, 0.25% (w/v) Coomassie Blue (Sigma Aldrich, product 
#27816)) followed by washing in Destaming Solution (10% (v/v) methanol, 5% (v/v) acetic 
acid).
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2.16.4 Purification of His-tagged protein
A 100 ml culture of transformed BL21 (DE3) E. coli cells was used for the purification of 
His-tagged Rv2745c protein. The culture was induced with 1 mM IPTG for 4 h before 
pelleting (3 500 rpm, 15 min). The pellet was frozen at -20°C and resuspended in 2 ml of 
BugBuster® Protein Extraction Reagent (Novagen, Madison, US, product # 70584-3) and 
incubated at room temperature for 20 min on a rotating mixer. To reduce the viscosity of the 
lysate produced from the release of genomic DNA 10 pi (1400U) of DNasel (Invitrogen, 
product # 18047-019) was added to the suspension in addition to 100 mg/ml of lysozyme. 
The insoluble cell debris was pelleted in a polycarbonate tube by ultracentrifugation 
(Beckman TL-100 ultracentrifuge, TLA 120.2 rotor) at 16 000 x g for 20 min at 4°C.
The soluble extract (supernatant) was loaded into a HIS-Select™ Spin Column (Sigma, 
product #H7787) using native conditions following the manufacturers’ protocol. Briefly, the 
mS-Select Spin Column was prepared by placing it into a collection tube and 600 pi of 
Equilibration Buffer (50 mM sodium phosphate, 0.3 M sodium chloride, pH 8.0) added onto 
the column prior to centrifugation (325-2,040 x g). The eluate was disposed of and the 
column placed back into the same collection tube. A maximum of 600 pi of the prepared 
cell extract was pipetted onto the column at a time and the centrifugation repeated until the 
entire cell extract had been passed through the column. The flow-through fractions were 
collected for later SDS-PAGE analysis. Unbound protein was washed off the column by 
centrifuging (325-2,040 x g) using 600 pi of Wash Buffer (50 mM sodium phosphate, 0.3 M 
sodium chloride, 5 mM imidazole, pH 8.0) for a total of two washes. A new collection tube 
was used to elute the target protein using up to 500 pi of Elution Buffer (50 mM sodium 
phosphate, 0.3 M sodium chloride, 250 mM imidazole, pH 8.0) and centrifuging as before. 
The samples were then analysed by SDS-PAGE.
The insoluble cytoplasmic fraction may consist of cell debris and aggregated target protein 
(inclusion bodies) and was purified by repeated washing with BugBuster® Protein Extraction 
Reagent followed by centrifiigation. The insoluble pellet was initially resuspended in the 
same volume of 1:10 BugBuster® Protein Extraction Reagent (containing 500 pg/ml of 
lysozyme) that was used to resuspend the original cell pellet. The suspension was mixed by
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vortexing for 1 min, incubated at room temperature for 5 min, followed by centrifugation 
(5 000 X g, 15 min, 4°C). The supernatant was removed from the pellet of inclusion bodies 
and resuspended in half the original culture volume of 1:10 diluted BugBuster® Reagent. 
Centrifiigation and washing was repeated for a total of three washes with the final 
centrifugation performed at 16 000 x g  for 15 min at 4°C. The pellet was resuspended in
1.5 ml of 6 X SDS-PAGE Sample Buffer, boiled for 5 min to denature proteins and analysed 
by SDS-PAGE. Insoluble protein was purified under denaturing conditions following the 
same procedure employed for soluble proteins however using the denaturing buffers 
described: Equilibration Buffer (0.1 M sodium phosphate, 8 M urea, pH 8.0), Wash Buffer 
(0.1 M sodium phosphate, 8 M urea, pH 8.0) and Elution Buffer (0.1 M sodium phosphate, 8 
M urea, pH 4.5 -  6.0).
2.16.5 Western Blot analysis
Uninduced and Induced whole cell lysates were subjected to SDS-PAGE analysis followed 
by transfer of the protein samples to PVDF Western Blotting membrane using a semi-dry 
blot apparatus at lOv for 3 h. The membrane was removed and incubated with gentle 
agitation in 20 ml of Blocking Buffer containing Phosphate Buffered Saline with 0.05% 
Tween-20 (v/v) (PBST) and 5% non-fat, dry milk (w/v) for 2 h at room temperature. The 
Blocking Buffer was then replaced with Anti-His (C-term) Antibody, conjugated to horse 
radish peroxidise (HRP) (Invitrogen, product #R93125), diluted 1:5000 in Blocking Buffer 
and incubated for 2 h at room temperature with agitation. The membrane was then washed
2 x 5  min in 20 ml PBST and developed using the Enhanced Chemiluminescence (ECL)
DNA Detection kit (Amersham Biosciences, Buckinghampshire, UK, product # RPN3004) 
following the manufacturers’ instructions.
2.16.6 Plasmid stability
The plasmid stability of the pET101/D-TOPO-Rv2745c construct in BL21 Star™ cells was 
assessed by performing a new transformation into BL21 E. coli cells, taking a single 
transformant colony and testing the isolate for growth on LB agar without selection, LB-
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ampicillin (100 pg/ml), LB with 1 mM IPTG and LB-ampicillin-IPTG. The plasmid 
instability was defined as an increase in CFU/ml on the LB plate containing IPTG compared 
to the colony count on the LB-ampicillin plate. Immediately prior to induction (ODeoo 
0.5-1.0), the culture was tested to determine the fraction of cells that still carried the plasmid 
by removing a 100 pi sample and plating a dilution of 1:10'^  on LB-IPTG and 
LB-ampicillin-IPTG and a dilution of 1:10"^  on LB and on LB-ampicillin. Plates were 
incubated overnight at 37°C.
2.16.7 Autoinduction of protein expression
Overnight Express™ Instant TB Medium (Novagen, Madison, WI, United States, product 
#71491) is an autoinduction medium used to induce high level expression of the fusion 
protein over time without the need to monitor cell density or add IPTG. The method selects 
for isolates that are able to continually express the fusion protein and relies on the fact that 
the cells preferentially use glucose in the medium until depletion when the cells then switch 
to lactose as their carbon source. The media was prepared as described by the manufacturer 
and a 2 ml aliquot inoculated with a single colony, grown to an ODeoo 0.5 and then used to 
inoculate a larger culture volume in a 1:100 dilution. Cultures were incubated at 37°C for 
approximately 16 h with shaking. Control cultures (with original pETlOl/D-TOPO 
expression vector) and test cultures (containing pETlOl/D-TOPO with fusion protein) were 
grown, soluble protein pelleted (3 000 rpm, 10 min, 4°C) and samples subjected to 
SDS-PAGE analysis.
2.16.7.1 In vitro translation system
The use of the cell-free protein biosynthesis system Easy Xpress™ Protein Synthesis Mini 
kit (Qiagen, product #32502), also called in vitro translation system, for the production of 
recombinant proteins was trialled as an alternative expression system. The Easy Xpress™ 
Protein Synthesis Mini kit enables production of proteins that may otherwise be toxic to the 
host E. coli cells. The kit uses E. coli lysates containing all the necessary translational 
machinery components including ribosomes, tRNAs and T7 RNA polymerase to provide a
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coupled transcription-translation system able to express proteins from T7 promoters. Easy 
Xpress™ Protein Synthesis Reactions were prepared according to the manufacturers’ 
protocol. Briefly, 1 pg of recombinant plasmid DNA was added to a tube of E. coli extract 
with 20 pi Easy Xpress™ Reaction Buffer and made up to a total reaction volume of 50 pi 
with RNase free water. The reaction was mixed gently by vortexing and centrifuged briefly 
to collect the contents at the bottom of the reaction tube. The reaction was incubated at 37°C 
for 1 h and proteins analysed by SDS-PAGE.
2.16.8 Development of expression construct with native C- 
terminus in E. co//
When expression of the His-tagged fusion protein failed, an alternative expression vector 
was chosen for the development of a Glutathione S-transferase (GST) tagged fusion protein 
using the pGEX-4T-2 expression vector (Amersham Biosciences, product #27-4581-01). 
The reading frame of the GST tagged fusion protein is maintained using specifically 
designed primers (Table 2.7) The Rv2745c gene was amplified and primarily cloned into 
pCR®U-Blunt-TOPO® vector and transformed into OneShot® Competent cells using Zero 
Blunt® TOPO® PCR Cloning Kit (Invitrogen, product #K2800-20). Positive transformants 
were selected on LB containing 50 pg/ml kanamycin and the cloned fragment excised from 
the TOPO® vector using EcoRl (Roche Molecular Biochemicals, product # 10703737001) 
and the Xhol (Roche Molecular Biochemicals, product #10899194001) restriction enzymes. 
The fragment was then sub-cloned into the EcoRI and Xhol sites of the CIAP treated 
pGEX-4T2 vector resulting in a 9 bp deletion of the vector sequence. The GST moiety is 
26 kDa and when added to the 11.8 kDa of the Rv2745c protein a fusion protein of 37.8 kDa 
is predicted.
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Table 2.7: Primer sequences for construction of GST-fusion protein and sequencing primers for the 
pGEX-4T2 vector.
Primer Sequence 5’-3’
pGEX/Rv2745c Fwd GAATTCCAATGGCGGCTTTGG
pGEX/Rv2745c Rev CTCGAGTTTAGGCCACCGCCA
pGEX 5’ sequencing GGGCTGGCAAGCCACGTTTGGTG
pGEX 3’ sequencing CCGGGAGCTGCATGTGTCAGAGG
Sael (4T63)
5saXI (4345) 
Sbel (4313) 
Xarl (4310)
KasI (4309) 
HpaI (41 -6 ) 
£coRV (4120) 
SssHII (40S1) 
5aMlI(3SS0 
Apa I (3SS1) 
laclq gene region 
5s rn i (3S51)
Mlul (36-70)
Apa 51(3354 ) 
SsfAPI (3353) 
p fiin  (3252)
SspMI (63)
EcoXI (269)
.VscI (466)
PG EX4T2
4 9 7 0  bp
AlwXl (2645)
glutathione S-transferase
s s tm  (656) 
a I (6S6)
(S33)
^  5' pGEX sequencing primer
5 amHI (931)
£coRI (941)
Sm al (948)
’0(1(951)
:koi (956)
'otl (962)
I '  pGEX sequencing primer
■01(1038) 
îsaAI (1148)
Aat II (1247)
Pstl (1924)
Ssal (2100)
Figure 2.9: The pGEX-4T-2 expression vector with N-terminal glutathione S-transferase tag.
pGEX-4T-2 vector contains the selective ampicillin resistance marker, the high-level IPTG-inducible promoter 
and the N-terminal glutathione S-transferase tag. It is a low-copy number plasmid containing the laclq region 
which binds to the lac operator o f T7 RNA polymerase promoters.
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2.16.9 Pilot expression of GST-fusion protein
Plasmid preparations from TOPIO DH5aE. coli cells of bacterial strains expressing the GST 
construct (control) and the GST-Rv2745c fusion were transformed into BL21(DE3)pLysS 
Competent cells and grown overnight (37°C with shaking) in 5 ml of 2 x YTA broth 
containing 100 pg/ml ampicillin. Fresh 5 ml cultures were inoculated with a 1:100 dilution 
of the overnight cultures and grown to an ODeoo of 0.5-1.0 before induction with IPTG to a 
final concentration of 0.5 mM. Samples (1 ml) were taken at 2 h and 4 h post induction, 
pelleted by centrifugation (13 000 rpm, 1 min) and pellets resuspended in 1 ml of ice cold 
1 X PBS lysis buffer. The samples were boiled in  6 x SDS PAGE sample buffer (0.35 M 
Tris-HCl (pH 6.8), 10.28% (w/v) SDS, 36% glycerol, 0.6 M dithiothreitol, 0.012% (w/v) 
bromophenol blue) for 5 min before analysing on a 12% polyacrylamide gel.
2.16.10 Pilot purification of soluble GST-fusion protein
The adapted pGEX-4Tl*_Rv2745c cloned construct (see Chapter 6: Section 6.3.2) was 
transformed into BL21 (DE3)pLysS E. coli competent cells and grown overnight at 37°C 
with shaking in  5 m l o f  2 x YTA medium with 100 pg/ml ampicillin. Large broths (500 ml) 
supplemented with 100 pg/ml ampicillin were inoculated at 1:100 dilution with overnight 
cultures and grown to an ODeoo 0.5-1.0. Expression of the protein was induced with 0.5 mM 
IPTG and grown in parallel with an uninduced culture at 30°C for 4 h. Bacterial cultures 
were centrifuged (3 500 x 15 min, 4°C) and cell pellets resuspended in  2 5  m l 1 x PBS 
lysis buffer. The suspension was sonicated on ice in short 15 s bursts alternated with 15 s of 
resting. Three cycles of sonication were performed and 250 pi of 20% Triton X-100 added 
to the suspension followed by gentle rocking (30 min, room temperature). Insoluble cellular 
material was pelleted from the lysate by centrifugation (12 000 x g, 15 min, 4°C). The 
supernatant was transferred to a fresh tube and aliquots of the supernatant and pellet were 
analysed by SDS-PAGE to determine the fraction in which the fusion protein was purified.
The bed volume of glutathione-sepharose 4B (Amersham Biosciences, product #27457401) 
was determined based on the sonicate volume whereby the bed volume is 1:100 of the
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sonicate volume. A slurry of 50% glutathione sepharose 4B was prepared by gently shaking 
the bottle of glutathione sepharose 4B to resuspend the medium. The required volume of 
glutathione sepharose was dispensed and washed, by centrifiigation (500 x g, 5 min, 4°C), 
with 10 ml of ice cold 1 x PBS per 1.33 ml of the slurry. For a 1.33 ml volume of the 
original slurry of Glutathione Sepharose 4B dispensed, 1 ml of 1 x PBS was added to 
sedimented beads for preparation of the 50% slurry. For each 100 ml of bacterial sonicate, 2 
ml of the 50% slurry of Glutathione Sepharose 4B was added to the sonicate before 
incubating at room temperature for 1 h with end-over-end rotation to ensure mixing. The 
glutathione sepharose-bound fusion protein was pelleted by centrifugation (500 x g, 5 min, 
4°C) and the supernatant retained for SDS-PAGE analysis. The beads were washed by 
gentle agitation in 5 ml of ice-cold PBS with Complete™ Protease Inhibitor Cocktail (Roche 
Molecular Biochemicals, product #1873580) prior to centrifuging (500 x g, 5 min, 4°C) and 
the supernatant removed and retained as before. Washing was repeated a total of three times 
before the slurry was transferred into an Empty Disposable PD-10 chromatography Colunm 
(Amersham Biosciences, product #17-0435-01). The PBS was eluted from the column and 
collected for SDS-PAGE analysis. The glutathione sepharose beads were resuspended using 
100 pi of Elution Buffer (50 mM Tris-HCl, pH 8.0, 20 mM reduced glutathione) by 
end-over-end rotation for 10 min and the protein was eluted from the column. The eluate 
was collected from the column in a microcentrifuge tube and the elution procedure repeated 
twice more for a total of three collected eluates. Supernatant and eluted fractions were 
analysed by SDS-PAGE to confirm purification of the fusion protein and to determine which 
fraction the protein was present in. Protein samples were stored for short periods at 4°C. 
Cycles of freeze/thawing purified protein samples was avoided due to potential for the 
protein to precipitate. Following prolonged storage the integrity of the protein samples was 
checked by SDS-PAGE analysis.
2.16.11 Protein quantification using Bradford Reagent
The protein concentration of eluted fractions was determined using the Bradford Reagent 
(Sigma product #B6916) method (Bradford 1976). A stock solution of 1 mg/ml bovine 
serum albumin was serially diluted in buffer (50 mM Tris-HCl, pH 8.0) to a range of
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concentrations in 50 pi volumes to provide a series of protein standards for quantification of 
the purified fiision protein. Room temperature equilibrated Bradford Reagent was added in
1.5 ml volumes to each standard, the samples were mixed and incubated at room temperature 
for 45 min to allow full colour development. The standards were measured at an O D 5 9 5  to 
produce a calibration curve used to measure the protein content of samples of unknown 
concentration. Unknown protein samples were prepared in buffer in the same way as the 
standards and measured at an O D 5 9 5 .
2.16.12 Bulk purification of soluble GST-fusion protein
Purification of the GST fusion protein from a 500 ml culture required a 250 pi bed (1/100 of 
the 25 ml sonicate volume) of Glutathione Sepharose 4B for packing the purification 
column. A 50% slurry of Glutathione Sepharose 4B was prepared by resuspending the 
medium by gentle agitation and pipetting 500 pi of the suspension into a 1.5 ml tube. The 
storage ethanol of the Glutathione Sepharose was removed by sedimentation of the medium 
by centrifugation (500  ^ g, I min) and washing in ice cold 1 x PBS. The medium was 
resuspended in 375 pi of 1 x PBS to produce 50% slurry.
For 100 ml of bacterial sonicate, 2 ml of 50% prepared slurry was added and incubated for 
30 min at room temperature with gentle agitation. The suspension was transferred to the 
disposable column and the medium left to settle before the column outlet was opened and the 
medium drained through the column trapping the GST-fusion molecules. Non-specific 
proteins were removed by washing the column with 10 bed volumes of 1 x PBS and 
repeating three times before elution of the protein was performed using 1 ml of Elution 
Buffer per ml of bed volume.
2.16.13 Bulk purification of insoluble GST-fusion protein
For insoluble proteins cells were pelleted by centrifugation were stored at -80°C overnight to 
help lyse the bacteria. The pellet was then resuspended in 25 ml of BugBuster® Reagent 
with Complete™ Protease Inhibitor Cocktail (Roche Molecular Biochemicals, product
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#1873 580) and the cells lysed by sonicating (3 x 15 g, 4°C). The sonicate was then 
centrifuged (15 000 rpm, 4°C, 30 min) and the supernatant retained for SDS-PAGE analysis. 
The pellet was resuspended in 25 ml PBS with 10 mM DTT, 0.1% SDS and 10% glycerol, 
sonicated and centrifuged again. The supernatant was again retained and the pellet 
resuspended by sonicating in 25 ml PBS with 10 mM DTT and 2 M urea. Resuspension of 
the pellet was repeated using PBS containing 10 mM DTT and 8 M urea. All supernatants 
were then analysed for soluble protein by SDS-PAGE. The 8 M supernatant was then 
dialysed sequentially against 6M , 5 M , 4 M , 3 M  and 2 M urea in PBS with 10 mM DTT. 
The buffer was changed every 2 h and any precipitated protein was spun out at high speed. 
Glutathione Sepharose 4B was prepared as described above and 1 ml resuspended in 2 M 
urea buffer added to the dialysate and rotated at 4°C for 1 h. The suspension was 
centrifuged, the supernatant removed and the Glutathione Sepharose washed with PBS 
containing 10 mM DTT and 2 M urea. The washed beads were then transferred into a 2-10 
ml column, allowed to settle and washed with 2 ml of 2 M urea buffer. The fusion protein 
was then eluted from the sepharose with 0.5 ml aliquots of 100 mM glutathione in 2 M urea 
buffer. It was then dialysed against PBS and stored at -80°C.
2.17 Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was used to detect DNA-binding properties of 
the purified recombinant protein.
2.17.1 Annealing of oligonucleotides
Complementary synthetic oligonucleotides corresponding to the predicted Rv2745c binding 
site were synthesised (Sigma Genosys) for four putative gene targets: Rv0251c, Rv0782, 
Rvl043c and Rv2596c (Table 2.8). Complementary oligonucleotides were annealed in 
1 X t e n  Buffer (10 x TEN Buffer: 100 mM Tris, 2.0 M NaCl, 10 mM EDTA, pH 8.0) at a 
molar ratio of 1:1 for 10 min at 95°C then cooled slowly to room temperature and diluted in 
sterile 1 X TEN Buffer to 4 pmol/pl. The scrambled Rv0251c oligonucleotide was prepared 
in the same manner.
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Table 2.8; Complementary oligonucleotides corresponding to the putative Rv2745c-binding site.
Oligo name Sequence (5’-3’)
R v0251c +  TTCCACCTCGGCGTTCACCGGAAGCGAACACTGTCACACAG
Rv0251 c - CTGTGTGACAGTGTTCGCTTCCGGTGAACGCCGAGGTGGAA
Rvl043c + TGCAGAGTCGGTGTTCGCTTCACGCGAACTAGGCGCGCCTA
Rvl043c - TAGGCGCGCCTAGTTCGCGTGAAGCGAACACCGACTCTGCA
Rv0782 + CGGCCACGACTTCTTCGCACTGGGCGCGGCCAGCGTCAGCC
Rv0782 - GGCTGACGCTGGCCGCGCCCAGTGCGAAGAAGTCGTGGCCG
Rv3596c+ GAGCGGCCATCGGTTCGCCGCCAGCGAACGCGGCAAAGTAC
Rv3596c- GTACTTTGCCGCGTTCGCTGGCGGCGAACCGATGGCCGCTC
2.17.2 Labelling of oligonucleotides
Oligonucleotides were labelled using the DIG Gel Shift Kit 2°^  Generation (Roche 
Molecular Biochemicals, product #03353591910) in a 10 pi reaction volume containing 1 x 
Labelling Buffer, 5 mM CoCb-solution, 0.05 mM DlG-ddUTP solution and terminal 
transferase 20U/pl. The labelling reaction was mixed, incubated at 37°C for 15 min and 
placed on ice. The reaction was then stopped by the addition of 2 pi of 0.2 M EDTA 
(pH 8.0). The labelled oligonucleotide reaction was brought to a final volume of 25 pi to 
obtain a final concentration of 4 ng/pl of labelled oligonucleotide.
2.17.3 Determination of iabeiiing efficiency
The labelling efficiency of the oligonucleotides was determined as recommended in the DIG 
Gel Shift Kit protocol. Briefly, a dilution series (1:0, 1:10, 1:100, 1:1000, 0:1) of each 
labelling reaction was prepared in TEN-buffer alongside a labelled control oligonucleotide 
supplied in the Roche Molecular Biochemicals kit. For each labelled oligonucleotide a 1 pi 
spot of the dilution series was applied to a small strip of positively charged nylon membrane 
alongside the dilution series of the DlG-labelled control oligonucleotide prepared to final 
concentrations of 4, 0.4, 0.04, 0.004 and 0 ng/pl. The DNA was fixed to the nylon 
membrane by cross-linking with UV-light using two cycles of auto-cross-linking in a UV 
Stratalinker, washed in Washing Buffer (0.1 M Maleic acid, 0.15 M NaCl; pH 7.5; 0.3% 
Tween® 20) for 2 min and blocked with 1 x Blocking Solution (10 x Blocking Solution;
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Roche Molecular Biochemicals, product #11096176001) diluted in Maleic Acid Buffer 
(0.1 M Maleic acid, 0.15 NaCl; pH 7.5) for 30 min. The membrane was then incubated with 
anit-Digoxigenin-AP conjugate (Roche Molecular Biochemicals, product #11093274910) 
for 30 min followed by two 15 min washes with Washing Buffer. The membrane was then 
equilibrated for 5 min with Detection Buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). The 
membrane was then placed, DNA side facing up, between two sheets of acetate and put 
inside a development folder before applying 1 ml of CPSD-ready-to-use solution (Roche 
Molecular Biochemicals, product #11755633001) onto the membrane. The top sheet of 
acetate was carefully lowered over the membrane to spread the substrate evenly without the 
introduction of air bubbles. This was incubated for 5 min at room temperature followed by 
removal of excess liquid and further incubation of the damp membrane at 37°C for 10 min to 
enhance the CSPD chemiluminescent detection. The membrane was exposed to X-ray film 
in the dark for 5 - 3 0  min and developed. The quantity of the DIG labelled DNA was then 
determined by comparing dilutions of the labelled oligonucleotide against the dilution series 
of the DIG labelled control oligonucleotide whereby the 0.04 ng/pl spot was the lowest 
dilution visible.
2.17.4 Protein binding reactions
Binding reactions were prepared using the DIG Gel Shift Kit according to the 
manufacturers’ instructions. Briefly, reactions were prepared on ice in 1.5 ml tubes, with the 
addition of each reagent in the following order: 4 pi Binding buffer, 1 pi poly [d(l-C)] at a 
concentration of 1 pg/pl, 1 pi poly L-lysine (0.1 pg/pl), 2 pi DlG-labelled oligo 
(0.4 ng/pl), 1 pi of purified protein (50 ng/pl) and the reaction made up to 20 pi with 
distilled water. A competitive binding reaction was performed with the addition of 1 pi 
unlabelled oligo at a concentration of 0.1 pg/pl and a negative control reaction performed 
without the addition of protein. Reactions were mixed carefiilly and incubated at room 
temperature for 15 min before transferring the tubes to ice. Each binding sample was then 
prepared for SDS-PAGE analysis by adding 5 pi of loading buffer with bromophenol blue 
and immediately applying each sample to a pre-electrophoresed 6 % non-denaturing 
polyacrylamide gel. The gel was run at 4°C and 60V for 2 h. Samples were transferred to a
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positively charged nylon membrane (Roche Molecular Biochemicals, product 
#11417240001) using Trans-Blot® Semi-Diy System apparatus (Bio-Rad). The membrane 
was prepared as described in section 2.16.3 for chemiluminescent detection of the protein 
binding reactions.
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3 Identification of viruience associated gene regulators 
and development of knockout mutants
3.1 Introduction
Genetic screens o f transposon (Tn) mutant libraries to identify mycobacterial genes 
involved in virulence have been carried out in a number of laboratories (Badarinarayana 
et al. 2001;Sassetti, Boyd, & Rubin 2001;Stewart et al. 2005). One screen (Pethe et al. 
2004) specifically targeted the identification of genes involved in inhibition of 
phagosome lysosome fusion. The transposon library used boasts approximately 8,000 
mutants confirmed by random analysis o f 100 isolates and was screened in pools of 
1,000. Macrophages were fed with iron-dextran to label lysosomes and then infected 
with an M. tuberculosis transposon mutant pool. The cells were then lysed and the iron- 
dextran-containing lysosomes recovered by several rounds of magnetic selection to 
enrich for mutants unable to avoid fusion with the lysosomal compartment and therefore 
defective in phagosomal arrest. Mutants were identified by sequencing a sample of the 
selected pools.
Here we aim to reanalyse the pools of selected mutants to identify more comprehensively 
the mutants with an attenuated phenotype. From these results we aimed to identify 
transcriptional regulators responsible for modulating gene expression important for 
M. tuberculosis survival within the macrophage. We use the TraSH technique (described 
in Chapter 2. Materials and methods: Section 2.7) to compare mutants present in the 
original library with those mutants present following the emichment procedure. 
Regulators identified from the TraSH screen are targeted for the development of 
knock-out mutants.
3.1.1 Transposon Screen by Microarray 1 (Haell labelled 
fragments)
In order to define genes that impair phagosome-lysosome fusion in the macrophage the 
original input pool o f -8,000 mutants was labelled with Cy3 or Cy5 fluorophores and
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compared against the enriched output pool of mutants associated with lysosomal 
organelles. The ratio of each fluorogenic pool (original input pool o f Tn mutantsioutput 
pool of lysosomal associated Tn mutants) was measured across 4 arrays including dye 
flips (i.e. 2 X Cy3/Cy5 and 2 x Cy5/Cy3). Mutants more abundant in the phagosome- 
lysosome pool would have a relatively high microarray signal in the output compared to 
the original library. The first TraSH screen identified only 156 transposon 
insertions/mutants in total. This was a considerably smaller number of mutants than 
expected. However, the ratios were ranked with their corresponding standard deviation 
and clearly a number of mutants were over represented in the transposon pool fi*om the 
lysosomal compartment in comparison to their abundance in the original library (data not 
shown).
The raw data was analysed using the statistical software program Significance Analysis 
of Microarrays (SAM) (Chu et al. 2007). SAM determines a T-statistic value or score (d) 
for each gene and plots the observed score against an expected score. Significant genes 
are identified based on whether they have either a positive or negative correlation with 
the response variable; in this case, higher or lower abundance of Tn flanking DNA 
present in the lysosomal-associated transposon pool. SAM also produces a level of 
confidence for the data set by computing a false discovery rate (FDR) for a list o f genes 
whose scores are higher than a certain threshold. The threshold for significance, 
determined by delta, is manually set by the user based on the FDR (Chu, Narasimhan, 
Tibshirani, & Tusher 2007). The FDR is set to achieve a balance between realistic 
numbers of false positives considered to be representative of the data set whilst also 
extracting a significant gene list. Figure 3.1 is a SAM plot showing the total number of 
significant genes identified under a FDR of 3.42% for the TraSH screen 1 dataset. It 
shows 34 mutants that are significantly over represented in the lysosomal associated 
transposon pool (indicated in red). Table 3.1 lists the genes that are significantly 
over-represented in the Tn pool from the lysosomal compartment in comparison to their 
abundance in the original library as determined by SAM. The genes and their associated 
function are listed in rank order of the q-value (%) which represents the chance that a 
mutant is a false positive and is an equivalent measure of the FDR. This validated 
method for significance testing of microarray data has incorporated an error for multiple 
testing and provides a good level of confidence in the resultant gene list by achieving a
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low number of false positives at 3.42% for all 60 significant genes indicated in the SAM 
plot (Figure 3.1).
From the list of genes that are affected by the transposon mutation, the gene Rv2745c 
(fold change = 6.59) was identified as a transcriptional regulatory protein (Camus et al. 
2002) and was selected for knockout mutant development. Rv2745c is the first gene of a 
cluster of three genes including Rv2742c a predicted membrane protein, and Rv2744c, 
encoding a 35kDa antigen (Manganelli et al. 2001). Several mutants highlighted in the 
present analysis were also found to be enriched in the lysosomal pool analysed by Pethe 
(Pethe et al. 2004). These included fadD26, a fatty-acid-CoA ligase involved in PDIM 
biosynthesis, (Camacho et al. 1999) and Rv3527, encoding a protein of unknown 
fimction. A further two mutants, Rv2107 and Rvl819c, were also enriched in the 
lysosomal pool of our screen and were among the mutants picked up by Pethe. The 
Rv2107 mutant was shown to be hypervirulent outgrowing wild-type strains in 
macrophage survival assays however was shown to exhibit an acidification profile 
comparable to that of the wild-type strain (Pethe et al. 2004). Rvl819c, an ATP binding 
cassette transporter, is thought to be involved in the active exportation of drugs across the 
membrane which may contribute to the multi-drug resistant characteristic of M. 
tuberculosis (Braibant, Gilot, & Content 2000). Together with the Pethe (Pethe et al. 
2004) results there is very strong evidence for these mutants being unable to arrest 
phagosome maturation and the resultant association with the lysosome.
Although the mutants recognised to be impaired for macrophage survival, as determined 
by the original Tn library screens described by Pethe (Pethe et al. 2004), are not identical 
to those highlighted in this screen, there is some overlap provided by fadD26, Rv3527, 
Rv2107 and Rvl819c. In the original screens a total o f 15 mutants were identified by 
Pethe and confirmed by sequencing analysis. By comparison, our screen identifies only 
26% of the mutants highlighted by Pethe. These differences may be explained by the 
variation in screening techniques. Perhaps in the generation of the Tn library, Pethe’s 
random selection of colonies plated from macrophage infections overlooked some 
mutants. The number of mutants isolated from each screen is indicative that 
phagolysosomal arrest is a multifactorial process whereby a number o f genes are 
associated with the phenotype. Considering the data fi*om the first TraSH screen we can 
question whether the Tn library does indeed contain the 8,000 mutants it is claimed to.
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The TraSH screen will not detect all mutants but the results here indicate the Tn library 
contains far fewer mutants, perhaps only in the region of a few hundred mutants.
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Figure 3.1: Significance Analysis of Microarrays (SAM) plot
The SAM plot illustrates the significant genes that are over ( -# - )  or under ( - • - )  expressed in the TraSH 
screen. A total o f 60 significant genes are determined for delta = 1.015 based on a false discovery rate o f  
3.42%. From this, the number o f false positives is calculated to be 2.05 o f the 60 significant genes.
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Table 3.1: List o f significant genes over represented in the lysosomal transposon pool as determined 
by SAM analysis
Gene name Fold change q-value % Gene fimction/product
fadD26 (Rv2930)* 14.42 0 Fatty-acid-CoA ligase
Rv3527* 3.24 0 Hypothetical protein
Rv3675 11.17 0 Possible membrane protein
Rvl227c 57.45 0 Probable transmembrane protein
Rvl034c 2.75 0 Probable transposase
Rv2943 2.16 0 Probable transposase
MT 0827 5.12 0 Hypothetical protein
MT_1499 3.38 0 PE PGRS family protein
RvI450c 3.43 0 PE_PGRS27
MT 2370.2 4.46 0 Hypothetical protein
lldDl (Rv0694) 2.18 0 Possible 1-lactate dehydrogenase
PE22 ^v2107)* 8.55 0 PE22
Rv2735c 3.05 0 Conserved hypothetical protein
RvI505c 8.0 0 Conserved hypothetical protein
RvlOBS 2.19 0 PE9
Rv2800 1.69 0 Possible hydrolase
Rvl387 2.03 0 PPE20
Rv3785 3.37 0 Hypothetical protein
pgsA3 (Rv2746c) 3.56 0 Probable pgp synthase
Rv0804 1.75 0 Conserved hypothetical protein
MT_0855 1.69 0 PE-PGRS family protein
RvI819c* 2.24 0 Probable drugs-transport transmembrane protein
papA2 (Rv3820c) 1.64 0 Conserved polyketide synthase associated protein
Rvl803c 1.75 2.18 PEJPGRS32
Rv2745c 6.59 2.18 Possible transcriptional regulatory protein
MT 1812 2.55 2.18 Hypothetical protein
fadD23 (Rv3826) 1.63 2.18 Probable fatty-acid-CoA ligase
MT_3024 1.31 2.18 Hypothetical protein
Rv3687c 1.51 3.42 Anti sigma factor antagonist
MT_2365 1.39 3.42 Hypothetical protein
Rv2957 1.4 3.42 Possible glycosyl transferase
fadD25 (Rvl521) 1.19 3.42 Probable fatty-acid-CoA ligase
Rv0449c 1.62 3.42 Conserved hypothetical protein
Rvl584c 1.73 3.42 Possible phiRvl phage protein
Note: Gene descriptions are by the Pasteur Institute (ht^://genolist.pasteur.fr/TubercuList) and MT annotations from 
the CDC1551 genomic database at The Institute of Genomic Research (TIGR). * denotes genes detected in the Pethe et 
al. (2004) screen.
92
Chapter 3. Identification of virulence associated gene regulators and development of
knockout mutants
3.1.2 Transposon Screen by Microarray 2 (Mspl/HlnPII labelled 
fragments)
Detection of any particular Tn insertion site by the TraSH method employed in Screen 1 
is dependent on a HaeO. restriction site being located within 500 bp of the Tn and also on 
the amplified restriction fi-agment overlapping with a probe on the microarray. In an 
attempt to increase the number of mutants detected in the TraSH screen, a second attempt 
to TraSH label the gDNAs was made which employed partial digestion with the more 
fi*equent cutting enzymes Mspl and HinPW, giving average fragment sizes of 74 and 86 
bp respectively. Preliminary TraSH experiments with the newly digested DNA obtained 
poor signal in both channels which was not significantly above background (results not 
shown). Variations in experimental protocol also failed to increase the signal above 
background levels. Increased concentrations of Cy dyes were used in conjunction with 
increased rounds of PCR cycles however fluorescence levels were unchanged. One 
reason for the failure to incorporate sufficient Cy dye in the Tn insertion sites may be that 
the Y-linkers may not bind as efficiently to the digested products used in screen 2 due to 
the shorter overhang (5’-GC) produced by the MspVHinPW digestion compared to the 
T/dell overhang (3’-GCGC) produced in the first screen. Increased ligation of Y-linkers 
could be achieved by using a new combination of restriction enzymes that cut both more 
frequently than HaeH and produce a larger overhang for binding o f the Y-linker. Sassetti 
and Badarinarayana (Badarinarayana et al. 2001;Sassetti, Boyd, & Rubin 2001) also 
performed partial digests using the same restriction enzymes MspVHinPW. However, 
following the first round of PCR, they performed in vitro transcription from a T7 
promoter in the Tn to produce RNA that was subsequently Cy-labelled during cDNA 
synthesis. This may be a more efficient method for labelling of partial digests.
3.2 Allelic exchange construct of Rv2745c regulator
We aimed to screen for regulators that affect trafficking and found only the one 
transcriptional regulator, Rv2745c, based on the results of the TraSH screens described 
above. This gene was then targeted for knockout mutagenesis. Within this project we 
used an allelic exchange method of mutagenesis (Husson, James, & Young 1990) for the 
development of knockout mutants in the Category III pathogen, M. tuberculosis. Gene
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knockout by allelic exchange requires a single recombination event to occur on both 
sides of the gene to effect allelic exchange (Kana & Mizrahi 2004). The double-cross- 
over event achieves replacement of the intervening gene with a selectable marker such as 
a hygromycin (Hyg) resistance cassette. Selection of these rare recombinant mutants is 
central to the success of the technique and can be achieved using a suicide delivery 
vector enabling discrimination of illegitimate clones to be screened out using the counter- 
selectable marker SacB (Reyrat et al. 1998). The allele replacement strategy employed 
here for substitution of the target gene with the hygromycin resistance cassette in 
M. tuberculosis used the pG5 counter-selectable suicide vector to produce the pM6 
construct (see Appendix 1: Figure 9.3) for the Rv2745c target. The pG5 vector carries an 
additional antibiotic resistance marker, kanamycin (Kan), to aid cloning into E. coli.
3.2.1 Southern Blot confirmation of ARv2745c mutant
The pM6 construct was electroporated into competent M. tuberculosis cells and plated 
onto selective media containing hygromycin and 2% sucrose. Approximately 12 
colonies were present on the pM6 transformation plates, and control plates with 
mycobacterium transformed with water were negative for growth. A random selection of 
four individual transformants was inoculated into 7H9 broth. These isolates were grown 
in the presence of hygromycin to late exponential phase and the genomic DNA was 
extracted before preparing the samples for Southern Blot analysis (see Materials and 
methods: Section 2.6.3). In confirming ARv2745c mutants, an Rv2745c probe was 
designed to detect the upstream sequence of the Rv2745c gene. BspEi digested gDNA 
from wild-type and mutant strains were examined by Southern Blot analysis and 
variation in hybridising DNA fragments was used to differentiate between a wild-type 
and knockout mutant.
Figure 3.2A shows the results of the Southern Blot analysis of the three transformants 
selected fi*om the pM6 electroporation plates (lanes 2-4). Wild-type gDNA is BspEi 
digested producing an Rv2745c-containing fragment of 5245 bp (Figure 3.2B, top). In 
the mutant the Rv2745c gene is knocked out and replaced with the hygromycin resistance 
cassette (1118 bp). Due to the presence of two BspEi sites in the hygromycin resistance 
cassette the Rv2745c probe hybridises to a 3230 bp fragment in the mutant (Figure 3.2A
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and B). Only the second transformant (Figure 3.2A, lane 3) v^ as positive for the 
insertional inactivation of Rv2745c. Transformants 1 and 3 (Figure 3.2A, lanes 2 and 4 
respectively) are consistent with the wild-type strain exhibiting a single fragment of ~5kb 
in length and are likely to be spontaneous mutants of hygromycin resistance or resultant 
of a single crossover event and resistant to the lethal effects o f sacB expression. The 
Rv2745 Compl A/B PCR product (Chapter 2. Materials and methods: Table 2.2), also 
used to make the Rv2745c probe, was run in lane 6 as a positive control.
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Figure 3.2: A) Southern Blot analysis of ARv2745c knockout mutant and H37Rv wild-type strain; 
probing with the DIG-labelled pM6 probe. B) A schematic diagram of the pM6 probe design for 
Southern Blot hybridisation.
A) The Southern Blot was performed by BspEl digestion o f gDNA samples o f mutant and wild-type 
transformants. Lanes 1: Promega 1 kb DNA ladder; 2: wild-type transformant; 3: ARv2745c mutant 
transformant; 4: wild-type transformant; 5: H37Rv strain (wild-type); 6: Rv2745c A/B PCR product 
(positive control); 7: Roche DNA Molecular Weight Marker VII DIG-labelled. B) Upper: a schematic 
diagram of BspEl restriction digested wild-type chromosome with the pM6 probe (1562 bp) binding to the 
upstream sequence o f Rv2745c; detecting a fragment o f 5246 bp. Lower: in the BspEl digested ARv2745c 
mutant chromosome Rv2745c is replaced with the hygromycin resistance cassette (Hyg) and the pM6 probe 
detects a fragment o f 3230 bp.
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3.3 Allelic exchange construct of Rv3058c regulator
As only one putative regulator was found in the TraSH screen for trafficking mutants 
further targets were sort fi’om other datasets. In an unpublished collaborative study 
between the University of Surrey laboratory and Dr Olivier Neyrolles’ laboratory at the 
Institute Pasteur, the iron-dextran phagolysosome strategy employed by Pethe et al was 
applied to a library of BCG mutants in human macrophages derived from peripheral 
blood mononuclear cells (PBMCs). TraSH was used as a read-out of mutant emichment 
in the phagolysosome pool and this indicated that a mutant in the gene Rv3058c was 
unable to inhibit phagosome-lysosome fusion. This gene was thus identified for 
characterisation in the present study. Rv3058c encodes a putative transcriptional 
regulator belonging to the TetR family of regulators (TIGR: http://www.tigr.org). The 
Rv3058c allelic exchange construct was produced using the pSMTlOO suicide vector to 
create the pM2 construct (see Appendix 1: Figure 9.1). The cloned recombinant vector 
was confirmed by restriction digest prior to electroporation of the construct into the 
HBTRv strain.
3.3.1 Southern Blot confirmation of ARv3058c mutant
The pM2 construct was electroporated into competent M. tuberculosis cells and plated 
onto selective media containing hygromycin and 2% sucrose. Fourteen colonies were 
present on the pM2 transformation plates, and control plates with mycobacterium 
transformed with water were negative for growth. A random selection of four individual 
transformants was inoculated into 7H9 broth. These isolates were grown in the presence 
of hygromycin to late exponential phase and the gDNA was extracted before preparing 
the samples for Southern Blot analysis (see Materials and methods). Figure 3.2A shows 
the results of the Southern Blot. Prepared gDNA was digested with EcoRi which 
produced an Rv5055c-containing fragment of 9510 bp in the wild-type (Figure 3.3B, 
top). In the mutant the Rv3058c gene is knocked out and replaced Avith the hygromycin 
resistance cassette (1118 bp). Digestion of the mutant gDNA with EcoRl produces a 
fragment of 4636 bp which hybridises to the Rv3058c probe.
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All four transformants are positive for the insertional mutation as illustrated by the 
hybridisation of the Rv3058c probe to fragments of >4.5 kb (Figure 3.3A, lanes 
2-5). The Southern Blot also shows the Rv3058c probe hybridising to the upstream 
sequence of Rv3058c present in the H37Rv strain as a larger fi-agment of approximately 
10 kb (Figure 3.3A, lane 6). The Rv3058c A/B PCR primers (see Chapter 2. Materials 
and methods: Table 2.1) were used to make the pM2 probe and the PCR product was run 
in lane 7 as a positive control for the Southern Blot hybridisation.
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Figure 3.3: A) Southern Blot analysis of ARv3058c knockout mutant and the H37Rv wild-type strain 
probing with the DIG-labelled pM2 probe. B) A schematic diagram of the pM2 probe design for 
Southern Blot hybridisation.
A) The Southern Blot was performed by EcoRl digestion o f gDNA samples o f mutant and wild-type 
transformants. Lane 1: 20 pi o f Roche DNA Molecular Weight Marker II DIG-labelled; 2: ARv3058c 
mutant transformant; 3: ARv3058c mutant transformant; 4: ARv3058c mutant transformant; 5: ARv3058c 
mutant transformant; 6: H37Rv strain (wild-type); 7: Rv3058c A/B PCR product (positive control); 8: 
Promega 1 kb DNA ladder. B) Upper: a schematic diagram o f EcoRl restriction digested H37Rv wild-type 
(wild-type) chromosome with the pM2 probe (1230 bp) binding the upstream sequence o f Rv3058c and 
detecting a fragment o f 9510 bp. Lower: in the restriction digested ARv3058c mutant, Rv3058c is replaced 
with the hygromycin resistance cassette (Hyg) and the pM2 probe detects a fragment o f 4636 bp.
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3.4 Allelic exchange construct of Rv2548 regulator
The next gene target, Rv2548, Avas selected for knockout mutant development based on 
the results of transposon library screens which highlighted this mutant to be attenuated in 
macrophage survival (Stewart et al. 2005). The Rv2548 gene is one of a homologue pair 
with the Rv2547 gene and exists adjacent to Rv2549c and Rv2550c, another homologue 
pair within the M. tuberculosis genome (TIGR). The existence of these pairs of genes 
may have arisen fi*om the replication of an original pair during evolution and their 
selection suggests some survival advantage to the organism. The Rv2548 protein 
contains a homologue of the pilT N-terminal domain termed a PIN-domain 
(http://genolist.pasteur.fi-/TubercuList/) which is suggested to be the toxic component of 
toxin-antitoxin (TA) opérons (Arcus, Rainey, & Turner 2005). There are 38 TA opérons 
in M. tuberculosis (Pandey & Gerdes 2005) encoding PIN proteins which control 
expression of genes by degrading RNA transcripts in bacteria and therefore Rv2548 
provided another interesting target putatively involved in gene regulation.
The Rv2548 allelic exchange construct was produced using the pG5 suicide vector to 
create the pM4 allelic exchange vector (see Appendix 1 : Figure 9.2). Restriction digest 
confirmation of the recombinant vector confirmed correct orientation of the inserted 
fragments prior to the electroporation of the construct into the H37Rv strain.
3.4.1 Southern Blot confirmation of ARv2548 mutant
The pM4 construct was electroporated into competent M  tuberculosis cells and plated 
onto selective media containing hygromycin and 2% sucrose. Fewer than twenty 
colonies were present on the PM4 transformation plates, and control plates with 
mycobacterium transformed with water were negative for growth. As per the Southern 
Blot analysis o f ARv2745c and ARv3058c, the technique was applied to confirm 
ARv2548 mutants. Three colonies were randomly picked from the electroporation plates 
of the pM4 construct. These were grown up in 7H9 broth (with hygromycin) and tested 
by Southern Blot analysis to determine whether insertional inactivation of the Rv2548 
gene had occurred.
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gDNA prepared from the transformants was digested with EcoBl. Figure 3.4A shows the 
results of Southern Blot analysis using the pM4 probe. The probe was designed to 
specifically detect the upstream region of Rv2548, hybridising to EcoRl digested 
fragments of 656 bp and 7157 bp in the parental strain (Figure 3.4B, top). Isolates 2 and 
3 (Figure 3.4A, lanes 3 and 4 respectively) show the DIG-labelled pM4 probe binding to 
two fragments (-0.7 kb and 7 kb) consistent with the size fragments predicted for the 
wild-type strain. Of the three transformants picked from the pM4 electroporation plates 
only the first isolate (Figure 3.4A, lane 2) was positive for the insertional inactivation of 
Rv2548. With the presence of the hygromycin gene in the mutant a further EcoRL 
restriction site is present, resulting in the probe binding to two fragments of 656 bp and 
1435 bp in length (Figure 3.4B, bottom). The control samples, EcoRl digest o f H37Rv 
and Rv2548 A/B PCR product used to make the pM4 probe were run in lanes 5 and 6 
respectively.
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Figure 3.4; A) Southern Blot analysis o f ARv2548 knockout mutant and the H37Rv wild-type strain 
probing with the DIG-labelled pM4 probe. B) A schematic diagram of the pM4 probe design for 
Southern Blot hybridisation.
A) The Southern Blot was performed by EcoRl digestion o f gDNA samples of mutant and wild-type 
transformants. Lane 1: Promega 1 kb DNA ladder; 2: ARv2548 mutant transformant; 3: wild-type 
transformant; 4: wild-type transformant; 5: H37Rv strain (wild-type); 6: Rv2548 A/B PCR product 
(positive control); 7: Roche DNA Molecular Weight Marker VII DIG-labelled. B) Upper: a schematic 
diagram o f EcoRl restriction digested wild-type chromosome with the pM4 probe (1505 bp) binding the 
upstream sequence o f Rv2548 detecting fragments o f 656 and 7157 bp. Lower: in the restriction digested 
ARv2548 mutant, Rv2548 is replaced with the hygromycin resistance cassette (Hyg) and the pM4 probe 
detects fragments o f 656 and 1435 bp.
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3.5 Complementation of knockout mutants
To complement the knockout strains it was decided to reintroduce into the chromosome a 
single copy o f the target gene using a plasmid that integrated into the L5 bacteriophage 
recombination site attB. It was also decided to drive expression o f the target genes with 
their natural promoters. However the promoter sites for each target gene have not been 
experimentally mapped and therefore it was decided to use the intergenic regions 
immediately upstream of the target gene ORF or predicted operon. Approximately 
270 bp sequence including the entire intergenic region upstream of Rv3058c was 
included in the complementing construct, pKl (see Appendix 2: Figure 9.4). Similarly, a 
380 bp sequence upstream of the Rv2745c target was also cloned into the complementing 
construct, pK2 (Appendix 2: Figure 9.5). It is hypothesised that the resultant 
complemented strain will have similar expression of the gene as the wild-type strain due 
to the inclusion of the genes’ own promoter. There is no intergenic region upstream of 
the Rv2548 gene (Figure 3.5). As the ORF of Rv2547 reads and ends within the start 
codon of Rv2548 (http://genolist.pasteur.fi-/ TubercuList/) it is probable that Rv2547 and 
Rv2548 are bicistronic and expressed from a promoter upstream of Rv2547. For that 
reason, a 125 bp region upstream of Rv2547 and Rv2548, incorporating the 39 bp 
intergenic region between Rv2546 and Rv2547, was cloned into the complementing 
construct pK3 (Appendix 2: Figure 9.6) for complementation of the ARv2548 knockout 
mutant. Therefore, in the resulting complemented strain there is an additional copy of the 
Rv2547 gene. Potential effects of the multiplicity of Rv2547 should be considered when 
comparing the phenotype or expression profile of the complemented strain with the wild- 
type and knockout mutant strains.
103
Chapter 3. Identification of virulence associated gene regulators and development of
knockout mutants
_LPP&_K
_lPRB-----------^ Rv2546,
%v2545
Rv2548
Rv2547
Prom oter
j 2870547
Rv2549c,___
Rv2550c
Î548 1--------1--------1--- 12871548
Rv2551c
aroE
LEGEND
Coding sequences:
virul ence, detox, adapt lipid metabo 1 i sm
•===> information pathway cel 1 wal 1, process
stab 1 e RNA «=> I S/phage PE/PPE
intermediary metabolism r -> unknown ' regulatory
conserved ==> conserved in M. bovis
rRNA V  tRNA
Figure 3.5: Rv2548 gene location on the M. tuberculosis chromosome
The start codon of the Rv2548 gene exists within the coding region of the upstream gene, Rv2547. There is 
no intergenic region between Rv2547 and Rv2548. The promoter region is indicated to lie upstream of 
Rv2547. Diagram sourced from http://genolist.pasteur.fr/TubercuList/.
To confirm the introduction of the complemented gene into the knockout mutant 
chromosome PCR analysis was performed using gDNA to determine the presence of 
each of the gene targets in each of the complemented strains (results not shown). 
Sequencing analysis was also performed (Lark Technologies, Cambridge, England) on 
each of the complementing constructs to detect the presence of mutations that may effect 
the functionality of the gene when inserted back into the mutant strain. The sequencing 
primers used are listed in Chapter 2. Materials and methods: Table 2.3.
Sequencing of the cloned Rv2745 gene fi-om the pK2 construct revealed no mutations in 
the sequence compared to the wild-type sequence obtained fi*om http://genolist.pasteur.fi-/ 
TubercuList/. The sequencing was confirmed using two sequencing primers, a forward 
primer upstream of the Rv2745c gene and the second, reverse, primer downstream of the 
Rv2745c gene (results not shown). The Rv2548 gene in the pK3 construct was also 
sequenced in a similar manner and the results of both sequencing runs confirmed the 
correct sequence of the ORF.
104
Chapter 3. Identification of virulence associated gene regulators and development of
knockout mutants
The sequencing results of the Rv3058c gene in the pKl complementing construct 
confirmed the presence of three individual base pair substitutions. Translation of the 
sequence reveals two amino acid changes (see Appendix 3: Figure 9.7). At position 145, 
glutamic acid has been substituted with glycine, a molecule half the molecular weight of 
glutamic acid. At position 155, lysine of the wild-type has been replaced with a glutamic 
acid, an amino acid of similar molecular weight to lysine but with differences in side 
chain groups. It is not known what, if  any, effects the introduced sequence error 
harboured by the complemented strain will have on gene expression or function. The 
phenotype of the complemented strain could be altered from that of the wild-type and 
this should be considered when using this strain in future experimental work. As these 
sequencing results were not obtained until further along in the experimental work, this 
pKl construct was transformed into the ARv3058c mutant and the isolated 
complemented strain was used in the proceeding work.
3.6 Bioinformatic analysis of virulence associated gene 
regulators
In order to gain insight into the function of each virulence-associated regulator all three 
were subject to bioinformatic investigation. This included searches for homologous 
genes in closely and distantly related bacterial species. The importance of investigating 
sequence homology of proteins is that this can be used to indicate a common function for 
the gene under question.
3.6.1 Rv3058c regulator
The protein sequence of the TetR-family transcriptional regulator, Rv3058c, was used to 
search a protein database using the Basic Local Alignment Search Tool (BLAST) and 
showed 100% identity and similarity to homologous genes of M. tuberculosis F11 and 
M. bovis AF2122/97 isolates. Identity describes the percentage o f amino acids in a query 
sequence that are exactly the same and found at the same position, whereas similarity 
gives the percentage of similar amino acids present at the same position in a given 
sequence (Tramontane 2007). The translated Rv3058c product showed some homology 
to an S. coelicolor A3(2) putative TetR-family regulator with 26% identity and 45%
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similarity across a 146 amino acid sequence. Rv3058c exhibited 34% identity and 58% 
similarity to TetR/AcrR type transcriptional regulator fi'om the Proteobacteria member 
Ralstonia eutropha across a 92 amino acid sequence. This putative regulator also 
showed some homology to an AcrR-type regulator of Bifidobacterium longum DJOlOA, 
demonstrating 33% identity and 50% similarity across 109 amino acids. The TetR 
family of regulators, to which AcrR-type regulators belong, are known to be preferential 
repressors of gene regulation (Ramos et al. 2005) with a helix-tum-helix DNA-binding 
motif (Huffman & Brennan 2002;Ramos, Martinez-Bueno, Molina-Henares, Teran, 
Watanabe, Zhang, Gallegos, Brennan, & Tobes 2005).
3.6.2 Rv2548 regulator
A BLAST search of the Rv2548 translated sequence fi'om M  tuberculosis H37Rv 
showed 100% homology to M. tuberculosis FI 1 and M. bovis AF2122/97 isolates. Other 
divergently related proteins were compared to Rv2548 including a pilT domain protein of 
Desulfococcus oleovorans (Hxd3) a member of the Proteobacteria, which exhibited 39% 
identity and 55% similarity. Another Proteobacteria member, Coxiella burnetii 
CbuG_Q212, with a PIN domain protein, exhibited 35% identity and 48% similarity. 
The predicted nucleic acid binding protein in the distantly related organism 
Pelotomaculum thermopropionicum SI showed 38% identity and 56% similarity and the 
Archaea Thermococcus kodakarensis KODl, with a predicted nucleic acid-binding 
protein containing PIN domain, exhibited 32% identity and 46% similarity.
3.6.3 Rv2745c regulator
The Rv2745c translated protein sequence was used to identify homologues o f the gene in 
related bacterial species. A BLAST search identified homologous genes in the 
M. tuberculosis clinical isolate type F ll and M  bovis to have 100% identity and 
similarity. A number of orthologs were discovered in several bacterial species including 
M  marinum, M. avium, Rhodococcus, Arthrobacter, Propionibacterium, 
Corynebacterium and Streptomyces. S. coelicolor A3(2) showed 38% identity and 65% 
similarity across a 72 amino acid sequence from a putative DNA-binding protein. Across 
a 49 amino acid sequence of the S. lividans PopR protein there was 63% identity and
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85% similarity compared to M  tuberculosis. Across a 67 amino acid sequence of the 
putative transcriptional regulator, 0 1 ^  of C. jeikeium there was 47% identity and 74% 
similarity, whereas the paralogue in C urealyticum exhibited 48% identity and 69% 
similarity compared to M. tuberculosis.
A selection of the identified orthologs was investigated for sequence conservation by 
alignment analysis of the translated genes. The analysis was performed using ClustalW2 
software (http://ebi.ac.uk/Tools/clustalw2). The translated sequences proposed for the 
M. tuberculosis F ll isolate, M. bovis AF2122/97, S. coelicolor A3_2, S. lividans, 
C. jeikeium and C. urealyticum were aligned against the M. tuberculosis H37Rv sequence 
and the pile up shown in Figure 3.6. The translated sequence for Rv2745c homologues 
in both M. tuberculosis and in M. bovis are the same length at 112 amino acids. In the 
genome of S. coelicolor the Rv2745c homologue is extended by 14 amino acids, in 
S. lividans by 36 amino acids, C. jeikeium by 6 amino acids and in C. urealyticum it is 
longer by 34 amino acids compared to the H37Rv M. tuberculosis strain. The 
M. tuberculosis Rv2745c amino acid sequence displayed significant similarity over its 
entire length to PopR of S. lividans and ClgR of S. coelicolor and Corynebacterium 
strains.
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Protein sequence alignment of Rv2745c from the M tuberculosis H37Rv strain, the F ll 
M tuberculosis isolate and in the closely related species of M bovis showed good homology 
between the strains.
M. tb_H37Rv_Rv2745c_112_aa 
M. tb_Fll_112_aa 
M. bovis_AF2122/97_112_aa
S. coellcolor_A3_2_126_aa 
' ' S. lividans_148_aa 
— — — — —  C. jeikeium_K411_118_aa
C. urealyticum_DSM_7109_146_aa
Figure 3.7: Protein sequence alignment of Rv2745c in M, tuberculosis strains, M  bovis and 
S. coelicolor and the protein paralogues, PopR in S. lividans and ClgR in S. coelicolor and 
Corynebacterium.
The translated amino acid sequence of Rv2745c homologues was compared using the multiple sequence 
alignment program CLUSTALW2 (http://ebi.ac.uk/Tools/clustalw2). The evolutionary relationship for the 
Rv2745c homologue/paralogue was then viewed using the phylogram function.
The protein sequence alignments indicate ClgR to be a related homologue of Rv2745c. 
ClgR in Streptomyces binds to a palindromic motif (CGC-5N-GCG) and is responsible 
for regulating expression of the Clp operon which encodes several proteolytic subunits 
thought to be involved in differentiation of Streptomyces (Bellier & Mazodier 2004). It 
was hypothesised that Rv2745c binds in vitro to a paralogue of the ClgR nucleotide 
sequence motif. A genome wide search in M  tuberculosis for similar binding sites was 
performed using the sequence search fiinction from TubercuList. A number of genes 
with ClgR-like binding motifs ranked high in our list of genes showing significant 
differential expression in the mutant (see Chapter 4). The genes identified with similar 
binding motifs and/or correlated with our microarray analysis were Rv0251c, Rvl043c, 
Rv0782 and Rv3596c. Table 2.8 lists the aforementioned genes and highlights the ClgR- 
like binding site for each gene.
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3.7 Discussion
Many genes and proteins have been implicated in macrophage survival and observed to 
be important in modulation of the phagosome. The action of these effectors arrests the 
maturation of the phagosome preventing its development into a toxic compartment. 
PknG is involved in blocking phagosome-lysosome fusion and promotes mycobacterial 
survival within the macrophage (Koul et al. 2001;Walburger et al. 2004). ManLAM aids 
arrest o f phagosome maturation by interfering with the TGN-phagosome pathway (Fratti 
et al. 2003). Macrophage activation is prohibited by production of the mycobacterial 
toxin LAM, which interrupts cytosolic Ca^  ^ signalling causing prevention of phagosome 
maturation (Malik et al. 2003). Several studies (Pethe et al. 2004;Stewart et al. 2005) 
have investigated the genetic determinants of phagosome inhibition by screening libraries 
of Tn mutants. Their system wide approaches have uncovered many gene targets 
implicated in M. tuberculosis survival in macrophages and in mice.
Here we attempt to re-analyse the Tn library selected by Pethe and colleagues. 
M. tuberculosis Tn mutants unable to avoid fusion with the lysosomal compartment were 
enriched in this hbraiy and identified by Pethe using sequencing. Affected genes 
identified from the Tn library screen were varied in function indicating multiple effectors 
are involved in phagosomal maturation (Pethe et al. 2004). The intramacrophage 
survival analysis of these mutants demonstrates that the inability to regulate phagosome 
maturation correlates with decreased bacterial survival in macrophages. The results of 
our TraSH analysis confirm some of the findings of Pethe's original screen of the same 
Tn library. Identified genes common to both screens were Rv3527 (a hypothetical 
protein), Rv2930 (fadD26), Rv2107 (PE22) and Rvl819c (a transmembrane transport 
protein). Pethe’s screen found 11 further mutants that were not represented in our screen. 
These included Rv0918, Rv0249c (a membrane anchor unit of the succinate 
dehydrogenate complex involved in aerobic respiration), Rvl522c (mmpL12), Rvl426c 
(lipO), Rvl361c (PPE19), Rv2941 (fadD28), Rv2336, Rv0986 (an ATP-binding ABC 
transporter), Rv3378c, Rv3377c (possible cyclase) and Rv3156 (nuoL, an NADH 
dehydrogenase). This Tn library was generated with the transposon Tn5370. A 
drawback of this element is revealed in one study (McAdam et al. 2002) which showed 
that Tn5370 inserts itself at preferential sites across the M. tuberculosis genome. These
110
Chapter 3. Identification of virulence associated gene regulators and development of
knockout mutants
hot spots exhibit a lower than average G+C content (54-62%) and sequencing exposed 
89% of the Tn insertion sites to be positioned in only 351 ORFs. Pethe's library is likely 
to be similar, with insertions occurring often in some genes/gene regions and rarely in 
others. This bias in the original input mutant pool will severely reduce the power of the 
selection, particularly when the output pool is assessed by sequencing of a random 
selection of clones. By taking the pools o f mutants provided by Pethe and re-examining 
their content by microarray we reveal a very different picture of which mutants are 
enriched by the selection. Microarray analysis of the library also enables us to survey the 
Tn library as a whole. Indeed, it was surprising that the TraSH analysis detected 
insertions in only 156 genes. This is clearly an underestimate because only 26% of the 
gene insertions sequenced by Pethe et al. were detected. Despite the low detection rate 
of the TraSH procedure these results are indicative of a mutant library with low coverage 
across the genome. Our analysis indicated 34 mutants to be significantly enriched in the 
phagolysosome. Even if  the library is less varied than we expected many of the mutants 
identified by Pethe were verified individually and therefore we can have good confidence 
in the selection of these mutants.
Only one transcriptional regulator, Rv2745c, was identified from the TraSH screen to be 
involved in phagosome maturation arrest. Bioinformatics analysis of the Rv2745c amino 
acid sequence revealed it to be a homologue o f ClgR and PopR found in Streptomyces 
and Corynebacteria. The importance of transcriptional regulators in macrophage 
survival has been indicated in a number of bacterial species. For example inactivation of 
the virulence-related regulators, PhoP and RpoS in Salmonella typhimurium, results in 
decreased virulence in animal infection models (Dominguez-Bemal et al. 2008). 
Similarly, inactivation of phoP in M. tuberculosis has recently been shown to cause 
attenuation in animal infection and a complete inability to grow in macrophages (Asensio 
et al. 2008). Conversely, a number of mutants in other two-component regulator systems 
have shown hypervirulence in mouse infection models. M. tuberculosis mutants in devR, 
tcrXY, trcS and kdpDE regulators killed mice more quickly than the wild-type strain and 
the devR mutant was found to increase in number in activated macrophages (Parish et al. 
2003). The hypervirulent phenotypes associated with these mutants highlights the 
importance of transcriptional regulators in maintaining a balance between bacterial and 
host cell survival. Another example of the role o f regulators in controlling bacterial 
virulence is the CRP homologue of M. tuberculosis (CRPmt) and its orthologue in
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M. bovis BCG (CRPbcg). These are cAMP responsive DNA-binding proteins (Bai et al. 
2007;Tutar 2008) which have been shown to have an important role in pathogenesis 
(Akhter et al. 2008).
In addition to Rv2745c we selected for further analysis two other regulators putatively 
involved in intra-macrophage survival of M. tuberculosis. The second transcriptional 
regulator, Rv3058c, was selected for further study based on the unpublished findings of 
an Rv3058c Tn mutant unable to inhibit phagosome-lysosome fusion in human 
macrophages. The third regulator, encoded by Rv2548, was selected from the results of a 
Tn screen of mutants (Stewart et al. 2005) to identify mutants unable to survive in in 
vitro macrophages.
All three regulators (Rv2745c, Rv3058c, and Rv2548) were targeted for allelic 
replacement. Confirmation of successful deletion of the transcriptional regulators was 
achieved by Southern Blot analysis of mutant strains. Complementation of the mutant 
strains was achieved/attempted by réintroduction of the genes with their respective 
untranslated upstream sequences, hypothesised to contain the promoter sites, and their 
incorporation into the complementing constructs. Réintroduction of the knocked-out 
genes to the attB site was confirmed by PCR, although subsequent sequencing revealed 
several non-synonymous sequence changes in the reintroduced Rv2548 gene. The effect 
of knocking out these regulators will be analysed by looking at the phenotypic growth of 
each strain compared to the wild-type strain and is detailed in the proceeding chapter.
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4 Phenotypic analysis of the ARv3058c, ARv2745c and 
ARv2548 mycobacterial mutants
4.1 Introduction
The ability to respond to different environments is vital for bacterial survival. In Chapter 
3, three mutant strains of M  tuberculosis were generated, each carrying a targeted 
deletion of a gene (Rv3058c, Rv2745c and Rv2548) that is predicted to be involved in the 
interaction between the bacterium and the host macrophage. The major aim of this study 
was to reveal the gene régulons of these putative regulators because the predicted 
function o f the regulated genes would be informative in understanding why the targeted 
regulators are important in the host pathogen interaction. It is also an objective to 
investigate the phenotype of the mutants in in vitro and in vivo environments.
In this chapter, the in vitro growth of the mutant M  tuberculosis strains is compared to 
the wild-type strain. Gene expression is dependent on growth phase and information on 
how quickly the different strains grow will be useful for interpretation of the 
transcriptional profiles of mutants, results of which are presented in Chapter 5. The 
mutants were also tested for resistance against heat shock and oxidative stress by 
exposure to hydrogen peroxide. Heat shock is used as a paradigm of the stressed cell as 
elevated temperature is an efficient way of inducing denatured proteins and damaged 
protein complexes. The heat shock assay is used here to assess the ability o f the mutants 
to resist this general stressed state. Intracellular mycobacteria are likely to encounter 
oxidative stress due to the production by phagosome associated NADPH oxidase of 
superoxide which can be dismutated to hydrogen peroxide (Zahrt & Deretic 2002). 
There is also of relevance to oxidative stress because Rv2745c is under control of SigE, 
the alternative sigma factor responsive to oxidative conditions (Manganelli et al. 2004a). 
To begin to understand the importance of Rv3058c, Rv2745c, and Rv2548 in vivo we 
assessed the abilities of knockout strains to grow in the macrophage cell line J774. 
Finally in collaboration with two laboratories with containment level 3 animal facilities 
we examined the ability o f the ARv2745c and ARv2548 strains to cause infection in 
C57BL/6 mice.
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4.1.1 /nwYrogrowth
To determine the growth curve properties of each mutant and its respective 
complemented strain all cultures were grown from frozen glycerol stocks in complete 
media (Middlebrook 7H9 broth) supplemented with OADC, in the absence of antibiotics. 
These were sub-cultured until they reached late-log phase of growth as determined by 
achieving an ODeoo = 1.0. A 1% inoculum of late-log phase culture was used to start up 
100 ml culture flasks for Day 0 of the growth curve. Cultures were grown at 37°C with 
agitation (200 rpm) and 1 ml samples taken every 24 h and the absorbance (ODeoo) 
measured. The absorbance is a measure of the particle density o f a culture and it depends 
on the particles (bacteria) being homogeneously distributed throughout the culture. 
Initial experiments used a culture inoculum grown to early log phase (ODeoo < 0.5) and a 
smaller inoculum volume which resulted in long lag phases and growth curves that would 
extend beyond 14 days to reach stationary phase (results not shown). Stationary phase 
was defined to occur at the peak of the growth curve outside of the exponential part of 
the curve. Log phase cultures were primarily used for inoculation into 100 ml flasks due 
to the susceptibility of M. tuberculosis to clump in liquid media (Anton, Rouge, & Dafie 
1996) during later phases o f growth. Clumping of the bacilli in broth culture would 
greatly affect absorbance readings and therefore much care was taken to avoid this.
Growth kinetics for all mutant strains, the complemented mutants and the parental strain 
are shown in Figure 4.1. A general observation is that all strains grew relatively well in 
Middlebrook 7H9 broth, reaching an ODeoo of approximately 2.0. However, there were 
some subtle differences in growth kinetics. The ARv3058c and ARv2745c mutant strains 
both reached stationary phase by Day 6 (Figure 4.1; A and B respectively); 24 hours 
earlier than the H37Rv strain. The complemented strain of ARv3058c, pKl, had a 
similar growth curve to that of the wild-type, but the complemented ARv2745c strain, 
pK2, was similar to the mutant reaching stationary phase earlier than the wild-type. The 
ARv2548 mutant strain did not reach stationary phase due to contamination of the culture 
following Day 4 of the experiment (Figure 4.1C). However, the ARv2548 mutant grew 
more rapidly than any other strain reaching an ODeoo = -1.75 within 4 days. The 
complemented ARv2548 strain, pK3, also became contaminated following Day 4, 
however it reached stationary phase later than the mutant and exhibited a growth curve
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more like the parental strain (Figure 4.1C). Cultures grown for longer than 7 days would 
often result in clumping and absorbance readings of these cultures are inaccurate.
In order to compare the growth rate o f each strain the generation times were determined 
fi'om the exponential phase of the growth curves depicted in Figure 4.1 and calculated as 
detailed in Chapter 2 (Materials and methods. Section 2.11). The generation time of each 
strain was compared against the wild-type H37Rv strain which achieved a doubling time 
of 26.53 hours. The mutant strains (ARv3058c, ARv2745c and ARv2548) achieved 
comparable doubling times of 19.74, 19.66 and 18.54 hours respectively, and the 
complemented strains had doubling times intermediate of mutant and wild-type strains 
(pKl = 21.81, pK2 = 22.88 and pK3 = 21.86). It is not possible to draw any firm 
conclusions about differences in broth growth curves between the mutants and wild-type 
strain because the optimised experiments were performed just once and the differences in 
growth were small. Such small differences were not thought to be sufficient to affect the 
interpretation of in vivo assays and therefore repeated growth curves under the same 
conditions were not attempted.
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Figure 4.1: Growth curves of wild-type (H37Rv), mutant and complemented strains.
In vitro growth curves o f the wild-type versus the KO mutant and complemented strains. A) Growth o f the 
wild-type strain, ARv3058c mutant and the ARv3058c strain complemented with the wild-type gene on the 
pKl plasmid. B) Growth of wild-type, ARv2745c mutant and the complemented pK2 strain. C) Growth of  
wild-type, ARv2548 mutant and the complemented pK3 strain. The data show values obtained from a 
single optimised experiment and show the ODeoo readings of mycobacterial strains in Middlebrook 7H9 
broth without antibiotics. Strains were grown to similar ODeoo before a 1% inoculum was used in a 100 ml 
culture flask grown at 37°C with shaking (250 rpm).
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4.2 Stress assays
M  tuberculosis bacilli face many challenges during their infective lifecycle. 
M. tuberculosis is a resilient bacterium that actively senses its environment and adapts its 
transcriptome to enable survival in changing conditions (Mariani & Colizzi 2005). 
Survival o f mycobacteria outside o f the human host is important for the successful 
transmission of bacilli to a new host. Outside of the host the organism may be exposed 
to variable temperatures and desiccation and it has evolved a complex cell wall that 
protects the bacterium in harsh conditions (Brennan & Nikaido 1995). To ensure 
intracellular survival o f bacteria within the macrophage the organism must repair damage 
from oxidative and nitrosative stress and changes in acidity (Garbe, Hilbler, & Deretic 
1996). Within the oxygen deprived lipid rich granuloma the organism down-regulates its 
metabolism and adapts its diet to use fatty acids as a carbon source (Russell 2003). In 
order to adjust to a multitude of conditions, changes in signal transduction and 
transcriptional regulation occur within the bacterial cell. Transcriptional regulators 
therefore play a very important role in balancing the production of proteins as they are 
required (Mariani & Colizzi 2005). As a result these organisms have adapted the ability 
to survive many forms of stress. Here we aim to determine whether the transcriptional 
regulator mutants are attenuated for survival compared to the parental strain when 
challenged with the stress conditions posed by heat shock and oxidative stress by 
exposure to H2O2 .
4.2.1 Heat shock
Elevated temperature substantially above 37°C is not a condition encountered by 
M. tuberculosis outside the laboratory. However, heat shock is an experimental 
condition often used to induce a stressed cell. Regulation of the heat shock response is 
important to mycobacterial survival in stress conditions as it enables bacilli to tolerate the 
harmful effects associated with dénaturation of proteins within the cells (Stewart et al. 
2001a). A sigE KO mutant has been previously shown to be defective in the heat shock 
response, and the inability o f M. leprae to survive at elevated temperatures is attributable 
to the lack of induction of sigE, sigB, the major heat shock opérons {hsp60, hspVO) and 
the absence of sigH (Williams et al. 2007). HspR and HrcA are important transcriptional
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repressors for the regulation of Hsp70 and Hsp60 respectively. Indeed, M. tuberculosis 
which has been deleted o f hspR has high level constitutive expression of the Hsp70 
operon and an AhspRAhrcA double mutant shows upregulation of both the Hsp70 and 
Hsp60 opérons (Stewart et al. 2002a). The importance of regulating this stress response 
during infection is demonstrated in experiments where a AhspR mutant shows reduced 
survival during chronic infection of mice (Stewart et al. 2001b). In light of the findings 
that Rv2745c is regulated by the heat inducible alternative sigma factor, SigE 
(Manganelli et al. 2001), we examined the survival of the ARv2745c mutant during heat 
shock. We also examined the survival of the ARv3058c and ARv2548 mutants during 
heat shock.
Strains were incubated at 37°C and 53°C and the CFU/ml were calculated using the 
Miles and Misra technique (Chapter 2, Materials and methods Section 2.9) at 0, 30, 60, 
90 and 120 min time points. Figure 4.2 shows the survival rates of each strain as a 
percentage of the CFU/ml to Time 0. In each instance the percentage survival of the 
mutant strain was reduced compared to the wild-type strain during heat shock. 
Following 60 min incubation at 53°C, survival of the ARv3058c, ARv2745c and 
ARv2548 mutant strains was reduced by 2-3 logs whereas survival of the wild-type (% to 
T=0) was approximately 10-fold higher than each of the mutant strains (Figure 4.2; A, B 
and C, respectively). At 120 min there was no detectable survival of any of the deletion 
mutants but there were still some surviving wild-type bacilli. An interesting observation 
when performing the CFU/ml counts was the difference in colony morphology of strains 
grown at 37°C and 53°C. Colonies grown at the higher temperature were reduced in size 
compared to colonies grown at the lower temperature and were obviously damaged by 
the elevated temperature and struggling to grow on the Middlebrook 7H11 media. These 
plates required several more days of incubation in order to count the colonies compared 
to those cultures incubated at 37°C during the heat shock assay.
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Figure 4.2: Effect of heat shock (53°C) on M. tuberculosis strains.
The data show the survival (CFU/ml) o f M  tuberculosis strains at 37°C and 53°C as a % o f  CPU counts at 
Time 0 min. Values obtained are from a representative experiment with error bars indicating the standard 
error o f the mean (om) determined from plating out two series of dilutions from each culture (i.e. two 
technical replicates).
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4.2.2 Oxidative Stress
Following phagocytic uptake of mycobacteria by macrophages, effector cells may 
become activated by IFN-y initiating killing of the invading bacilli via multiple 
mechanisms including exposure to reactive oxygen and nitrogen intermediates (Garbe, 
Hilbler, & Deretic 1996;Jackett et al. 1983). Reactive oxygen species (ROS) produced 
by mammalian cells play an important role in anti-microbial defence (Adams et al. 1997) 
and evidence suggests that tubercle bacilli are susceptible to the toxic effects o f hydrogen 
peroxide (Lowrie & Andrew 1988) despite limited protective effects of mycobacterial 
production of catalase (Li et al. 1998). It is well documented that mycobacterial 
alternative sigma factors are induced when bacilli are exposed to environmental stresses 
(Manganelli et al. 2004b). Regulatory mutants o f sigH and sigB in M. tuberculosis 
exhibit impaired survival when exposed to oxidative stress (Manganelli et al. 
2004a;Raman et al. 2001). SigF, involved in virulence of M. tuberculosis, is up- 
regulated upon peroxide exposure; is required for resistance to hydrogen peroxide in 
M  smegmatis (Gebhard et al. 2008;Michele, Ko, & Bishai 1999) and is necessary for 
mycobacterial survival during oxidative stress (Gebhard et al. 2008). SigE has been 
shown to be responsible for regulating genes important in cell wall integrity required 
during macrophage infection (Fontan et al. 2008). Sigma factors have much overlap and 
redundancy illustrated by SigH regulation of SigE and shared recognition between these 
regulators for the SigB promoter (Raman et al. 2001;Song et al. 2008). Recently, the 
Rv2745c putative transcriptional regulator has been indicated to belong to the SigE 
regulon with evidence for the presence of a consensus sequence within the promoter 
region of Rv2745c recognised by SigE (Garbe, Hilbler, & Deretic 1996;Song et al. 2008). 
In light of the extensive evidence indicating sigma factors to be virulence associated and 
SigE induced expression of Rv2745c, this led to the investigation of ARv2745c 
resistance to oxidative stress. As the regulators chosen for this study (Rv2745c, Rv2548 
and Rv3058c) are all predicted to be important during macrophage survival investigation 
of the further two mutants for resistance to oxidative stress was also undertaken.
Experiments were performed to examine the growth effect on exposing the 
M. tuberculosis strains to hydrogen peroxide. Exposure of H2O2 was performed at two 
concentrations (2 mM and 4 mM) and the cultures left at 37°C for 120 min. In order to 
determine if  there were subtle changes in sensitivity between the wild-type and mutant
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strains oxidative stress assays were designed to achieve a low level of killing. Other 
researchers have used higher concentrations of H2O2 (5 mM) and an increased exposure 
time (240 min) to determine the oxidative susceptibility o f deletion mutants (Parish et al. 
2003) however such high level killing may mask the small differences in 
sensitivity/resistance of the strains. Figure 4.3 shows the results of the oxidative stress 
assay. Colony counts (CFU/ml) obtained at 2 mM and 4 mM H2O2 are calculated as a 
percentage survival compared to 0 mM baseline. Error bars represent the standard 
deviation of the colony counts obtained across three biological replicates. A two tailed 
t test illustrated no significant difference between 0 mM and 2 mM H2O2 exposure in the 
wild-type strain (P value = 0.1485). The same test indicated decreased bacterial survival 
of the wild-type strain when exposed to the higher concentration of 4 mM H2O2 
(P value = 0.0582) although the P value indicates this result to be not statistically 
significant. These results indicated a sensitive experimental design for determining 
oxidative susceptibility o f the deletion mutants compared to the wild-type strain. A two- 
way ANOVA was applied to test the factors of concentration and strain for statistical 
significance using the cut-off for significance of P < 0.05 and the dependency between 
factors (interaction) was also assessed. The factor of concentration o f H2O2 had no 
significant interaction with the factor of strain (P value = 0.9165) therefore the results for 
each factor are independent of one another. There was no significant affect o f strain on 
% survival for each concentration of H2O2 tested (P value = 0.3374). However, there was 
a significant affect of concentration on % survival o f each strain. P value = <0.0001. In 
summary, there is no significant difference in the % survival between each strain 
however the concentration of H2O2 significantly affects the % survival. Future work in 
determining the survival ability of these mutants in response to oxidative stress should 
include a further test concentration of >4 mM H2O2 or incubation for a longer time 
without inducing high levels of killing. In doing so, it will be shown whether there are 
subtle but nevertheless significant differences in survival capabilities o f each mutant 
strain in comparison to the wild-type. From the preliminary oxidative stress assays 
performed we can conclude that each mutant strain has similar survival capabilities to the 
wild-type strain under the conditions tested.
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Figure 4.3: Effect of oxidative stress (H2O2) on M. tuberculosis strains.
Early log phase cultures (OD6oo=0.1) o f M  tuberculosis strains were aliquoted into 12-well plates and 
exposed to 2 mM or 4 mM H2O2 for 2 hours (37°C). Following a 2 h incubation the number o f CFU/ml 
was determined for each strain (H37Rv, ARv3058c, ARv2745c and ARv2548) using the Miles and Misra 
technique (see Chapter 2, Materials and Methods) by plating serial dilutions and the % survival compared 
to 0 mM was calculated.
4.3 Macrophage survival
Central to M tuberculosis pathogenesis is the ability to grow in a macrophage. The 
regulators Rv2745c and Rv3058c were chosen for this study because there was some 
evidence that Tn mutants of these regulators traffick to lysosomes. Similarly, Rv2548 
was highlighted to be attenuated for macrophage survival (Stewart et al. 2005). Many 
intracellular infection studies have illustrated supported growth of the H37Rv strain in 
J774 murine macrophage cell line (Ajmitige et al. 2000;Dayaram et al. 2006;Zhang et al. 
2005). To fiirther examine a possible role for these regulators (Rv3058c, Rv2548 and 
Rv2745c) in intracellular survival the viability of each mutant was assessed using J774 
macrophages and CFU/ml determinations were made over a four day infection. 
Intracellular survival o f each mutant and its corresponding complemented strain was 
compared against the wild-type FI37Rv strain.
Macrophage survival assays were repeated several times for experimental optimisation 
and could not be extended beyond a four-day infection assay as the quickly replicating
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cell-line rapidly achieved confluent growth by Day 4. Macrophages were seeded in 
24-well plates at a density of 4 x 10^  cells/ml/well and infected with M. tuberculosis 
strains at a 1:1 ratio. Preliminary experiments had demonstrated this to be the optimum 
number of macrophages to use in this assay (data not shown). Figure 4.4 shows the 
results of a macrophage infection assay using wild-type, mutants and two complemented 
strains (pK2 and pK3) (referred to as Macrophage survival assay I). In this assay the 
wild-type H37Rv strain replicated over a three day period, achieving a 2.5-fold increase. 
At the 3 day time point there was no difference in intracellular replication/survival 
between the ARv3058c and ARv2548 mutants and the wild-type H37Rv (Figure 4.4A 
and B). The ARv2745c mutant showed reduced replication in the mouse macrophages at 
3 days post-infection (Figure 4.4C). The complemented ARv2745c strain, pK2, 
replicated similarly to the wild-type strain during the 3 day infection demonstrating 
successful complementation of the mutant. To confirm the attenuation of the ARv2745c 
strain during macrophage infection a second assay was performed.
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Figure 4.4; Macrophage survival assay I
J744 murine macrophages were seeded at 4x10^ CFU/well and infected at a 1:1 ratio with bacterial strains 
for 2 hours followed by removal o f extracellular bacteria by washing. A) Macrophages infected with 
H37Rv and ARv3058c strains were lysed with 0.1% v/v o f Triton X-100 at Days 0, 1, 2 and 3 post 
infection. The number o f CFU/well was calculated using the Miles and Misra technique (see Chapter 2, 
Materials and Methods) by plating serial dilutions. B) The number o f CFU/well was calculated from lysed 
macrophages infected with H37Rv, ARv2548 and pK3 strains. C) The number o f CFU/well was 
determined from lysed macrophages infected with H37Rv, ARv2745c and pK2 strains.
Figure 4.5 illustrates the results of the Macrophage survival assay II. Bacterial 
growth/survival was determined over a 4 day macrophage infection. Unlike in the
125
Chapter 4. Phenotypic analysis of the ARv3058c, ARv2745c and ARv2548
mycobacterial mutants
previous experiment, the wild-type strain did not replicate over the course of this 4 day 
infection. This is clearly a problem in an assay designed to test if  the mutant strains had 
lost the capacity for intracellular growth. Indeed, there was no detectable difference in 
the CPU counts of the mutants compared to the wild-type strain in this experiment. The 
results of this assay give inconclusive findings as to the intracellular survival rates of the 
KO and complemented strains as the wild-type did not show normal replication 
throughout the infection assay.
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Figure 4.5: Macrophage survival assay II
J744 murine macrophages were seeded at 4x10^ CFU/well and infected at a 1:1 ratio with bacterial strains 
for 2 hours followed by removal of extracellular bacteria by washing. A) Macrophages infected with 
H37Rv and ARv3058c strains were lysed with 0.1% v/v o f Triton X-100 at Days 0, 1, 2 and 4 post 
infection. The number of CFU/well was calculated using the Miles and Misra technique (see Chapter 2, 
Materials and Methods) by plating serial dilutions. B) The number o f CFU/well was calculated from lysed 
macrophages infected with H37Rv, ARv2548 and pK3 strains. C) The number o f CFU/well was 
determined from lysed macrophages infected with H37Rv, ARv2745c and pK2 strains.
127
Chapter 4. Phenotypic analysis of the ARv3058c, ARv2745c and ARv2548
mycobacterial mutants
4.4 Mouse infection
To further investigate the role o f the targeted regulator genes during infection, the 
mutants were assessed for in vivo survival using a mouse model of infection. The 
ARv2548 mutant strain was infected into mice in the category 3 containment animal 
facilities at Imperial College London with tissues brought back to the University o f 
Surrey for assay.
Preparations of the ARv2548 mutant, wild-type H37Rv and the complemented ARv2548 
strain, pK3, were used for intranasal infection of C57BL/6 mice with a bacterial load of 
approximately 1200 CFU/animal. The lungs were harvested at 0, 14 and 84 days 
following infection and spleens at 14 and 84 days post infection and the organ colony 
counts were determined. As shown in Figure 4.6A the wild-type strain increased until 
day 14 then dropped to below day 0 levels at day 84. This was unexpected as the 
bacterial load of virulent M. tuberculosis should increase by 3-4 logs in the lungs over 
several weeks before levelling off as a relatively stable chronic infection (Mogues et al.
2001). In comparison the ARv2548 mutant and complemented ARv2548 strain, pK3, 
replicated similarly to the wild-type in the lung during the first 14 days but showed no 
decrease in CPUs during the next 70 days. In examining levels of systemic spread of 
each strain a measurement of virulence can be achieved by comparison to the wild-type 
strain. Figure 4.6B shows the results of systemic spread of the bacilli to the spleen. 
There is less dissemination of the wild-type than either the ARv2548 or complemented 
pK3 strain. Again these results show a much lower bacterial load of M. tuberculosis in 
the spleens than would be expected with a virulent strain in this model (Jeon et al. 2008).
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Figure 4.6: In vivo intranasal infection of mice with H37Rv, ARv2548 and the complemented 
ARv2548 strain, pK3.
C57BL/6 mice were infected with 3x10^ CFU/ml o f bacteria via the intranasal route. A) Mice were killed 
at Days 0, 14 and 84 post infection and determinations o f CFU/ml calculated using the Miles and Misra 
technique (see Chapter 2, Materials and methods) from plating serial dilutions o f homogenised lung. B) 
The systemic spread o f bacilli was determined as described above using the spleens o f mice killed at 14 
and 84 days post infection. The error bars show the standard error o f the mean.
The ARv2745c mutant was supplied to Dr Olivier Neyrolles’ laboratory at the Institute 
Pasteur where characterisation of infectivity was performed using C57BL/6 mice. The 
infection study of the ARv2745c mutant was performed similarly to that carried out for 
the ARv2548 mutant where mice were infected by the intranasal route however with an 
intended bacterial inoculum of 50-100 CFU/animal. Furthermore, the duration of the 
infection study was shorter with the lung and spleen of mice harvested at 1, 21 and 42
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days post-infection. Differences between in vivo infection assays are merely variations in 
experimental protocol used by the two groups (Imperial and Pasteur). Figure 4.7A shows 
the colony counts determined per organ for the wild-type and ARv2745c mutant strains. 
The density of both strains climbed at a rapid rate from day 1 to day 24 with a 100-fold 
increase in bacterial load. Forty two days post infection the growth rate of both strains 
was arrested and no significant change was observed in CFU load in the lung from day 
21. Figure 4.7B shows dissemination of bacilli to the spleen. Dissemination of bacteria 
between the wild-type and ARv2745c mutant strains is highly comparable with a 
bacterial load of <750 CFU/organ at 21 days following infection. Forty two days 
following infection there is no further increase in bacterial load in the spleen for either 
strain. Again the growth of the wild-type H37Rv was less than expected in previous 
experiments in these laboratories.
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Figure 4.7: In vivo intranasal infection of mice with H37Rv and ARv2745c strains.
C57BL/6 mice were infected with IxlCf CFU/ml o f bacteria via the intranasal route. A) Mice were killed 
at Days 1,21 and 42 post infection and determinations o f CFU/organ calculated using the Miles and Misra 
technique (see Chapter 2, Materials and methods) from plating serial dilutions. B) The systemic spread of 
bacilli was determined as described above using the spleens o f mice killed at 21 and 42 days post infection. 
The error bars show the standard error o f the mean.
131
Chapter 4. Phenotypic analysis of the ARv3058c, ARv2745c and ARv2548
mycobacterial mutants
4.5 Discussion
In this chapter the basic growth characteristics of the M. tuberculosis mutant strains 
deleted of Rv2548c, Rv3058c and Rv2745c (generated in Chapter 3) were assessed 
alongside resistance to the general stress insult, heat shock. The ability of the mutants to 
replicate in J774 macrophages and for Rv3058c and Rv2745c to infect and replicate in 
mice was also investigated in collaboration with partner laboratories.
A large number of preliminary experiments were carried out to determine the optimal 
procedures for analysing the growth curves of the strains. Particular problems were 
experienced in contamination of cultures repeatedly sampled in Class I cabinets and in 
growing seed cultures to a similar cell density during exponential growth phase. This 
was likely due to a variation in doubling times between strains. The growth curves 
showed increased growth rates for each of the mutant strains compared to the wild-type. 
The KO mutants exhibited shorter generation times compared to the wild-type strain and 
the complemented mutant strains exhibited generation times intermediate between the 
wild-type and mutants possibly suggesting that the mutant phenotypes had not been fully 
reverted to wild-type via réintroduction of the deleted gene. However, the slow 
generation time of the wild-type may be indicative o f the acquisition of a mutation that 
affects growth and this will be further discussed below. Ideally, the growth o f each strain 
would be repeated several times to give an estimate of biological variation that may occur 
between experiments. However, the main objective was to establish that there were no 
major differences in growth that would affect the ability to carry out transcriptional 
profiling of broth cultures or would need to be taken into consideration when interpreting 
transcription profiles or in vivo growth. The differences observed were relatively subtle.
In order to survive, mycobacteria must sense and respond quickly to exogenous stimuli. 
Transcriptional regulators respond to these stimuli and order the expression of necessary 
genes as a survival mechanism. Expression profiling of transcriptional regulators 
exposed to stress conditions is outside the aims of our work here but could provide 
insight as to what stimuli induces activation of these regulators. Rather here, we look at 
survival of these mutants when exposed to stress stimuli such as heat and oxidative 
stress. The heat stress assay enables indication of an attenuated survival phenotype when 
compared to the parental strain. Results here indicate that all three regulatory mutants
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have reduced survival capabilities at elevated temperatures. There was obvious 
susceptibility of heat shock survival for each of the mutant strains compared to the wild- 
type which required up to 30 min further exposure at 53°C for 100% of bacilli to be 
killed. This result implicates the Rv3058c, Rv2745c and Rv2548 transcriptional 
regulators to be involved in the orchestration of gene regulation during heat stress 
conditions. This finding supports the view that these regulators are implicated in 
macrophage survival where the bacilli are faced with a multitude of stresses necessitating 
the induction of several regulatory genes. As the SigE regulon is known to be induced in 
response to heat shock the finding that the ARv2745c mutant is more sensitive to heat 
shock than the wild-type agrees with published findings for SigE regulation of Rv2745c. 
Further work to corroborate the finding that these mutants have reduced survival under 
heat shock compared to the wild-type strain would provide important validation of these 
results. There was no significant difference in the susceptibility of the ARv3058c, 
ARv2745c or ARv2548 mutant strains of M. tuberculosis compared to the wild-type 
strain when exposed to oxidative stress. Exposure of 4 mM H2O2 indicated reduced % 
survival in the wild-type strain however, the statistical significance of this result bordered 
the 0.05 cut-off for significance and therefore the susceptibility of mutant survival could 
not be compared compellingly relative to the wild-type strain. Although not statistically 
significant, preliminary findings indicate reduced survival of all strains and the wild-type 
following H2O2 exposure at 4 mM. Further development and optimisation o f the 
oxidative stress assay is required to confirm the phenotypic survival for each strain. In 
conclusion, the results presented here indicate that these transcriptional regulators are not 
involved in oxidative stress survival under the conditions tested but evidence indicates 
that these regulators may be involved in the heat shock response.
Transcriptional regulatory systems are commonly implicated in the control of 
mechanisms associated with bacterial pathogenesis. For example, M. tuberculosis 
deleted of the heat shock regulator HspR is attenuated during persistent infection of mice 
(Stewart et al. 2001c) and deletion of the cAMP receptor protein (CRP) attenuates 
virulence (Rickman et al. 2005). Numerous sigma factors are essential for virulence 
(Rodrigue et al. 2006) and mutants in several two component systems have altered 
survival phenotypes; àphoP and AmprA mutants are attenuated for survival in a murine 
infection model (Perez et al. 2001;Zahrt & Deretic 2001) and a AprrA grows more slowly 
in a macrophage infection model compared to the wild-type strain (Ewann et al. 2002).
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Furthermore, deletion mutants of devR, tcrXY, trcS and kdpDE also exhibited attenuated 
survival in vivo with a hypervirulent phenotype observed for the AdevR mutant during 
the acute stage of infection (Parish et al. 2003). The present project was based on 
experimental evidence from high-throughput screens that suggested that the Rv3058c, 
Rv2745c or Rv2548 regulators may be important for virulence of M. tuberculosis. In this 
chapter we attempted to validate this hypothesis using ex vivo and in vivo models of 
infection.
Macrophage infection studies using the J774 macrophage-like cell line revealed no 
evidence that either of the ARv3058c or ARv2548 mutants were impaired for 
intracellular replication. In the first macrophage experiment, the wild-type strain 
demonstrated replication but the Rv2745c strain did not replicate and had significantly 
decreased survival after 3 days. This attenuated phenotype was reversed by 
réintroduction of the wild-type gene using the pK2 integrating vector. In a repeated 
macrophage infection, neither the wild-type nor the ARv2745c strain showed any 
replication making it impossible to confirm if  the ARv2745c strain was attenuated for 
intracellular growth. The J774 cell line is a convenient host cell for laboratory work but 
it holds some problems for intracellular infection assays with mycobacteria because the 
monolayer can over-grow within 3-4 days and begin to detach. For slow growing 
mycobacteria a longer infection may be necessary to observe replication. This may have 
been the problem with the repeated macrophage infection assay in this study. Since these 
experiments were performed, the ARv2745c strain was compared to the wild-type for 
intracellular growth in bone marrow-derived murine macrophages over 7 days, and this 
demonstrated a growth defect for ARv2745c which was partially complemented by 
complementation with pK2 (data not shown, performed by other lab members).
In both of the mouse infection experiments using C57BL/6 mice the wild-type strain did 
not replicate as expected. H37Rv should replicate in the lung for several weeks 
post-infection, peaking at around 1x10^ CFU/lung and then maintaining this load through 
the chronic phase o f infection (Martens et al. 2008). An explanation for the poor in vivo 
replication in these experiments is that the wild-type strain used in these infections had 
become attenuated by acquisition of a mutation during multiple broth passages in the 
laboratory. Indeed, researchers have identified the forced dissociation of the H37 strain 
into two variants; the virulent H37Rv strain and the avirulent H37Ra strain where
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continuous culturing resulted in the assortment of two sub-populations of bacteria 
(Steenken, Jr., Oatway, Jr., & Petroff 1934). Typing is easily determined by ISd/70 
fingerprinting of the H37 laboratory strain to confirm its identity as the virulent sub-type 
(Bifani et al. 2000).
It is thought that this occurred after generation of the mutants as even in the broth culture 
(Figure 4.1) the generation time for the wild-type was slow compared to both the mutants 
and the complemented strains. From these experiments it is thus not possible to 
determine if  the ARv2548 or ARv2745c strains are attenuated for growth in the mouse. 
These experiments would need to be repeated with the wild-type strain sourced directly 
from the original laboratory stock of H37Rv. It should be noted that the transcriptional 
studies (Chapter 5) were performed with an earlier passage of the wild-type strain.
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5 Expression profiling of transcriptional regulator 
mutants
5.1 Introduction
Expression of a gene involves transcription of the DNA open reading frame to mRNA and 
subsequent translation of the mRNA to a protein which may be posttranslationally modified. 
Measurement of mRNA provides a snapshot of the level of gene transcription in a biological 
sample and normally correlates with the level of expression of the translated protein. To 
gain insight into gene fimction, expression profiling analysis can be used to understand 
changes that occur in an organism in response to environmental conditions or as a result of 
targeted gene deletion. The expression profile of an organism can be deduced on a whole 
genome scale using microarrays which gives a global picture of gene expression. On a much 
smaller scale specific genes are targeted using quantitative reverse transcription PGR (qRT- 
PCR) techniques. Here we profile gene expression in each of the M. tuberculosis regulator 
mutants created and also in each corresponding complemented strain using microarrays. 
Validation of microarray data was performed on a small set of targeted genes from one 
mutant strain using qRT-PCR.
5.2 Microarray analysis
Microarray analysis of RNA transcripts was used to identify variations in gene expression 
between transcriptional regulator mutants and the wild-type H37Rv strain. It is hypothesised 
that variations in gene expression between the strains is a direct result from the deletion of 
the transcriptional regulator in the mutant and hence will identify the gene targets the 
regulator controls. It is important to bear in mind that any changes in gene expression may 
also be due to an indirect effect of the deletion. Gene products of complemented mutants 
were also characterised using microarrays to confirm that any changes observed in the 
mutant were due to removal of the specific gene target and that upon replacing the gene back 
these changes are reversed.
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5.2.1 Expression profiling the ARv3058c mutant and 
complemented strain pKI
The Rv3058c regulator is predicted to be of the repressor type belonging to the TetR/AcrR 
family of regulators. It was therefore hypothesised that by knocking out this regulator the 
mutant strain would exhibit the up-regulation of genes belonging to the Rv3058c regulon. 
Significant genes that were up- and down-regulated in the ARv3058c KO strain compared to 
the wild-type were determined by rank product analysis and are tabulated in Table 5.1. The 
table hsts the proportions of up- and down-regulated genes in different functional groups. 
Of the 10 genes significantly up-regulated in the mutant, 3 genes belong to the cell wall and 
cell processes fimctional category. These cell membrane associated genes include two small 
proteins of unknown function (Rv3346c and Rv3355c) which are highly similar to each 
other in sequence homology (apparent by multiple sequence alignment using NTI Vector) 
with 84.7% consensus positions and 84.7% identity. The third is an integral cell membrane 
protein encoded by Rv3675. Up-regulated genes involved in metabolism and respiration 
include grcC2 (Rv0989c) that encodes the enzyme cydA (Rvl623c) and cydB {Rv1622c). 
CydA and CydB subunits form a cytochrome bd oxidase involved in aerobic respiration and 
are implicated to be important for bacterial survival during low aeration (Kana et al. 2001). 
There is a small gap of 11 bp between these adjacent cytochromes and their induction is 
likely due to these genes belonging to the same operon where their regulation may be 
operated by a common mechanism.
Up-regulation of Rv0129c, belonging to the lipid metabolism functional category, encodes 
the fibronectin-binding protein C (Ag85C, FbpC) which has mycolyltransferase activity 
involved in cord factor formation necessary for maintaining the integrity of the cell wall 
(Jackson et al. 2002). Rv3130c and Rv3131 were up-regulated in the mutant strain and their 
induction has been observed to be DosR (Rv3133c)-dependent during hypoxic growth 
conditions (Park et al. 2003). Rv3131 is similar to Rv2032 which is predicted to encode a 
nitroreductase (Purkayastha, McCue, & McDonough 2002). It may be that the Rv3131 gene 
product is also involved in the detoxification of nitrogen-containing compounds generated 
during macrophage infection. The induction of both cytochrome bd oxidase and genes of the
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DosR regulon have been identified to be independent responses to low aeration (Boon & 
Dick 2002;Kana et al. 2001;Park et al. 2003). A possible explanation for the up-regulation 
of these hypoxia-associated genes {cydA, cydB, RvSlSOc and Rv3131) could be due to 
reduced oxygen levels in the culture as harvesting of RNA transcripts occurred in late log 
phase cultures. Reduced oxygen levels in the mutant culture compared to the wild-type is 
corroborated by earlier findings of the ARv3058c mutant demonstrating a shorter generation 
time and reaching stationary phase more rapidly than the wild-type strain (see Chapter 4) 
explaining why the cultures may be in different phases of growth at the time of RNA 
harvest.
Eight genes were found to be significantly down-regulated in the ARv3058c strain compared 
to the wild-type. As expected, Rv3058c appears as the most down-regulated gene (see Table 
5.2). Two genes of the FbpB/Ag85B operon (Armitige et al. 2000) fbpB {Rvl886c) and 
Rv1885c were down-regulated. Similarly to FbpC (above), FbpB catalyzes the transfer of 
mycolic acids to form trehalose dimycolate (cord factor) of the cell wall (Belisle et al. 1997). 
Rvl885c has been likened to a chorismate mutase of the AroQ structural class involved in 
the synthesis of phenylalanine and tyrosine (Schneider et al. 2008). Down-regulation of the 
resuscitation promoting factor, rpfB {Rvl009) gene (Tufariello et al. 2006), was observed in 
combination with the conserved hypothetical genes Rv0950c and Rv2190c. fadD7 (Rv0119), 
a probable fatty-acid-CoA synthetase involved in lipid degradation and the 
phosphofimctokinase, pjkB (Rv2029c), involved in glycolysis were also shown to be down- 
regulated compared to the parental strain.
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Table 5.1: Rank product analysis showing significantly up- and down-regulated genes in each functional 
group of the ARv3058c strain also given as a percentage of the total o f up- or down-regulated genes.
Functional group Up-regulated genes Down-regulatedgenes
% of genes 
on array
No. % No. %
Cell wall, cell processes 3 30 1 12.5 18.68
Virulence, detoxification, 
adaptation 0 0 0 0 4.61
Intermediary metabolism, 
respiration 3 30 1 12.5 22.83
Unknown 0 0 0 0 0.38
PE/PPE 1 10 0 0 4.26
Insertion sequences and phages 0 0 0 0 3.75
Lipid transport/ metabolism 1 10 2 25 6.09
Stable RNA 0 0 0 0 0
Information pathways 0 0 0 0 5.71
Regulatory proteins 0 0 1 12.5 4.84
Conserved hypothetical protein 2 20 3 37.5 22.35
Conserved mM. bovis 0 0 0 0 6.55
Total no. 10 8 3924*
♦Represents the total number of genes on the microarray (see Section 2.13)
Overall, the distribution of up-regulated genes across different functional categories (Table 
5.1) fails to highlight any particular group to be regulated by Rv3058c and provides little 
clue as to which genes may be directly or indirectly regulated by Rv3058c. This is best 
illustrated by the up-regulation of one mycolyl transferase gene (fbpC) and the down- 
regulation of another (fbpB). The one trend that is evident is that a number of genes that are 
known to be differentially regulated in different growth phases have significantly altered 
expression in the mutant. Firstly rpfB is down-regulated and the gene product is thought to 
stimulate growth of dormant cells (Mukamolova et al. 1998). CyD and DosR regulated 
genes are also associated with stationary phase cultures. While it is possible that Rv3058c is 
directly involved in regulation of these genes it seems more likely that these changes are due 
to the bacterial cultures being at slightly different stages of growth.
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Table 5.2: Fold-change o f statistically significant differentially expressed genes in the ARv3058c as 
determined by rank product analysis.
Gene Function Fold-change
MtH37Rv-3346c Conserved transmembrane protein 2.6214
MtH37Rv-0129c Fibronectin binding protein C 2.3983
MtH37Rv-3675 Possible membrane protein 2.1215
MtH37Rv-3355c Probable integral membrane protein 2.22
MtH37Rv-3131 Conserved hypothetical protein 2.0443
MtH37Rv-0989c Probable polyprenyl-diphosphate synthase 2.0486
MtH37Rv-1623c Probable integral membrane cytochrome D ubiquinol oxidase(subunit I)
1.7906
MtH37Rv-1622c Probable integral membrane cytochrome D ubiquinol oxidase(subunit n) 1.8879
MtH37Rv-0834c PE-PGRS femily protein 1.9489
MtEB7Rv-3130c Triacylglycerol synthase 1.8529
MtH37Rv-3058c Possible transcriptional regulatory protein (TetR family) 0.0959
MtH37Rv-1886c Fibronectin binding protein B 0.3627
MtH37Rv-1885c Conserved hypothetical protein 0.4194
MtH37Rv-1009 Probable resuscitation promoting fector rpfB 0.441
MtH37Rv-0950c Conserved hypothetical protein 0.4093
MtH37Rv-2029c Probable phosphofructokinase PfkB 0.423
MtH37Rv-2190c Conserved hypothetical protein 0.4831
MtH37Rv-0119 Probable fetty-acid-CoA ligase fedD7 0.4533
The fold-change of commonly up- or down-regulated genes of the ARv3058c mutant and the 
complemented strain are listed in (Table 5.3). Of the 10 genes up-regulated in the mutant, 9 
of these genes are commonly up-regulated in the complemented strain compared to the wild- 
type. Additionally, of the 8 genes down-regulated in the mutant, 6 genes are similarly down- 
regulated in the complemented strain (Table 5.3). These results strongly indicate that 
complementation of the mutant strain was unsuccessful and/or that both the mutant and 
complemented mutant strains were at similar and later stages of growth compared to the 
wild-type. Such a result could be due to effects on gene expression when replacing the gene, 
using an integrating vector, into the attB site on the chromosome. It is possible that the 
integrated sequence did not harbour the Rv3058c promoter sequence as predicted. 
Alternatively, as discussed in Chapter 3, the sequencing of the complemented strain 
highlighted three base-pair substitutions, altering two amino acids which could produce a 
non-functional gene product (Appendix 3, Figure 9.7). Indeed a very probable explanation 
for the down-regulation of Rv3058c itself in the ARv3058c complemented strain suggests
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that it is not expressed under these conditions as the pKinta-encoded Rv3058c would still 
hybridise to the array probe despite the mutations. A further 3 genes were down-regulated in 
the ARv3058c complemented strain including RvlOlO, a probable dimethyladenosine 
transferase (KsgA), Rv2758c, an antitoxin, and Rv0063 and oxidoreductase. In addition to 
the 9 genes up-regulated in the ARv3058c complemented strain, as hsted in Table 5.3, 
another 74 genes were up-regulated in this strain and are detailed in Appendix 4, Table 9.1. 
The induction of so many genes in the complemented strain may be due to knock-on effects 
of inserting the Rv3058c gene at the attB site.
Table 53: Fold-change o f common genes significantly up- or down-regulated in the ARv3058c mutant 
and ARv3058c complemented strains.
Rv No. (gene) Fold-change Rv No. (gene) Fold-change
tK O t  compl. 4 KO 4 compl.
Rvl622c (cydB) 1.89 3.68 Rv3058c 0.1 0.1
Rvl623c (cydA) 1.79 3.63 Rvl886c (fbpB) 0.36 0.46
Rv0129c (fbpC) 2.4 3.19 Rvl885c 0.42 0.4
Rv3130c 1.85 2.48 Rvl009 (ipffl) 0.44 0.43
Rv3346c 2.62 2.09 Rv0950c 0.41 0.41
Rv3131 2.04 1.92 Rv2190c 0.48 0.52
Rv3675 2.12 1.96
Rv3355c 2.22 1.77
Rv0989c (grcC2) 2.05 1.67
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5.2.2 Expression profiling the ARv2548 mutant and complemented 
strain pK3
Rv2548 is the toxic component of a toxin-antitoxin (TA) operon which may function to 
control gene expression by degrading RNA transcripts. Therefore it was hypothesised that 
the ARv2548 strain may have an altered mRNA profile compared to its wild-type parental 
strain. A total of 38 genes were significantly more abundant in the ARv2548 strain (Table 
5.4). This, taken together with the observation that there was no down-regulation of any 
genes in the mutant, is consistent with Rv2548 functioning as an RNase. The number of 
significantly more abundant mRNA transcripts divided among functional categories is hsted 
in Table 5.4. A 26.32% proportion of all up-regulated genes were of unknown function and 
10.53% were involved in virulence, detoxification and adaptation. Interestingly, the 
antitoxin (Rv2547) of the Rv2548 operon was up-regulated in ARv2548. Typically, the 
labile antitoxin of a TA operon also functions to regulate transcription of the operon (Gerdes 
2000). In light of this, one feasible explanation for up-regulation of antitoxin is the absence 
of the physical toxin-antitoxin complex which conceivably would result in more antitoxin 
transcripts available for promoting transcription of the TA operon.
Table 5.4: Rank product analysis showing numbers o f significantly up-regulated genes in each functional 
group of the ARv2548 mutant strain also given as a percentage of the total o f up-regulated genes.
Functional group Up-regulated genes % ofgenes 
on array
No. %
Cell wall, cell processes 2 5.26 18.68
Virulence, detoxification, adaptation 4 10.53 4.61
Intermediary metabolism, respiration 9 23.68 22.83
Unknown 0 0 0.38
PE/PPE 0 0 4.26
Insertion sequences and phages 0 0 3.75
Lipid transport/ metabolism 1 2.63 6.09
Stable RNA 0 0 0
Information pathways 2 5.26 5.71
Regulatory proteins 2 5.26 4.84
Conserved hypothetical protein 10 26.32 22.35
Conserved in M  bovis 8 21.05 6.55
Total no. 38 3924*
♦Represents the total number of genes on the microarray (see Section 2.13)
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A number of more abundant mRNAs in the ARv2548 deleted strain may be transcribed as 
polycistronic transcripts (Table 5.5). Transcripts of Rv2660c and Rv2661c as well as the 
divergently transcribed Rv2662 were up-regulated in the ARv2548 strain compared to the 
wild-type and have all been shown to be up-regulated in the starvation model (Betts et al.
2002). Although Rv2662 exists divergently from the upstream adjacent gene, Rv2661c, they 
may share a common upstream activation site indicated by a 94 bp overlap across these 
small encoded proteins. Evidence exists for the co-expression of adjacent gene pairs, 
independent of orientation, where the presence of a common upstream activation site is 
important for correlated expression (Cohen et al. 2000). This would explain the correlated 
expression of Rv2660c, Rv2661c and Rv2662 in this study and that which was also observed 
by Betts et al (Betts et al. Duncan 2002). Another putative operon induced in the ARv2548 
mutant included the genes Rv0789c, Rv0790c, Rv0791c and Rv0792c. Rv0789c-Rv0791c 
are conserved hypothetical proteins with Rv0790c having an orthologue in M. bovis and 
found to be up-regulated at high temperatures (Betts et al. 2002). Rv0792c is annotated as a 
putative transcriptional regulator of the GntR family which are exclusively described as 
repressors (Gerischer 2002).
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Table 5.5: Fold-change o f statistically significant differentially expressed genes in the ARv2548 strain as 
determined by rank product analysis.
Gene Function Fold-change
MtH37Rv-2661c Hypothetical protein 3.1139
MtH37Rv-2913c Possible D-amino acid aminohydrolase 3.0175
MtH37Rv-0790c Hypothetical protein 3.5006
MtH37Rv-0654 Probable dioxygenase 3.8606
MtH37Rv-0792c Probable transcriptional regulatory protein (GntR femily) 3.4315
MtH37Rv-2660c Hypothetical protein 2.9805
MtH37Rv-0791c Possible lipoprotein (LprO) 3.6156
MtH37Rv-0251c Heat-stress-induced ribosome-binding protein A 3.3217
MtH37Rv-2011c Conserved hypothetical protein 3.4435
MtH37Rv-0768 Probable aldehyde dehydrogenase NAD dependent (AldA) 2.7368
MtH37Rv-2662 Hypothetical protein 3.0686
MtH37Rv-2912c Probable transcriptional regulatory protein (TetR family) 2.7521
MtH37Rv-1221 Alternative RNA polymerase sigma fector (SigE) 3.0463
MtH37Rv-3531c Hypothetical protein 3.3286
MtH37Rv-2466c Conserved hypothetical protein 2.2872
MtH37Rv-3406 Probable dioxygenase 2.8893
MtH37Rv-1285 Probable sulphate adenylyltransferase subunit 2 (CysD) 2.8827
MtH37Rv-3463 ' Conserved hypothetical protein 2.5341
MtH37Rv-0331 Possible dehydrogenase/reductase 3.1599
MtH37Rv-3054c Conserved hypothetical protein 2.8197
MtH37Rv-2036 Conserved hypothetical protein 2.689
MtH37Rv-1804c Conserved hypothetical protein 2.7366
MtH37Rv-2035 Conserved hypothetical protein 2.401
MtH37Rv-1936 Possible monooxygenase 2.9117
MtH37Rv-2617c Probable transmembrane protein 2.4595
MtH37Rv-0837c Hypothetical protein 2.1396
MtH37Rv-1317c Probable regulatory protein of the adaptive response (AlkA) 1.6815
MtH37Rv-3530c Possible oxidoreductase 3.0427
MtH37Rv-2547 Conserved hypothetical protein, antitoxin 2.1814
MtH37Rv-0350 Probable chaperone protein (DnaK/Hsp70) 2.9431
MtH37Rv-0789c Hypothetical protein 2.7793
MtH37Rv-2516c Hypothetical protein 2.7243
MtH37Rv-0571c Conserved hypothetical protein 2.7704
MtH37Rv-0347 Probable conserved membrane protein 2.701
MtH37Rv-0764c Cytochrome P450 (Cyp51) 2.4433
MtH37Rv-1952 Conserved hypothetical protein, antitoxin 2.2322
MtH37Rv-2503c Probable succinyl-Co A:3 -ketoacid-coenzyme A (ScoB) 2.5081
MtH37Rv-2616 Conserved hypothetical protein 2.8129
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Those gene transcripts more abundant in the ARv2548 mutant and involved in virulence 
include the small heat shock protein (hsp) Acr2 (Rv0251c). This gene is up-regulated in 
many environments including heat shock (Stewart et al. 2001), nutrient starvation (Betts et 
al. 2002), non-replicating persistence and following phagocytic uptake by the macrophage 
(Schnappinger et al. 2003). Acr2 is also important for the progression of lung pathology in 
mice infected with M. tuberculosis (Wilkinson et al. 2005). The Acr2 protein is negatively 
regulated by hspR and positively by sigE (Pang & Howard 2007;Stewart et al. 2002a). Other 
virulence associated genes found to be more abundant in the mutant were Rvl952, an anti­
toxin, and dnaK (Rv0350) encoding the DnaK/Hsp70 chaperone protein which is negatively 
regulated by hspR (Rv0353) (Stewart et al. 2001). This gene is similarly induced in many 
stress environments including heat shock (Stewart et al. 2002a) and in the macrophage 
(Schnappinger et al. 2003). In concordance with the up-regulation of the above chaperones 
the aE alternative sigma factor {Rvl221) was up-regulated in the ARv2548 mutant and is 
known to regulate the heat shock response (Manganelli et al. 1999;Stewart et al. 2002). aE 
is itself regulated by another heat responsive alternate sigma factor aH (Rv3223c). A gene 
of unknown function, Rv2466c, also regulated by aH (Raman et al. 2001) was up-regulated 
in the ARv2548 mutant however the sigH transcript itself was not differentially expressed.
Among the other genes found to be more abundant in the mutant were Rv2912c, a probable 
transcriptional regulator of the TetR family of regulators; Rv2913c, a possible D-amino acid 
aminohydrolase; and Rv0331, a gene of unknown function shown to be expressed during 
high temperature and starvation (Betts et al. 2002;Stewart et al. 2002a).
With the predominance of up-regulated genes previously shown to be associated with 
induction during nutrient depletion and/or heat shock or phagocytosis it is suggestive that the 
Rv2548 toxin may be responsible for degrading transcripts involved in stress responses 
when they are not required under normal conditions. With the absence of the toxin these 
transcripts accumulate. Alternatively, deletion of the toxin in the mutant strain may have 
invoked a stress response whereby several genes involved in mediating cellular responses to 
changing conditions were induced to maintain cellular functions.
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Unexpectedly, Rv2548 did not exhibit significant down-regulation in the mutant as 
determined by rank product analysis using the stringent pfy cut-off of 10%. Rv2548 did 
however give a fold-change of 0.5 (results not shown). The profiling results of this mutant 
indicate that several significant changes occur in our mutant strain with the over abundance 
of some 38 gene transcripts. Taken together with our knowledge of the activity of TA pairs 
the profiling results imply the successful disruption of the Rv2548 toxin and the 
accumulation of transcripts that the toxin may regulate, either directly or indirectly. 
Rv2025c and Rv3824c were the only transcripts significantly more abundant in the ARv2548 
complemented strain compared to wild-type with a fold-change of 2.05 and 1.77 respectively 
(Table 5.6). In the ARv2548 mutant strain Rv2025c had a fold-change of 1.5 however rank 
product analysis determined the result to be not significantly different from the wild-type. 
Additionally, Rv3824c exhibited a fold-change of 0.99 in the ARv2548 mutant, indicating 
expression of the gene to be comparable to that of the wild-type. Rv2462c and Rv2913c 
were the only genes significantly down-regulated in the ARv2548 complemented strain with 
a fold-change of 0.22 and 0.3 respectively (Table 5.6). Rv2913c was up-fegulated >3-fold in 
the ARv2548 and its down-regulation in the ARv2548 complemented strain indicates this 
mRNA as a target for RNase degradation by Rv2548. With so few genes differentially 
expressed in the complemented strain it is highly indicative that the mutant strain was 
successfully complemented and therefore exhibiting an expression profile comparable to the 
parental strain.
It is important to highlight that the complemented strain has two copies of the unstable anti­
toxin molecule encoded by Rv2547. This extra copy of the anti-toxin molecule could 
provide the complemented strain with greater control over the stable toxin component and 
therefore further minimise degradation of RNA transcripts. If this were true then one may 
expect up-regulation of expressed genes in the ARv2548 complemented strain compared to 
the wild-type. However, this hypothesis is not supported by the expression profiling data for 
the Rv2548 complemented strain (Table 5.6) which shows the complemented strain to be 
comparable to wild-type with only two genes (Rv2025c and Rv3824c) significantly up- 
regulated.
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Table 5.6: Fold-change o f statistically significant differentially expressed genes in the ARv2548 
complemented strain as determined hy rank product analysis.
Gene Function Fold-change
MtH37Rv-2025c Possible conserved membrane protein 2.0484
MtH37Rv-3824c Probable tRNA methyltransferase (TrmU) 1.7676
MtH37Rv-2462c Probable trigger fector (TF) protein (TiG) 0.2188
MtH37Rv-2913c Probable D-amino acid aminohydrolase 0.3008
5.2.3 Expression profiling the ARv2745c mutant and 
complemented strain pK2
The transcriptional regulatory protein, Rv2745c, identified in the TraSH screen, is highly 
similar to the transcriptional activator, ClgR, in Streptomyces (see Chapter 3). ClgR is 
involved in the regulation of several proteolytic subunits, encoded by the Clp operon, 
implicated in Streptomyces differentiation (Bellier & Mazodier 2004). Transcriptional 
profiling of the ARv2745c mutant demonstrated that 31 genes were up-regulated compared 
to the wild-type and 9 were down-regulated. A count of all differentially expressed genes in 
the ARv2745c mutant with respect to the functional group to which these genes belong is 
provided in Table 5.7. Of those genes down-regulated in the ARv2745c mutant three are 
conserved hypothetical genes (Rvl043c, Rv2744c, and Rvl996) (Table 5.8). The other 
down-regulated genes comprised the acr2 chaperone gene, a fumarate reductase subunit 
(Rvl552), a dehydrogenase (Rv0697), a transposase for IS6110 {Rv2168c\ an exported 
protein (Rvll84) and the putative transcriptional regulator (Rv2745c) (Table 5.8). 
Successfiil deletion of the Rv2745c gene is supported by the microarray results showing the 
significantly reduced expression for this gene, achieving a fold-change of 0.5. In addition, 
the neighbouring downstream gene, Rv2744c, which appears to be part of a single 
transcription unit, achieved significant down-regulation with a fold-change of 0.54. Of the 
remaining 7 genes significantly down-regulated in the knock-out strain, 4 of these were also 
significantly down-regulated in the complemented strain (see Appendix 4, Table 9.2) 
including Rv0251c, Rv0697, Rvl996 and Rv 1184c.
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Table 5.7: Rank product analysis showing s^nifîcantly up- and down-regulated genes in each functional 
group of the ARv2745c mutant strain also given as a percentage o f die total o f up- or down-regulated 
genes.
Functional group Up-regulated genes Down-regulatedgenes
% ofgenes 
on array
No. % No. %
Cell wall, cell processes 3 9.68 1 11.11 18.68
Virulence, detoxification, 
adaptation 3 9.68 1 11.11 4.61
Intermediaiy metabolism, 
respiration 5 16.13 2 22.22 22.83
Unknown 0 0 0 0 0.38
PE/PPE 2 6.45 0 0 4.26
Insertion sequences and phages 0 0 1 11.11 3.75
Lipid transport/ metabolism 2 6.45 0 0 6.09
Stable RNA 0 0 0 0 0
Information pathways 0 0 0 0 5.71
Regulatory proteins 2 6.45 1 11.11 4.84
Conserved hypothetical protein 14 45.16 3 33.33 22.35
Conserved inM. bovis 0 0 0 0 6.55
Total no. 31 9 3924*
♦Represents the total number of genes on fee microarray (see Section 2.13)
Transcription of Rv2745c and Rv2744c was restored in the complemented strain (fold- 
changes of 1.01 and 0.8 respectively) (data not shown) suggesting that re-insertion of 
Rv2745c at the attB site on the ARv2745c mutant genome was successfiil. However, 
transcription of acr2 was not complete in the complemented strain -  the acr2 gene 
(Rv0251c) achieved was down-regulated 10 fold in the mutant (0.1 fold-change) but only 4 
fold (0.25 fold-change) in the complemented strain compared to wild-type (Appendix 4, 
Table 9.2). Transcription of Rvl043c was also restored in the complemented strain (0.43 in 
the mutant and 0.71 in the complement (results not shown)). Both acr2 and Rv1043c are 
shown later in this chapter to have putative Rv2745c binding sites. Increased transcription 
of these particular genes in the complemented strain is thus an important indicator that the 
re-introduced Rv2745c gene was expressed in the complemented strain and that acr2 and 
Rvl043c are under direct control of Rv2745c. However, Rvl996 had a fold-change of 0.45 
in the knock-out and 0.47 m the complemented strain and Rv 1184c had a fold-change of 0.54 
and 0.46 in the knock-out and complemented strain respectively. A further gene, encoding a 
probable dehydrogenase (Rv0697), was commonly down-regulated in the mutant and
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complemented strain with a fold-change of 0.45 and 0.38 respectively. In total four of the 
nine genes identified to be down-regulated in the mutant remain down-regulated in the 
complemented strain indicating that complementation of the Rv2745c gene was only 
partially successfiil or that some of the down regulated genes in the knockout strain represent 
secondary mutations that caimot be complemented.
It should also be noted that more genes were down-regulated in the complemented mutant 
strain compared to wild-type than in the non-complemented mutant. This may be due to 
unintentional differences in the growth phase of the different strains or due to the effects of 
réintroduction of the Rv2745c gene on an AttB integrating vector. These down-regulated 
genes in the complemented strain included, a large operon of ribosomal genes: Rv0702 
{rplD), Rv0704, Rv0705 (rpsS), Rv0706 {rplV), Rv0707 (rpsC), and Rv0709 (rpmC). In 
addition, there are several other genes, implicated in information pathways, also shown to be 
down-regulated. These include Rv0667 QpoB) and Rv0668 (rpoC), both DNA-directed 
RNA polymerase beta subunits; Rvl297 {rhd) a transcription termination factor; Rvl642 
(rpml) and Rvl643 (rplT), yet further large ribosomal subunits; Rv2092c QielY) an ATP- 
dependent DNA hehcase and Rv2783c (gpsl) important in RNA processing and mRNA 
degradation. Together a substantial 14.44% of down-regulated genes belong to information 
pathways and 6.67% are regulatory proteins (Table 5.9). There is the reduced transcription 
of several genes involved in the cell wall/processes totalling 16.67% of all down-regulated 
genes found in the ARv2745c complemented strain. These include those proteins of the 
Rv3917c (parB) operon alongside Rv3918c iparA) and Rv3919c {gid) (Appendix 4, Table 
9.2). In addition, the cell wall associated protein, Rv3921c, and the hypothetical protein, 
Rv3920c, were also down-regulated. Several more opérons (Rvl869c -  RvI872c; Rv0765c 
-  Rv0766c, Rv0768 -  Rv0769; Rv0790c -  Rv0792c) are down-regulated in the 
complemented strain.
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Table 5.8: Rank product analysis listing statistically significant fold-changes of differentially expressed 
genes in the ARv2745c mutant strain.
Gene Function Fold-change
MtH37Rv-0467 Isocitrate lyase (Id) 3.156
MtH37Rv-3085 Probable short-chain type dehydrogenase/reductase 2.9978
MtH37Rv-3128c Conserved hypothetical protein 2.7634
MtH37Rv-2626c Conserved hypothetical protein 2.5747
MtH37Rv-2625c Probable conserved transmembrane alanine and leucine richprotein
2.3922
MtH37Rv-2033c Conserved hypothetical protein 2.3771
MtH37Rv-1998c Conserved hypothetical protein 2.6963
MtH37Rv-2624c Conserved hypothetical protein 2.7
MtH37Rv-2030c Conserved hypothetical protein 2.2873
MtH37Rv-2029c Possible phosphofimctokinase (PfkB) 2.2777
MtH37Rv-0244c Probable acyl-CoA dehydrogenase (FadES) 2.3077
MtH37Rv-2003c Conserved hypothetical protein 2.2475
MtH37Rv-2623 Conserved hypothetical protein (TB31.7) 2.2103
MtH37Rv-2025c Possible conserved membrane protein 2.316
MtH37Rv-2004c Conserved hypothetical protein 2.1637
MtH37Rv-1040c PE family protein (PE8) 2.2485
MtH37Rv-1130 Conserved hypothetical protein 2.0263
MtH37Rv-1809 PPE family protein (PPE33) 2.0642
MtH37Rv-3132c Two component sensor histadine kinase (DevS) 1.9159
MtH37Rv-3133c Two component transcriptional regulatory protein (DevR),
LuxR/UhpA-family
1.9809
MtH37Rv-2252 Conserved hypothetical protein 1.8991
MtH37Rv-3418c lOkDa chaperonin (GroES) 1.8608
MtH37Rv-3417c 60 kDa chaperonin 1 (GroELl) 1.858
MtH37Rv-1131 Probable citrate synthase I (GltAl) 1.934
MtH37Rv-2816c Conserved hypothetical protein 1.8438
MtH37Rv-0468 Probable 3 -hydroxybutyryl-CoA dehydrogenase (FadB2) 1.8696
MtH37Rv-1571 Conserved hypothetical protein 1.8738
MtH37Rv-2911 Probable D-alanyl-D-alanine carboxypeptidase (DacB2) 1.9326
MtH37Rv-1908c Catalase-peroxidase-peroxynitritase (KatG) 1.7848
MtH37Rv-2699c Conserved hypothetical protein 1.7561
MtH37Rv-3251c Probable rubredoxin (RubA) 1.7053
MiH37Rv-0251c Heat shock ribosome-binding protein A (Hsp/Acr2) 0.1031
MtH37Rv-1552 Probable fumarate reductase flavoprotein subunit (FrdA) 0.4064
MtH37Rv-0697 Probable dehyrogenase 0.4463
MtH37Rv-1043c Putative protease 0.4303
MtH37Rv-2168c Putative transposase for insertion sequence element IS6110 0.5007
MtH37Rv-2745c Possible transcriptional regulatory protein 0.5004
MtH37Rv-2744c Conserved 35 kDa alanine-rich protein (35kd_ag) 0.5374
MtH37Rv-1996 Conserved hypothetical protein 0.4533
MtH37Rv-1184c Possible exported protein 0.5418
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Although Rv2745c is predicted to be a transcriptional activator and thus we expect directly 
regulated genes to be down-regulated in the mutant, 31 genes were observed to be up- 
regulated in the ARv2745c mutant strain. A high proportion (45%) of up-regulated genes 
encoded conserved hypothetical proteins of unknown fimction and approximately 16% of all 
up-regulated genes are involved in metabolism and respiration (Table 5.7). Almost 10% of 
up-regulated genes encode products predicted to be involved in cell wall/ processes 
associated with the cell wall and an equal proportion are involved in virulence, detoxification 
and adaptation. The mutant had several groups of up-regulated genes, which may be 
transcribed as polycistronic transcripts (Rv2623 - Rv2626c; Rv2025c, Rv2029c - Rv2030c, 
Rv2033c; Rv3132c - Rv3133c; Rv3417c (groELl) - Rv3418c (groES); Rvll30  - Rvll31\ 
Rv2003c - Rv2004c). GroELl and GroES are chaperones thought to be involved in 
virulence (Qamra, Srinivas, & Mande 2004) as is the catalase peroxidise, KatG, also seen to 
be induced in the mutant (Ng et al. 2004). Ici (Rv0467), encoding isocitrate lyase, was up- 
regulated in the mutant along with the neighbouring gene, fadB2 (Rv0468), a hydroxyacyl 
CoA dehydrogenase. A study (Fisher, Plikaytis, & Shinnick 2002) found id  and fadB2 
induced during acid conditions alongside Rvll30  and Rvll31  all of which are sigE regulated 
(Manganelli et al. 2001). Id  is important during macrophage survival (Bentrup & Russell 
2001) and the genes fadB2 and Rvl 130 are proposed to be involved in fatty acid metabolism 
(Fisher, Plikaytis, & Shinnick 2002). Such a response mimics the induction of several of the 
same genes also involved during macrophage survival (Hoener Zu Bentrup et al. 1999). 
Taken together, these results support the view that Rv2745c may be directly or indirectly 
important for the modulation of genes during macrophage survival. Of the 31 genes up- 
regulated in the ARv2745c mutant, only one gene, Rvl809 (PPE33), was commonly up- 
regulated in the complemented strain. Another gene, encoding a probable rubredoxin 
{Rv3251c), was up-regulated in the mutant (1.71 fold-change) and conversely down- 
regulated in the ARv2745c complemented strain (0.25).
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Table 5^: Rank product analysis showing significantly up- and down-regulated genes in each functional 
group of the ARv2745c complemented strain also given as a percentage of the total o f up- or down- 
regulated genes.
Functional group Up-regulated genes Down-regulated % of genesgenes on array
No. % No. %
Cell vrall, cell processes 18.68
3 15.79 15 16.67
Virulence, detoxification. 2 10.53 2 2.22 4.61adaptation
Intermediary metabolism. 1 5.26 23 25.56 22.83respiration
Unknown 0 0 0 0 0.38
PE/PPE 1 5.26 4 4.44 4.26
Insertion sequences and phages 5 26.32 1 1.11 3.75
Lipid transport/ metabolism 0 0 5 5.56 6.09
Stable RNA 0 0 0 0 0
Information pathways 1 5.26 13 14.44 5.71
Regulatory proteins 0 0 6 6.67 4.84
Conserved hypothetical protein 5 26.32 14 15.56 22.35
Conserved inM. bovis 1 5.26 7 7.78 6.55
Total no. 19 90 3924*
♦Represents the total number of genes on the microarray (see Section 2.13)
5.3 Bioinformatic search of ClgR-like binding sites
Many transcriptional activators will recognise and bind a specific motif within a gene 
sequence. In Streptomyces, ClgR binds to a palindromic motif (CGC-5N-GCG). In order to 
test our hypothesis that the highly similar transcriptional regulator, Rv2745c 
(see Chapter 3), is a paralogue of ClgR we sought to identify similar sequence motifs within 
the 5’ sequence of down-regulated genes observed in the transcriptional profile for the 
ARv2745c mutant. The M. tuberculosis H37Rv genome was explored using the Sequence 
Analysis Search Pattern fimction available on the TubercuList web server 
(http://genohst.pasteur.fr/TubercuList/genome). Five genes were identified to have good 
potential binding motifs for the ClgR homologue (Table 5.10). The acr2 gene (Rv0251c), 
encoding the small alpha crystallin heat shock protein important in pathogenesis and 
Rv1043c, a predicted endopeptidase were both observed to be significantly down-regulated 
in the ARv2745c mutant. The other three genes, clpPl (Rv2461c), clpCl (Rv3596c) and 
ptrBb (Rv0782), also encode proteases and were not significantly down-regulated in the
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ARv2745c mutant. However clpPl and ptrBb, the latter of which functions to cleave peptide 
bonds on the C-termiuus of argininyl and lysyl residues, both fell within the top 30 genes 
down-regulated as determined fi’om rank product analysis (Appendix 4, Table 9.3). ClpCl 
showed no differential expression in the mutant with a fold-change of 1.05, highly 
comparable to the wild-type. It is possible that analysis of transcripts in other conditions 
such as heat shock would have revealed a greater effect of Rv2745c deletion on the 
expression of these genes. The combination of predicted ClgR binding sites and the 
microarray data is, however, strongly indicative that Rv2745c encodes a ClgR homologue 
and that it regulates expression of the Acr2 chaperone and the Rvl043c, ClpPl and PtrB 
proteases (and maybe ClpCl).
Table 5.10: Clg^-like binding sites identified in M. tuberculosis.
L t Z ____________________________ Sequence (S>-3’)________________________
acr2 118 CTGTGTGACAGTGTTCGCTTCCGGTGAACGCCGAGGTGGAA
178 TAGGCGCGCCTAGTTCGCGTGAAGCGAACACCGACTCTGCA{Rvl043c) -------------  --------------
ptrBb 68 GGCCACGACTTCTTCGCACTGGGCGCGGCCAGCGTCAGCCTG
clpPl 111 AACGTGACCGTATGACGCTGTAAGCGAACGCGCCGGTTTCA
clpCl 128 GAGCGGCCATCGGTTCGCCGCCAGCGAACGCGGCAAAGTAC
5.4 Validation of microarray analysis by quantitative real time PCR
Expression profiling results of the ARv2745c mutant and ARv2745c complemented strains 
showed the differential expression of many genes and in order to confirm the microarray 
data, specific genes were chosen for analysis by quantitative real time PCR (qRT-PCR) 
using the Applied Biosystems (ABI) Prism® 7000 Sequence Detection System. The 
identification of putative Rv2745c binding sites and hence the genes with which it has a 
direct interaction, led us to concentrate validation of the microarray results to those genes 
with binding sites (Table 5.10).
5.4.1 Quantitative real time PCR
RNA samples were those used in the microarray analysis and for further biological
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replication a second round of RNA extractions were performed totalling 8 biological 
replicates for the qRT-PCR analysis. Primer sets were first tested for efficiency and 
specificity before using the primer/probe sets together in qRT-PCR. Figure 5.1 compares the 
induction ratios of the microarray analysis and the qRT-PCR results for each gene target. In 
the ARv2745c mutant the clpCl (Rv3596c) gene achieved no change in expression compared 
to the wild-type strain across four replicate arrays. Similar findings were replicated for 
clpCl when using qRT-PCR analysis. Although there appears to be a small induction of the 
clpCl gene, the overlap of error bars between the microarray and qRT-PCR analysis prove 
this induction to be insignificant between the two sets of results. Highly repeatable results 
were achieved for the second clp protease, clpPl (Rv2461c), with both expression analyses 
indicating reduced expression of the gene in the ARv2745c mutant strain. Again, qRT-PCR 
analysis corroborated with the microarray data for the acr2 (Rv0251c) gene supporting the 
observation that this important heat shock protein is indeed down-regulated. Unfortunately, 
qRT-PCR results for the final gene target, Rv1042c, failed to provide any amplification of 
the gene using the designed primer/probe set (data not shown).
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Figure 5.1; Comparison of qRT-PCR and microarray expression analysis of genes in the ARv2745c 
mutant strain.
A comparison of the induction ratios achieved in the ARv2745c mutant for selected genes (Rv3596c, Rv246Ic 
and Rv025Jc) using microarrays and qRT-PCR analysis. Error bars depict the variation between 4 replicate 
microarrays and for qRT-PCR analysis error bars indicate the variation between 8 biological replicate RNA 
samples.
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Similarly, using qRT-PCR analysis to validate the microarray data we sort to determine the 
induction ratios of the same four genes for the ARv2745c complemented strain (Figure 5.2). 
Both qRT-PCR and microarray analysis indicated the clpCl gene (Rv3596c) to be down- 
regulated (0.85 and 0.78 fold-change, respectively) in the ARv2745c complemented strain. 
ClpPl (Rv2461c) showed similar down-regulation determined by both methods for 
expression analysis. Although, it should be noted that the median induction ratio was very 
similar between analytical methods, the degree of variation was much greater when using 
qRT-PCR analysis for this gene target. This is due to increased biological variation when 
using a second round of extracted RNA fi*om the strain that was not used in the original 
microarrays. Again similar results were obtained for acr2 (Rv0251c) expression between the 
two methods for gene expression analysis. qRT-PCR analysis was performed for Rv1043c, 
however due to lack of primer/probe amplification of this gene target (as observed for the 
ARv2745c mutant strain) the microarray results could not be corroborated (results not 
shown).
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Figure 5.2: Comparison of qRT-PCR and microarray expression analysis of genes in the ARv2745c 
complemented strain.
A comparison of the induction ratios achieved in the ARv2745c complemented mutant for selected genes 
(Rv3596c, Rv2461c and Rv0251c) using microarrays and qRT-PCR analysis. Error bars depict the variation 
between 4 replicate microarrays and for qRT-PCR analysis error bars indicate the variation between 8 
biological replicate RNA samples.
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The Pearson’s Product Moment Correlation (Pearson’s Correlation) is a statistical test used 
to measure the correlation between two variables and was applied to the induction ratios 
fi*om the microarray and qRT-PCR data. A comparison of the expression results achieved a 
Pearson Correlation of 1.0 and 0.99 for the ARv2745c mutant strain and ARv2745c 
complement strain respectively. This illustrates that there is a strong positive linear 
relationship between the microarray and qRT-PCR results thus confirming the microarray 
data for the gene targets tested. The Pearson Correlation is sensitive to outliers present in the 
dataset and assumes a normal distribution in both datasets being compared. In light of the 
disadvantages of the Pearson Correlation, the Spearman rank correlation (Corder & Foreman 
2009) was also performed as this statistical test differs fi’om the former in that it does not 
assume normality and is less sensitive to bias due to outliers. The Spearman correlation 
achieved perfect positive linear correlation between the microarray and qRT-PCR data.
Table 5.11: Results o f the Spearman and Pearson Correlation tests comparing die microarray and qRT- 
PCR results.
Statistical Test ARv2745c Rv2745ccomplement
Pearson Correlation 1.0 0.99
Spearman Correlation 1.0 1.0
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5.5 Discussion
In this chapter M  tuberculosis strains deleted of the putative regulator genes Rv3058c, 
Rv2548c and Rv2745c, were grown in broth and transcriptional profiles compared to wild- 
type with the aim of identifying the genes controlled by each regulator. For the ARv3058c 
mutant 10 genes were significantly up-regulated and 8 genes down-regulated. Four of the 
up-regulated genes {cydA, cydB, Rv3130c and Rv3131) are linked with growth in hypoxic 
conditions and in stationary phase growth (Kana et al. 2001;Park et al. 2003). Other 
significantly differentially expressed genes including the mycolyl transferase genes fbpB 
(down-regulated) and jbpC (up-regulated) and the resuscitation promotion factor gene rpfB 
(down-regulated) are associated with active growth of the bacterium. While it is possible 
that the Rv3058c regulator is involved in controlling these genes it is also possible that the 
mutant strain was sampled once it had reached stationary phase and the wild-type strain was 
still in logarithmic growth. Great effort was made to ensure that the cultures were cultured 
in parallel and that they were sampled at similar CDs, however, we have noted that Rv3058c 
grows marginally faster than the parental strain and reaches stationary phase in a shorter time 
(Chapter 4). Rv3058c was targeted for this study because high throughput studies had 
indicated that disruption of the gene abrogated the ability of the bacterium to inhibit 
phagosome lysosome fusion (unpublished study). However, this phenotype has not been 
verified in the individual mutant and preliminary studies indicate that the ARv3058c strain 
does not appear to be attenuated for growth in the macrophage (Chapter 4). Nevertheless, 
differences in expression of these key metabohc and growth genes in the ARv3058c strain 
could conceivably affect the intracellular bacterium and make it more susceptible to traffic to 
lysosomes.
Comparing the differential expression of up and down-regulated genes in the ARv3058c 
mutant and the ARv3058c complemented strain there is good evidence to suggest the 
complementation of a functional Rv3058c gene was unsuccessful. Ninety percent of the 
genes up-regulated in the complemented strain were also up-regulated in the ARv3058c 
mutant. Similarly, 6 of the 8 genes significantly down-regulated in the ARv3058c mutant 
were also down-regulated in the ARv3058c complemented strain and there was no
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restoration of transcription to wild-type levels of the Rv2058c gene itself. This result could 
be due to a number of factors. Firstly, as the promoter site for the gene is unmapped it could 
be that the upstream sequence of the Rv3058c gene used for complementation did not in fact 
contain the genes’ own promoter. Other assays such as transcriptional start site mapping 
would need to be performed to definitively determine the Rv3058c promoter region. As 
discussed in Chapter 3, the complement construct, pKl, was sequenced and revealed 2 
amino acid changes present in the polypeptide. It is unknown whether these amino acid 
changes could have severely affected the transcription of a fimctional gene product or the 
stability of the mRNA. Perhaps expression of the gene may have been effected by the 
insertion of the Rv3058c sequence at the attB site within the chromosome (Guilhot, Jackson, 
& Gicquel 1999). Lastly, there is the possibility that secondary mutations have arisen in the 
ARv3058c complemented strain that may alter expression of the Rv3058c gene from the 
expected wild-type levels. The additional up and down-regulated genes in the 
complemented strain may be a consequence of insertion of Rv3058c at the attB site.
In the Rv2548 mutant there were 38 genes significantly up-regulated and no genes 
significantly down-regulated. This provides good evidence for Rv2548 function in 
repression of gene expression via degradation of RNA transcripts. Further confirmation for 
the Rv2547/Rv2548 as a TA operon is the observed up-regulation of the antitoxin (Rv2547); 
perhaps resultant because without the toxin there are more antitoxin molecules unable to 
form a TA complex, and therefore available for promoting transcription of the TA operon. 
Many of the genes induced have been associated with the heat shock response; acr2, dnaK, 
Rv0353 and sigE or in the starvation model; Rv2660c, Rv2661c, Rv2662, or indeed both; 
Rv0353 and acr2. With the induction of so many genes associated with stress responses 
there is good evidence for the Rv2548 toxin to be a vital regulator as without this toxin there 
is an increase in the mRNA transcripts of these genes. An alternative explanation is that the 
deletion of Rv2548 stresses the cell resulting in up-regulation of stress genes.
Compared to the Rv2548 mutant, the complemented strain showed a huge decrease in the 
number of differentially expressed genes. This result indicates that complementation was 
successful and it further confirms the role of Rv2548 in the regulation of some 38 genes with 
more abundant transcripts in the mutant. There was no significant differential expression of
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the Rv2548 gene in the ARv2548 complemented strain indicating that expression of the 
strain was highly comparable to wild-type levels.
The protein sequence encoded by Rv2745c is highly similar to the DNA-binding 
transcriptional activator, ClgR, of Streptomyces coelicolor. It was hypothesised that the 
Rv2745c gene product is a homologue of ClgR. The microarray results and qRT-PCR 
analysis of the ARv2745c strain, combined with identification of putative ClgR-like binding 
sites in gene promoters, provide supporting evidence that Rv2745c is a fimctional 
homologue of ClgR. Four genes {acr2, Rv0251c; ptrBb, Rv0782, Rvl043c; and clpPl, 
Rv2461c) identified to have good ClgR-like binding motifs were among the 30 most down- 
regulated genes in the transcriptional profile of the mutant. Down-regulation of acr2 and 
clpPl gene targets was further corroborated by the qRT-PCR results. ClpCl {Rv3596c) was 
also identified to have a binding site however was not found to have significantly altered 
expression in the mutant. ClpC is a stress protein belonging to the HSPlOO family of 
molecular chaperones (Kar et al. 2008) and its induction may also be limited to a stress- 
response as indicated in B. subtilis (Kar et al. 2008). Thus ClpCl induction by Rv2745c 
may not occur except under stress conditions. In future experiments, repetition of ARv2745c 
transcriptional analysis under stress conditions may confirm the direct regulation of ClpCl 
by Rv2745c. Together, the identification of a binding site/differential expression of the three 
proteases, {ptrB, clpCl and clpPl) corresponds with the activity of the ClgR homologue 
involved in regulating ClpP protease expression. Proteolytic control enables tight regulation 
of cellular levels of protein in response to a specific signal. It is conceivable that the mutant 
strain is unable to respond to the changing environment by the loss of essential proteases 
which normally fimction to quickly regulate cellular levels of protein. In vivo this could 
result in modification of the phagosome to the acidic phagolysosome. Further expression 
studies of the ARv2745c mutant using altered growth conditions such as low pH would 
certainly work towards understanding the function of these genes shown to be activated by 
Rv2745c. Many genes were observed to be down-regulated in the ARv2745c complemented 
strain however partial or complete restoration of transcription of acr2, Rvl043c, clpPl and 
ptrBb was observed indicating successful réintroduction of the Rv2745c activator and 
association of Rv2745c as the regulator of these genes.
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Using expression arrays we have aimed to identify member genes of the régulons for three 
transcriptional regulators, Rv3058c, Rv2548 and Rv2745. On a whole genome scale the 
genes revealed belong to all different classes including proteins of the cell wall, involved in 
metabolism, respiration, information pathways, virulence and regulatory systems. Overall, a 
majority of differentially expressed genes were of the intermediary metabolism and 
respiration class or were a conserved hypothetical protein.
Further work aiming to elucidate the Rv3058c transcriptional regulon may include a search 
for inverted repeats in genes that are differentially regulated in the transcriptional profile of 
the ARv3058c mutant. In addition, genome scale chromatin immunoprécipitation (ChIP) 
and hybridisation to microarrays (ChlP-on-chip) will aid identification of the direct 
interaction between Rv3058c and gene promoters (McGrath et al. 2009) and would also help 
to understand the transcriptional profile and identify the Rv3058c regulon. TA opérons are 
evidenced to be stress response elements that help survival of the prokaiyote cell during 
unfavourable conditions. The antitoxin interacts with the regulatory toxin of the TA operon 
to neutralise mRNA cleavage and thereby together fiinctioning to regulate translation 
(Pandey & Gerdes 2005). Therefore, further characterisation of the putative Rv2548 toxin 
should include the extension of expression profiling studies of the ARv2548 mutant strain 
following exposure to environmental stresses. This may elucidate the conditions under 
which the TA operon is responsible for regulating gene expression and may also function to 
corroborate gene sets highlighted in the transcriptional profile of the ARv2548 mutant 
observed in this study. Further understanding of Rv2548 regulation in M. tuberculosis could 
be gained by creating a mutant defective in the anti-toxin (Rv2547) of the TA operon. 
Transcriptional profiling of such a mutant should indicate whether the labile antitoxin 
regulates transcription of the TA operon. It would be expected in a ARv2547 mutant to 
observe the down-regulation of the Rv2548 toxin and the up-regulation of mRNA transcripts 
targeted by the Rv2548 toxin.
The Rv2745c transcriptional activator was chosen for further characterisation of the 
regulation mechanism employed by this target. Putative ClgR-like binding sites were 
identified among differentially expressed genes and three of these genes (acr2, clpCJ, and 
clpPl) were successfiiUy validated by qRT-PCR. ClpCl {Rv3596c) has an identified
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binding site however its expression is unaltered in the ARv2745c mutant. Down-regulation 
of the predicted endopeptidase, Rv1043c, could not be confirmed by qRT-PCR using the 
designed primer/probe set. It remains to be experimentally verified whether these putative 
binding sites are targeted by the Rv2745c complex and this is the aim of the following 
chapter.
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6 Expression of recombinant Rv2745c protein and its 
interaction with gene promoter
6.1 Introduction
In Chapter 3, bioinformatic analysis revealed the Rv2745c gene product to be highly 
similar to the transcriptional activator, ClgR {dp  gene regulator), in Streptomyces. ClgR 
in Streptomyces binds to an imperfect palindromic motif (CGC-5N-GCG) and is 
responsible for regulating expression of the Clp operon which encodes several proteolytic 
subunits thought to be involved in differentiation of Streptomyces (Bellier & Mazodier 
2004). It was hypothesised that Rv2745c may be involved in regulating a similar subset 
of genes by a similar mechanism in M. tuberculosis. In Chapter 5, transcriptional 
profiling analysis showed that the deletion of Rv2745c in M. tuberculosis resulted in 
down-regulation of a number of genes including four genes with ClgR-like binding 
motifs present in the upstream region of the gene {clpP {Rv2461c), acr2 (Rv0251c), ptrB 
{Rv0782) and Rv1042c). The present chapter describes experiments to confirm the direct 
interaction of Rv2745c protein with these putative binding sites/promoters. Recombinant 
Rv2745c/ClgR was produced in E. coli and then the DNA-binding properties of Rv2745c 
protein to the specified gene targets was investigated using Electrophoretic Gel Mobility 
Shift Assay (EMSA).
6.2 Development of pET101 His-tagged fusion protein
Cloning of Rv2745c into the pETlOl/D-TOPO His-tag expression vector (Figure 6.1) 
was confirmed by BglV digestion which produced four fi-agments of sizes: 2316, 2151, 
1388 and 234 bp. This construct was then used to express the recombinant His-tagged 
protein in BL21(DE3) E. coli cells.
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Figure 6.1: The pET101/D-TOPO/Rv2745c expression construct carries P-lactamase the ampiciilin 
resistance gene, the high-level IFTG-inducihle promoter, C-terminal V5 epitope and the C-terminal 
6 xHis tag.
The Rv2745c gene was cloned into the pETlOl/D-TOPO® cloning site to produce the pETlOl/D- 
TOPO/Rv2745c recombinant protein expression construct. The recombinant protein has six C-terminal 
His residues and expression o f  the gene is under the control o f  the IPTG-inducible T7 promoter. The 
construct contains the selective ampiciilin resistance marker, a C-terminal V5 epitope, T7 
promoter/priming site and a T7 reverse priming site.
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6.2.1 Sequencing results of His-tagged expression construct
Two individual pET101/D-TOPO/Rv2745c isolates were sent for sequencing by 
Cogenics. The two sequenced constructs were aligned with the predicted fusion protein 
sequence (Figure 6.2). The first three base pairs following the CACC 5’ overhang of the 
pETlOl/D-TOPO cloning site (see Chapter 2. Materials and methods) is the start codon 
of the fusion protein and is indicated by the beginning of the boxed sequence (see 
Figure 6.2). The start codon of the Rv2745c gene in isolate pET101-Rv2745#3 (top 
sequence of alignment) contained a single base-pair deletion and therefore was not 
selected for further protein expression work. Results demonstrate greater than 590 
consecutive bases analysed with greater than 99% accuracy of base identity for pETlOl- 
Rv2745c isolate #8 (middle sequence in alignment). The only difference between the 
sequences was the insertion of an unknown nucleotide in the second ribosomal binding 
site (highlighted in green) of the same isolate however the electropherogram of the 
plasmid DNA sequence following sequencing (data not shown) shows no peak for this 
nucleotide. The construct was also sequenced in the reverse using the T7 Reverse 
sequencing primer (priming site highlighted in blue) which confirmed the lack of any 
base insertion at this point (data not shown). Combined results of forward and reverse 
sequencing of the constructs confirm the pET101-Rv2745c#8 cloned construct to be 
without mutation. This isolate was therefore chosen for use in further expression studies.
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6.2.2 Pilot expression of His-tagged fusion protein
Induction of the recombinant His-tagged fusion protein was observed to reduce the 
amount of total protein present in the cell lysate compared to uninduced samples as seen 
in the 6 h time course shown in Figure 6.3. Induction of the ~14kDa recombinant 
His-tagged fusion protein could not be seen when comparing whole cell lysates of the 
uninduced and induced cultures.
Decreasing the growth temperature of the BL21(DB3) E. coli transformants to 30°C and 
reducing the concentration o f IPTG to 0.5 mM was implemented to attempt to increase 
the yield of flision-protein expression. Two different clones of pETlOl/D- 
TOPO/Rv2745c were examined under these induction conditions. Samples o f whole 
protein lysate from 4 h induced cultures were compared in parallel with uninduced 
cultures and separated on an SDS-PAGE (Figure 6.4). Similarly to the pilot expression 
assay induction (Figure 6.4, lanes 3 and 6) lead to a lower amount of total protein 
compared to uninduced cultures (Figure 6.4, lanes 2 and 5). This is normal during IPTG 
induction of recombinant expression vectors however, at the lower growth temperature 
and reduced concentration of IPTG there was still no detectable expression of the 
expected 14 kDa fusion-protein in the induced cultures.
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Figure 6.3: SDS-PAGE analysis of samples from 1 mM IPTG induced cultures of BL21(DE3) E. coli 
cells transformed with pET101/D-TOPO/Rv2745c and grown at 37°C.
BL21(DE3) E. coli cells were transformed with pET101/D-TOPO/Rv2745c construct, seeded into 5 ml 
cultures, grown at 37®C with shaking to an ODgoo 0.5-1.0, induced with 1 mM IPTG and samples taken at 0 
hrs and every hour post induction for 6 h. A) lane 1: BenchMark^'^ Protein Ladder; lanes 2 and 3: 
uninduced and induced cultures, respectively for 0 time point; lanes 4 and 5; uninduced and induced 
cultures, respectively, 1 h post induction; lanes 6 and 7: uninduced and induced cultures, respectively, 2 h 
post induction; lanes 8 and 9: uninduced and induced cultures respectively, 3 h post induction. B) lane 1 : 
BenchMark^’'* Protein Ladder; lanes 2 and 3: uninduced and induced, respectively, 4 h post induction; lanes 
4 and 5: uninduced and induced cultures, respectively, 5 h post induction; lanes 6 and 7: uninduced and 
induced cultures, respectively, 6 h post induction; lanes 8 and 9: uninduced and induced cultures 
respectively, overnight samples.
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Figure 6.4: SDS-PAGE analysis of samples from 0.5 mM IPTG induced cultures of BL21(DE3) 
E. coli cells transformed with pET101/D-TOPO/Rv2745c and grown at 30°C.
BL21(DE3) E. coli cells were transformed with pET101-Rv2745c construct, seeded into 5 ml cultures, 
grown at 30°C with shaking to an ODôoo 0.5-1.0 and induced with 0.5 mM IPTG for 4 h. Lane 1: 
Rainbow '^'  ^Protein Ladder; lanes 2 and 3: uninduced and induced cultures, respectively (clone #1); lane 4: 
empty; lanes 5 and 6: uninduced and induced cultures, respectively (clone #2); lane 7: BenchMark™ 
Protein Ladder.
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6.2.3 Purification of His-tagged protein
Bulk expression of the pET101/D-TOPO/Rv2745c construct was carried out and 
purification of the His-tagged Rv2745c protein was performed to determine whether the 
fusion protein was expressed but at low levels and required large volumes of culture to be 
grown up in order to extract enough protein for detection of the recombinant protein. 
The soluble fi*action of the cell lysate was run-through the HIS-Select column 
(Figure 6.5; lanes 2 and 3). The column was washed twice (lanes 4 and 5) and bound 
soluble protein was eluted off the column with Elution Buffer containing 250 mM 
imidazole (lane 6). There was no detectable protein bound to the HIS-Select column as 
determined by SDS-PAGE analysis. This result could be explained by the lack of fusion- 
protein expression or perhaps by the need to optimise methods for extraction of soluble 
or insoluble recombinant protein from the cells.
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Figure 6.5: SDS-PAGE analysis of samples from soluble His-tagged fusion protein purification using 
HIS-Select column.
A 100 ml broth culture was inoculated with a 1:100 dilution o f transformed BL21(DE3) E. coli cells with 
the pET101/D-TOPO/Rv2745c construct. The culture was grown to OD o^o o f 0.5, induced with 1 mM 
IPTG and grown for 4 h at 37°C with shaking. Cells were recovered by centrifugation and the cell extract 
put through a HIS-Select column. Lane 1: BenchMark^^  ^Protein Ladder; lane 2: first run-through o f cell 
extract; lane 3: second run-through o f cell extract; lane 4: first wash off the column; lane 5: second wash of  
the column; lane 6: eluted target protein; lane 7: BenchMark™ Protein Ladder.
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As an alternative protein extraction protocol, the BugBuster® Protein Extraction Reagent 
was used. The soluble protein extract from IPTG induced pET101/D-TOPO/Rv2745c 
cultures was again passed through a His-Select column and bound protein eluted with 
imidazole and analysed by SDS-PAGE. As before, no 14 kDa protein was eluted 
although lower molecular weight products were found which were analysed by 
LC-MS-MS and confirmed to be a mix of E. coli peptides (data not shown).
The insoluble cytoplasmic fraction may consist of aggregated fusion-proteins also called 
inclusion bodies. Purification of the inclusion bodies was performed via multiple 
centrifugation steps with BugBuster® Reagent and lysozyme treatment then purified 
under denaturing conditions using a HIS-Select column. Samples from 5 ml cultures at 
0, 1, 2, and 3 h post induction with IPTG were subjected to SDS-PAGE analysis 
(Figure 6.6). Purified insoluble protein eluted from the HIS-Select column produced a 
single protein band approximately 10 kDa in size. Uninduced samples (Figure 6.6, lanes 
2, 4, 6 and 8) produced a protein product comparable to that observed for induced 
cultures (lanes 3 ,5 ,7  and 9).
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115.5
Figure 6.6: SDS-PAGE analysis of samples from a time course experiment of induced insoluble cell 
lysates containing the pET101/D-TOPO/Rv2745c expression construct extracted using BugBuster 
Reagent and HIS-Select column purifîed.
BL21(DE3) E. coli cells transformed with the pET101/D-TOPO/Rv2745c expression construct were 
seeded into 5 ml cultures and induced with IPTG, Insoluble proteins were extracted and the lysate passed 
through a HIS-Select column to purify the fusion protein. Lane 1 : BenchMark'' '^  ^Protein Ladder; lane 2: 0 
h uninduced sample; lane 3: 0 h induced sample; lane 4: 1 h uninduced; lane 5: 1 h induced; lane 6: 2 h 
uninduced; lane 7: 2 h induced; lane 8: 3 h uninduced; lane 9: 3 h induced.
To determine if the pET101/D-TOPO/Rv2745c fusion protein was expressed in the 
insoluble form but perhaps at low levels further analysis of insoluble lysate was 
performed this time using a 100 ml culture volume. A sample of the cell extract was run 
on a SDS-PAGE gel prior to binding of the lysate to the HIS-Select column (Figure 6.7; 
lane 7) and shows multiple proteins of different sizes with the majority of protein product 
approximately 10 kDa in size. The denaturing cell extract eluted from the column 
(Figure 6.7; lane 2) produced a single band of protein similar in size to the majority of 
product from the protein prep in lane 7. Washing of the HIS-Select column resulted in 
little protein being eluted from the column (Figure 6.7; lanes 3 and 4). Final elution of 
the His-bound fusion protein under denaturing conditions showed that no protein bound 
to the column (Figure 6.7; lane 5).
174
Chapter 6, Expression o f  recombinant Rv2745c protein and its interaction with gene
promoters
kDa
Insoluble Column wash 
flow through 
(denaturing)
2 3 4
Eluted Inclusion 
body prep
Figure 6.7: SDS-PAGE analysis of samples from the purifieation of the insoluble fraction of 
pET101/D-TOPO/Rv2745c fusion protein using denaturing conditions.
Cultures (100 ml) o f BL21(DE3) E. coli cells transformed with pET101/D-TOPO/Rv2745c and induced 
with 1 mM IPTG was extracted for insoluble protein and inclusion body purification performed using 
BugBuster Reagent, lysozyme and multiple centrifugation steps. Prepared inclusion bodies were passed 
through a HIS-Select purification column. Lane 1: BenchMark™ Protein Ladder; lane 2: insoluble cell 
extract flow through from HIS-Select column using denaturing conditions; lane 3: wash 1; lane 4: wash 2; 
lane 5: eluted fusion protein; lane 6: BenchMark™ Protein Ladder; lane 7; inclusion body protein prep 
without HIS-Select column purification.
6.2.4 Autoinduction of protein expression
Autoinduction media (Overnight Express'*’’^  Instant TB Medium) was used to induce 
expression of the recombinant protein as it typically provides higher yields of soluble 
protein without the need for IPTG induction and can be suitable for the expression of 
potentially toxic proteins. The autoinduction media regulates uninduced growth until a 
high cell density is reached by the preferential metabolism of glucose in the medium. 
Gradually as glucose decreases in the medium the cells use lactose as a carbon source 
which acts on the lac repressor to enable transcription thereby initiating the slow 
induction of fusion protein expression. Autoinduction media has the potential to improve
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the expression of toxic proteins as there is no definitive switch offion for protein 
expression and the induction is gradual consequently selecting for those BL21(DE3) 
E. coli isolates that are able to continuously express the protein. Uninduced control 
samples were analysed alongside induced samples using SDS-PAGE. There was no 
induction of the expected 14 kDa His-tagged protein present in any of the three isolates 
tested (pET101-Rv2745c#8, pET101-Rv2745c#19 and pET 101 -Rv2745c#24) (results not 
shown). Induced and uninduced samples for each isolate were highly similar to that 
obtained in Figure 6.4 where induction of recombinant protein expression was performed 
at 30°C with 0.5 mM IPTG.
6.2.5 In vitro translation
Frequently, foreign proteins expressed in E. coli are found to be toxic to the cells and 
therefore those cells able to express the protein are killed leaving a sub-population of 
cells unable to express the protein (Saida et al. 2006). To rule out the effects of toxicity 
of the fusion protein on E. coli cells, an in vitro translation system. Easy Xpress™, was 
employed for synthesis of the recombinant His-tagged protein. In vitro translation 
systems allow proteins that are toxic to E. coli cells to be expressed (Klammt et al. 2006) 
and also allows for the inclusion of protease inhibitors which can be used to stop 
degradation of recombinant proteins that are susceptible to protease degradation. In 
Streptomyces the ClgR protein (homologue of Rv2745c) is a target for ClpP (Bellier & 
Mazodier 2004) degradation and thus the inability to detect expression of the 
recombinant Rv2745c protein in whole cell expression systems could be due to 
degradation. The in vitro system allows for control o f this. Purified plasmid DNA from 
pET101/D-TOPO/Rv2745c #8 isolate was used as template for the in vitro translation. 
The results of the in vitro translation are shown in Figure 6.8. The positive control 
(Figure 6.8, lanes 2 and 6) is a 32 kDa elongation factor with a C-terminal 6 x His tag 
followed by the test samples o f the in vitro translation reaction using pETlOl/D- 
TOPO/Rv2745c plasmid without protease inhibitor (lane 3) and pETlOl/D- 
TOPO/Rv2745c plasmid with protease inhibitor (lane 4). Samples 2-4 were boiled prior 
to loading onto the SDS-PAGE gel. These samples are repeated in lanes 6-9 however 
were not boiled prior to loading of the gel. The positive controls (lanes 2 and 6) illustrate 
the induction of expression of a 32 kDa elongation factor fused to a 6xHis tag evident
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between 37.1 and 25.9 kDa protein markers. There is no expression of the 14 kDa 
Rv2745c-His fusion protein. Although the in vitro translation system is sensitive to 
nuclease contamination there is no detectable difference in protein yield between 
reactions with or without protease inhibitors. There is some loss of protein yield in those 
samples that were boiled prior to loading onto the SDS-PAGE gel.
Boiled Not boiled
Protease
inhibitors
kDa
Control Control
Figure 6.8: SDS-PAGE analysis of m vitro translation reactions using the Easy Express system for 
synthesis of pET101/D-TOPO/Rv2745c #8 fusion protein.
The Easy Xpress in vitro translation system was employed for synthesis o f the pET101/D-TOPO/Rv2745c 
#8  fusion protein. Lane 1 : BenchMark™ Protein Ladder; lanes 2-4 are in vitro translation reactions that 
have been boiled prior to loading onto the SDS-PAGE gel; lane 2: positive control; lane 3: without protease 
inhibitor; lane 4: with protease inhibitor; lane 5: empty; lanes 6-8  are in vitro translation reactions that 
have not been boiled prior to loading onto the SDS-PAGE gel; lane 6 : positive control; lane 7: without 
protease inhibitor; lane 8 : with protease inhibitor.
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6.2.6 Plasmid stability testing
As methods for the induction o f the recombinant His-tagged protein were unsuccessful it 
was considered whether the recombinant expression vector carrying the Rv2745c gene 
from M. tuberculosis was unstable when expressed in E. coli. To test the stability of the 
expression construct a plasmid stability assay was performed in E. coli cells. The 
pET101/D-TOPO/Rv2745c expression vector, maintained in DH5a E. coli cells, was 
isolated from two separate clones and used in fresh transformation experiments with One 
Shot® BL21(DE3)pLysS Competent E. coli cells. Table 6.1 lists the number of colonies 
present on the transformation plates with various selective properties.
Table 6.1: Plasmid stability testing of positive clones containing the pET101/D-TOPO/Rv2745c 
expression vector with the His-tagged fusion protein
Plate Clone 1 (CFU/ml)
Clone 2 
(CFU/ml)
LB 6.1 X 10® 5.2 X 10®
LB + AMP 5.0 X 10® 4.8 X 10®
LB + AMP + IPTG 0 0
LB + IPTG 2.5 X 10^ 3.5 X 10^
All viable cells will grow on LB agar without addition of ampiciilin for selection of 
plasmid positive clones or IPTG for the induction of fusion-protein expression. Table 6.1 
indicates good cell viability for both clones tested with 6.1 x 10^  and 5.2 x 10^  CFU/ml 
available for transformation. Cells that still cany the plasmid upon plating the 
transformation reaction will grow on LB with ampiciilin. The vector isolated from clone 
1 achieved a transformation rate o f 5.0 x IQ^  CFU/ml and clone 2 achieved a 
transformation rate of 4.8 x 10^  CFU/ml. Cells that have lost the plasmid or mutants that 
cannot express the recombinant protein will grow on LB containing IPTG. This is 
explained by the fact that those cells that are able to express the recombinant protein will 
not grow in the presence of IPTG because they are incapable o f cell maintenance as all 
resources are dedicated to the expression of the recombinant protein. Therefore the 
difference in the number of cells that carry the plasmid (4.8-5.0 x 10^  CFU/ml) and the 
number of cells unable to express the recombinant protein (2.5-3.5 x  CFU/ml) is 
indicative of the number of positive transformants able to express the recombinant 
protein and this is equivalent to >99% of the culture. This result confirms that the
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plasmid is stable in E. coli and the transformants should be capable of expressing the 
His-fusion protein.
6.3 Development of GST -fusion recombinant expression 
construct
With confirmation of a stable pET101/D-TOPO-Rv2745c construct verified to be 
without mutation and unable to be expressed in a cell-fi'ee system it remains 
undetermined as to why expression of this recombinant protein proved unsuccessful. It 
was hypothesised that perhaps the C-terminal His tag prevented expression of the fusion 
protein and therefore it was decided to use a completely different expression system and 
design the fusion of the gene to an N-terminal tag. The new expression construct was 
designed using the pGEX-4T-2 expression vector with an N-terminal glutathione 
S-transferase tag. Cloning of the pGEX-4T-2/Rv2745c recombinant vector was 
confirmed by PCR screening transformant clones using the pGEX-Rv2745c forward and 
reverse primer pair (Table 2.7). Positive transformants were further confirmed by Pstl 
digestion which produced two fragments of sizes; 4176 and 1127 bp. The recombinant 
vector was then used in a pilot expression assay.
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Figure 6.9: pGEX-4T-2 recombinant expression vector.
Construction o f the pGEX-4T-2/Rv2745c recombinant expression vector was performed by amplifying the 
Rv2745c gene from M  tuberculosis gDNA, cloning into PCR®-Blunt II-TOPO®, excising the insert and 
sub-cloning the fragment into pGEX-4T-2 at the EcoRl cloning site.
PfM. {22(^ 7) 
a t  API (2398) 
4paBI(2399)
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6.3.1 Pilot expression of pGEX-4T-2/Rv2745c fusion protein
A pilot expression assay of the pGEX-4T-2/Rv2745c fusion protein was performed using 
five transformants confirmed to contain the recombinant expression vector by restriction 
digest analysis. Uninduced control samples were analysed by SDS-PAGE alongside 
induced samples for each o f the five clones in addition to a GST-only control isolate 
without the fusion protein and the results are shown in Figure 6.10. The SDS-PAGE 
indicates induction of a protein approximately 20 kDa present in each of the five isolates. 
The GST control protein is known to be 25.7 kDa in size but runs at approximately 18 
kDa in the gel (Figure 6.1 OB, lane 7). Estimation of the size o f the induced recombinant 
protein of each isolate (Figure 6.10A; lanes 3, 5 and 7, B: lanes 3 and 5) against the 
molecular weight marker appears to be inconsistent with the expected size for the 
GST-Rv2745c fusion protein predicted to be -38.4 kDa. The induced protein seen in 
Figure 6.10 is only -2  kDa larger than the GST-only control (Figure 6. lOB, lane 7).
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Figure 6.10: SDS-PAGE analysis of samples from a pilot induction of the GST-fusion protein in 
BL21(DE3) E. coli cells and induction of GST-only control.
BL21(DE3) E. coli cells were transformed with pGEX-4T-2/Rv2745c construct, seeded into 5 ml cultures, 
grown at 37°C with shaking to an OD o^o 0.5-1.0, induced with 0.5 mM IPTG and samples taken at 3 hrs 
post induction. A) Lane 1: BenchMark™ Protein Ladder; lanes 2 and 3: uninduced and induced cultures, 
respectively, from isolate #5; lanes 4 and 5: uninduced and induced cultures, respectively, from isolate #10; 
lanes 6  and 7: uninduced and induced cultures, respectively, from isolate #15. B) Lane 1: BenchMark™ 
Protein Ladder; lanes 2 and 3: uninduced and induced cultures, respectively, from isolate #17; lanes 4 and 
5: uninduced and induced cultures, respectively, from isolate #18; lanes 6 and 7: uninduced and induced 
cultures, respectively, from a control clone transformed with GST-only.
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6.3.2 Sequencing results of pGEX-4T-2/Rv2745c recombinant 
construct
Due to the unexpected size o f the GST-Rv2745c fusion protein the pGEX-4T-2/Rv2745c 
construct was prepared for sequencing and sent to Cogenics to determine whether the 
construct contained any mutations that may cause truncation of the protein. Sequencing 
results (Appendix 3) showed that within the multiple-cloning site a single adenine was 
missing from the pGEX-4T-2 vector (Figure 6.11). From this it was determined that the 
original pGEX-4T-2 vector used for design and construction of the GST-fusion protein 
was in fact the pGEX-4T-l vector (GE Healthcare product #27-4580-01) (Figure 6.1 IB). 
The single nucleotide difference between the two vectors is illustrated in Figure 6.11A 
and B. Consequently, the cloned Rv2745c reading frame inserted into the EcoRL site of 
the pGEX-4T-l vector was expressed out-of-frame and translated into a truncated 
“nonsense” polypeptide approximately 29.5 kDa in size. The nonsense recombinant 
construct was termed pGEX-4T-2*/Rv2745c.
The pGEX-4T-2*/Rv2745c construct was corrected by linearising the plasmid using 
EcoRl (Figure 6.110), performing a fill-in reaction using Klenow enzyme (Figure 6.110: 
bp highlighted in red) and re-ligating the vector. This abolished the EcoRl restriction 
site; added a 4 bp insertion and reversed the frame-shift to read the corrected complete 
GST-fusion sequence. Positive clones were confirmed by EcoRl digestion followed by 
cutting with BgR to produce three fragments of 2643, 1483 and 1177 bp in size and 
termed pGEX-4T-l*/Rv2745c.
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pGEX-47-2
_________Throm bin_________
^LeuVal Pro Arg'^ GIy Ser^Pro Giy lie Pro Gly Ser Thr Arg Ala Ala Ala Ser
CTG GTT COG CGT ,GGA TCC, CC QGA ATT.QCC GG,G, TCG A^ QT OGA ,GCG GCC GCA.TCG TSA
BamHI EcoR l' s m a  x h o l  Not I S top codon
pGEX-4T-1
Thrombin
Leu Val Pro Ar^Gly Ser'pro Glu Phe Pro Gly Arg Leu Glu Arg Pro His Arg Asp
CTG GTT CCG CGT ,GGA TCC, CCG ,GAA TTC, CCG G,GT OGA ,CTC GAG,CGG CCGCAT CGT GAG ISA
' V  -------- 2 d — 7 :1 = !------- _ y — — — ^  s to p  codons
B BamHI EcoR I Sm a I Sal I x h o  I Not
iI I
TCC CCG GAA TTC CCG GGT TCC CCG G A ATT CCC GGG T
AGG GGC e r r  A/sjS GGC CCA AGG GGC CTT AA ^GGG CCC A
EcoR I
Figure 6.11: Schematic diagram illustrating the cloning site o f pGEX-4T-2 used for design and 
construction o f the pGEX-4T-2*/Rv2745c vector, the single base change o f the pGEX-4T-l vector 
that resulted in a frame shift upstream o f the EcoRl cloning site and the steps used to resolve the 
frame shift.
A) The pGEX-4T-2 expression vector was used for the design and construction o f  the pGEX-4T- 
2yRv2745c recombinant vector by cloning into the EcoRl site. Sequencing o f the fusion protein 
highlighted the absence o f an adenine (A) residue (highlighted in red). B) The absence o f this base 
upstream o f the EcoRl cloning site (red arrow) is identical to the pGEX-4T-l expression vector. C) The 
frame-shift mutation in the cloned fusion-protein was rectified by linearising the vector by cutting with 
EcoRl and filling-in the 5’ overhanging ends (bases highlighted in red) using Klenow enzyme and re- 
ligating the vector. The final construct (pGEX-4Tl*-Rv2745c) lacks the EcoRl restriction site and 
contains a 4 bp insertion (highlighted in red) reverting the frame-shift to read the complete correct fiision 
polypeptide sequence.
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6.3.3 Pilot expression of pGEX-4T-1*/Rv2745c
A pilot expression assay o f the pGEX-4T-l*/Rv2745c fusion protein was performed 
using three transformants confirmed to contain the corrected recombinant fusion protein 
as determined by EcoRL and Bgli digests. Uninduced and induced samples o f each clone 
were taken at 2 and 5 h post induction with IPTG and analysed by SDS-PAGE alongside 
a GST-only clone (Figure 6.12). Results show the induction o f a protein of 
approximately 30 kDa for each isolate. As seen previously (Figure 6.10) the GST protein 
of 25.7 kDa appears to run at -18 kDa in the gel (Figure 6.12A; lanes 7 and 9) therefore 
estimating the size o f the induced protein against the molecular weight marker is 
inaccurate. Using the GST-only control as a relative marker it can be seen that the 
induced protein of each isolate is approximately 10 kDa larger than GST control and 
therefore correlates with the predicted size of the designed pGEX-4T-l*/Rv2745c fusion 
protein of -38.4 kDa.
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Figure 6.12: SDS-PAGE analysis of samples from a pilot induction of the GST-fusion protein using 
the adapted pGEX-4T-l*/Rv2745c construct and a GST-only control transformed into BL2I(DE3)
E. coli cells.
BL21(DE3) E. coli cells were transformed with pGEX-4T-l*/Rv2745c construct, seeded into 5 ml 
cultures, grown at 37°C with shaking to an ODôoo 0.5-1.0, induced with 0.5 mM IPTG and samples taken at 
2 h and 5 h post induction. A) Lanes 1 and 10: BenchMark™ Protein Ladder; lanes 2 and 3: uninduced 
and induced cultures, respectively, at 2 h post induction from isolate #1; lanes 4 and 5: uninduced and 
induced cultures, respectively, at 5 h post induction (isolate #1); lanes 6  and 7: uninduced and induced 
cultures, respectively, at 2 h post induction (GST-only control clone); lanes 8 and 9: uninduced and 
induced cultures at 5 h post induction (GST-only control clone). B) Lanes 1 and 10: BenchMark™ Protein 
Ladder; lanes 2 and 3: uninduced and induced cultures, respectively, at 2 h post induction (isolate #3); 
lanes 4 and 5: uninduced and induced cultures, respectively, at 5 h post induction (isolate #3); lanes 6  and 
7: uninduced and induced cultures, respectively, at 2 h post induction (isolate #2); lanes 8 and 9: uninduced 
and induced cultures, respectively, at 5 h post induction (isolate #2).
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6.3.4 Expression of soluble and insoluble pGEX-4T-1*/Rv2745c 
fusion protein
Cultures (50 ml) of BL21(DE3) E. coli cells were induced with 0.5 mM IPTG and grown 
at 30°C for 5 h before preparing the cell lysate for soluble and insoluble proteins. Two 
clones were compared for the induction of the GST-Rv2745c fusion protein 
(Figure 6.13). Lanes 2 and 3 are samples of clone #3 jfrom an uninduced culture with 
insoluble and soluble fractions, respectively. Samples in lanes 4 and 5 are also of clone 
#3 from an induced culture with the induction of the fusion protein observed between the
25.9 and 37.1 kDa markers. Induction of the pGEX-4T-l*/Rv2745c fusion protein is 
more prominent in the insoluble fraction (lane 4) than in the soluble fraction (lane 5) 
although only half the volume of insoluble sample was loaded onto the gel. Samples 
from clone #2 (lanes 6-9) appear very similar to that observed for clone #3 with induction 
of the fusion protein occurring between the 25.9 and 37.1 kDa markers.
#3 #3 #2 #2
ins sol ins sol ins sol ins sol 
IPTG - - + + - -  + +
1 2 3 4 5 6 7 8 9  10
kDa
82.2—
64.2^
48.8^
37.1 _  ,GST-Rv2745c
25.9- 
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14.8-
Figure 6.13: SDS-PAGE analysis of insoluble and soluble pGEX-4T-l*/Rv2745c fusion protein 
extracts from uninduced and induced cultures of BL21(DE3) E. coli transformed cells.
Cell lysates from uninduced and induced cultures o f BL21(DE3) E. coli cells, transformed with pGEX-4T- 
1*/Rv2745c construct, were prepared for insoluble (ins) and soluble (sol) proteins. Lanes 1 and 10: 
BenchMark^'^ Protein Ladder; lanes 2 and 3: uninduced culture, insoluble and soluble fractions, 
respectively (clone #3); lanes 4 and 5: induced culture, insoluble and soluble fractions, respectively (clone 
#3). Lanes 6  and 7: uninduced culture, insoluble and soluble fractions, respectively (clone #2); lanes 8 and 
9: induced culture, insoluble and soluble fractions, respectively (clone #2).
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Induction of expression of the fusion protein was confirmed by Western blot analysis 
with anti-GST antibody and compared to uninduced BL21(DE3) E. coli cells carrying the 
recombinant vector (Figure 6.14). Figure 6.14, lane 2 indicates induction of the 
GST-Rv2745c fusion protein which is absent in the uninduced culture (lane 1). These 
soluble protein extracts were also compared to insoluble protein extracts of uninduced 
and induced cultures represented in lanes 5 and 6 respectively. It is evident that a higher 
yield of pGEX-4T-l*/Rv2745c protein is obtained in the insoluble protein fraction (lane 
6). Induction of the recombinant fusion protein in BL21(DE3) E. coli cells was 
compared against the induction of cells transformed with a GST-only control vector. 
Figure 6.14, lanes 3 and 4 are anti-GST antibody labelled samples of soluble protein 
extracts from uninduced and induced cultures, respectively, transformed with a GST-only 
vector. It is evident from the soluble cell lysates that there is some leakiness of GST 
expression in the uninduced culture (lane 3) and good expression of the GST protein in 
the induced culture (lane 4). Comparing the yield o f GST protein in the soluble (lanes 3 
and 4) and insoluble fractions (lane 7 and lane 8) is inconclusive from this blot as the 
chemiluminescent detection appears saturated at these levels. It is clear though that 
induced BL21(DE3) E. coli cells transformed with pGEX-4T-l*/Rv2745c fusion protein 
produces higher yields of insoluble recombinant protein (lane 6) compared to soluble 
recombinant protein (lane 2).
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Figure 6.14: Western Blot, using anti-GST antibody, of protein extracts from BL21(DE3) E. coli ceils 
transformed with either the pGEX-4T-l*/Rv2745c recombinant fusion vector or the GST control 
vector.
BL21(DE3) E. coli cells were transformed with either the recombinant pGEX-4T-l*/Rv2745c vector. 
Samples o f soluble and insoluble cell lysates were transferred to a PVDF membrane and primed with 
primary goat anti-GST antibody serum followed by the secondary donkey anti-goat IgG-AP. 
Chemiluminescent detection o f proteins was performed with CSPD. Lanes 1-4 are soluble protein extracts 
and lanes 5-8 are insoluble extracts. Lanes 1 and 2: soluble samples o f uninduced and induced cell lysates, 
respectively; lanes 3 and 4: soluble samples o f uninduced and induced GST-only transformed cell lysates, 
respectively; lanes 5 and 6 : insoluble samples o f uninduced and induced cell lysates transformed with the 
recombinant vector, respectively; lanes 7 and 8 : insoluble samples o f uninduced and induced cultures 
transformed with the GST-only control vector, respectively.
6.3.4.1 Purification of pGEX-4T-1*/Rv2745c recombinant protein 
from soluble extracts
The preferred method for purification of fusion-proteins is from soluble protein extracts 
as insoluble proteins require solubilisation in a urea based buffer causing dénaturation of 
the protein which then requires subsequent refolding of the protein for downstream 
applications. We have already determined increased yield of the GST-fusion protein 
present in the insoluble fraction (Figure 6.13, lane 4). It was therefore necessary to 
optimise for the expression of soluble protein by lowering the growth temperature of the 
culture to 30°C and reducing the concentration of the inducer IPTG to 0.5 mM.
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Glutathione sepharose 4B purification o f the recombinant Rv2745c fiision protein was 
performed on transformed BL21(DE3) E. coli cells that were induced under optimised 
conditions for the expression of soluble protein. Non-specific proteins fi'om cultures 
transformed with either the GST-only control or pGEX-4T-l*/Rv2745c recombinant 
vectors were eluted off the column followed by washing of the column to remove further 
non-specific proteins. Glutathione sepharose 4B purification was successful for the 
induced GST-only control culture however the recombinant GST-Rv2745c fusion protein 
could not be purified at detectable levels by the same method (results not shown) as 
determined by SDS-PAGE analysis.
6.3.4.2 Purification of pGEX-4T-1*/Rv2745c recombinant protein 
from Inclusion bodies
High level expression of foreign GST-fusion proteins in E. coli often results in the 
formation of inclusion bodies. Inclusion bodies are aggregates of incorrectly folded 
protein (Villaverde & Mar Carrio 2003) that must be solubilised before they can be 
purified using GST. Efforts to achieve maximum solubility of expressed protein 
included growing the culture at lower temperature, inducing a high cell density for a 
short time, reducing the concentration of IPTG and recovering the inclusion bodies fi'om 
the bacterial lysate using the dénaturant, Triton X-IOO. Figure 6.15 shows a SDS-PAGE 
gel of the purification of GST-Rv2745c fusion protein from soluble and inclusion body 
fractions from 200 ml culture volumes. Non-specific protein washes through the column 
(Figure 6.I5A, lane 2) yet much of the fusion protein from the insoluble fraction fails to 
bind to the GST affinity chromatography medium and elutes during the wash steps 
(Figure 6.15A, lanes 3, 5 and 7) probably due to its insolubility. However, some 
insoluble protein remains bound and is eluted off the column with Elution Buffer 
containing 10 mM reduced glutathione (Figure 6.15B, lanes 3, 5 and 7). There is also the 
presence of some smaller proteins binding to the glutathione sepharose represented by 
the fainter bands present (Figure 6.15B, lanes 3 and 5). Only small quantities o f protein 
insufficient for further assays were purified. As observed previously in Section 6.3.4.1 
the GST-Rv2745c fusion protein is expressed in soluble and insoluble forms however 
undetectable levels of soluble GST-Rv2745c protein were purified using this method.
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Figure 6.15: Medium scale purification of GST-fusion protein from soluble and inclusion body 
fractions.
BL21(DE3) E. coli cells were transformed with pGEX-4T-l*/Rv2745c construct, seeded into 200 ml 
cultures, grown at 37°C with shaking to an OD o^o 0.5-1.0, induced with 0.5 mM IPTG for 3 hrs and 
centrifuged. The soluble protein fraction was separated from inclusion bodies by sonication and 
centrifugation and each purified on column using glutathione sepharose 4B. Inclusion bodies were 
recovered using 1% Triton X-100. A) Lanes 1 and 10: BenchMark™ Protein Ladder; lanes 2 and 3: initial 
run through from GST affinity chromatography column o f soluble and inclusion body aggregate samples, 
respectively; lanes 4 and 5: run through o f first PBS wash off the column from soluble and inclusion bodies 
fractions, respectively; lanes 6  and 7: run through o f  second PBS wash o ff the column from soluble and 
inclusion body fractions, respectively; lanes 8 and 9: run through o f final PBS wash off the column from 
the soluble and inclusion body fractions, respectively. B) Lanes 1 and 10: BenchMark™ Protein Ladder; 
lanes 2 and 3: first elution of bound protein from soluble and inclusion body fractions, respectively; lanes 4 
and 5: second elution o f bound protein from soluble and inclusion body fractions, respectively; lanes 6  and 
7: third elution o f bound protein from soluble and inclusion body fractions, respectively; lanes 8 and 9: run 
through off column from final PBS wash of soluble and inclusion body fractions, respectively.
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It was also attempted to purify the insoluble protein following solubilisation 8 M urea. 
This preparation was then sequentially dialysed against 6 M, 5 M, 4 M, 3 M, and 2 M 
urea to remove the dénaturant. The dialysate was prepared with Glutathione Sepharose 
4B beads in 2 M urea buffer and eluted off the GST-affinity column. However the 
collected samples contained undetectable levels o f protein by SDS-PAGE analysis or by 
Bradford assay quantification (results not shown). This may be due to the protein 
precipitating out of solution at a step during the sequential removal of dénaturant or due 
to poor binding to the glutathione beads in the presence of 2 M urea. Furthermore, as 
inclusion body preparations employ conditions that are not ideal for obtaining the 
original functionality of purified proteins it was decided that optimisation of soluble 
protein expression was preferred over preparing insoluble protein that would require 
refolding for downstream applications.
6.3.5 Optimisation of large-scale expression and purification of 
soluble pGEX-4T-1*/Rv2745c recombinant protein
Optimisation of expression and purification of soluble GST-fusion protein used reduced 
concentrations of IPTG (0.4 mM) for induction of protein expression and a larger culture 
volume of 1 L grown at 30°C. Cells were then immediately prepared for protein 
purification using protease inhibitors and avoiding cycles of ffeeze/thawing. Lysozyme 
and 1% Triton X-100 was added to culture lysates to increase the yield of solubilised 
recombinant protein. Insoluble debris was pelleted out at high speed and the soluble 
lysate incubated with glutathione sepharose 4B medium for >2 h with rocking at 4°C. 
The concentration of glutathione was increased to 20 mM for elution of bound protein 
and eluted fractions immediately quantified using Bradford reagent. Protein samples 
were stored above 4°C to prevent precipitation of protein.
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Figure 6.16: Large scale purification of GST-fusion protein from soluble cell fractions.
BL21(DE3) E. coli cells were transformed with either the GST-control vector or the pGEX-4T-l*/Rv2745c 
construct, seeded into a 1 L culture, grown at 30°C with shaking to an ODéoo 0.5-1.0, induced with 0.4 mM 
IPTG for 3 h and centrifiiged. The soluble protein fraction was separated from inclusion bodies by 
sonication and centrifugation and purified on column using glutathione sepharose 4B. Lane 1; 
BenchMark™ Protein Ladder; lanes 2, 3, 4 and 5: sequential elutions o f bound pGEX-4T-l*/Rv2745c 
recombinant protein from the GST affinity chromatography column; lane 6 ; elution o f bound GST-control 
protein.
6.3.6 Quantification of purified GST-fusion protein
Following optimisation of expression and purification of soluble GST-fusion protein 
Bradford Reagent was used for quantification of purified protein eluted off the affinity 
purification column. Figure 6.17 plots the absorbance of eluted GST-fusion protein 
against a 5-point standard curve of BSA standards. Eluted fractions of GST-fusion 
protein were quantified at 0.124 mg/ml and used in the Electrophoretic Mobility Shift 
Assay (EMSA) detailed in the following section.
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Figure 6.17: Absorbance (595 nm) of BSA protein standards (mg/ml) and the relative quantification 
of purified GST-fusion protein.
BSA standards, were prepared fresh in Tris-HCl buffer from 1 mg/ml stocks and the absorbance 
(595nm) determined to produce the calibration curve. The concentration (mg/ml) o f the unknown sample 
(purified GST-fusion protein), was determined from the calibration curve.
6.3.7 Electrophoretic Mobility Shift Assay
The Rv2745c gene product is highly similar to the transcriptional regulator, ClgR {dp  
gene regulator), in Streptomyces. It was hypothesised that Rv2745c binds to a ClgR-like 
binding motif found in several promoter regions of genes identified in Chapter 3. The 
EMSA was used to determine if Rv2745c displayed the DNA-binding activity predicted 
for two of the genes indicated to have a ClgR-like binding sequence. Oligonucleotide 
sequences corresponding to putative Rv2745c binding sites were designed for each of the 
selected gene targets {acr2 (Rv0251c) andptrB (Rv0782c)) based on the identification of 
a good putative ClgR-like binding site in the 5’ region of the gene (see Chapter 4). 
Purified and quantified GST-Rv2745c was used at 50 ng/EMSA reaction.
The purified Rv2745c protein illustrated high specificity for binding to the putative 
ClgR-like binding motif present in the oligonucleotide sequence of acr2 (Rv0251c)
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tTTCCACCTCGGCGTTCACCGGAAGCGAACACTGTCACACAG) tested (Figure 
6.18, lane 2). No shift was observed in the control reaction of DIG-labelled 
oligonucleotide without protein (lane 1) or in the competitive control reaction using an 
excess of unlabelled competitive oligonucleotide in the presence of purified protein 
(lane 3). The competitive control reaction uses 10-fold excess of unlabeled probe and is 
therefore indicative of specificity for the DNA target. Double bands present at the 
bottom of each lane are artefacts fi’om the movement of the positively charged nylon 
membrane over the 6% non-denaturing polyacrylamide gel. Some warping is apparent in 
the chemiluminescent detection of the EMSA however this effect was observed on many 
occasions where protein-DNA interaction had occurred in a sample.
OIG-oligo
DKrollgo OJG-oligo + protein 
only + protein + unlabelled ollgo
1
Figure 6.18: Purified Rv2745c protein displays binding activity to putative ClgR-like binding motif 
present in the acr2 (Rv0251c) promoter.
Western blot detection o f Rv0251c specific DIG-labelled DNA oligonucleotide and the in vitro interaction 
of Rv2745c purified protein using EMSA. Lane 1: DIG-labelled Rv0251c oligonucleotide (0.8 ng) control; 
lane 2: purified Rv2745c protein (50 ng) and DIG-labelled Rv0251c oligonucleotide (0.8 ng); lane 3: 
Rv2745c protein (50 ng) with DIG-labelled Rv0251c oligonucleotide (0.8 ng) and an excess o f unlabelled 
Rv0251c oligonucleotide (0.1 pg).
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Purified protein was titrated across several gel shift reactions to determine the 
concentration of protein necessary for stabilisation of the protein-DNA complex. 
Figure 6.19 illustrates the titration of GST-bound Rv2745c fusion protein from 100 ng, 
50 ng, 25 ng, and 12.5 ng per gel shift reaction. In this experiment the highest 
concentration, 100 ng (lane 1), of GST-Rv2745c protein shifted only some of the 
DIG-labelled oligonucleotide and the majority remained unbound. The relatively poor 
shift compared to Figure 6.18 may be due to gradual precipitation of the GST-Rv2745c 
during storage which may render it less able to bind the palindromic motif. At the lowest 
concentration, 12.5 ng (lane 4), a very weak shift of the acr2 oligonucleotide was 
detectable demonstrating that the binding interaction at low protein levels did not 
disappear. An additional control is the absence of binding to a scrambled acr2 
oligonucleotide (Figure 6.19, lane 7), indicative of the sequence specificity of binding.
ng 100 50 25 12.5
MG-ollgo
only
0
Unlabelled
ollgo
100
Scrambled
ollgo
50 so
1 2 3 4 5 6 7 8
Figure 6.19: Titration of GST-Rv2745c: acr2 (Rv0251c) promoter interaction.
EMSA detection using a fixed amount o f DIG-labelled Rv0251c probe incubated with reaction mixtures 
containing 100 ng GST-Rv2745c purified protein (lane 1); 50, 25, and 12.5 ng GST-Rv2745c (lanes 2, 3, 
and 4 respectively); lane 5: DIG-labelled Rv0251c probe only; lane 6: 100 ng GST-Rv2745c with DIG- 
labelled Rv0251c probe and 100-fold excess of unlabelled probe; lane 7: 50 ng GST-Rv2745c with a 
%GC-matched DIG-labelled probe; lane 8: 50 ng GST-Rv2745c and DIG-labelled Rv0251c probe (again).
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Figure 6.20: Rv2745c displays binding activity to putative ClgR-like binding motif present in ptrB  
(RVÜ782).
EMSA of DIG-labelled Rv0782 probe with purified Rv2745c protein. Lane 1 : Rv2745c protein (50 ng) 
mixed with DIG-labelled Rv0782 probe (0.8 ng) and unlabelled Rv0782 probe (0.1 pg); lane 2: 50 ng of 
Rv2745c purified protein was mixed with DIG-labelled Rv0782 probe; lane 3: DIG-labelled Rv0782 probe 
only.
Rv2745c demonstrated interaction with the putative ClgR-like binding motif present in 
the oligonucleotide sequence of ptrB (Rv0782) (GGCCACGACTTCTTCGCACTGG 
GCGCGGCCAGCGTCAGCCTG) (Figure 6.20, lane 2). As observed with the previous 
target (Rv0251c) there is warping of the polyacrylamide gel. It is proposed that the 
warping is observed as a result of the protein-DNA interaction and the formation of this 
high molecular weight product affects the electrophoretic separation of the samples either 
side of the reaction. Specificity of the reaction is demonstrated by the reduction of 
binding to the labelled probe in the presence of 10-fold excess of unlabelled 
oligonucleotide (lane 1).
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6.4 Discussion
The aim of this chapter was to demonstrate that the Rv2745c protein interacts with the 
promoter region of genes which were differentially regulated in the ARv2745c 
M. tuberculosis strain. Bioinformatic analysis (Chapter 3) identified an Rv2745c 
homologue, ClgR, in Streptomyces, Rv1043c, acr2, clpC, clpP and ptrB were identified 
to have ClgR-like binding sites and transcriptional profiling of the ARv2745c mutant 
(Chapter 5) identified Rvl043c and acr2 to be significantly down-regulated compared to 
wild-type and ptrB and clpP to be ranked in the top 30 down regulated genes. In this 
chapter the putative ClgR binding-sites of acr2 and ptrB were targeted for EMSA 
analysis using purified GST-Rv2745c fusion protein. We sought to express the putative 
transcriptional activator as a recombinant protein vrith an IPTG-inducible vector and 
purify the recombinant protein for use in gel shift reactions. Efforts to express Rv2745c 
using a C-terminal His-tag fusion system were unsuccessful although sequencing of the 
cloned construct confirmed the correct in-frame sequence of the fusion protein. A low 
molecular weight protein observed upon purification of whole cell lysates did not 
correspond to the predicted weight for the fiision protein. Mass spectrometry also 
confirmed this low molecular weight product to contain no mycobacterial peptides and 
therefore it was determined not to be our protein of interest. The stability o f the 
recombinant vector was then tested as unstable plasmid constructs can cause difficulties 
when trying to express a fusion protein. However, the plasmid stability assay determined 
the His-fusion construct to be stable and could not explain the lack of induction of the 
fiision protein. Furthermore, toxicity of the fusion protein to E. coli cells was ruled out 
as the His-tagged protein could not be expressed even when employing a cell free 
system. It remains undetermined as to why the Rv2745c protein could not be expressed 
using a His-tag fusion. One explanation for the difficulties in expressing the Rv2745c 
protein may be its’ targeted degradation. Rv2745c may be regulated by ClpP in a 
negative feedback system designed to regulate its own production. This hypothesis could 
be tested using a AClpP E. coli strain to express the His-tagged Rv2745c protein. Indeed, 
ClpP regulation of ClgR and Lon is implicated in S. lividans to be dependent on two 
C-terminal alanine residues (Bellier, Gominet, & Mazodier 2006). The peptide sequence 
of Rv2745c ends in valine-alanine residues (see Chapter 3, Figure 3.6) therefore if  it is
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also a substrate for ClpP degradation the motif may be altered in M  tuberculosis or there 
may be a number of different motifs targeted by the Clp protease.
Successful expression of the Rv2745c protein was observed using an N-terminal GST-tag 
for recombinant protein purification. Higher concentrations of the fusion protein were 
expressed in insoluble fractions but following solubilisation and removal o f the 
dénaturant there was a dramatic loss in protein concentration likely due to precipitation 
of the protein. In vitro binding reactions require the expressed protein to be in its native 
state enabling full function of the protein and therefore it was decided that optimisation 
of expression and purification of soluble protein was required. In doing so, difficulties 
associated with refolding proteins to their native state could be avoided. Our results 
indicate Rv2745c interaction with two of the putative ClgR-like binding motifs present in 
the upstream regions of acr2 (Rv0251c) and ptrB {Rv0782) confirming this protein to be 
a homologue of the ClgR transcriptional activator. It was found that GST-Rv2745c 
protein precipitated during storage for more than a week and this may be responsible for 
weak shifts in some EMSA reactions. Moreover the presence of the fused GST may alter 
the folding of the native protein and impede formation of a stable complex. The shift 
may therefore be improved by cleaving the GST tag from the purified protein using 
thrombin. Alternatively, the Rv2745c DNA binding regulator may require chaperone 
proteins for stable binding. This is true for other regulators of chaperone proteins such as 
HspR. Enhanced DNA-binding of the HspR-DnaK/DnaJ complex occurs in the presence 
of mycobacterial GroEL chaperone molecules and probably plays a role in the folding of 
the complex to function as a co-repressor vrith HspR (Das Gupta, Bandyopadhyay, & 
Das Gupta 2008). Similarly, ClgR isolated from Bifidobacterium breve requires Hsp60 
as a coactivator for specific binding to the ClpC promoter region (Ventura, Fitzgerald, & 
Sinderen 2005). Indeed much evidence exists for the multifactorial regulation of acr2. 
acr2 has been shown to be down-regulated by the heat shock repressor protein HspR 
(Stewart et al. 2002), up-regulated by SigE under SDS stress (Manganelli, Voskuil, 
Schoolnik, & Smith 2001) and both positively and negatively regulated by the 
two-component system MprAB (Pang & Howard 2007). It is interesting to speculate that 
chaperone control of ClgR (Rv2745c) may provide yet a further level for feedback and 
regulation of Acr2 expression.
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In this chapter, acr2 and ptrB have been identified to be directly regulated by the 
Rv2745c (ClgR) transcriptional activator. Further work to characterise the context of the 
protein-DNA interaction exhibited by these genes could be achieved using DNase 
footprinting. This may further confirm the binding site and determine the binding 
affinity of the protein by observing what concentration is required for visualisation of the 
footprint. Primer extension analysis could be applied for identification of the 
transcriptional start point for RNA transcription of the regulated genes. It was not 
confirmed, from these preliminary results, whether in vitro binding was observed for the 
further three targets (Rvl043c, clpC and clpP) with Rv2745c. Future studies should 
examine binding to the promoter regions of these genes to aid in interpretation of the 
transcriptional profiling of the Rv2745c mutant M. tuberculosis strain. For example, 
there was no evidence of down-regulation of the clpC gene in the Rv2745c mutant. 
EMSA studies would determine whether this is due to lack of interaction between 
Rv2745c and the ClpC promoter or whether the transcriptional profiling was not 
performed in conditions in which Rv2745c activation of ClpC occurs.
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7 Final discussion and future work
The WHO estimates that two million people die every year from TB - it is the worlds 
biggest infectious killer (World Health Organisation 2008). Mycobacterium tuberculosis 
infects one third of the worlds population however fewer than 10% of individuals suffer 
from active TB disease. A key characteristic of M. tuberculosis is its ability to evade the 
host immune response, surviving in asymptomatic infection for up to several decades 
before re-activating to cause disease usually at a time when the host is immune- 
suppressed, for example in individuals receiving chemotherapy or infected with HIV 
(Lillebaek et al. 2002). Central to this is the ability of M  tuberculosis to survive in the 
macrophage. However, the mechanisms of intracellular survival are not fully understood 
and it is hoped that by elucidating the host-pathogen interactions new targets for effective 
drug and vaccine design will be discovered. A successful vaccine would target not only 
actively dividing bacteria but also intracellular bacteria that may be in a reduced state of 
replication. Ideally the vaccine would also be effective in all populations and age groups 
and against all forms of disease.
Upon macrophage uptake of M. tuberculosis, the bacilli reside in the membrane bound 
vesicle, the phagosome. Live bacilli are necessary for macrophage survival whereas 
dead bacilli are shown to quickly traffick through the endocytic pathway to the acidic 
lysosomal compartment (Oh & Straubinger 1996;Yates, Hermetter, & Russell 2005). 
Activated macrophages kill invading bacilli by successful maturation of the phagosome 
to the phagolysosome, however it is at a point along the endocytic pathway that 
M. tuberculosis is able to arrest normal phagosome maturation via a cascade of signalling 
and trafficking events characterised by the retention of Rab5 and TACO and lack of 
Rab7 and the elevated pH to 6.2. This requires systematic orchestration of gene 
expression and protein production which is governed by several transcriptional regulators 
of M. tuberculosis. This project focused on understanding howM  tuberculosis adapts to 
life within a macrophage. The bacterium ensures its’ survival within the phagocyte by a 
number of strategies including prevention of phagosome fusion with lysosomes thus 
inhibiting the phagosome from maturing into a microbicidal compartment.
The project aims were to contribute to the current understanding of the regulation of 
genes that are required for M. tuberculosis survival within the human macrophage.
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High-throughput screening o f M. tuberculosis transposon mutants during macrophage 
infection was used to select for mutants defective for the ability to parasitize 
macrophages. Re-screening of a selected transposon library (Pethe et al. 2004) using 
TraSH enabled identification of mutants defective in arresting phagosome maturation and 
together with a comparative analysis with other biologically relevant data sets enabled 
identification of putative gene regulators associated with macrophage survival. The 
identified regulators were then successfully targeted for the development o f gene 
knockout mutants. These mutants were then individually characterised for survival, 
growth and virulence using a variety o f conditions, namely, macrophages, broth cultures 
and mice. Transcriptional profiling of the deletion mutants versus the wild-type strain in 
in vitro conditions was performed to help elucidate the regulon of the regulators and to 
contribute to understanding how adaptation to survival within a macrophage is 
orchestrated.
The first gene assessed in this project was Rv3058c encoding a TetR/AcrR type regulator 
identified fi’om an unpublished experiment to identify BCG mutants that are unable to 
arrest phagosome maturation and traffic to phagolysosomes in human macrophages 
derived fi’om PBMCs. After deletion of the gene in M  tuberculosis H37Rv, assessment 
in macrophages demonstrated that the mutant was not attenuated in macrophages 
compared to the wild-type strain. In agreement with this, the high-throughput 
intramacrophage survival screen of Rengarajan (Rengarajan, Bloom, & Rubin 2005) did 
not identify Rv3058c to be important for survival in murine macrophages, however, 
Rv3058c was indicated as important for survival in mice after 1 week of infection by the 
in vivo TraSH study by Sassetti (Sassetti & Rubin 2003). One might predict that a gene 
putatively important for phagosome-lysosome fusion would be attenuated for 
intracellular survival. This is, however, not always the case as demonstrated by mutant 
M. tuberculosis and BCG strains with aberrant trafficking but unaltered or hypervirulent 
intra-macrophage survival (Pethe et al. 2004;Stewart et al. 2005). An alternative 
explanation is that Rv3058c is not involved in phagolysosome inhibition and was 
misidentified in our unpublished phagolysosome selection screen. Future work on this 
regulator should include recapitulation of this trafficking phenotype in the Rv3058c 
mutant.
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Despite the uncertainty regarding the importance of Rv3058c to virulence, transcription 
profiling was performed to reveal the genes controlled by this putative regulator. Ten 
genes were up-regulated in this mutant and 8 were down-regulated. A number of the 
up-regulated genes have been shown in previous studies to be up-regulated in stationary 
phase mycobacteria or mycobacteria in hypoxic conditions (Boon & Dick 2002;Kana et 
al. 2001;Park et al. 2003) and several down-regulated genes are known to be involved in 
active growth (Schneider et al. 2008;Tufariello et al. 2006). Reversal of these gene 
expression differences was not achieved in the complemented mutant. This may be 
indicative that the observed differences were not a result of deletion of Rv3058c and by 
inference that the affected genes were not directly regulated by Rv3058c. However, it 
may also be due to technical problems in expressing a functional Rv3058c including the 
presence of two non-synonymous mutations in the introduced Rv3058c. Thus the genes 
controlled by Rv3058c remain to be determined.
A transposon mutant in the Rv2548 gene, predicted to encode a PIN-domain (pilT 
N-terminal domain) protein belonging to a TA operon, was seen to be attenuated for 
survival in macrophages (Stewart et al. 2005). This gene was also shown to be important 
for growth in mice in the high-throughput TraSH studies by Sassetti et al (Sassetti & 
Rubin 2003). In the present project, a mutant H37Rv strain deleted of Rv2548 was 
generated and its intracellular survival phenotype assessed in the J774 macrophage cell 
line. There was no evidence that the strain was attenuated. However, given the evidence 
fi’om other studies that this gene is involved in virulence, further intracellular survival 
assays should be performed using primary macrophages and more specifically human 
monocyte-derived macrophages to provide a more relevant in vitro infection model. 
Preliminary findings indicate the ARv2548 mutant to be more susceptible to oxidative 
stress and elevated temperatures compared to the parental strain.
Many studies have used C57BL/6 mice as an in vivo infection model (McKiimey John D 
et al. 2000;Sherman et al. 2004;Tufariello et al. 2006). Other studies have used the SCID 
mouse model and identified mutants with either increased or decreased virulence 
(Gordhan et al. 2002;McAdam et al. 2002;Parish et al. 2003). It was attempted to assay 
the in vivo survival of the ARv2548 strain in C57BL/6 mice (performed in collaboration 
with Imperial College). However, the wild-type strain appeared to have become 
attenuated during successive in vitro passages and these experiments need repeating
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using an original isolate of the parental M. tuberculosis strain. A further consideration 
for future in vivo studies may be the use of a SCID mouse model as it is proven to be 
highly sensitive to changes in bacterial virulence (Smith et al. 2001) and is perhaps 
therefore more suitable for use in acute infection models. In the immunocompromised 
SCID mouse, disease progresses rapidly and these mice may be more susceptible to 
strains that are only mildly attenuated. This may therefore prove to be a better model for 
the detection of small changes between strains.
Expression profiling of the ARv2548 mutant provided compelling evidence for Rv2548 
gene function as a PIN-domain protein involved in down-regulating protein expression 
via degradation of mRNA transcripts. The RNase activity of Rv2548 could be confirmed 
by preparing oligonucleotide substrates designed with a fluorophore and quencher 
molecule in close proximity. Once cleaved by the RNase, separation of the fluorophore 
and quencher emits a signal that can be quantitatively correlated to the level of RNase 
activity observed for each substrate. A large number of genes were significantly up- 
regulated in the deletion mutant and there was a distinct absence of down-regulated gene 
expression. The genes induced in the mutant strain included many previously shown to 
be involved in the stress response including acr2, dnaK, Rv0353 and sigE and these 
changes were reversed by réintroduction of the Rv2548c gene on an integrating 
construct. There are 38 TA opérons in M. tuberculosis (Pandey & Gerdes 2005). 
Generally the toxin proteins are small hydrophobic molecules and the corresponding 
antitoxin is antisense to the toxin gene or exhibits high complementarity (Fozo, Hemm, 
& Storz 2008). The vapBC opérons comprise the largest family of bacterial PIN-domain 
proteins functioning as TA opérons with ribonuclease activity (Robson et al. 2009). The 
VapBC protein complex binds inverted repeat DNA sequences in vapBC promoter region 
in M. smegmatis. Over expression of the toxin component (VapC) inhibits growth of 
M. smegmatis through inhibition of translation and this phenotype is reversed when 
VapC is co-expressed with its cognate antitoxin, VapB (Robson, McKenzie, Cursons, 
Cook, & Arcus 2009). The up-regulated genes identified in the Rv2548 mutant may 
represent targets of the RNase or are indicative of a stress response induced by other 
changes conferred by loss of Rv2548. Further molecular and biochemical 
characterisation of the Rv2548 gene may indicate its autoregulation and interdependency 
with its cognate antitoxin, as described above for vapBC, and would be necessary to 
prove its action and specificity as an RNase.
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The third gene that was assessed in this project was Rv2745c, which was identified in the 
TraSH re-screen of the Pethe et al transposon library that had been selected by affinity 
purification of iron loaded phagolysosomes. In the first intracellular survival assay in 
J774 macrophages the gene replacement mutant of Rv2745c appeared to be attenuated 
for survival. This result was not repeated in a second similar assay but in this case the 
wild-type did not demonstrate growth. Assays using quickly proliferating cell lines like 
J774 are perhaps not well suited to these studies as the monolayer can over grow quickly. 
The Rv2745c mutant has been assessed by other members of the laboratory in primary 
bone marrow-derived macrophages and shown to be defective for growth compared to 
the wild-type (unpublished results). An experiment to assess the virulence of ARv2745c 
using C57BL/6 mice was unsuccessful and no conclusions can be drawn from it as the 
wild-type inoculum showed low virulence as had been observed for the mouse 
experiment with ARv2548.
Transcriptional profiling of ARv2745c revealed that 31 genes were up-regulated 
compared to the wild-type and 9 were down-regulated. Bioinformatic analysis indicated 
a high degree of similarity in amino acid sequence between Rv2745c and ClgR, a 
transcriptional activator of S. lividans. The high degree of identity between Rv2745c of 
M. tuberculosis and ClgR led to the hypothesis that Rv2745c is a homologue of ClgR. 
ClgR recognises and binds to a short palindromic sequence motif (CGC-4N-GCG) 
present in genes of the Streptomyces ClgR regulon and include clpPlP2, clpCl, Ion and 
clgR itself. It was therefore questioned whether Rv2745c recognised a similar sequence 
motif for DNA-binding in M. tuberculosis. A genome wide bioinformatic search for the 
existence of ClgR-like motif present in promoter regions of genes highlighted five genes 
with potential binding sites. Two of these genes were significantly down-regulated 
(acr2, Rv1043c) in the deletion mutant, two {clpPI and ptrB), although not within the 
stringent cut-off of significance, were within the top 30 most down-regulated genes. 
Validation of the microarray data was performed on this small sub-set of genes using 
QRTPCR to see if  the microarray results could be replicated using a highly sensitive 
technique. Results of the QRTPCR analysis closely correlated with the microarray data 
for three of the genes tested, specifically, acr2, clpPl and clpCl. The fourth target, 
Rv1043c, could not be amplified using the designed probe/primer set and therefore the 
microarray data for this target remains to be validated.
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Several attempts to express the JRv2745c gene product as a C-terminal fusion protein 
failed and therefore the recombinant protein was hypothesised to be toxic to E. coli cells. 
Following failed attempts to express the fusion protein in a cell-free translation system 
designed for the expression of toxic proteins this hypothesis was rejected. Recently, it 
has been described that the two C-terminal alanine residues present in ClgR and Lon are 
important for their targeted degradation by ClpPl/P2 protease (Bellier, Gominet, & 
Mazodier 2006). The C-terminal end of Rv2745c differs from that of ClgR and Lon as it 
ends with a valine-alanine peptide sequence. Our unsuccessful attempts to express the 
protein 'with a C-terminal fusion indicate these residues may be very important for a 
functional protein (coinciding with the findings of Bellier et al 2000) as successful 
expression of the Rv2745c regulator was achieved by cloning the gene into a completely 
different expression vector using an N-terminal GST fusion. Optimisation of Rv2745c 
expression by varying conditions for protein induction, such as growth temperature and 
concentration of IPTG still observed the bulk of expressed recombinant protein to be 
insoluble.
Results of gel-shifr experiments using purified recombinant protein tentatively observed 
Rv2745c binding to two of the promoter regions tested, namely, acr2 and ptrB. The 
presence of similar ClgR-like binding motifs present in upstream region of both 
substrates positive for Rv2745c recognition and binding further supported the hypothesis 
for Rv2745c as a homologue of ClgR. Included in the small set of genes identified as 
having good binding motifs are an important set of proteases, ptrB, (an endopeptidase), 
clpPl (a stress-induced serine protease) and the associated molecular chaperone, clpCl, 
(belonging to HSPlOO family (Kar et al. 2008)). The stress inducible ClpCl and ClpPl 
subunits are involved in ClgR degradation (Engels et al. 2004) and the latter is essential 
for intracellular survival of Listeria monocytogenes (Gaillot et al. 2000). A further 
Rv2745c targeted chaperone with a ClgR-like binding motif, acr2, encodes a small alpha 
crystallin heat-inducible protein (Stewart et al. 2001) important in pathogenesis 
(Wilkinson et al. 2005). The combination of predicted ClgR binding sites and the 
microarray data strongly supports the hypothesis that Rv2745c encodes a ClgR 
homologue and that it regulates expression of the Acr2 chaperone, Rvl043c, ClpPl and 
PtrB proteases.
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Deregulation of these genes in the Rv2745c mutant resulted in reduced survival in J774 
macrophages however further experiments using bone marrow derived macrophages 
(BMMs) are necessary to confirm the phenotype for this mutant. Future work on the 
regulators studied in this project should also include trafficking experiments in BMMs 
using confocal microscopy to definitively identify the mycobacterial cellular locahsation. 
Transcriptional profiling of the mutants should be performed under altered conditions 
including macrophage infection and under stress conditions as regulated genes may only 
be induced when comparing mutant and wild-type expression under the relevant 
conditions. In doing so, this may help to reveal the Rv3058c regulon which remains 
largely undefined. In order to fully map the binding sites of transcription factors 
Chlp-on-chip analysis should be applied to enable increased understanding of the gene 
regulatory networks and may also complement the transcriptional profiling. Further 
in vivo experiments are required using an original laboratory stock of H37Rv proven to 
replicate following infection. The infection models described here were performed in 
C57BL/6 mice over a 42 or 84 day period. Using a SCID mouse model may prove more 
suitable for monitoring acute infection however; a short duration of infection may mask 
any virulence phenotype and this requires careful consideration when planning further 
studies.
7.1 Concluding remarks
Mycobacterial virulence is a multifactorial process encompassing many mechanisms for 
modulating phagosome maturation including pH control, genes attributable to persistence 
and metabolic regulation, enzymes involved in DNA repair systems, biosynthesis of 
lipids and amino acids. It is a dynamic relationship between the survival strategies 
employed by the pathogen and the defence of the host immune system. The ability of 
M. tuberculosis to survive within the macrophage and cause persistent infection is 
controlled by the dynamic orchestration of gene expression via transcriptional regulation. 
Regulation of gene expression can be achieved using a variety of mechanisms such as the 
activity of alternative sigma factors, two component regulatory systems and the 
hyperphosphorylation of guanine. Identification of transcriptional regulators (and their 
opérons) implicated in intracellular survival will provide potential drug and vaccine 
targets for the development of therapeutics that restrict mycobacterial persistence and 
eradicate latent infection.
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Important aims for future research should look at identifying the key genes controlled by 
these regulators and other transcriptional regulators and the elucidation of their specific 
role in pathogenesis. Transcriptional regulators make good targets for drug design 
because the effective modulation of a transcription factor will alter gene expression and 
protein production and has the potential to render the organism non-viable. Identifying 
important mycobacterial regulatory genes active during intracellular infection may realise 
novel therapeutic targets for drug design. Transcriptional profiling of the developed 
mutants during intracellular infection will provide further insight into the global 
regulation of mycobacterial genes implicated in modulating the host cell and promoting 
survival of bacilli within the macrophage.
208
References
8 References
1. Adams, L. B., Dinauer, M. C., Morgenstem, D. E., & Krahenbuhl, J. L. 1997, 
"Comparison of the roles of reactive oxygen and nitrogen intermediates in the host 
response to Mycobacterium tuberculosis using transgenic mice ", Tubercle and Lung 
Disease, vol. 78, no. 5-6, pp. 237-246.
2. Agarwal, N., Raghunand, T. R., & Bishai, W. R. 2006, "Regulation of the expression 
of whiBl in Mycobacterium tuberculosis: role of cAMP receptor protein". 
Microbiology, vol. 152, no. 9, pp. 2749-2756.
3. Akhter, Y., Yellaboina, S., Farhana, A., Ranjan, A., Ahmed, N., & Hasnain, S. E. 
2008, "Genome scale portrait of cAMP-receptor protein (GRP) régulons in 
mycobacteria points to their role in pathogenesis". Gene, vol. 407, no. 1-2, pp. 148-
158.
4. Anes, E., Kuhnel, M. P., Bos, E., Moniz-Pereira, J., Habermann, A., & Griffiths, G. 
2003, "Selected lipids activate phagosome actin assembly and maturation resulting in 
killing of pathogenic mycobacteria". Nature Cell Biology, vol. 5, no. 9, pp. 776-778.
5. Anton, V., Rouge, P., & Daffé, M. 1996, "Identification of the sugars involved in 
mycobacterial cell aggregation", FEMS Microbiology Letters, vol. 144, no. 2-3, pp. 
167-170.
6. Arcus, V. L., Rainey, P. B., & Turner, S. J. 2005, "The PIN-domain toxin-antitoxin 
array in mycobacteria". Trends in Microbiology, vol. 13, no. 8, pp. 360-365.
7. Armitige, L. Y., Jagannath, C., Wanger, A. R., & Norris, S. J. 2000, "Disruption of 
the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis 
H37Rv: effect on growth in culture and in macrophages". Infection and Immunity, 
vol. 68, no. 2, pp. 767-778.
8. Armstrong, J. A. & Hart, P. D. 1971, "Response of cultured macrophages to 
Mycobacterium tuberculosis, with observations on fusion of lysosomes with 
phagosomes". The Journal of Experimental Medicine, vol. 134, no. 3, pp. 713-740.
9. Amaout, M. A. 1990, "Structure and function of the leukocyte adhesion molecules 
CD11/CD18", Blood, vol. 154, pp. 465-473.
10. Asensio, J. A. G., Arbues, A., Perez, E., Gicquel, B., & Martin, C. 2008, "Live 
tuberculosis vaccines based on phoP mutants: a step towards clinical trials". Expert 
Opinion on Biological Therapy, vol. 8, no. 2, pp. 201-211.
11. Avarbock, A., Avarbock, D., Teh, J. S., Buckstein, M., Wang, Z., & Rubin, H. 2005, 
"Functional regulation of the opposing (p)ppGpp synthetase/hydrolase activities of
209
References
RelMtb from Mycobacterium tuberculosis". Biochemistry, vol. 44, no. 29, pp. 9913- 
9923.
12. Badarinarayana, V., Estep, P. W., Shendure, J., Edwards, J., Tavazoie, S., Lam, F., & 
Church, G. M. 2001, "Selection analyses of insertional mutants using subgenic- 
xosoXviXionrmmys.", Nature Biotechnology, Yo\. 19, no. 11, pp. 1060-1065.
13. Bai, G., Gazdik, M. A., Schaak, D. D., & McDonough, K. A. 2007, "The 
Mycobacterium bovis BCG cyclic AMP receptor-like protein is a functional DNA 
binding protein in vitro and in vivo, but its activity differs from that of its M. 
tuberculosis ortholog Rv3676", Infection and Immunity, vol. 75, no. 11, pp. 5509- 
5517.
14. Balasubramanian, V., Pavelka, Jr. M. S., Bardarov, S. S., Martin, J., Weisbrod, T. R., 
McAdam, R. A., Bloom, B. R , & Jacobs, W. R. Jr. 1996, "Allelic exchange in 
Mycobacterium tuberculosis with long linear recombination substrates". Journal of 
Bacteriology, vol. 178, pp. 273-279.
15. Balasubramanian, V., Wiegeshaus, E. H., Taylor, B. T., & Smith, D. W. 1994, 
"Pathogenesis of tuberculosis: pathway to apical localization". Tubercle and Lung 
Disease, vol. 75, pp. 168-178.
16. Balcewicz-Sablinska, M. K., Keane, H., Komfield, H., & Remold, H. G. 1998, 
"V?i\hogomc Mycobacterim tuberculosis evades apoptosis of host macrophages by 
release of TNF-R2, resulting in inactivation of TNF-a", The Journal of Immunology, 
vol. 161, pp. 2636-2641.
17. Bardarov, S., Kriakov, J., Carrière, C., Yu, S., Vaamonde, C., McAdam, R. A., 
Bloom, B. R., HatfuU, G. F., & Jacobs, W. R. Jr. 1997, "Conditionally replicating 
mycobacteriophages : a system for transposon dehvery to Mycobacterium 
tuberculosis.", PNAS, vol. 94, no. 20, pp. 10961-10966.
18. Behr, M. A. & Small, P. M. 1997, "Has BCG attenuated to impotence?". Nature, vol. 
389, pp. 133-134.
19. Behsle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J., & Besra, G. S. 
1997, "Role of the major antigen of Mycobacterium tuberculosis in cell wall 
biogenesis". Science, vol. 276, pp. 1420-1422.
20. Bellier, A. & Mazodier, P. 2004, "ClgR, a novel regulator of clp and Ion expression 
in Streptomyces", Journal of Bacteriology, vol. 186, pp. 3238-3248.
21. Bellier, A., Gominet, M., & Mazodier, P. 2006, "Post-translational control of the 
Streptomyces lividans ClgR regulon by ClpP", Microbiology, vol. 152, no. 4, pp. 
1021-1027.
22. Bentrup, K. H. & Russell, D. G. 2001, "Mycobacterial persistence: adaptation to a 
changing environment". Trends in Microbiology, vol. 9, no. 12, pp. 597-605.
210
References
23. Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. 2002, 
"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence 
by gene and protein expression profiling". Molecular Microbiology, vol. 43, no. 3, 
pp. 717-731.
24. Bifani, P., Moghazeh, S., Shopsin, B., Driscoll, J., Ravikovitch, A., & Kreiswirth, B. 
N. 2000, "Molecular characterisation of Mycobacterium tuberculosis H37Rv/Ra 
variants: distinguishing the mycobacterial laboratory strain". Journal of Clinical 
Microbiology, vol. 38, no. 9, pp. 3200-3204.
25. Black, G. F., Weir, R. E., Floyd, S., Bliss, L., Wamdorff, D. K., Crampin, A. C., 
Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J. M., Branson, K., Chaguluka, S. 
D., Donovan, L., Jarman, E., King, E., Fine, P. E., & DockreU, H. M. 2002, "BCG- 
induced increase in interferon-gamma response to mycobacterial antigens and 
efficacy of BCG vaccination in Malawi and the UK: two randomised controlled 
studies". The Lancet, vol. 359, no. 9315, pp. 1393-1401.
26. Bloom, B. R. & Murray, C. J. L. 1992, "Tuberculosis: commentary on a reemergent 
killer". Science, vol. 257, pp. 1055-1064.
27. BMJ Publishing Group Limited 2002, "BCG, TB and the UK", Drug and 
Therapeutics Bulletin, vol. 40, no. 10, pp. 78-80.
28. Bogdan, C., Paik, J., Vodovotz, Y., & Nathan, C. 1992, "Contrasting mechanisms for 
suppression of macrophage cytokine release by transforming growth factor-beta and 
interleukin-10",/owrwûr/ of Biological Chemistry, vol. 267, no. 32, pp. 23301-23308.
29. Boon, C. & Dick, T. 2002, "Mycobacterium bovis BCG response regulator essential 
for hypoxic dormancy". The Journal of Bacteriology, vol. 184, no. 24, pp. 6760- 
6767.
30. Boshoff, H. L M., Myers, T. G., Copp, B. R., McNeil, M. R , Wilson, M. A., &
Barry, C. E., Ill 2004, "The transcriptional responses of Mycobacterium tuberculosis 
to inhibitors of metabolism: novel insights into drug mechanisms of action", 
J.Biol.Chem., vol. 279, no. 38, pp. 40174-40184.
31. Bradford, M. M. 1976, "A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding". 
Analytical Biochemistry, vol. 72, pp. 248-254.
32. Braibant, M., Gilot, P., & Content, J. 2000, "The ATP binding cassette (ABC) 
transport systems of Mycobacterium tuberculosis", FEMS Microbiology Reviews, 
vol. 24, no. 4, pp. 449-467.
33. Braunstein, M., Espinosa, B. J., Chan, J., Belisle, J. T., & Jacobs, W. R. Jr. 2003, 
"SecA2 functions in the secretion of superoxide dismutase A and in the virulence of 
Mycobacterium tuberculosis.". Molecular Microbiology, vol. 48, no. 2, pp. 453-464.
211
References
34. Brennan, P. J. & Nikaido, H. 1995, "The envelope of mycobacteria", Review 
of Biochemistry, vol. 64, pp. 29-63.
35. Bucci, C., Thomsen, P., Nicoziani, P., McCarthy, J., & Van Dears, B. 2000, "Rab7:
A key to lysosome biogenesis". Molecular Biology of the Cell, vol. 11, pp. 467-480.
36. Butler, D. 2000, "New fronts in an old war". Nature, vol. 406, pp. 670-672.
37. Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B., & Guilhot, C. 1999, 
"Identification of a virulence gene cluster of Mycobacterium tuberculosis by 
signature-tagged transposon vmiàgonQsis", Molecular Microbiology, vol. 34, no. 2, 
pp. 257-267.
38. Camus, J. C., Pryor, M. J., Medigue, C., & Cole, S. T. 2002, "Re-annotation of the 
genome sequence of Mycobacterium tuberculosis YQlPcv", Microbiology, vol. 148, 
no. 10, pp. 2967-2973.
39. Centers for Disease Control and Prevention 2006, "Emergence of Mycobacterium 
tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004", 
Morbidity and Mortality Weekly Report, vol. 55, pp. 301-308.
40. Chang, S. T., Linderman, J. J., & Kirschner, D. E. 2005, "Multiple mechanisms allow 
Mycobacterium tuberculosis to continuously inhibit MHC class It-mediated antigen 
presentation by macrophages". Proceedings from the National Academy of Sciences 
of the United States of America, vol. 102, no. 12, pp. 4530-4535.
41. Chen, P., Ruiz, R. E., Li, Q., Silver, R. F., & Bishai, W. R. 2000, "Construction and 
characterization of z. Mycobacterium tuberculosis mutant lacking the alternate sigma 
factor gene, sigF\ Infection and Immunity, vol. 68, no. 10, pp. 5575-5580.
42. Chitale, S., Ehrt, S., Kawamura, 1., Fujimura, T., & Shimono, N. 2001,
"KoqotNûîqsxA Mycobacterium tuberculosis protein associated with mammahan cell 
entry". Cellular Microbiology, vol. 3, pp. 247-254.
43. Chu, G., Narasimhan, B., Tibshirani, R., & Tusher, V. 2007, Significance analysis of 
Microarrays.
44. Chua, J. & Deretic, V. 2004, "Mycobacterium tuberculosis reprograms waves of 
phosphatidylinositol 3-phosphate on phagosomal organelles.". Journal of Biological 
Chemistry, vol. 279, pp. 36982-36992.
45. Cirillo, J. D., Barletta, R. G., Bloom, B., & Jacobs, W. R. Jr. 1991, "A novel 
transposon trap for Mycobacteria: isolation and characterisation of IS1096", Journal 
of Bacteriology, vol. 173, pp. 7772-7780.
46. Clemens, D. L. 1996, "Characterisation of fho Mycobacterium tuberculosis 
phagosome". Trends in Microbiology, vol. 4, pp. 113-118.
212
References
47. Clemens, D. L. & Horwitz, M. A. 1996, Mycobacterium tuberculosis 
phagosome interacts with early endosomes and is accessible to exogenously 
administered transferrin". The Journal o f Experimental Medicine, vol. 184, pp. 1349- 
1355.
48. Clemens, D. L. & Horwitz, M. A. 1995, "Characterisation of fho Mycobacterium 
tuberculosis phagosome and evidence that phagosomal maturation is inhibited". 
Journal of Experimental Medicine, vol. 181, pp. 257-270.
49. Clemens, D. L., Lee, B.-Y., & Horwitz, M. A. 2000a, "Deviant Expression of Rab5 
on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis 
and Legionella pneumophila is associated with altered phagosomal fate". Infection 
and Immunity, vol. 68, no. 5, pp. 2671-2684.
50. Clemens, D. L., Lee, B.-Y., & Horwitz, M. A. 2000b, "Mycobacterium tuberculosis 
and Legionella pneumophila phagosomes exhibit arrested maturation despite 
acquisition of Rab7", Infection and Immunity, vol. 68, no. 9, pp. 5154-5166.
51. Cobum, P. S., Baghdayan, A. S., Dolan, G. T., & Shankar, N. 2008, "An AraC-type 
transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island 
contributes to pathogenesis and intracellular macrophage survival". Infection and 
Immunity, vol. 76, no. 12, pp. 5668-5676.
52. Cohen, B. A., Mitra, R. D., Hughes, J. D., & Church, G. M. 2000, "A computational 
analysis of whole-genome expression data reveals chromosomal domains of gene 
expression". Nature Genetics, vol. 26, pp. 183-186.
53. Cole, S. T., Brosch, R., Parkhill, J., Gamier, T., Churcher, C., Harris, D., Gordon, S. 
V., Eiglmeier, K., Gas, S., Barry, 1.1. C., Tekai, F., Badcock, K., Basham, D.,
Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., FeltweU, T., 
Gentles, S., Hamlin, N., Holroyd, S., Homsby, T., Jagels, K., & Barrell, B. G. 1998, 
"Deciphering the biology of Mycobacterium tuberculosis from the complete genome 
sequence". Nature, vol. 393, no. 6685, pp. 537-544.
54. Collins, D. M., de Kawakami, R. P., Lisle, G. W., Pascopella, L., Bloom, B. R., & 
Jacobs, W. R. Jr. 1995, "Mutation of the principal sigma factor causes loss of 
vimlence in a strain of the Mycobacterium tuberculosis complex". Proceedings from 
the National Academy of Sciences of the United States of America, vol. 92, pp. 8035- 
8040.
55. Connolly, S. F. & Kusner, D. J. 2007, "The reflation of dendritic cell function by 
calcium-signaling and its inhibition by microbial pathogens.". Immunologic 
Research, vol. 39, no. 1-3, pp. 115-127.
56. Corder, G. W. & Foreman, D. 1. 2009, Nonparametric statistics for non-statisticians: 
a step-by-step approach Wiley.
213
References
57. Cox, J. S., Chen, B., McNeil, M., & Jacobs, W. R. Jr. 1999, "Complex lipid 
determines tissue-specific rephcation of Mycobacterium tuberculosis in mice". 
Nature, vol. 402, pp. 79-83.
58. Cronje, L., Edmondson, N., Eisenach, K. D., & Bomman, L. 2005, "Iron and iron 
chelating agents moàvXzto Mycobacterium tuberculosis growth and monocyte- 
macrophage viability and effector functions", FEMS Immunology and Medical 
Microbiology, vol. 45, pp. 103-112.
59. Crowle, A. J., Dahl, R., Ross, E., & May, M. H. 1991, "Evidence that vesicles 
containing living, vrnxlovA Mycobacterium tuberculosis or Mycobacterium avium in 
cultured human macrophages are not acidic". Infection and Immunity, vol. 59, no. 5, 
pp. 1823-1831.
60. Dahl, J. L., Kraus, C. N., Boshoff, H. 1. M., Doan, B., Foley, K., Avarbock, D., 
Kaplan, G., Mizrahi, V., Rubin, H., & Barry, C. E. 2003, "The role of RelMtb- 
mediated adaptation to stationary phase in long-term persistence of Mycobacterium 
tuberculosis in mice". Proceedings of the National Academy ofSciences of the 
United States of America, vol. 100, no. 17, pp. 10026-10031.
61. Das Gupta, T., Bandyopadhyay, B., & Das Gupta, S. K. 2008, "Modulation of DNA- 
binding activity of Mycobacterium tuberculosis HspR by chaperones". Microbiology, 
vol. 154, no. 2, pp. 484-490.
62. Davies, P. D. 2000, "Tuberculosis: the global epidemic". Journal of the Indian 
Medical Association, vol. 98, no. 3, pp. 100-102.
63. Davis, E. O., Jenner, P. J., Brooks, P. C., Colston, M. J., & Sedgwick, S. G. 1992, 
"Protein splicing in the maturation of M  tuberculosis recA protein: a mechanism for 
tolerating a novel class of intervening sequence". Cell, vol. 71, no. 2, pp. 201-210.
64. Davis, E. O., Thangaraj, H. S., Brooks, P. C., & Colston, M. J. 1994, "Evidence of 
selection for protein introns in the RecAs of pathogenic mycobacteria", EMBOJ, vol. 
13, no. 3, pp. 699-703.
65. Davis, N. K. & Chater, K. F. 1992, "The Streptomyces coelicolor whiB gene encodes 
a small transcription factor-like protein dispensable for growth but essential for 
sporulation.". Molecular and General Genetics, vol. 232, no. 3, pp. 351-358.
66. Dayaram, Y. K., Talaue, M. T., Connell, N. D., & Venketaraman, V. 2006, 
"Characterisation of a glutathione metabolic mutant of Mycobacterium tuberculosis 
and its resistance to glutathione and nitrosoglutathione". The Journal of Bacteriology, 
vol. 188, no. 4, pp. 1364-1372.
67. de Boer, A. S., Borgdorff, M. W., Vynnycky, E., Sebek, M. M., & van Soolingen, D. 
2003, "Exogenous reinfection as a cause of recurrent tuberculosis in a low-incidence 
zroz", International Journal of Tubercle Lung Disease, vol. 7, pp. 145-152.
214
References
68. De Maio, J., Zhang, Y., Ko, C., & Bishai, W. R. 1997, "Mycobacterium tuberculosis 
sigF is part of a gene cluster with similarities to the Bacillus subtilis sigF and sigB 
opérons". Tubercle and Lung Disease, vol. 78, pp. 3-12.
69. De Maio, J., Zhang, Y., Ko, C., Young, D. B., & Bishai, W. R. 1996, "A stationary- 
phase stress-response sigma factor from Mycobacterium tuberculosis". Proceedings 
from the National Academy ofSciences of the United States of America, vol. 93, pp. 
2790-2794.
70. De Voss, J. J., Rutter, K., Schroeder, B. G., & Barry, C. E. 1999, "Iron acquisition 
and metabolism by mycobacteria". Journal of Bacteriology, vol. 181, pp. 4443-4451.
71. Deghmane, A. E., Soualhine, H., Bach, H., Sendide, K., Itoh, S., Tam, A., Noubir, S., 
Talal, A., Lo, R., Toyoshima, S., Av-Gay, Y., & Hmama, Z. 2007, "Lipoamide 
dehydrogenase mediates retention of coronin-1 on BCG vacuoles, leading to arrest in 
phagosome maturation". Journal of Cell Science, vol. 120, no. 16, pp. 2796-2806.
72. Deretic, V., Singh, S., Master, S., Harris, J., Roberts, E., Kyei, G., Davis, A., de 
Haro, S., Naylor, J., Lee, H. H., & Vergne, 1. 2006, "Mycobacterium tuberculosis 
inhibition of phagolysosome biogenesis and autophagy as a host defence 
mechanism". Cellular Microbiology, vol. 8, no. 5, pp. 719-727.
73. Desjardins, M., Nzala, N. N., Corsini, R., & Rondeau, C. 1997, "Maturation of 
phagosomes is accompanied by changes in their fusion properties and size-selective 
acquisition of solute materials from endosomes". Journal of Cell Science, vol. 110, 
no. 18, pp. 2303-2314.
74. Desjardins, M. 1995, "Biogenesis of phagolysosomes: the 'kiss and run' hypothesis". 
Trends in Cell Biology, vol. 5, pp. 183-186.
75. Desjardins, M., Celis, J. E., Van Meer, G., Dieplinger, H., Jahraus, A., Griffiths, G., 
& Huber, L. A. 1994, "Molecular characterisation of phagosomes". The Journal of 
Biological Chemistry, vol. 269, no. 51, pp. 32194-32200.
76. Dietrich, G., Vivet, J. F., & Hess, J. 2003, "Novel vaccination strategies based on 
rQQorrA>m2miMycobacterium bovis BCG", International Journal of Medical 
Microbiology, vol. 292, pp. 441-451.
77. Dominguez-Bemal, G., Tierrez, A., Bartolomé, A., Martinez-Pulgarin, S., Salguero,
F. J., Antonio Orden, J., & de la Fuente, R. 2008, "Salmonella enterica serovar 
Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes are 
attenuated in pigs, and survive and multiply in porcine iutestinal macrophages and 
fibroblasts, respectively". Veterinary Microbiology, vol. 130, no. 3-4, pp. 298-311.
78. Drecktrah, D., Knodler, L. A., Howe, D., & Steele-Mortimer, O. 2007, "Salmonella 
trafficking is defined by continuous dynamic interactions with the endolysosomal 
system". Traffic, vol. 8, pp. 212-225.
215
References
79. Duclos, S., Corsini, R., & Desjardins, M. 2003, "Remodeling of endosomes during 
lysosome biogenesis involves kiss and run' fusion events regulated by rabS", Journal 
of Cell Science, vol. 116, no. 5, pp. 907-918.
80. Edwards, K. M., Cynamon, M. H., Voladri, R. K., Hager, C. C., DeStefano, M. S., 
Tham, K. T., Lakey, D. L., Bochan, M. R., & Kemodle, D. S. 2001, "Iron-cofactored 
superoxide dismutase inhibits host responses to Mycobacterium tuberculosis", 
American Journal of Respiratory and Critical Care Medicine, vol. 164, pp. 2213- 
2219.
81. Ehlers, M. R. W. & Daffé, M. 1998, "Interactions hotsNQonMycobacterium 
tuberculosis and host cells: are mycobacterial sugars the key?". Trends in 
Microbiology, vol. 6, no. 8, pp. 328-335.
82. Eisenhut, M., Paranjothy, S., Abubakar, 1., Bracebridge, S., Lilley, M., Mulla, R., 
Lack, K., Chalkley, D., & McEvoy, M. 2009, "BCG vaccination reduces risk of 
infection vfith Mycobacterium tuberculosis as detected by gamma interferon release 
assay". Vaccine, vol. 27, no.44, pp. 6116-6120.
83. Erill, 1., Campoy, S., & Barbé, J. 2007, "Aeons of distress: an evolutionary 
perspective on die bacterial SOS response", FEMS Microbiology Reviews, vol. 31, 
no. 6, pp. 637-656.
84. Ernst, J. D. 1998, "Macrophage receptors for Mycobacterium tuberculosis". Infection 
and Immunity, \o\. 66, pp. 1277-1281.
85. Ewann, F., Jackson, M., Pethe, K., Cooper, A., Mielcarek, D., Ensergueix, B., 
Gicquel, B., Locht, C., & Supply, P. 2002, "Transient requirement of the PrrA-PrrB 
two-component system for early intracellular multiphcation of Mycobacterium 
tuberculosis". Infection and Immunity, vol. 70, pp. 2256-2263.
86. Ewer, K., Deeks, J., Alvarez, L., Bryant, G., Waller, S., Andersen, P., Monk, P., & 
Lalvani, A. 2003, "Comparison of T-cell-based assay with tuberculin skin test for 
diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis 
outbreak". Lancet, vol. 361, pp. 1168-1173.
87. Fairbaim, 1. P., Stober, C. B., Kumararatne, D. S., & Lammas, D. A. 2001, "ATP- 
mediated killing of intracellular mycobacteria by macrophages is a P2X7-dependent 
process inducing bacterial death by phagosome-lysosome fusion". The Journal of 
Immunology, vol. 167, no. 6, pp. 3300-3307.
88. Falkow, S. 1988, "Molecular Koch's postulates applied to microbial pathogenicity". 
Reviews of Infectious Disease, vol. 10, Suppl. 2, pp. S274-276.
89. Fattorini, L., Migliori, G. B., & Cassone, A. 2007, "Extensively drug-resistant (XDR) 
tuberculosis: an old and new threat", Annali delVInstituto Superiore di Sanita, vol.
43, no. 4, pp. 317-319.
216
References
90. Feng, Y., Press, B., & Wandinger-Ness, A. 1995, "Rab7: an important regulator of 
late endocytic membrane traffic". The Journal of Cell Biology, vol. 131, no. 6, pp. 
1435-1452.
91. Fenton, M. J. & Vermeulen, M. W. 1996, "Immunopathology of tuberculosis: roles 
of macrophages and monocytes". Infection and Immunity, vol. 64, no. 3, pp. 683-690.
92. Ferrari, G. 1999, "A coat protein on phagosomes involved in the intracellular survival 
of mycobacteria". Cell, vol. 97, pp. 435-447.
93. Fine, P. E. 2001, "BCG: the challenge continues", Scandinavian Journal of Infectious 
Diseases, vol. 33, no. 4, pp. 243-245.
94. Fisher, M. A., Plikaytis, B. B., & Shinnick, T. M. 2002, "Microarray analysis of the 
Mycobacterium tuberculosis transcriptional response to the acidic conditions found 
in phagosomes", Jowma/ of Bacteriology, vol. 184, no. 14, pp. 4025-4032.
95. Fontan, P. A., Aris, V., Alvarez, M. E., Ghanny, S., Cheng, J., Soteropoulos, P., 
Trevani, A., Pine, R., & Smith, 1.2008, "Mycobacterium tuberculosis sigma factor E 
regulon modulates the host inflammatory response". The Journal of Infectious 
Diseases, vol. 198, no. 6, pp. 877-885.
96. Fozo, E. M., Hemm, M. R., & Storz, G. 2008, "Small toxic proteins and the antisense 
RNAs that repress them". Microbiology and Molecular Biology Reviews, vol. 72, no. 
4, pp. 579-589.
97. Fratti, R. A., Chua, J., Vergne, L, & Deretic, V. 2003, "Mycobacterium tuberculosis 
glycosylated phosphatidylinositol causes phagosome maturation arrest.".
Proceedings of the National Academy of Sciences of the United States of America, 
vol. 100, pp. 5437-5442.
98. Fratti, R. A., Backer, J. M., Gruenberg, J., Corvera, S., & Deretic, V. 2001, "Role of 
phosphotidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and 
mycobacterial phagosome maturation arrest". The Journal of Cell Biology, vol. 154, 
no. 3, pp. 631-644.
99. Frehel, C., Chastellier, C., Lang, T., & Rastogi, N. 1986, "Evidence for inhibition of 
fusion of lysosomal and prelysosomal compartments with phagosomes in 
macrophages infected with pathogenic Mycobacterium avium". Infection and 
Immunity, vol. 52, pp. 252-262.
100. Frischkom, K., Sander, P., Scholz, M., Teschner, K., Prammananan, T., & 
Bottger, E. C. 1998, "Investigation of mycobacterial recA function: protein introns in 
the RecA of pathogenic mycobacteria do not affect competency for homologous 
iQQOVcAimziion", Molecular Microbiology, vol. 29, no. 5, pp. 1203-1214.
217
References
101. Gaillot, O., Pellegrini, E., Bregenholt, S., Nair, S., & Berche, P. 2000, "The 
ClpP serine protease is essential for the intracellular parasitism and virulence of 
Listeria monocytogenes.". Molecular Microbiology, vol. 35, no. 6, pp. 1286-1294.
102. Garhe, T. R., Hilbler, N. S., & Deretic, V. 1996, "Response of 
Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates.". 
Molecular Medicine, vol. 2, no. 1, pp. 134-142.
103. Gebhard, S., Humpel, A., McLellan, A. D., & Cook, G. M. 2008, "The 
alternative sigma factor SigF of Mycobacterium smegmatis is required for survival of 
heat shock, acidic pH and oxidative stXQSs", Microbiology, vol. 154, no. 9, pp. 2786- 
2795.
104. Geiman, D. E., Kaushal, D., Ko, C., Tyagi, S., Manabe, Y. C., Schroeder, B.
G., Fleischmann, R. D., Morrison, N. E., Converse, P. J., Chen, P., & Bishai, W. R. 
2004, "Attenuation of late-stage disease in mice infected by the Mycobacterium 
tuberculosis mutant lacking the SigF alternate sigma factor and identification of 
SigF-dependent genes by microarray analysis". Infection and Immunity, vol. 72, no.
3, pp. 1733-1745.
105. Geiman, D. E., Ra^unand, T. R., Agarwal, N., & Bishai, W. R. 2006, 
"Differential gene expression in response to exposure to antimycobacterial agents 
and other stress conditions among sovon. Mycobacterium tuberculosis whiB-like 
gQiiQs", Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2836-2841.
106. Gerdes, K. 2000, "Toxin-Antitoxin Modules May Regulate Synthesis of 
Macromolecules during Nutritional Stxtss",J.Bacteriol, vol. 182, no. 3, pp. 561-572.
107. Gerischer, U. 2002, "Specific and global regulation of genes associated with 
the degradation of aromatic compounds in bacteria". Journal o f Molecular 
Microbiology and Biotechnology, vol. 4, no. 2, pp. 111-121.
108. Gillooly, D. J., Morrow, 1. C., Lindsay, M., Gould, R., Bryant, N. J., GauUier, 
J., Parton, R. G., & Stenmark, H. 2000, "Localisation of phosphatidylinositol 3- 
phosphate in yeast and mammalian cells". The European Molecular Biology 
Organisation Journal, vol. 19, pp. 4577-4588.
109. Glickman, M., Cox, J., & Jacobs, W. R. Jr. 2000, "A novel mycolic acid 
cyclopropane synthetase is required for cording, persistence, and virulence of 
Mycobacterium tuberculosis". Molecular Cell, vol. 5, no. 4, pp. 717-727.
110. Gomez, J. E. & McKinney, J. D. 2004, "M. tuberculosis persistence, latency 
and drug tolerance". Tuberculosis, vol. 84, pp. 29-44.
111. Gomez, M., Doukhan, L., Nair, G., & Smith, 1.1998, " sigA is an essential 
gene in Mycobacterium smegmatis", Molecular Microbiology, vol. 29, pp. 617-628.
218
References
112. Gordhan, B. G., Smith, D. A., Alderton, H., McAdam, R. A., Bancroft, G. J., 
& Mizrahi, V. 2002, "Construction and phenotypic characterization of an auxotrophic 
mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis".
Infection and Immunity, vol. 70, no. 6, pp. 3080-3084.
113. Gould, T. A., van de Langemheen, H., Munoz-Elias, E. J., McKinney, J. D.,
& Sacchettini, J. C. 2006, "Dual role of isocitrate lyase 1 in the glyoxylate and 
methylcitrate cycles'm Mycobacterium tuberculosis", Molecular Microbiology, vol. 
61, no. 4, pp. 940-947.
114. Grange, J. M. 1996, Mycobacteria and Human Disease, 2nd edn, Oxford 
University Press, New York.
115. Guilhot, C., Jackson, M., & Gicquel, B. 1999, "Mobile genetic elements and 
plasmids: tools for genetic studies," m Mycobacteria: Molecular Biology and 
Virulence, C. Ratledge & J. Dale, eds., Blackwell Publishing, pp. 17-37.
116. Hamer, L., DeZwaan, T. M., Montenegro-Chamorro, M. V., Frank, S. A., & 
Hamer, J. E. 2001, "Recent advances in large-scale transposon mutagenesis". Current 
Opinion in Chemical Biology, vol. 5, no. 1, pp. 67-73.
117. Hao, M., & Maxfield, F.R. 2000, "Characterisation of rapid membrane 
intemahsation and recycling," The Journal of Biological Chemistry, vol. 275, pp. 
15279-15286.
118. Harries, A. D. & Dye, C. 2006, "Tuberculosis", Annals of Tropical Medicine 
and Parasitology, vol. 100, no. 5-6, pp. 415-431.
119. Hart, P. D. 1967, "Efficacy and applicability of mass BCG vaccination in 
tuberculosis control", British Medical Journal, vol. 1, pp. 587-592.
120. Henry, R. M., Hoppe, A. D., Joshi, N., & Swanson, J. A. 2004, "The 
uniformity of phagosome maturation in macrophages". The Journal of Cell Biology, 
vol. 164, no. 2, pp. 185-194.
121. Hensel, M., Shea, J. E., Gleeson, C., Jones, M. D., Dalton, E., & Holden, E.
W. 1995, "Simultaneous identification of bacterial virulence genes by negative 
selection". Science, vol. 269, pp. 400-403.
122. Hestvik, A. L. K., Hmama, Z., & Av-Gay, Y. 2005, "Mycobacterial 
manipulation of the host cell", FEMS Microbiology Reviews, vol. 29, pp. 1041-1050.
123. Hill, P. C., Brookes, R. H., Fox, A., Jackson-Sillah, D., Jeffiies, D. J., Lugos, 
M. D., Donkor, S. A., Adetifa, 1. M., de Jong, B. C., Aiken, A. M., Adegbola, R. A.,
& McAdam, K. P. 2007, "Longitudinal assessment of an ELISPOT test for 
Mycobacterium tuberculosis infection", PLoS Pathogens, vol. 4, no. 6, pp. 1061- 
1070.
219
References
124. Hinds, J., Mahenthiralingamn, E., Kempsell, K. E., Dunacan, K., Stokes, R. 
W., Parish, T., & Stoker, N. G. 1999, "Enhanced gene replacement in mycobacteria". 
Microbiology, vol. 145, pp. 519-527.
125. Hmama, Z., Gabathuler, R., Jefferies, W. A., de Jong, G., & Reiner, N. E. 
1998, "Attenuation of HLA-DR expression by mononuclear phagocytes infected with 
Mycobacterium tuberculosis is related to intracellular sequestration of immature class 
n  heterodimers". The Journal of Immunology, vol. 161, pp. 4882-4893.
126. Hochberg, Y. & Benjamini, Y. 1990, "More powerful procedures for multiple 
significance testing". Statistics in Medicine, vol. 9, no. 7, pp. 808-811.
127. Hoener Zu Bentrup, K., Miczak, A., Swenson, D. L., & Russell, D. G. 1999, 
"Characterization of activity and expression of isocitrate lyase in Mycobacterium 
avium znà Mycobacterium tuberculosis". Journal of Bacteriology, vol. 181, pp. 
7161-7167.
128. Hoppe, H. C., Dewet, B. J. M., CyvfQS, C., Daffe, M., & Ehlers, M. R. W. 
1997, "Identification of phosphatidylinositol mannoside as a mycobacterial adhesin 
mediating both direct and opsonic binding to nonphagocytic mammalian cells". 
Infection and Immunity, vol. 65, pp. 3896-3905.
129. Huebner, R. E., Schein, M. F., & Bass, J. B. J. 1993, "The tuberculin skin 
test". Clinical Infectious Disease, vol. 17, pp. 968-75.
130. Huffinan, J, L. & Brennan, R. G. 2002, "Prokaryotic transcription regulators: 
more than just the helix-tum-helix motif. Current Opinion in Structural Biology, 
vol. 12, no. 1, pp. 98-106.
131. Hunter, R. L., Venkataprasad, N., & Olsen, M. R. 2006, "The role of 
trehalose dimycolate (cord factor) on morphology of virulent M. tuberculosis in 
vitro". Tuberculosis, vol. 86, no. 5, pp. 349-356.
132. Hunter, S. W. & Brennan, P. J. 1990, "Evidence for the presence of a 
phosphatidylinositol anchor on the hpoaribinomannan and lipomannan of 
Mycobacterium tuberculosis". Journal of Biology and Chemistry, vol. 265, pp. 9272- 
9279.
133. Husson, R. N., James, B. E., & Young, R. A. 1990, "Gene replacement and 
expression of foreign DNA in mycobacteria". Journal of Bacteriology, vol. 172, no.
2, pp. 519-524.
134. Huynh, K. K. & Grinstein, S. 2007, "Regulation of vacuolar pH and its' 
modulation by some microbial species". Microbiology and Molecular Biology 
Reviews, vol. 71, no. 3, pp. 452-462.
135. Jackett, P. S., Andrew, P. W., Aber, V. R., & Lowrie, D. B. 1983, "Guinea 
pig alveolar macrophages probably kill M. tuberculosis H37Rv and H37Ra in vivo by
220
References
producing hydrogen peroxide". Advances in Experimental Medicine and Biology, 
vol. 162, pp. 99-104.
136. Jackson, M., Raynaud, C., Lanéelle, M.-A., Guilhot, C., Laurent-Winter, C.,
Ensergueix, D., Gicquel, B., & Daffé, M. 2002, "Inactivation of the antigen 85C gene 
profoundly affects the mycolate content and alters the permeability of the 
Mycobacterium tuberculosis cell , Molecular Microbiology, vol. 31, no. 5,
pp. 1573-1587.
137. Jeon, B. Y., Derrick, S. C., Lim, J., Kohbab, K., Dheenadhayalan, V., Yang,
A. L., Kreiswirth, B., & Morris, S. L. 2008, "Mycobacterium bovis BCG 
immunization induces protective immunity against nine àiWQVQni Mycobacterium 
tuberculosis strains in mice". Infection and Immunity, vol. 76, no. 11, pp. 5173-5180.
138. Kalpana, G. V., Bloom, B., & Jacobs, W. R. Jr. 1991, "Insertional 
mutagenesis and illegitimate recombination in mycobacteria". Proceedings from the 
National Academy of Sciences of the United States of America, vol. 88, pp. 5433- 
5437.
139. Kana, B. D. & Mizrahi, V. 2004, "Molecular genetics of Mycobacterium 
tuberculosis in relation to the discovery of novel drugs and vaccines". Tuberculosis, 
vol. 84, pp. 63-75.
140. Kana, B. D., Weinstein, E. A., Avarbock, D., Dawes, S. S., Rubin, H., & 
Mizrahi, V. 2001, "Characterization of the cydAB-encoded cytochrome bd oxidase 
from Mycobacterium smegmatis". The Journal of Bacteriology, vol. 183, no. 24, pp. 
7076-7086.
141. Kar, N. P., Sikriwal, D., Rath, P., Choudhaiy, R. K., & Batra, J. K. 2008, 
"Mycobacterium tuberculosis ClpCl: characterization and role of the N-terminal 
domain in its function", FEBS Journal, vol. 275, no. 24, pp. 6149-6158.
142. Kaufmann, S. H. E. 2007, "The contribution of immunology to the rational 
design of novel antibacterial vaccines". Nature Reviews Microbiology, vol. 5, no. 7, 
pp. 491-504.
143. Kaufmann, S. H. E. 2001, "How can immunology contribute to the control of 
tuberculosis?". Nature Reviews, Immunology, vol. 1, pp. 20-30.
144. Kaushal, D., Schroeder, B. G., Tyagi, S., Yoshimatsu, T., Scott, C., Ko, C., 
Carpenter, L., Mehrotra, J., Manabe, Y. C., Fleischmann, R. D., & Bishai, W. R. 
2002, "Reduced immunopathology and mortality despite tissue persistence in a 
Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH", 
Proceedings from the National Academy of Sciences of the United States of America, 
vol. 99, no. 12, pp. 8330-8335.
221
References
145. Kelley, V. A. & Schorey, J. S. 2003, "Mycobacterium's arrest of phagosome 
maturation in macrophages requires Rab5 activity and accessibihty to iron". 
Molecular Biology of the Cell, vol. 14, pp. 3366-3377.
146. Klammt, C., Schwarz, D., Lohr, F., Schneider, B., Dotsch, V., & Bernhard, F. 
2006, "Cell-free expression as an emerging technique for the large scale production 
of integral membrane protein". The FEBS Journal, vol. 273, no. 18, pp. 4141-4153.
147. Koch, R. 1882, "Die Aetiologie der Tuberkulose", Klinische Wochenschrift 
(Berlin), vol. 19, pp. 221-230.
148. Koul, A., Choidas, A., Tyagi, A. K., Drlica, K., Singh, Y., & Ullrich, A.
2001, "Serine/threonine protein kinases PknF and PknG of Mycobacterium 
tuberculosis: characterization and locahzation". Microbiology, vol. 147, no. 8, pp. 
2307-2314.
149. Kurthkoti, K., Kumar, P., Jain, R , & Varshney, U. 2008, "Important role of 
the nucleotide excision repair pathway in Mycobacterium smegmatis in conferring 
protection against commonly encountered DNA-damaging zgonXs", Microbiology, 
vol. 154, no. 9, pp. 2776-2785.
150. Kusner, D. J. 2004, "Mechanisms of mycobacterial persistence in 
tuberculosis". Clinical Immunology, vol. 114, pp. 239-247.
151. Kusner, D. J. & Adams, J. 2000, " ATP-induced killing of virulent 
Mycobacterium tuberculosis within human macrophages requires phospholipase D", 
The Journal of Immunology, vol. 164, no. 379, p. 388.
152. Kusner, D. J. & Barton, J. A. 2001, "ATP stimulates human macrophages to 
kill intracellular vmAont Mycobacterium tuberculosis via calcium-dependent 
phagosome-lysosome frision". The Journal of Immunology, vol. 167, pp. 3308-3315.
153. Lalvani, A., Pathan, A  A., McShane, H., Wilkinson, R. J., Latif, M., Conlon,
C. P., Pasvol, G., & Hill, A. V. 2001, "Rapid detection of Mycobacterium 
tuberculosis infection by enumeration of antigen specific T cells", American Journal 
of Respiratory Critical Care Medicine, vol. 163, pp. 824-828.
154. Lambert, M.-L., Hasker, E., Van Deun, A., Roberfroid, D., Boelaert, M., & 
Van der Stuyfr, P. 2003, "Recurrence in tuberculosis: relapse or reinfection". The 
Lancet Infectious Diseases, vol. 3, pp. 282-287.
155. Lawe, D. C., Patki, V., Heller-Harrison, R., Lambright, D., & Corvera, S. 
2000, "The FYVE domain of early endosome antigen 1 is required for both 
phosphatidylinositol 3-phosphate and Rab5 binding". The Journal of Biological 
Chemistry, vol. 275, no. 5, pp. 3699-3705.
156. Le Cabec, V., Carreno, S., Moisand, A., Bordier, C., & Maridonneau-Parini,
1.2002, "Complement receptor 3 (CDl lb/CD18) mediates type 1 and type 11
222
References
phagocytosis during nonopsonic and opsonic phagocytosis, respectively". Journal of 
Immunology, vol. 169, pp. 2003-2009.
157. Lee, J.-H., Karakousis, P. C., & Bishai, W. R. 2008, "Roles of SigB and SigF 
in the Mycobacterium tuberculosis sigma factor network". Journal of Bacteriology, 
vol. 190, no. 2, pp. 699-707.
158. Lee, W. L., Kim, M. K., Schreiber, A. D., & Grinstein, S. 2005, "Role of 
ubiquitin and proteasomes in phagosome maturation". Molecular Biology of the Cell, 
vol. 16, no. 4, pp. 2077-2090.
159. Li, Z., Kelley, C., Collins, F., Rouse, D., & Morris, F. 1998, "Expression of 
katG in Mycobacterium tuberculosis is associated with its growth and persistence in 
mice and guinea pigs". Journal of Infectious Diseases, vol. 177, no. 4, pp. 1030- 
1035.
160. Lillebaek, T., Dirksen, A., Baess, 1., Strange, B., Thomsen, V. 0 ., & 
Andersen, A. B. 2002, "Molecular evidence of endogenous reactivation of 
Mycobacterium tuberculosis after 33 years of latent infection". The Journal of 
Infectious Diseases, vol. 185, pp. 401-404.
161. Lipscomb, M. F. & Masten, B. J. 2002, "Dendritic cells: immune regulators 
in health and disease". Physiological Reviews, vol. 82, pp. 97-130.
162. Lounis, N., Truffot-Pemot, C., Grosset, J., Gordeuk, V. K., & Boelaert, J. R. 
2001, "Iron znà Mycobacterium tuberculosis infection". Journal of Clinical Virology, 
vol. 20, pp. 123-126.
163. Lowrie, D. B. & Andrew, P. W. 1988, "Macrophage antimycobacterial 
mechanisms", British Medical Bulletin, vol. 44, no. 3, pp. 624-634.
164. Ludwig, T., Griffiths, G., & Hoflack, B. 1991, "Distribution of newly 
synthesised lysosomal enzymes in the endocytic pathway of normal rat kidney cells". 
Journal of Cell Biology, vol. 115, no. 6, pp. 1561-1572.
165. Luo, M., Fadeev, E. A., & Groves, J. T. 2005, "Mycobactin-mediated iron 
acquisition within macrophages". Nature Chemical Biology, vol. 1, no. 3, pp. 149-
153.
166. Madigan, M. & Martinko, J. 2005, Brock Biology of Microorganisms, 11 edn, 
Prentice Hall.
167. Malik, S. A., Denning, G. M., & Kusner, D. J. 2000, "Inhibition of Ca^  ^
signalling hy Mycobacterium tuberculosis is associated vrith reduced phagosome- 
lysosome fusion and increased survival within human macrophages". Journal of 
Experimental Medicine, vol. 191, no. 2, pp. 287-302.
223
References
168. Malik, Z. A., Iyer, S. S., & Kusner, D. J. 2001, "Mycobacterium tuberculosis 
phagosomes exhibit altered calmodulin-dependent signal transduction: contribution 
to inhibition of phagosome-lysosome fusion and intracellular survival in human 
macrophages". The Journal of Immunology, vol. 166, pp. 3392-4001.
169. Malik, Z. A., Thompson, C. R., Hashimi, S., Porter, B., Iyer, S. S., & Kusner,
D. J. 2003, "Cutting edge: Mycobacterium tuberculosis blocks Ca^  ^signaling and 
phagosome maturation in human macrophages via specific inhibition of sphingosine 
fJnzsQ.", Journal of Immunology, vol. 170, no. 6, pp. 2811-2815.
170. Manabe, Y. C., Saviola, B. J., Sun, L., Murphy, J. R., & Bishai, W. R. 1999a, 
"Attenuation of virulence m Mycobacterium tuberculosis expressing a constitutively 
active iron repressor". Proceedings from the National Academy of Sciences of the 
United States of America, vol. 96, pp. 12844-12848.
171. Manabe, Y. C., Chen, J. M., Ko, C. G., Chen, P., & Bishai, W. R. 1999b, 
"Conditional sigma factor expression, using the inducible acetamidase promoter, 
reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 
16-Kilodalton alpha-crystallin homologue". The Journal of Bacteriology, vol. 181, 
no. 24, pp. 7629-7633.
172. Manganelh, R., Dubnau, E., Tyagi, S., Kramer, F. R., & Smith, 1 .1999, 
"Differential expression of 10 sigma factor genes ‘m Mycobacterium tuberculosis". 
Molecular Microbiology, vol. 31, no. 2, pp. 715-724.
173. Manganelh, R., Fattorini, L., Tan, D., Iona, E., Orefici, G., Altavilla, G., 
Cusatelli, P., & Smith, I. 2004a, "The extra cytoplasmic function sigma factor cr^  is 
essential for Mycobacterium tuberculosis virulence in mice". Infection and Immunity, 
vol. 72, pp. 3038-3041.
174. Manganelh, R., Prowedi, R., Rodrigue, S., Beaucher, J., Gaudreau, L., & 
Smith, 1.2004b, "a factors and global gene regulation in Mycobacterium 
tuberculosis". The Journal of Bacteriology, vol. 186, no. 8, p. 2516.
175. Manganelh, R., Voskuil, M. I., Schoolnik, G. K., & Smith, 1.2001, "The 
Mycobacterium tuberculosis ECF sigma factor a :^ role in global gene expression and 
survival in macrophages". Molecular Microbiology, vol. 41, no. 2, pp. 423-437.
176. Mariani, F. & Cohzzi, V. 2005, "How Mycobacterium tuberculosis 
orchestrates its "environment-sensing" to survive in human macrophages.
Comparison of the MTB transcriptomes in different growth conditions to select 
infection-associated genes for a new TB vaccine.". Recent research developments in 
genes and genomes, vol. 1, pp. 61-82.
177. Martens, G. W., Arikan, M. C., Lee, J., Ren, F., Vallerskog, T., & Komfeld,
H. 2008, "Hypercholesterolemia impairs immunity to tuberculosis". Infection and 
Immunity, vol. 76, no. 8, pp. 3464-3472.
224
References
178. McAdam, R. A., Weisbrod, T. R., Martin, J., Scuderi, J. D., Brown, A. M., 
Cirillo, J. D., Bloom, B., & Jacobs, W. R. Jr. 1995, "In vivo growth characteristics of 
leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated 
by transposon mutagenesis". Infection and Immunity, vol. 63, pp. 1004-1012.
179. McAdam, R. A., Quan, S., Smith, D. A., Bardarov, S., Betts, J. C., Cook, F. 
C., Hooker, E. U., Lewis, A. P., Woollard, P., Everett, M. J., Lukey, P. T., Bancroft, 
G. J., Jacobs, W. R. Jr., & Duncan, K. 2002, "Characterisation of z Mycobacterium 
tuberculosis H37Rv transposon hbrary reveals insertions in 351 ORFs and mutants 
with altered virulence". Microbiology, vol. 148, pp. 2975-2986.
180. McDonough, K. A., Kress, Y., & Bloom, B. R. 1993, "Pathogenesis of 
tuberculosis: interaction of Mycobacterium tuberculosis with macrophages".
Infection and Immunity, vol. 61, no. 7, pp. 2763-2773.
181. McFadden, J. 1996, "Recombination in mycobacteria". Molecular 
Microbiology, vol. 21, pp. 205-211.
182. McGrath, P. T., Lee, H., Zhang, L., Iniesta, A. A., Hottes, A. K., Tan, M. H., 
Hillson, N. J., Hu, P., Shapiro, L., & McAdams, H. H. 2009, "High-throughput 
identification of transcription start sites, conserved promoter motifs and predicted 
régulons.". Nature Biotechnology, vol. 25, no. 5, pp. 584-592.
183. McKinney John D, Bentrup, K. H. z., Munoz-Elias, E. J., Miczak, A., Chen, 
B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R. Jr., & Russell, D. G. 
2000, "Persistence of Mycobacterium tuberculosis in macrophages and mice requires 
the glyoxylate shunt enzyme isocitrate lyase". Nature, vol. 406, pp. 735-738.
184. McKinney, J. D. 2000, "In vivo veritas: The search for TB drug targets goes 
live". Nature Medicine, vol. 6, no. 12, pp. 1330-1333.
185. Mellman, 1., Fuchs, R., & Helenius, A. 1986, "Acidification of the endocytic 
and exocytic pathways". Annual Review of Biochemistry, vol. 55, pp. 663-700.
186. Michele, T. M., Ko, C., & Bishai, W. R. 1999, "Exposure to antibiotics 
induces expression of the Mycobacterium tuberculosis sigF gene: implications for 
chemotherapy against mycobacterial persistors". Antimicrobial Agents and 
Chemotherapy, vol. 43, no. 2, pp. 218-225.
187. Miles, A. A. & Misra, S. S. 1938, Journal of Hygiene, vol. 38, p. 732.
188. Mizrahi, V. & Andersen, S. J. 1998, "DNA repair in Mycobacterium 
tuberculosis. What have we learnt from the genome sequence?". Molecular 
Microbiology, vol. 29, no. 6, pp. 1331-1339.
189. Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R., & North, R. J. 2001, 
"The relative importance of T cell subsets in immunity and immunopathology of
225
References
airborne Mycobacterium tuberculosis infection in mice". The Journal of 
Experimental Medicine, vol. 193, no. 3, pp. 271-280.
190. Moyo, V. M., Gangaidzo, I. T., Gordeuk, V. R., Kiire, C. F., & Macphail, A. 
P. 1997, "Tuberculosis and iron overload in Africa: a review". The Central African 
Journal of Medicine, vol. 43, pp. 334-339.
191. Mukamolova, G. V., Kaprelyants, A. S., Young, D. I., Young, M., & Kell, D.
B. 1998, "Abacterial cytokine". Proceedings of the National Academy of Sciences of 
the United States of America, vol. 95, no. 15, pp. 8916-8921.
192. Munoz-Elias, E. J. & McKinney, J. D. 2005, "M tuberculosis isocitrate lyases
1 and 2 are jointly required for in vivo growth and virulence". Nature Medicine, vol. 
11, no. 6, pp. 638-644.
193. Munoz-Elias, E. J., Upton, A. M., Cherian, J., & McKinney, J. D. 2006, "Role
of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular 
growth, and vimlence". Molecular Microbiology, vol. 60, no. 5, pp. 1109-1122.
194. Murphy, R. F. 1991, "Maturation models for endosome and lysosome 
biogenesis". Trends in Cell Biology, vol. 1, no. 4, pp. 77-82.
195. Mwandumba, H. D., Russell, D. G., Nyirenda, M. H., Anderson, J., White, S. 
A., Molyneux, M. E., & Squire, S. B. 2004, "Mycobacterium tuberculosis resides in 
nonacidified vacuoles in endocytically competent alveolar macrophages from 
patients with tuberculosis and HIV infection". The Journal of Immunology 4592- 
4598.
196. Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D., & McKinney, J. D.
2004, "Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering 
the phagocyte oxidative burst ", Molecular Microbiology, vol. 52, no. 5, pp. 1291- 
1302.
197. Norman, E., Dellagostin, O. A., McFadden, J., & Dale, J. W. 1995, "Gene 
replacement by homologous recombination in Mycobacterium bovis BCG", 
Molecular Microbiology, vol. 16, pp. 755-760.
198. Noss, E. H., Harding, C. V., & Boom, W. H. 2000, "Mycobacterium 
tuberculosis inhibits MHC class n  antigen processing in murine bone marrow 
macrophages". Cellular Immunology, vol. 201, pp. 63-74.
199. Oh, Y.-K. & Straubinger, R. M. 1996, "Intracellular fate of Mycobacterium 
avium: use of dual-label spectrofluorometiy to investigate the influence of bacterial 
viability and opsonisation on phagosomal pH and phagosome-lysosome interaction". 
Infection and Immunity, vol. 64, no. 1, pp. 319-325.
226
References
200. Pandey, D. P. & Gerdes, K. 2005, "Toxin-antitoxin loci are highly abundant 
in free-living but lost from host-associated prokaryotes". Nucleic Acids Research, 
vol. 33, no. 3, pp. 966-976.
201. Pang, X. & Howard, S. T. 2007, "Regulation of the a-crystallin gene acr2 by 
the MprAB two-component system of Mycobacterium tuberculosis". The Journal of 
Bacteriology, vol. 189, no. 17, pp. 6213-6221.
202. Parish, T., Smith, D. A., Kendall, S., Casali, N., Bancroft, G. J., & Stoker, N. 
G. 2003, "Deletion of two-component regulatory systems increases the virulence of 
Mycobacterium tuberculosis", Infection and Immunity, vol. 71, no. 3, pp. 1134-1140.
203. Park, H. D., Guinn, K. M., Harrell, M. L, Liao, R., Voskuil, M. L, Tompa, M., 
Schoolnik, G. K., & Sherman, D. R. 2003, "Rv3133c/dosR is a transcription factor 
that mediates the hypoxic response of Mycobacterium tuberculosis", Molecular 
Microbiology, vol. 48, no. 3, pp. 833-843.
204. Parlati, P., Varlamov, O., Paz, K., McNew, J. A., Hurtado, D., Sollner, T. H., 
& Rothman, J. E. 2002, "Distinct SNARE complexes mediating membrane ftision in 
Golgi transport based on combinatorial specificity". Proceedings from the National 
Academy of Sciences of the United States o f America, vol. 99, pp. 5424-5429.
205. Pehcic, V., Reyrat, J.-M., & Gicquel, B. 1996, "Expression of the Bacillus 
subtilis sacB gene confers sucrose sensitivity in mycobacteria". Journal of 
Bacteriology, vol. 178, no. 4, pp. 1197-1199.
206. Pehcic, V., Jackson, M., Reyrat, J.-M., Jacobs, W. R. Jr., Gicquel, B., & 
Guilhot, C. 1997, "Efficient allelic exchange and transposon mutagenesis in 
Mycobacterium tuberculosis". Proceedings from the National Academy of Sciences 
of the United States of America, vol. 94, pp. 10955-10960.
207. Perez, E., Samper, S., Bordas, C., Guilhot, C., Gicquel, B., & Martin, C.
2001, "An essential role forphoP in Mycobacterium tuberculosis virulence". 
Molecular Microbiology, vol. 41, pp. 179-187.
208. Pethe, K., Swenson, D. L., Alonso, S., Anderson, J., Wang, C., & Russell, D. 
G. 2004, "Isolation of Mycobacterium tuberculosis mutants defective in the arrest of 
phagosome maturation". Proceedings from the National Academy of Sciences of the 
United States of America, vol. 101, no. 37, pp. 13642-13647.
209. Potuckova, L., Kelemen, G. H., Findlay, K. C., Lonetto, M. A., Buttner, M.
J., & Kormanec, J. 1995, "A new RNA polymerase sigma factor, sigma F, is required 
for the late stages of morphological differentiation in Streptomyces spp". Molecular 
Microbiology, vol. 17, no. 1, pp. 37-48.
210. Primm, T. P., Andersen, S. J., Mizrahi, V., Avarbock, D., Rubin, H , & Barry,
C. E. 2000, "ITie stringent response of Mycobacterium tuberculosis is required for 
long-term survival". Journal of Bacteriology, vol. 182, no. 17, pp. 4889-4898.
227
References
211. Purkayastha, A., McCue, L. A., & McDonough, K. A. 2002, "Identification of 
z Mycobacterium tuberculosis putative classical nitroreductase gene whose 
expression is coregulated with that of the acr gene within macrophages, in standing 
versus shaking cultures, and under low oxygen conditions", Infectlmmun., vol. 70, 
no. 3, pp. 1518-1529.
212. Qamra, R., Srinivas, V., & Mande, S. C. 2004, "Mycobacterium tuberculosis 
GroEL homologues unusually exist as lower oligomers and retain the ability to 
suppress aggregation of substrate proteins", Jowrwa/ of Molecular Biology, vol. 342, 
no. 2, pp. 605-617.
213. Raja, A. 2004, "Immunology of tuberculosis". The Indian Journal of Medical 
Research, vol. 120, no. 4, pp 213-232.
214. Raman, S., Hazra, R., Dascher, C. C., & Husson, R. N. 2004, "Transcription 
regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its 
role in virulence". The Journal of Bacteriology, vol. 186, no. 19, pp. 6605-6616.
215. Raman, S., Song, T., Puyang, X., Bardarov, S., Jacobs, W. R., Jr., & Husson, 
R. N. 2001, "The alternative sigma factor SigH regulates major components of 
oxidative and heat stress responses in Mycobacterium tuberculosis". The Journal of 
Bacteriology, vol. 183, no. 20, pp. 6119-6125.
216. Ramos, J. L., Martinez-Bueno, M., Molina-Henares, A. J., Teran, W., 
Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., & Tobes, R. 2005, "The 
TetR family of transcriptional xqçxqssoîs" , Microbiology and Molecular Biology 
Reviews, vol. 69, no. 2, pp. 326-356.
217. Rand, L., Hinds, J., Springer, B., Sander, P., Buxton, R. S., & Davis, E. O. 
2003, "The majority of inducible DNA repair genes m Mycobacterium tuberculosis 
are induced independently of RecA", Molecular Microbiology, vol. 50, no. 3, pp. 
1031-1042.
218. Ratledge, C. 2004, "Iron, mycobacteria and tuberculosis". Tuberculosis, vol. 
84, pp. 110-130.
219. Raupach, B. & Kaufinann, S. H. E. 2001, "Immune responses to intracellular 
bacteria". Current Opinion in Immunology, vol. 13, pp. 417-428.
220. Rengarajan, J., Bloom, B. R., & Rubin, E. J. 2005, "Genome-wide 
requirements fox Mycobacterium tuberculosis adaptation and survival in 
macrophages". Proceedings of the National Academy of Sciences of the United States 
of America, vol. 102, no. 23, pp. 8327-8332.
221. Reyrat, J.-M., Berthet, P., & Gicquel, B. 1995, "The urease locus of 
Mycobacterium tuberculosis and its utilisation for the demonstration of allelic 
exchange m Mycobacterium bovis bacillus Calmette-Guerin. ", Proceedings from the
228
References
National Academy of Sciences of the United States of America, vol. 92, pp. 8768- 
8772.
222. Reyrat, J. M., Pelicic, V., Gicquel, B., & Rappuoli, R. 1998, 
"Counterselectable markers: untapped tools for bacterial genetics and pathogenesis". 
Infection and Immunity, vol. 66, no. 9, pp. 4011-4017.
223. Rickman, L., Scott, C., Hunt, D. M., Hutchinson, T., Menéndez, M. C., 
Whalan, R., Hinds, J., Colston, M. J., Green, J., & Buxton, R. S. 2005, "A member of 
the cAMP receptor protein family of transcription regulators in Mycobacterium 
tuberculosis is required for virulence in mice and controls transcription of the rpfA 
gene coding for a resuscitation promoting factor". Molecular Microbiology, vol. 56, 
no. 5, pp. 1274-1286.
224. Robson, J., McKenzie, J. L., Oursons, R., Cook, G. M., & Arcus, V. L. 2009, 
"The vapBC operon ûom Mycobacterium smegmatis is an autoregulated toxin- 
antitoxin module that controls growth via inhibition of translation.", Journal of 
Molecular Biology, vol. 390, no. 3, pp. 353-367.
225. Rohde, K., Yates, R. M., Purdy, G. E., Russell, D. G. 2007, "Mycobacterium 
tuberculosis and the environment within the phagosome". Immunological Reviews, 
vol. 219, no. 1, pp. 37-54.
226. Rothel, J. S. & Andersen, P. 2005, "Diagnosis ofXzieni Mycobacterium 
tuberculosis infection: is the demise of the Mantoux test imminent?". Expert Review 
of Anti-infective Therapy, vol. 3, no. 6, pp. 981-993.
227. Russell, D. G. 2003, "Phagosomes, fatty acids and tuberculosis". Nature Cell 
Biology, vol. 5, no. 9, pp. 776-778.
228. Russell, D. G. 2001, "Mycobacterium tuberculosis: here today, and here 
tomorrow". Nature Reviews. Molecular Cell Biology, vol. 2, pp. 1-9.
229. Rustad, T. R., Harrell, M. I , Liao, R., & Sherman, D. R. 2008, "The enduring 
hypoxic response of Mycobacterium tuberculosis.", PLoS ONE, vol. 3, no. 1, p. 
el502.
230. Saida, P., Uzan, M., Odaert, B., & Bontems, F. 2006, "Expression of highly 
toxic genes in E. coli: special strategies and genetic tools". Current Protein and 
Peptide Science, vol. 7, no. 1, pp. 47-56.
231. Sassetti, C. M. & Rubin, E. J. 2003, "Genetic requirements for mycobacterial 
survival during infection". Proceedings from the National Academy of Sciences of the 
United States of America, vol. 100, no. 22, pp. 12989-12994.
232. Sassetti, C. M., Boyd, D. H., & Rubin, E. J. 2001, "Comprehensive 
identification of conditionally essential genes in mycobacteria". Proceedings from
229
References
the National Academy of Sciences of the United States of America, vol. 98, no. 22, 
pp. 12712-12717.
233. Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H., & Russell, D. G. 
1998, "Cytokine activation leads to acidification and increases maturation of 
Mycobacterium avmw-containing phagosomes in murine macrophages.", JoMwa/ of 
Immunology, vol. 160, no. 3, pp. 1290-1296.
234. Schlesinger, L. S., Bellinger-Kawahara, C. G., Payne, N. R., & Horwitz, M. 
A. 1990, "Phagocytosis o îMycobacterium tuberculosis is mediated by human 
monocyte complement receptors and complement component C3", Journal of 
Immunology, vol. 144, pp. 2771-2780.
235. Schlesinger, L. S., Hull, S. R., & Kaufinan, T. M. 1994, "Binding of the 
terminal mannosyl units of lipoarabinomannan from a virulent strain of 
Mycobacterium tuberculosis to human macrophages". Journal of Immunology, vol. 
152, pp. 4070-4079.
236. Schlesinger, P. H. 1994, "Measuring the pH of pathogen-containing
phagosomes", in Cell Biology, vol. 45, pp. 289-311.
237. Schluger, N. W. 2001, "Recent advances in our understanding of human host 
responses to tuberculosis". Respiratory Research, vol. 2, pp. 157-163.
238. Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan,
I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., & Schoolnik, G. K. 2003, 
"Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: 
insights into the phagosomal environment". The Journal of Experimental Medicine, 
vol. 198, no. 5, pp. 693-704.
239. Schneider, C. Z., Parish, T., Basso, L. A., & Santos, D. S. 2008, "The two 
chorismate mutases from hoik Mycobacterium tuberculosis m é Mycobacterium 
smegmatis: biochemical analysis and limited regulation of promoter activity by 
aromatic amino acids". The Journal of Bacteriology, vol. 190, no. 1, pp. 122-134.
240. Schuller, S., NeeÇes, J., Ottenhoff, T., Thole, J., & Young, D. 2001, "Coronin 
is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in 
phagosome maintenance". Cellular Microbiology, vol. 3, no. 12, pp. 785-793.
241. Selwyn, P. A., Hartel, D., Lewis, V. A , Schoenbaum, E. E., Vermund, S. H., 
Klein, R. S., Walker, A. T., & Friedland, G. H. 1989, "Prospective study of the risk 
of tuberculosis among intravenous drug users with human immunodeficiency virus 
infection", JoMZ72ûf/ of Medicine, vol. 120, no. 9, pp. 545-550.
242. Seto, S., Matsumoto, S., Ohta, I., Tsujimura, K., & Koide, Y. 2009, 
"Dissection of Rab7 locahsation on Mycobacterium tuberculosis phagosome" 
Biochemical and Biophysical Research Communications, vol. 387, no. 2, pp. 272- 
277.
230
References
243. Sherman, D. R., Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., & 
Smith, S. 2004, "Mycobacterium tuberculosis H37Rv:ARDl is more virulent thanM 
bovis Bacille Calmette-Guerin in long-term murine infection". The Journal of 
Infectious Diseases, vol. 190, no. 1, pp. 123-126.
244. Sherman, D. R., Voskuil, M., Schnappinger, D., Liao, R., Harrell, M. I., & 
Schoolnik, G. K. 2001, "Regulation of ihs Mycobacterium tuberculosis hypoxic 
response gene encoding a-crystallin". Proceedings of the National Academy of 
Sciences of the United States of America, vol. 98, no. 13, pp. 7534-7539.
245. Shi, L., Jung, Y.-J., Tyagi, S., Gennaro, M. L., & North, R. J. 2003, 
"Expression of Thl-mediated immunity in mouse lungs induces aMycbacterium 
tuberculosis transcription pattern characteristic of nonreplicating persistence". 
Proceedings from the National Academy of Sciences of the United States of America, 
vol. 100, no. 1, pp. 241-246.
246. Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J. M., Brech, A., 
Callaghan, J., Toh, B. H , Murphy, C., Zerial, M., & Stenmark, H. 1998, "EEAl links 
PI(3)K function to Rab5 regulation of endosome fusion". Nature, vol. 394, pp. 494- 
498.
247. Simonsen, A., Gaullier, J. M., D'Arrigo, A., & Stenmark, H. 1999, "The Rab5 
effector EEAl interacts directly with syntaxin-6". Journal of Biological Chemistry, 
vol. 274, no. 41, pp. 28857-28860.
248. Smith, 1.2003, "Mycobacterium tuberculosis pathogenesis and molecular 
determinants of virulence". Clinical Microbiology Reviews, vol. 16, pp. 463-496.
249. Smyth, G. K. 2004, "Linear models and empirical Bayes methods for 
assessing differential expression in microarray experiments". Statistical Applications 
in Genetics and Molecular Biology, vol. 3, no. 1, p. Article 3.
250. Smyth, G. K. 2005, "Limma: linear models for microarray data," in 
Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. 
Gentleman et al., eds.. Springer, New York, pp. 397-420.
251. Sohveri, J. A., Gomez, J., Bishai, W. R., & Chater, K. F. 2000, "Multiple 
paralogous genes related to the Streptomyces coelicolor developmental regulatory 
gene whiB are present in Streptomyces and other actinomycetes". Microbiology, vol. 
146, no. 2, pp. 333-343.
252. Song, T., Song, S.-E., Raman, S., Anaya, M., & Husson, R. N. 2008, "Critical 
role of a single position in the -35 element for promoter recognition 1 by 
Mycobacterium tuberculosis SigE vs. S\^" , Journal of Bacteriology.
253. Sonnenberg, P., Murray, J., Glynn, J. R., Shearer, S., Kambashi, B., & 
Godfrey-Faussett, P. 2001, "HIV-1 and recurrence, relapse, and reinfection of
231
References
tuberculosis after cure: a cohort study in South African mineworkers". Lancet, vol. 
358, pp. 1687-1693.
254. Stanley, S. A., Raghavan, S., Hwang, W. W., & Cox, J. S. 2003, "Acute 
infection and macrophage subversion hy Mycobacterium tuberculosis require a 
specialized secretion system". Proceedings from the National Academy o f Sciences of 
the United States of America, vol. 100, no. 22, pp. 13001-13006.
255. Steenken, W., Jr., Oatway, W. H , Jr., & Petroff, S. A. 1934, "Biological 
studies of the tubercle bacillus: III. Dissociation and pathogenicity of the r and s 
variants of the human tubercle bacillus (H37)", The Journal of Experimental 
Medicine, vol. 60, no. 4, pp. 515-540.
256. Stenmark, H. & OUckonen, V. M. 2001, "The Rab GTPase family". Genome 
Biology, vol. 2, no. 5, p. 3007.1-3007.7.
257. Stewart, G. R., Snewin, V. A., Walzl, G., Hussell, T., Tormay, P., O’Gaora,
P., Goyal, M., Betts, J., Brown, I. N., & Young, D. B. 2001, "Overexpression of heat- 
shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase 
of infection". Nature Medicine, vol. 7, no. 6, pp. 732-737.
258. Stewart, G. R., Wemisch, L., Stabler, R., Mangan, J. A., Hinds, J., Laing, K. 
G., Young, D. B., & Butcher, P. D. 2002a, "Dissection of the heat-shock response in 
Mycobacterium tuberculosis using mutants and microarrays". Microbiology, vol.
148, pp. 3129-3138.
259. Stewart, G. R., Patel, J., Robertson, B. D., Rae, A., & Young, D. B. 2005, 
"Mycobacterial mutants with defective control of phagosomal acidification", PLoS 
Pathogens, vol. 1, no. 3, pp. 0001-0010.
260. Stewart, G. R., Robertson, B. D., & Young, D. B. 2003, "Tuberculosis: a 
problem with persistence". Nature Reviews, Microbiology, vol. 1, no. 2, pp. 97-105.
261. Stewart, G. R., Wemisch, L., Stabler, R., Mangan, J. A., Hinds, J., Laing, K.
G., Butcher, P. D., & Young, D. B. 2002b, "The heat shock response of 
Mycobacterium tuberculosis: linking gene expression, immunology and 
pathogenesis". Comparative and Functional Genomics, vol. 3, no. 4, pp. 348-351.
262. Stokes, R. W. & Speert, D. P. 1995, "Lipoarabinomannan inhibits nonopsonic 
binding of Mycobacterium tuberculosis to murine macrophages". Journal of 
Immunology, \o\. 155, pp. 1361-1369.
263. Stover, C. K., de la Cruz, V. P., Bansal, G. P., Hanson, M. S., Fuerst, T. R., 
Jacobs, W. R. Jr., & Bloom, B. R. 1992, "Use of recombinant BCG as a vaccine 
dehvery vehicle.". Advances in Experimental Medicine and Biology, vol. 323, pp. 
175-182.
232
References
264. Sturgül-Koszycki, S., Schaible, U. E., & Russell, D. G. 1996, 
"Mycobacterium-contnrmng phagosomes are accessible to early endosomes and 
reflect a transitional state in normal phagosome biogenesis", TEe EMBO Journal, vol. 
15, pp. 6960-6968.
265. Sturgill-Koszycki, S., Schelesinger, P. H., Chakraborty, P., Haddix, P. L., 
Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., & Russell, D. G. 
1994, "Lack of acidification in Mycobacterium phagosomes produced by exclusion 
of the vesicular proton ATPase", Science, vol. 263, pp. 678-681.
266. Sureka, K., Ghosh, B., Dasgupta, A., Basu, J., Kundu, M., & Bose, 1.2008, 
"Positive feedback and noise activate the stringent response regulator Rel in 
mycobacteria", PLoS ONE, vol. 3, no. 3, p. el771.
267. Sutton, R. B., Fasshauer, D., Jahn, R., & Brunger, A. T. 1998, "Crystal 
structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution". 
Nature, vol. 395, no. 6700, pp. 347-353.
268. Taylor, Z. & O'Brien, R. J. 2001, "Tuberculosis elimination: are we willing to 
pay the price?", American Journal of Respiratory Critical Care Medicine, vol. 163,
pp. 1-2.
269. Thorson, L. M., Doxsee, D., Scott, M. G., Wheeler, P., & Stokes, R. W. 2001, 
"Eflect of mycobacterial phospholipids on interaction of Mycobacterium tuberculosis 
with macrophages". Infection and Immunity, vol. 69, pp. 2172-2179.
270. Timm, J., Post, F. A., Bekker, L.-G., Walther, G. B., Wainwright, H. C., 
Manganelh, R., Chan, W.-T., Tsenova, L., Gold, B., Smith, I., Kaplan, G., & 
McKinney, J. D. 2002, "Differential expression of iron-, carbon-, and oxygen- 
responsive mycobacterial genes in the lungs of chronically infected mice and 
tuberculosis patients". Proceedings from the National Academy of Sciences of the 
United States o f America, vol. 100, no. 24, pp. 14321-14326.
271. Tramontano, A. 2007, Introduction to Bioinformatics Chapman and 
Hall/CRC Press.
272. Traoré, H. N., & Meyer, D. 2007, 'Necrosis of host cells and survival of 
pathogens following iron overload in an in vitro model of co-infection with human 
immunodeficiency virus (HIV) nnà. Mycobacterium tuberculosis", International 
Journal of Antimicrobial Agents, vol. 29, no. 4, pp. 465-470.
273. Tufariello, J. M., Mi, K., Xu, J., Manabe, Y. C., Kesavan, A. K., Drumm, J., 
Tanaka, K., Jacobs, W. R., Jr., & Chan, J. 2006, "Deletion of the Mycobacterium 
tuberculosis resuscitation-promoting factor Rvl009 gene results in delayed 
reactivation from chronic tuberculosis". Infection and Immunity, vol. 74, no. 5, pp. 
2985-2995.
233
References
274. Tutar, Y. 2008, "Syn, anti, and finally both conformations of cyclic AMP are 
involved in the CRP-dependent transcription initiation mechanism in E. coli lac 
operon". Cell Biochemistry and Function, vol. 26, no. 4, pp. 399-405.
275. Underhill, D. M., Ozinsky, A , Smith, K. D., & Aderem, A. 1999, "ToU-like 
receptor-2 mediates mycobacteria-induced proinflammatory signaling in 
macrophages". Proceedings from the National Academy of Sciences of the United 
States of America, vol. 96, no. 25, pp. 14459-14463.
276. Velasco-Velazquez, M. A., Barrera, D., Gonzalez-Arenas, A., Rosales, C., & 
Agramonte-Hevia, J. 2003, "MdiCXOphdigQ-Mycobacterium tuberculosis interactions: 
role of complement receptor 3", Microbial Pathogenesis, vol. 35, pp. 125-131.
277. Ventura, M., Fitzgerald, G. F., & Sinderen, D. v. 2005, "Genetic and 
transcriptional organization of the clpC locus in Bifidobacterium breve UCC 2003", 
Applied and Environmental Microbiology, vol. 71, no. 10, pp. 6282-6291.
278. Vergne, I., Chua, J., & Deretic, V. 2003, "Tuberculosis toxin blocking 
phagosome maturation inhibits a novel Ca^ *^ / calmodulin-PI3K hVPS34 cascade". 
Journal of Experimental Medicine, vol. 198, no. 4, pp. 653-659.
279. Via, L. E., Fratti, R. A , McFalone, M., Pagan-Ramos, E., Deretic, D., & 
Deretic, V. 1998, "Effects of cytokines on mycobacterial phagosome maturation.". 
Journal of Cell Science, vol. I l l ,  no. 7, pp. 897-905.
280. Via, L. E., Deretics, D., Ulmer, R. J., Hilbler, N. S., Huber, L. A., & Deretic, 
V. 1997, "Arrest of mycobacterial phagosome maturation is caused by a block in 
vesicle fiision between stages controlled by rab5 and rab7". The Journal of Biological 
Chemistry, vol. 272, no. 20, pp. 13326-13331.
281. Vieira, O. V., Botelho, R. J., & Grinstein, S. 2002, "Phagosome maturation: 
aging gracefully". The Biochemical Journal, vol. 366, no. 3, pp. 689-704.
282. Vieira, O. V., Botelho, R. J., Rameh, L., Brachmann, S. M., Matsuo, T., 
Davidson, H. W., Schreiber, A., Backer, J. M., Cantley, L. C., & Grinstein, S. 2001, 
"Distinct roles of class I and class II phosphatidyhnositol 3-kinases in phagosome 
formation and maturation". The Journal of Cell Biology, vol. 155, no. 1, pp. 19-25.
283. Vijayan, V. K. 2007, "Miliary tuberculosis and its sequelae". The Indian 
Journal of Medical Research, vol. 126, no. 3, pp. 176-178.
284. Villaverde, A. & Mar Carrio, M. 2003, "Protein aggregation in recombinant 
bacteria: biological role of inclusion bodies". Biotechnology Letters, vol. 25, no. 17, 
pp. 1385-1395.
285. Walburger, A., Koul, A., Ferrari, G., Nguyen, L., Prescianotto-Baschong, C., 
Huygen, K., Klebl, B., Thompson, C., Bacher, G., & Pieters, J. 2004, "Protein Kinase
234
References
G from Pathogenic Mycobacteria Promotes Survival Within Macrophages", Science, 
vol. 304, no. 5678, pp. 1800-1804.
286. Wards, B. J. C. D. M. 1996, "Electroporation at elevated temperatures 
substantially improves transformation efficiency of slow-growing mycobacteria.", 
FEMSMicrobiology Letters, vol. 145, no. l,pp. 101-105.
287. Wayne, L. G. & Lin, K. Y. 1982, "Glyoxylate metabolism and adaptation of 
Mycobacterium tuberculosis to survival under anaerobic conditions". Infection and 
Immunity, vol. 37, no. 3, pp. 1042-1049.
288. Weiss, G. 2002, "Iron and Immunity: a double edged sword", European 
Journal of Clinical Investigation, vol. 32, pp. 70-78.
289. West, A. H. & Stock, A. M. 2001, "Histidine kinases and response regulator 
proteins in two-component signaling systems". Trends in Biochemical Sciences, vol. 
26, no. 6, pp. 369-376.
290. Wilkinson, K. A., Stewart, G. R., Newton, S. M., Vordermeier, H. M., Wain,
J. R., Murphy, H. N., Homer, K., Young, D. B., & Wilkinson, R. J. 2005, "Infection 
biology of a novel a-crystallin of Mycobacterium tuberculosis: Acr2", The Journal of 
Immunology, vol. 174, no. 7, pp. 4237-4243.
291. Wilkinson, Wilkinson, De, S., Haslov, Pasvol, Singh, Svarcova, & Ivanyi 
1998, "Human T- and B-cell reactivity to the 16 kDa alpha-ciystallin protein of 
Mycobacterium tuberculosis", Scandinavian Journal of Immunology, vol. 48, no. 4, 
pp. 403-409.
292. Williams, E. P., Lee, J. H., Bishai, W. R., Colantuoni, C., & Karakousis, P. C. 
2007, "Mycobacterium tuberculosis SigF regulates genes encoding cell wall- 
associated proteins and directly regulates the transcriptional regulatory genephoYl", 
The Journal of Bacteriology, vol. 189, no. 11, pp. 4234-4242.
293. Wilhams, D. L., Pittman, T. L., Deshotel, M., Oby-Robinson, S., Smith, I., & 
Husson, R. 2007, "Molecular basis of the defective heat stress response in 
Mycobacterium leprae". The Journal of Bacteriology, vol. 189, no. 24, pp. 8818- 
8827.
294. World Health Organisation 2002, Global Tuberculosis control: surveillance, 
planning, financing, WHO, Geneva, Switzerland.
295. World Health Organisation 2006, Guidance for national tuberculosis 
programmes on the management of tuberculosis in children. World Health 
Organisation, Geneva, Switzerland.
296. World Health Organisation 2008a, Global Tuberculosis control: WHO report. 
World Health Organisation, Geneva, Switzerland.
235
References
297. World Health Organisation 2008b, Anti-tuberculosis drug resistance in the 
world: WHO report. World Health Organisation, Geneva, Switzerland.
298. World Health Organisation 1994, WHO tuberculosis programme: framework 
for effective TB control. World Health Organisation, Geneva, Switzerland.
299. World Health Organisation 2005, Global Tuberculosis control: WHO report. 
World Health Organisation, Geneva, Switzerland.
300. Yan, M., Collins, R. F., Grinstein, S., & Trimble, W. S. 2005, "Coronin-1 
function is required for phagosome formation". Molecular Biology of the Cell, vol.
16, no. 7, pp. 3077-3087.
301. Yates, R. M., Hermetter, A., & Russell, D. G. 2005, "The kinetics of 
phagosome maturation as a function of phagosome/lysosom fusion and acquisition of 
hydrolytic activity". Traffic, vol. 6, pp. 413-420.
302. Zahrt, T. C. 2003, "Molecular mechanisms regulating persistent 
Mycobacterium tuberculosis infection". Microbes and Infection, vol. 5, pp. 159-167.
303. Zahrt, T. C. & Deretic, V. 2001, "Mycobacterium tuberculosis signal 
transduction system required for persistent infections". Proceedings of the National 
Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12706- 
12711.
304. Zahrt, T. C. & Deretic, V. 2002, "Reactive nitrogen and oxygen intermediates 
and bacterial defenses: unusual adaptations m Mycobacterium tuberculosis". 
Antioxidants and Redox Signalling, vol. 4, no. 1, pp. 141-159.
305. Zhang, Y. 2004, "Persistent and dormant tubercle bacilh and latent 
tuberculosis". Frontiers in Bioscience: a journal and virtual library, vol. 9, pp. 1136- 
1156.
306. Zhang, Y., Hatch, K., Wemisch, L., & Bacon, J. 2008, "A Bayesian Change 
point model for differential gene expression patterns of the DosR regulon of 
Mycobacterium tuberculosis", BMC Genomics, vol. 9, no. 1, p. 87.
307. Zhang, J., Jiang, R., Takayama, H., & Tanaka, Y. 2005, "Survival of vimlent 
Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 
upregulation and release resulting from necrosis in J774 macrophages". Microbiology 
and Immunology, vol. 49, no. 9, pp. 845-852.
308. Zheng, P. Y. & Jones, N. L. 2003, "Helicobacterpylori strains expressing the 
vacuolating cytotoxin intermpt phagosome maturation in macrophages by recmiting 
and retaining TACO (coronin 1) protein.". Cellular Microbiology, vol. 5, no. 1, pp. 
25-40.
236
References
309. Zimmerli, S., Edwards, S., & Ernst, J. D. 1996, "Selective receptor blockade 
during phagocytosis does not alter the survival and growth of Mycobacterium 
tuberculosis in human macrophages", American Journal of Respiratory Cell and 
Molecular Biology, vol. 15, pp. 760-770.
237
Appendix 1. Allelic exchange constructs
9 Appendices
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Aua I (7066)
A ; a l ( 683i) \  H M m (7204)
Æ a  1 (6617) \  \  1 %M(725i) / / ^ n i ( 2i8)
RvaOS&aD— ^ V -  '  "x  ^sacB
Aval (6168)
Xbal(^2)
A jq 1 (3002)
BanHl 14759
Nco I (4689)
pM2
7251 bp
-HMm(20i7)
R v 3058c A / B  / I K  ,  ,
K A ; a  1 (3510)
Æul(3 8 2 2 )
Ava I (4108)
Figure 9.1: pM2 plasmid construct is based on pSMTlOO with upstream and downstream sequences 
of the Rv3058c M. tuberculosis gene
The hygromycin resistance cassette o f the pSMTlOO plasmid has been flanked by the upstream (Rv3058c 
A/B, l,246kb) and the downstream (Rv3058c C/D, L36kb) regions of the Rv3058c gene amplified fi’om 
M  tuberculosis and cloned into the suicide plasmid to create the allelic exchange construct pM2. The 
cloned regions read in the same orientation as they would be transcribed in M. tuberculosis.
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22wl(i)
R/2548GO
AhalCqot)
I-M3
&oFI(647t)
<^ jel(626^
r KANAnoI(8i9)
pM4
8662lp
-  sacB
.JBcoR[(2g9^
R/2548AB
&oM(goEÿ) —
SpdQr^
Smolte)
Figure 9.2: pM4 plasmid construct is PG5-based with the upstream and downstream sequences of 
the Rv2548 M. tuberculosis gene.
The pM4 construct has the hygromycin resistance cassette o f the pG5 plasmid flanked by the upstream 
(Rv2548 A/B) and the downstream (Rv2548 C/D) regions o f the Rv2548 gene amplified from 
M tuberculosis and cloned into the suicide plasmid to create the allelic exchange construct pM4. The 
cloned regions read in the same orientation as they would be transcribed in M. tuberculosis
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Xbalii)
Rv2745c C/D
Ncol (7528) 
^Æal(7 4 6 i)
AitU (7195) 
H M 3 -
#01(6335) 
#el(6
PM6
8975 tp
KAN
Ndel (1300)
sacB
Rv2745c A/B
Apal (4882)
Azffl(4797)
#eI(476o)
Figure 9.3: pM6 plasmid construct is PG5-based with the upstream and downstream sequences of 
the Rv2745c M. tuberculosis gene.
The pM6 construct has the hygromycin resistance cassette o f the pG5 plasmid flanked by the upstream 
(Rv2745c A/B) and the downstream (Rv2745c C/D) regions o f the Rv2745c gene amplified from 
M  tuberculosis and cloned into the suicide plasmid to create the allelic exchange construct pM6 . The 
cloned regions read in the same orientation as they would be transcribed in M. tuberculosis.
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iVbfl(i)
Rv3058c Coirpl C/D
Ncol (5101)
Not I {4855)
KAN
&0 RI (3575)
4?al(2455)
Figure 9.4: The complementing construct pKl is pKinta-based and carries the Rv3058c gene 
including the genes’ own putative promoter.
pKl is the complementing construct used to supplement the ARv3058c mutant with a functional copy of  
the Rv3058c gene. It carries the kanamycin resistance cassette for selection in mycobacteria.
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ftti (5424) M)ti (1)
Rv2745c CompI A/B
^ 1 (4 8 5 5 ).
KAN
A t I (3585)
£00 RI (3575;
A f I (3183)
C 0 IE I
Apa IJ (730)
INT
Figure 9.5; The complementing construct pK2 is pKinta-based and carries the Rv2745c gene 
including the genes’ own putative promoter
pK2 is the complementing construct used to supplement the ARv2745c mutant with a functional copy o f  
the Rv2745c gene. It carries the kanamycin resistance cassette for selection in mycobacteria.
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KAN
M(4484)
EooRL (4474)
J%tl (4 0 8 2 )
pK3
5753 bp
Rv2548 CompI A/B
Psti (751)
AM  (9 0 0 ) 
LacZ
ApaU. (1629)
C0IEI
Figure 9.6: The complementing construct pK3 is pKinta-based and carries the Rv2548 gene including 
the genes’ own putative promoter
pK3 is the complementing construct used to supplement the ARv2548c mutant with a functional copy o f  
the Rv2548 gene. It carries the kanamycin resistance cassette for selection in mycobacteria.
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1 VTSHAADEKQ AAPPMRRRGD RHRQAILRAA RELLEETPFA ELSVRAISLR
51 AGVARSGFYF YFDSKYSVLA QILAEATEEL EEASQHFSAR QPGESPEQFV
101 NRMIGSVAAV YANNDPVLRA CNAARQSDME IRDILERQFQ VLLR5t IGVF
151 EAEVgAGTAH PISEDLPTLV RTLAATTALM LTGDALLVGP DSDAARRVRV
201 LEQMWLNALW GGGKAP*
Figure 9.7: Sequencing results of pKl construct
The sequencing results o f  the pKl complement construct translated to the amino acid sequence. The 
sequence highlights in blue two amino acid changes differing from the wild-type amino acid sequence. 
Glycine replaces glutamic acid at position 145 and glutamic acid replaces lysine at position 155.
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Table 9.1: Fold-change of statistically significant differentially expressed genes in the ARv3058c 
complemented strain as determined by rank product analysis.
Gene Function Fold -change
MtH37Rv-1622c Probable integral membrane cytochrome D ubiquinol oxidase(subunit n) 3.6796
MtH37Rv-1623c Probable integral membrane cytochrome D ubiquinol oxidase(subunit I) 3.6259
MtH37Rv-2069 Probable RNA polymerase sigma factor (SigC) 3.3479
MtH37Rv-0129c Fibronectin binding protein C 3.1943
MtH37Rv-0101 Probable peptide synthetase Nrp 3.2254
MtH37Rv-0099 Possible fatty-acid-CoA ligases (FadDlO) 2.728
MtH37Rv-1157c Conserved hypothetical Ala-, Pro-rich protein 2.6147
MtH37Rv-3130c Triacylglycerol synthase (Tgsl) 2.4768
MtH37Rv-3310 Acid phophatase (SapM) 2.3875
MtH37Rv-0098 Conserved hypothetical protein 2.6199
MtH37Rv-1158c Conserved hypothetical Ala-, Pro-rich protein 2.3012
MtH37Rv-1846c Possible transcriptional regulatory protein 2.2516
MtH37Rv-0997 Hypothetical protein 2.3614
MtH37Rv-1697 Conserved hypothetical protein 2.2735
MtH37Rv-2350c Probable membrane-associated phospholipase C 2 (PlcB) 2.2286
MtH37Rv-3258c Conserved hypothetical protein 2.1666
MtH37Rv-1621c Component linked with assembly o f cytochrome transport(CydD) 2.2257
MtH37Rv-3346c Conserved transmembrane protein 2.0918
MtH37Rv-1547 Probable DNA polymerase III alpha chain (DnaEl) 2.0664
MtH37Rv-3131 Conserved hypothetical protein 1.9243
MtH37Rv-2074 Conserved hypothetical protein 1.8996
MtH37Rv-3711c Probable DNA polymerase III epsilon subunit (DnaQ) 2.0888
MtH37Rv-1813c Conserved hypothetical protein 1.9853
MtH37Rv-0847 Probable lipoprotein (LpqS) 1.9921
MtH37Rv-3675 Possible membrane protein 1.9591
MtH37Rv-1987 Possible chitinase 1.8742
MtH37Rv-3330 Penicillin-binding protein (DacBl) 1.9625
MtH37Rv-0100 Conserved hypothetical protein 1.9463
MtH37Rv-0660c Conserved hypothetical protein, possible antitoxin 1.837
MtH37Rv-0996 Probable conserved transmembrane protein 1.9053
MtH37Rv-2706c Hypothetical protein 1.845
MtH37Rv-2894c Probable integrase/recombinase (XerC) 1.8847
MtH37Rv-0659c Conserved hypothetical protein, toxin 1.7879
MtH37Rv-1497 Probable esterase (LipL) 1.769
MtH37Rv-0128 Probable conserved transmembrane protein 1.7941
MtH37Rv-3267 Conserved hypothetical protein, CPSA-related protein 1.8028
MtH37Rv-1996 Conserved hypothetical protein 1.7856
245
Appendix 4. Summary of expression data
MtH37Rv-3096 Conserved hypothetical protein 1.7595
MtH37Rv-3209 Conserved hypothetical threonin and proline rich protein 1.7713
MtH37Rv-3811 Conserved hypothetical protein 1.7396
MtH37Rv-3355c Probable integral membrane protein 1.771
MtH37Rv-3354 Conserved hypothetical protein 1.7706
MtH37Rv-0990c Hypothetical protein 1.7513
MtH37Rv-1738 Conserved hypothetical protein 1.7204
MtH37Rv-3005c Conserved hypothetical protein 1.7098
MtH37Rv-1690 Probable lipoprotein (LprJ) 1.7333
MtH37Rv-0967 Conserved hypothetical protein 1.7173
MtH37Rv-0343 Isoniazid inducible gene protein (IniC) 1.6906
MtH37Rv-3717 Conserved hypothetical protein 1.6768
MtH37Rv-2150c Cell division protein (FtsZ) 1.7164
MtH37Rv-3246c Two component sensory transduction transcriptional regulatory protein (MtrA) 1.6646
MtH37Rv-3127 Conserved hypothetical protein 1.6918
MtH37Rv-2119 Conserved hypothetical protein 1.6594
MtH37Rv-3171c Possible non-heme haloperoxidase (HpX) 1.6732
MtH37Rv-3587c Probable conserved membrane protein 1.6607
MtH37Rv-2163c Probable penicillin-binding membrane protein (PbpB) 1.6536
MtH37Rv-0849 Probable conserved integral membrane transport protein 1.6703
MtH37Rv-0989c Probable polyprenyl-diphosphate synthase (GrcC2) 1.6736
MtH37Rv-2986c Probable DNA-binding protein Hu homologue (HupB) 1.6616
MtH37Rv-1221 Alternative RNA polymerase sigma factor (SigE) 1.6565
MtH37Rv-0190 Conserved hypothetical protein 1.6368
MtH37Rv-2165c Conserved hypothetical protein 1.6314
MtH37Rv-1619 Conserved membrane protein 1.6471
MtH37Rv-2987c Probable 3-isopropyhnalate dehydratase (LeuD) 1.6319
MtH37Rv-1772 Hypothetical protein 1.6193
MtH37Rv-3259 Conserved hypothetical protein 1.619
MtH37Rv-3252c Probable transmembrane alkane 1-monooxygenase (AlkB) 1.5948
MtH37Rv-1220c Probable methyltransferase 1.643
MtH37Rv-2147c Conserved hypothetical protein 1.6059
MtH37Rv-3245c Two component sensory transduction histidine kinase (MtrB) 1.6037
MtH37Rv-0888 Probable exported protein 1.5562
MtH37Rv-1548c PPE family protein (PPE21) 1.5894
MtH37Rv-2148c Conserved hypothetical protein 1.5874
MtH37Rv-2963 Probable integral membrane protein 1.5948
MtH37Rv-0848 Possible cysteine synthase A (CysK2) 1.6256
MtH37Rv-1698 Conserved hypothetical protein 1.6068
MtH37Rv-1620c Probable component linked with the assembly o f cytochrome(CydC)
1.469
MtH37Rv-1095 Probable phoH-like protein (PhoH2) 1.5764
MtH37Rv-2102 Conserved hypothetical protein 1.5523
MtH37Rv-2905 Probable conserved alanine rich lipoprotein (LppW) 1.5779
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MtH37Rv-3414c Probable alternative RNA polymerase sigma-D factor (SigD) 1.5586
MtH37Rv-0430 Conserved hypothetical protein 1.5762
MtH37Rv-0882 Probable transmembrane protein 1.5405
MtH37Rv-3058c Possible transcriptional regulatory protein (probably TetR-family) 0.099
MtH37Rv-1010 Probable dimethyladenosine transferase (KsgA) 0.3928
MtH37Rv-1885c Conserved hypothetical protein 0.3993
MtH37Rv-0950c Conserved hypothetical protein 0.4059
MtH37Rv-1009 Probable resuscitation-promoting factor (RpfB) 0.4317
MtH37Rv-1886c Secreted antigen 85B fibronectin-binding protein (FbpB) 0.4595
MtH37Rv-2190c Conserved hypothetical proteiu 0.523
MtH37Rv-0063 Possible oxidoreductase 0.5467
MtH37Rv-2758c Conserved hypothetical protein, antitoxin 0.6195
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Table 9.2: Fold-change of statistically significant differentially expressed genes in the ARv2745c 
complemented strain as determined hy rank product analysis.
Gene Function Fold-change
MtH37Rv-2428 Alkyl hydroperoxidase reductase C protein (AhpC) 3.1585
MtH37Rv-2814c Probable transposase 3.3336
MtH37Rv-3640c Probable transposase 3.5728
MtH37Rv-2649 Probable transposase for insertion sequence element IS6110 2.9186
MtH37Rv-2415c Conserved hypothetical protein 2.4554
MtH37Rv-3201c Probable ATP-dependent DNA helicase 2.4327
MtH37Rv-1371 Probable conserved membrane protein 2.594
MtH37Rv-1526c Probable glycosyltransferase 3.0008
MtH37Rv-2185c Conserved hypothetical protein TB16.3 2.6918
MtH37Rv-3637 Possible transposase 2.4641
MtH37Rv-0473 Possible conserved transmembrane protein 2.5224
MtH37Rv-2897c Conserved hypothetical protein 2.7397
MtH37Rv-1764 Putative transposase 2.5357
MtH37Rv-0387c Conserved hypothetical protein 2.2856
MtH37Rv-2917 Conserved hypothetical alanine and arginine rich protein 2.2595
MtH37Rv-2530c Conserved hypothetical protein with PIN domain 2.4891
M1H37RV-1809 PPE family protein (PPE33) 2.4755
MtH37Rv-2319c Hypothetical protein 2.3783
MtH37Rv-0090 Possible membrane protein 2.3918
MtH37Rv-0654 Probable dioxygenase 0.1548
MtH37Rv-0791c Conserved hypothetical protein 0.1979
MtH37Rv-1297 Probable transcription termination factor, Rho homologue 0.2249
MtH37Rv-3530c Possible oxidoreductase 0.2289
MtH37Rv-3251c Probable rubredoxin (RubA) 0.2508
MtH37Rv-3921c Probable conserved transmembrane protein 0.2638
MtH37Rv-3463 Conserved hypothetical protein 0.3149
MtH37Rv-2912c Probable transcriptional regulatory protein (probably TetRfamily)
0.274
MtH37Rv-0790c Hypothetical protein 0.2271
MtH37Rv-0792c Probable transcriptional regulatory protein (probably GntRfamily)
0.284
MtH37Rv-3531c Hypothetical protein 0.2937
MtH37Rv-1286
Probable bi-functional enzyme: sulphate adenyltransferase
subunit I (CysN/CysC)
0.3192
MtH37Rv-1643 Probable 50S ribosomal protein L20 (RplT) 0.3241
MtH37Rv-0706 Probable 50S ribosomal protein L22 (RplV) 0.2993
MtH37Rv-2990c Hypothetical protein 0.2636
MtH37Rv-3250c Probable Rubredoxin (RubB) 0.2965
MtH37Rv-3920c Hypothetical protein similar to JAG protein 0.2801
MtH37Rv-1870c Conserved hypothetical protein 0.2623
MtH37Rv-3662c Conserved hypothetical protein 0.2554
MtH37Rv-0280 PPE family protein (PPE3) 0.2748
MtH37Rv-0251c Heat shock ribosome-binding protein A (Hsp/Acr2) 0.2458
248
Appendix 4. Summaiy of expression data
MtH37Rv-3842c
MtH37Rv-0768
Probable glycerophosphoryl diester phosphodiesterase
(GlpQl)
Probable aldehyde dehydrogenase NAD-dependent (AldA)
0.3195
0.3206
MtH37Rv-1642 Probable 50S ribosomal protein L35 (Rpml) 0.3184
MtH37Rv-0705 Probable 30S ribosomal protein SI9 (RpsS) 0.3405
MtH37Rv-3290c Probable L-lysine-epsilon aminotransferase (Lat) 0.3574
MtH37Rv-0704 Probable 50S ribosomal protein L2 (RplB) 0.3442
MtH37Rv-1285 Probable sulphate adenylyltransferase subunit 2 (CysD) 0.3343
MtH37Rv-2590 Probable fatty-acid-CoA-ligase (FadD9) 0.2909
MtH37Rv-0177 Probable conserved Mce-associated protein 0.3503
MtH37Rv-0677c Probable conserved membrane protein (MmpS5) 0.3611
MtH37Rv-3092c Probable conserved integral membrane protein 0.3616
MtH37Rv-1869c Probable reductase 0.3661
MtH37Rv-2391 Ferredoxin-dependent sulfite reductase (SirA) 0.3691
MtH37Rv-0766c Probable cytochrome P450 123 (Cypl23) 0.3646
MtH37Rv-0697 Probable dehydrogenase 0.3779
MtH37Rv-0611c Hypothetical protein 0.3891
MtH37Rv-3917c Probable chromosome partitioning protein (ParB) 0.3861
MtH37Rv-0702 Probable 50S ribosomal protein L4 (RplD) 0.3814
MtH37Rv-1871c Conserved hypothetical protein 0.4001
MtH37Rv-3269 Conserved hypothetical protein 0.3915
MtH37Rv-1196 PPE family protein (PPE 18) 0.3942
MtH37Rv-1534 Probable transcriptional regulator 0.3946
MtH37Rv-0668 DNA-directed RNA polymerase beta chain (RpoC) 0.386
MtH37Rv-1178 Probable aminotransferase 0.3984
MtH37Rv-1593c Conserved hypothetical protein 0.3999
MtH37Rv-0586 Probable transcriptional regulatory protein (GntR family) 0.4024
MtH37Rv-3918c Probable chromosome partitioning protein (ParA) 0.3975
MtH37Rv-3919c Probable glucose-inhibited division protein (GidB) 0.3977
MtH37Rv-3095 Hypothetical transcriptional regulatory protein 0.3873
MtH37Rv-1300 Probable protein homologue o f  HemK 0.4044
MtH37Rv-3869 Possible conserved membrane protein 0.4062
MtH37Rv-1168c PPE family protein (PPE17) 0.41
MtH37Rv-1195 PE family protein (PE 13) 0.3988
MtH37Rv-0769 Probable dehydrogenase/reductase 0.4077
MtH37Rv-2327 Conserved hypothetical protein 0.4052
MtH37Rv-2913c Possible D-amino acid aminohydrolase 0.4081
MtH37Rv-0821c
MtH37Rv-3523
Probable phosphate-transport system transcriptional 
regulatory protein (PhoY2) 
Probable lipid carrier protein or keto acyl-CoA thiolase
(Ltp3)
0.4193
0.4202
MtH37Rv-0282 Conserved hypothetical protein 0.4222
MtH37Rv-0765c Probable oxidoreductase 0.4178
MtH37Rv-2662 Hypothetical protein 0.4194
MtH37Rv-3486 Conserved hypothetical protein 0.4222
MtH37Rv-0707 Probable 3 OS ribosomal protein S3 (RpsC) 0.4352
MtH37Rv-1312 Conserved hypothetical secreted protein 0.4268
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MtH37Rv-2901c Conserved hypothetical protein 0.4447
MtH37Rv-3271c Probable conserved integral membrane protein 0.439
MtH37Rv-3487c Probable esterase/lipase (LipF) 0.4449
MtH37Rv-1872c Possible L-lactate dehydrogenase (LldD2) 0.4478
MtH37Rv-2783c Bifimctional protein polyribonucleotide nucleotidyl­transferase: guanosine pentaphosphate synthetase (GpsI) 0.4282
MtH37Rv-1471 Probable thioredoxin (TrxBl) 0.4408
MtH37Rv-1846c Possible transcriptional regulatory protein 0.4497
MtH37Rv-2656c Possible phiRv2 prophage protein 0.4424
MtH37Rv-2661c Hypothetical protein 0.4333
MtH37Rv-0140 Conserved hypothetical protein 0.4426
MtH37Rv-0824c Probable acyl-desaturase (DesAl) 0.4282
MtH37Rv-2368c Probable phoH-like protein (PhoHl) 0.4589
MtH37Rv-1594 Probable quinolinate synthetase (NadA) 0.4628
MtH37Rv-1533 Conserved hypothetical protein 0.4494
MtH37Rv-0709 Probable 508 ribosomal protein L29 (RpmC) 0.458
MtH37Rv-1184c Possible exported protein 0.4568
MtH37Rv-0667 DNA-directed RNA polymerase beta chain subunit (RpoB) 0.4621
MtH37Rv-1094 Possible acyl-desaturase (DesA2) 0.4576
MtH37Rv-0243 Probable acetyl-CoA acyltransferase (FadA2) 0.469
MtH37Rv-2709 Probable conserved transmembrane protein 0.4709
MtH37Rv-2092c Probable ATP-dependent DNA helicase (HelY) 0.4539
MtH37Rv-1996 Conserved hypothetical protein 0.4687
MtH37Rv-1734c Conserved hypothetical protein 0.4691
MtH37Rv-1797 Conserved membrane protein 0.4671
MtH37Rv-1831 Hypothetical protein 0.4732
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Table 9.3: Fold-change of top 30 genes down-regulated in the ARv2745c mutant strain as determined 
by rank product analysis.
Gene Function Fold-change
MtH37Rv-0251c Heat shock ribosome-binding protein A (Hsp/Acr2) 0.1031
MtH37Rv-1552 Probable fumarate reductase flavoprotein subunit (FrdA) 0.4064
MtH37Rv-0697 Probable dehyrogenase 0.4463
MtH37Rv-1043c Conserved hypothetical protein 0.4303
MtH37Rv-2168c Putative transposase for insertion sequence element IS6110 0.5007
MtH37Rv-2745c Possible transcriptional regulatory protein 0.5004
MtH37Rv-2744c Conserved 35 kDa alanine-rich protein (35kd_ag) 0.5374
MtH37Rv-1996 Conserved hypothetical protein 0.4533
MtH37Rv-1184c Possible exported protein 0.5418
MtH37Rv-3269 Conserved hypothetical protein 0.5585
MtH37Rv-2590 Probable fatty-acid-CoA ligase (FadD9) 0.5827
MtH37Rv-1361c PPE family protein (PPE 19) 0.5923
MtH37Rv-0250c Conserved hypothetical protein 0.5852
MtH37Rv-0249c Probable succinate dehydrogenase membrane anchorsubunit
0.5754
MtH37Rv-3157 Probable NADH dehydrogenase I, chain M (NuoM) 0.5678
MtH37Rv-3178 Conserved hypothetical protein 0.5679
MtH37Rv-0707 Probable 3 OS ribosomal protein S3 (RpsC) 0.6037
MtH37Rv-2947c Probable polyketide synthase (Pksl5) 0.5506
MtH37Rv-2461c Probable ATP-dependent Clp protease proteolytic subunit 1
(ClpPl)
0.6321
MtH37Rv-1563c Maltooligosyltrehalose synthase (TreY) 0.607
MtH37Rv-3130c Triacylglycerol synthase (Tgsl) 0.6121
MtH37Rv-1868 Conserved hypothetical protein 0.596
MtH37Rv-1196 PPE family protein (PPE 18) 0.6171
MtH37Rv-0842 Probable conserved integral membrane protein 0.638
MtH37Rv-0414c Probable thiamine-phosphate pyrophosphorylase (ThiE) 0.6266
MtH37Rv-0696 Probable membrane sugar transferase 0.6324
MtH37Rv-0782 Probable protease II (PtrBb) 0.6338
MtH37Rv-2460c Probable ATP-dependent Clp protease proteolytic subunit 2(ClpP2)
0.6408
MtH37Rv-2186c Conserved hypothetical protein 0.6456
MtH37Rv-0243 Probable acetyl-CoA acyltransferase (FadA2) 0.6561
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Appendix 5 -  Recipes 
Media
Middlebrook 7H11 agar(Becton Dickinson)
Middiebrook 7H11 media 10.5 g 
Glycerol 2.5 ml
Adjust volume to 450 ml with distilled water
OADC 50 ml (added aseptically after autoclaving)
Middiebrook 7H9 broth (Beaton Dickinson)
Middlebrook 7H9 media 2.35 g 
Glycerol 1 ml
Tween 80 250 pi
Adjust volume to 450 ml with distilled water
OADC 50 ml (added aseptically after autoclaving)
Luria-Bertani agar
Tryptone 5 g
Yeast extract 2.5 g
NaCl 5 g
Agar 5 g
Adjust volume to 500 ml with distilled water
Luria-Bertani broth
Tryptone 5 g
Yeast extract 2.5 g
NaCl 5 g
Adjust volume to 500 ml with distilled water
2 X YTA broth
Tiyptone 16 g
Yeast extract 10 g
NaCl 5 g
Adjust volume to 1 L with distilled water
Sterilise by autoclaving then aseptically add 100 pg/ml ampicillin
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Brain Heart infusion Agar
Brain heart infiision agar 47 g
Distilled water 1000 ml
Sterilise by autoclaving
OADC
Solution A:
Bovine serum albumin 50 g
D-Glucose 20 g
NaCl 8.5 g
Catalase 0.04 g
Distilled water 750 ml
Solution B:
Oleic acid 0.5 g
20 mM NaOH 41.5 ml
Once solution B is dissolved add to solution A 
Stir covered for 1 h
Adjust volume to 1 L with distilled water
Filter sterilise using 0.22 pm Millipore filters (4 x 250 ml)
SOC medium
Tryptone 20 g
Yeast extract 5 g
NaCl 0.5 g
IM KCl 2.5 ml
Adjust volume to 1 L with distilled water 
Adjust pH to 7.0 with NaOH 
Sterilise by autoclaving
1 M (sterile) glucose 20 ml (added aseptically after autoclaving)
Genomic Extraction
CTAB (Cetyitrimethyiammonium bromide) soiution
NaCl 4.1 g
Cetrimide (Hexadecyltrimethylammonium bromide, Sigma H5882) 10 g
Adjust volume to 100 ml with distilled water
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GTE Solution
IMTris-HCipHS.O 5 ml
0.5 M EDIA 4 ml
0.5 M Glucose 20 ml
Adjust volume to 200 ml with distilled water
Agarose Gel Electrophoresis
10 X TAB buffer
Tris base 48g
Glacial acetic acid 11.42 ml
0.5 M EDIA 2 0 ml
Adjust volume to 1 L with distilled water
1% Agarose gei
Agar 0.5 g
1 X TAE 49.5 ml
Microarrav Hybridisation
Prehybridisation soiution
20 X SSC 8.75 ml
20% SDS 250 pi
BSA (lOOmg/ml) 5 ml
Adjust volume to 50 ml with distilled water
Hybridisation soiution
Cy3/Cy5 labelled DNA 10.5 pi
20 X SSC 3.2 pi
2% SDS 2.3 pi
Wash A
20 X SSC 20 ml
20% SDS 1 ml
Adjust volume to 400 ml with distilled water
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Wash B
20 X SSC 1.2 ml
Distilled water 398.8 ml
Southern Blot
Prehybridisation soiution
DIG Easy Hyb Granules (Bottle 7)
Distilled water (added in two portions) 64 ml
Denaturing Solution
SMNaOH 100 ml
5MNaCl 300 ml
Adjust volume to 600 ml with distilled water
Neutralising solution
2MTris-HClpH7.5 250 ml
5MNaCl 600 ml
Adjust volume to 1 L with distilled water
Washing buffer
1 M maleic acid 100 ml
SMNaCl 30 ml
Adjust to pH 7.5
Adjust volume to 1 L with distilled water
Tween 20 3 ml (added aseptically after autoclaving)
1 X Blocking soiution
10 X Blocking solution (Bottle 6) 20 ml
Maleic acid buffer 180 ml
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Maleic acid buffer
Maleic acid 11.61 g
NaCl 8.77 g
Adjust to pH 7.5 with NaOH pellets 
Adjust volume to 1 L with distilled water 
Sterilise by autoclaving
Antibody solution
Anti-Digoxigenin-AP (vial 4) 2 pi (pipetted from surface of centrifuged vial,
10 000 rpm for 5 min)
1 X Blocking solution 20 ml
Detection buffer
2MTris-HClpH7.5 50 ml
5 M NaCl 20 ml
Adjust to pH 9.5
Adjust volume to 1 L with distilled water 
Sterilise by autoclaving
10 X  PBS
NaCl 80 g
KCl 2 g
Na2HP04 14.4 g
K H 2 P O 4  2.4 g
Adjust pH to 7.4 
Distilled water to 1000 ml 
Sterilise by autoclaving
Western Blot 
Blocking Buffer
IxPB S 474.75 ml
Tween 20 0.25 ml
Non-fat dry milk powder 25 g
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Protein Expression
6 X  SDS-PAGE sample buffer
Stacking buffer (pH6.8) 7 ml
Glycerol 3.6 ml
SDS 1.28 g
Dithiothreitol 0.93 g
Bromophenol blue 1.2 mg
Mix until all SDS is dissolved in solution 
Aliquot (0.5 ml) and store -20°C
Resolving Buffer
Tris base 90.86 g
SDS 2.0 g
Adjust pH to 8.8
Adjust volume to 500 ml with distilled water
Stacking Buffer
Tris base 6.055 g
Adjust pH to 6.8
Adjust volume to 500 ml with distilled water
Resolving SDS-PAGE Acryiamide Gel
30% Acryiamide (37.5:1 acryiamide: bis-acrylamide) 4 ml
Resolving Buffer 2.5 ml
Distilled water 3.5 ml
10% APS 100 pi
TEMED 10 pi
Stacking SDS-PAGE Acryiamide Gel
30% Acryiamide (37.5:1 acryiamide: bis-acrylamide) 1 ml
Stacking Buffer 1.5 ml
Distilled water 3.5 ml
10% APS 60 pi
TEMED 6 pi
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10 X  Running Buffer
2.5MTris-HCl 100 ml
2 M glycine 275 ml
Adjust pH to 8.0
Adjust volume to 1 L with distilled water
Coomassie Biue Staining Soiution
Coomassie Blue R-250 0.25 g
Ethanol 100 ml
Distilled water 100 ml
Stir until dye is completely dissolved (~1 h)
Acetic acid 25 ml
Adjust volume to 250 ml with distilled water
De-staining Soiution
Ethanol 400 ml
Acetic acid 100 ml
Adjust volume to 1 L with distilled water
Gel Shift 
10 X TEN Buffer
2.5 M Tris-HCl 40 ml
0.5 M EDIA 2 0 ml
5 M NaCl 400 ml
Adjust pH to 8.0
Adjust volume to 1 L with distilled water
10 X TBE Buffer
2.5 M Tris-HCl 360 ml
2.5 M Boric acid 360 ml
0.5 M EDIA 40 ml
Adjust to pH 8.0
Adjust volume to 1 L with distilled water
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6% non-denaturing Polyacrylamide Gei
30% Acryiamide (37.5:1 acryiamide: bis-acrylamide) 2 ml
10 X TBE Buffer 1 ml
Distilled water 7 ml
10% APS 100 pi
TEMED 10 pi
Protein Purification
HiS-Seiect® Spin Column Equilibration Buffer
IM NaCl 60 ml
lM N aH 2P0 4  1 0  ml
Adjust pH to 8.0
HiS-Seiect® Spin Column Wash Buffer
IMNaCI 60 ml
lM N aH 2P0 4  1 0  ml
1 M Imidazole 1 ml
Adjust pH to 8.0
HiS-SeiecI® Spin Column Elution Buffer
1 M NaCl 60 ml
1 MNaH2P0 4  1 0  ml
1 M Imidazole 50 ml
Adjust pH to 8.0
1 X PBS Lysis Buffer
NaCl 8  g
KCl 0.2 g
Na2HP04 1.44 g
KH2PO4 0.24 g
Dissolve in 800 ml distilled water 
Adjust to pH 7.4
Adjust volume to 1 L with distilled water
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GST-Elution Buffer
50 mM Tris-HCl
10 mM reduced glutathione
Adjust to pH 8.0
Dispense in small aliquots (1-10 ml) and store at -20°C
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